
                                SEQUENCE LISTING

<110> Jane Buckner
      David J. Rawlings
      Peter Cook
      Soo Jung Yang

<120> ARTIFICIAL ANTIGEN-SPECIFIC
  IMMUNOREGULATORY T (AIRT) CELLS

<130> SCRI.351WO

<150> 63129288            
<151> 2020-12-22  

<150> 63155486            
<151> 2021-03-02  

<150> 63179068            
<151> 2021-04-23  

<150> 63274375            
<151> 2021-11-01  

<160> 1455

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 1
Cys Ala Val Val Asn Met Asp Ser Asn Tyr Gln Leu Ile Trp Gly Ala
 1               5                  10                  15      
Gly Thr Lys Leu
            20  


<210> 2
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 2
Cys Ala Asp Ala Gly Gly Thr Ser Tyr Lys Leu Phe Gly Gln Gly Thr
 1               5                  10                  15      
Ile Leu
        


<210> 3
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 3
Cys Ile Pro Gly Ser Glu Glu Tyr Gly Asn Lys Leu Val Phe Gly Ala
 1               5                  10                  15      
Gly Thr Ile Leu
            20  


<210> 4
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 4
Cys Ala Val Gly Ala Leu Ala Gly Thr Ala Ser Lys Leu Thr Phe
 1               5                  10                  15  


<210> 5
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 5
Cys Ala Val Gln Ala Gly Gly Asn Asn Arg Leu Ala Phe
 1               5                  10              


<210> 6
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 6
Cys Ile Ala Ile Tyr Asn Phe Asn Lys Phe Tyr Phe
 1               5                  10          


<210> 7
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 7
Cys Ile Val Ser His Asn Ala Gly Asn Met Leu Thr Phe
 1               5                  10              


<210> 8
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 8
Cys Ala Leu Lys Tyr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10          


<210> 9
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 9
Cys Ile Val Arg Val Glu Ile Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10                  15  


<210> 10
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 10
Cys Ala Gly Gly Phe Ser Asp Gly Gln Lys Leu Leu Phe
 1               5                  10              


<210> 11
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 11
Cys Ala Val Ile Glu Thr Ser Gly Ser Arg Leu Thr Phe
 1               5                  10              


<210> 12
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 12
Cys Ala Leu Ser Arg Ala Gly Thr Gly Asn Gln Phe Tyr Phe
 1               5                  10                  


<210> 13
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 13
Cys Ile Glu Tyr Asn Phe Asn Lys Phe Tyr
 1               5                  10  


<210> 14
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 14
Cys Ile Val Pro Ala Asn Thr Gly Gly Phe Lys Thr Ile
 1               5                  10              


<210> 15
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 15
Cys Ala Leu Ser Glu Leu Ser Ile Gln Gly Ala Gln Lys Leu Val
 1               5                  10                  15  


<210> 16
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 16
Cys Val Val Asn Ser Trp Ala Gly Asn Gln Phe Tyr
 1               5                  10          


<210> 17
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 17
Cys Ala Leu Ser Glu Ser Gly Ala Asn Ser Lys Leu Thr
 1               5                  10              


<210> 18
<211> 9
<212> PRT
<213> Homo sapiens

<400> 18
Ile Val Tyr Gly Gly Phe Lys Thr Ile
 1               5                  


<210> 19
<211> 14
<212> PRT
<213> Homo sapiens

<400> 19
Cys Leu Val Gly His Gly Ser Ser Asn Thr Gly Lys Leu Ile
 1               5                  10                  


<210> 20
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 20
Cys Ala Val Arg Asp Pro Leu Tyr Asn Phe Asn Lys Phe Tyr
 1               5                  10                  


<210> 21
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 21
Cys Leu Val Gly Gly Gly Ala Asp Gly Leu Thr
 1               5                  10      


<210> 22
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 22
Cys Ala Gly Asp Ser Gly Tyr Ala Leu Asn
 1               5                  10  


<210> 23
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 23
Cys Ala Val Ser Gly Gly Gly Ala Asp Gly Leu Thr Phe
 1               5                  10              


<210> 24
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 24
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 25
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 25
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 26
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 26
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 27
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 27
Cys Ile Leu Arg Asp Val Trp Ser Asn Phe Gly Asn Glu Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 28
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 28
Cys Ile Leu Arg Asp Val Trp Ser Asn Phe Gly Asn Glu Lys Leu Thr
 1               5                  10                  15      


<210> 29
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 29
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 30
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 30
Cys Ala Leu Gln Thr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10          


<210> 31
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 31
Cys Ala Val Asn Thr Gly Asn Gln Phe Tyr Phe
 1               5                  10      


<210> 32
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 32
Cys Ala Val Asn Thr Gly Asn Gln Phe Tyr Phe
 1               5                  10      


<210> 33
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 33
Cys Ala Ala Leu Asn Thr Asp Lys Leu Ile Phe
 1               5                  10      


<210> 34
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 34
Cys Val Ala Asn Lys Ile Leu Gln Ala Ser Lys Leu Phe
 1               5                  10              


<210> 35
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 35
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 36
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 36
Cys Ile Leu Arg Asp Val Trp Ser Asn Phe Gly Asn Glu Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 37
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 37
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 38
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 38
Cys Ala Tyr Arg Ser Gly Tyr Met Glu Tyr Gly Asn Lys Leu Val
 1               5                  10                  15  


<210> 39
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 39
Cys Leu Val Gly Asp Asn Asp Tyr Lys Leu Ser Phe
 1               5                  10          


<210> 40
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 40
Cys Ala Val Glu Leu Gly Asp Ser Trp Gly Lys Phe Gln Phe
 1               5                  10                  


<210> 41
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 41
Cys Ala Ala Pro Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10              


<210> 42
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 42
Cys Ala Val Gly Trp Glu Asp Gly Thr Ala Ser Lys Leu Thr Phe
 1               5                  10                  15  


<210> 43
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 43
Cys Leu Val Gly Asp Gly Gly Ser Phe Ser Gly Gly Tyr Asn Lys Leu
 1               5                  10                  15      
Ile Phe
        


<210> 44
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 44
Cys Ala Val Gln Ala Asp Gly Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  


<210> 45
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 45
Cys Ala Phe Ile Gly Gly Ser Asn Tyr Lys Leu Thr Phe
 1               5                  10              


<210> 46
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 46
Cys Ala Gly Pro Tyr Asn Thr Asp Lys Leu Ile Phe
 1               5                  10          


<210> 47
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 47
Cys Ala Ala Ser Ala Asn Tyr Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10                  15      


<210> 48
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 48
Cys Ala Val Thr Leu Gly Gly Gly Ser Glu Lys Leu Val Phe
 1               5                  10                  


<210> 49
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 49
Cys Ala Val Gly Ala Gly Ser Asn Tyr Gln Leu Ile Trp
 1               5                  10              


<210> 50
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 50
Cys Leu Val Ala Gly Ala Gly Gly Tyr Asn Lys Leu Ile Phe
 1               5                  10                  


<210> 51
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 51
Cys Ala Gly Pro Ser Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10              


<210> 52
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 52
Cys Ile Val Leu Gly Gly Ala Asp Gly Leu Thr Phe
 1               5                  10          


<210> 53
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 53
Cys Ile Val Trp Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10              


<210> 54
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 54
Cys Ile Ala Phe Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10          


<210> 55
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 55
Cys Leu Val Gly Glu Ala Ala Gly Asn Lys Leu Thr Phe
 1               5                  10              


<210> 56
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 56
Cys Ala Val Gly Arg Gly Gly Ser Gln Gly Asn Leu Ile Phe
 1               5                  10                  


<210> 57
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 57
Cys Ala Met Arg Glu Gly Arg Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  15      


<210> 58
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 58
Cys Ala Met Ser Val Leu Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 59
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 59
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 60
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 60
Cys Ala Val Asn Thr Gly Asn Gln Phe Tyr Phe
 1               5                  10      


<210> 61
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 61
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 62
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 62
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 63
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 63
Cys Ala Val Glu Asp Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10                  


<210> 64
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 64
Cys Ala Leu Gln Thr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10          


<210> 65
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 65
Cys Ile Leu Arg Asp Val Trp Ser Asn Phe Gly Asn Glu Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 66
<211> 8
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 66
Cys Asp Ser Gly Asp Met Arg Phe
 1               5              


<210> 67
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 67
Cys Ala Gly Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 68
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 68
Cys Ala Leu Gln Thr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10          


<210> 69
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 69
Cys Ala Leu Gln Thr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10          


<210> 70
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 70
Cys Ala Leu Gln Thr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10          


<210> 71
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 71
Cys Ala Ala Ser Glu Gly Asp Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  15  


<210> 72
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 72
Cys Ala Val Lys Phe Ala Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 73
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 73
Cys Ala Met Arg Glu Gly Trp Gln Ala Gly Asn Thr Leu Ile Phe
 1               5                  10                  15  


<210> 74
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 74
Cys Ala Val Val Asp Ala Ser Ser Lys Leu Ile Phe
 1               5                  10          


<210> 75
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 75
Cys Leu Val Gly Gly Tyr Asn Asn Asn Asp Met Arg Phe
 1               5                  10              


<210> 76
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 76
Cys Ala Glu Ser Arg Tyr Ser Gly Tyr Ser Thr Leu Thr Phe
 1               5                  10                  


<210> 77
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 77
Cys Ala Leu Ser Glu Tyr Gly Asn Lys Leu Val Phe
 1               5                  10          


<210> 78
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 78
Cys Ala Ser Ser Leu Ala Thr Ser Gly Gly Gly Ser Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 79
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 79
Cys Ala Ser Ser Leu Ala Thr Ser Gly Gly Gly Ser Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 80
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 80
Cys Ala Ser Ser Leu Ala Thr Ser Gly Gly Gly Ser Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 81
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 81
Cys Ser Val Glu Ala Thr Arg Ala Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 82
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 82
Cys Ala Ser Ser Leu Glu Arg Asp Gly Tyr Thr Phe
 1               5                  10          


<210> 83
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 83
Cys Ala Ser Ser Leu Glu Ala Ser Ser Tyr Asn Ser Pro Leu His Phe
 1               5                  10                  15      


<210> 84
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 84
Cys Ala Ser Ser Leu Glu Arg Glu Thr Gln Tyr Phe
 1               5                  10          


<210> 85
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 85
Cys Ala Ser Ser Pro Thr Thr Gly Gly Asp Glu Ala Phe Phe
 1               5                  10                  


<210> 86
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 86
Cys Ala Ser Ser Leu Gly Pro Gly Gln Arg Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 87
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 87
Cys Ser Ala Arg Thr Glu Ala Tyr Glu Gln Tyr Phe
 1               5                  10          


<210> 88
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 88
Cys Ser Ala Arg Asp Gln Gln Arg Val Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 89
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 89
Cys Ala Ser Ser Leu Gly Leu Arg Gly Glu Asn Ile Gln Tyr Phe
 1               5                  10                  15  


<210> 90
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 90
Cys Ala Ser Arg Pro Val Ala Gly Leu Pro His Phe
 1               5                  10          


<210> 91
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 91
Cys Ala Ser Ser Phe Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 92
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 92
Cys Ala Ser Ser Ile Val Asp Arg Gly Gly Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 93
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 93
Cys Ala Ser Ser Leu Gly Tyr Gly Val Ser Thr Gly Glu Leu Phe
 1               5                  10                  15  


<210> 94
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 94
Cys Ala Ser Ser Leu Arg Ala Trp Glu Thr Gln Tyr Phe
 1               5                  10              


<210> 95
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 95
Cys Ala Ser Ser Leu Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 96
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 96
Cys Ala Ser Ser Leu Arg Trp Gly Asp Gly Gly Lys Leu Phe
 1               5                  10                  


<210> 97
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 97
Cys Ala Ser Ser Gln Gly Gly Asp Arg Gly Glu Ser Glu Ala Phe
 1               5                  10                  15  


<210> 98
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 98
Cys Ala Ser Ser Val Arg Thr Leu Asp Thr Gly Glu Leu Phe
 1               5                  10                  


<210> 99
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 99
Cys Ala Thr Ser Ser Arg Met Gly Gly Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 100
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 100
Cys Ala Ser Ser Pro Gly Thr Ser Tyr Glu Gln Tyr Phe
 1               5                  10              


<210> 101
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 101
Cys Ala Ser Ala Gly Pro Gly Ala Asn Val Leu Thr Phe
 1               5                  10              


<210> 102
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 102
Cys Ala Ser Gly Gln Val Leu Ser Ser Gly Ser Asn Pro Ser Asp Thr
 1               5                  10                  15      
Gln Tyr Phe
            


<210> 103
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 103
Cys Ala Ser Lys Gly Thr Val Tyr Asn Glu Gln Phe
 1               5                  10          


<210> 104
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 104
Cys Ala Ser Arg Lys Asp Ser Ser Gly Asn Thr Ile Tyr Phe
 1               5                  10                  


<210> 105
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 105
Cys Ala Ser Arg Lys Asp Ser Ser Gly Asn Thr Ile Tyr Phe
 1               5                  10                  


<210> 106
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 106
Cys Ala Ser Ser Phe Thr Glu Gly Tyr Thr Phe
 1               5                  10      


<210> 107
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 107
Cys Ala Ser Ser Gly Arg Ala Leu Tyr Asn Glu Gln Phe
 1               5                  10              


<210> 108
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 108
Cys Ala Ser Ser Leu Ala Leu His Glu Gln Phe
 1               5                  10      


<210> 109
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 109
Cys Ala Ser Ser Leu Leu Met Ala Ala Gly Tyr Thr Phe
 1               5                  10              


<210> 110
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 110
Cys Ala Ser Ser Leu Val Gly Arg Asp Thr Glu Ala Phe
 1               5                  10              


<210> 111
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 111
Cys Ala Ser Ser Asn Gly Gln Gly Ala Glu Thr Gln Tyr Phe
 1               5                  10                  


<210> 112
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 112
Cys Ala Ser Ser Leu Ala Gly Gly Glu Pro Phe
 1               5                  10      


<210> 113
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 113
Cys Phe Ser Arg Pro Ile Thr Asp Arg Asn Glu Gln Asn Phe
 1               5                  10                  


<210> 114
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 114
Cys Pro Ser Pro Leu Val Gly Gly Gly Arg Phe
 1               5                  10      


<210> 115
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 115
Cys Ser Val Ser Gly Gly Pro Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 116
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 116
Cys Ser Val Gly Gln Thr Asp Ser Pro Leu His Phe
 1               5                  10          


<210> 117
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 117
Cys Ser Ala Gly Gln Gly Gly Thr Gly Glu Leu Phe Phe
 1               5                  10              


<210> 118
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 118
Cys Ser Val Ala Ala Leu Ala Gly Phe Gln Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 119
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 119
Cys Ser Ala Ser Arg Trp Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 120
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 120
Cys Ser Ala Gly Val Gly Gly Gln Glu Thr Gln Tyr Phe
 1               5                  10              


<210> 121
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 121
Cys Ser Ala Tyr Arg Thr Trp Asp Gln Glu Thr Gln Tyr Phe
 1               5                  10                  


<210> 122
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 122
Cys Ser Ala Arg Glu Pro Asp Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  


<210> 123
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 123
Cys Ala Ser Ser Leu Ala Ser Ala Gly Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 124
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 124
Cys Ala Ser Ser Leu Asn Trp Asp Thr Glu Ala Phe Phe
 1               5                  10              


<210> 125
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 125
Cys Ala Ser Ser Phe Ser Pro Ala Gly Ser Glu Ala Phe Phe
 1               5                  10                  


<210> 126
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 126
Cys Ala Ser Ser Leu Glu Gly Gln Gly Ala Ser Glu Gln Phe Phe
 1               5                  10                  15  


<210> 127
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 127
Cys Ala Ser Ser Gln Gly Leu Ala Gly Val Gln Glu Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 128
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 128
Cys Ala Ser Ser Pro Thr Ala Leu Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 129
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 129
Cys Ala Ser Ser Phe Arg Phe Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 130
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 130
Cys Ala Ser Ser Val Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 131
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 131
Cys Ala Ser Ser Phe Arg Ala Leu Ala Ala Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 132
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 132
Cys Ala Ser Ser Ile Arg Thr Ser Gly Asp His Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 133
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 133
Cys Ala Ser Ser Gln Tyr Gln Ser Leu Val Arg Gly Asn Asn Glu Gln
 1               5                  10                  15      
Phe Phe
        


<210> 134
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 134
Cys Ala Ser Ser Phe Pro Gln Val Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 135
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 135
Cys Ala Ser Ser His Val Asp Arg Gly Gly Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 136
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 136
Cys Ala Ile Arg Ala Gly Thr Gly Glu Tyr Glu Gln Phe
 1               5                  10              


<210> 137
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 137
Cys Ala Ser Gly Gly Gly Ser Val Gly Gln Gly Val Phe Asp Gly Tyr
 1               5                  10                  15      
Thr Phe
        


<210> 138
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 138
Cys Ala Ser Lys Gly Thr Val Tyr Asn Glu Gln Phe
 1               5                  10          


<210> 139
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 139
Cys Ala Ser Arg Asp Pro Gly Gln Arg Gly Tyr Ala Thr Asn Glu Lys
 1               5                  10                  15      
Leu Phe
        


<210> 140
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 140
Cys Ala Ser Arg Lys Asp Ser Ser Gly Asn Thr Ile Tyr Phe
 1               5                  10                  


<210> 141
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 141
Cys Ala Ser Arg Leu Ala Gly Gly Glu Gln Phe
 1               5                  10      


<210> 142
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 142
Cys Ala Ser Ser Leu Ala Ile Val Arg Glu Gln Phe
 1               5                  10          


<210> 143
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 143
Cys Ala Ser Ser Ser Gly Thr Val Asn Thr Glu Ala Phe
 1               5                  10              


<210> 144
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 144
Cys Ser Ala Arg Val Arg Asp Arg Gly Leu Gly Ala Asn Val Leu Thr
 1               5                  10                  15      
Phe
    


<210> 145
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 145
Cys Ala Ser Gln Gly Ala Leu Thr Ser Thr Phe
 1               5                  10      


<210> 146
<211> 7
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 146
Cys Ala Ser Arg Arg Pro Gly
 1               5          


<210> 147
<211> 13
<212> PRT
<213> Homo sapiens

<220> 

<400> 147
Cys Ala Ser Ser Leu Ala Gly Ser Arg Glu Arg Tyr Phe
 1               5                  10              


<210> 148
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 148
Cys Ala Ser Ser Ile Asn Ala Leu Val Gly Glu Gln Phe Phe
 1               5                  10                  


<210> 149
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 149
Cys Ala Ser Ser Pro Ala Phe Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 150
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 150
Cys Ala Ser Ser Leu Asp Gly Leu Thr Asn Thr Glu Ala Phe Phe
 1               5                  10                  15  


<210> 151
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 151
Cys Ser Ala Thr Leu Gly Gly Asp Tyr Gly Tyr Thr Phe
 1               5                  10              


<210> 152
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 152
Cys Ser Ala Gln Leu Ala Gly Gly Gly Gly Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 153
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 153
Cys Ser Ala Phe Pro Gly Gly Asp Thr Glu Ala Phe Phe
 1               5                  10              


<210> 154
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 154
Cys Ala Ser Ser Tyr Val Gly Gly Asp Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 155
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 155
Cys Ala Met Gly Glu Thr Gly Gly Pro Lys Thr Ile Phe
 1               5                  10              


<210> 156
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 156
Cys Ala Val Asn Thr Gly Phe Gln Lys Leu Val Phe
 1               5                  10          


<210> 157
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 157
Cys Ala Val Arg Gly Gly Gly Ala Asp Gly Leu Thr Phe
 1               5                  10              


<210> 158
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 158
Cys Ala Leu Glu Ser Leu Leu Leu Ile Lys Glu Thr Ser Gly Ser Arg
 1               5                  10                  15      
Leu Thr Phe
            


<210> 159
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 159
Cys Ala Ala Lys Thr Gly Tyr Ser Ser Ala Ser Lys Ile Ile Phe
 1               5                  10                  15  


<210> 160
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 160
Cys Ala Ala Asp Glu Phe Val Arg Asn Tyr Gly Gly Ala Thr Asn Lys
 1               5                  10                  15      
Leu Ile Phe
            


<210> 161
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 161
Cys Ala Pro Pro Pro Arg Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 162
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 162
Cys Ala Leu Arg Val Tyr Asn Phe Asn Lys Phe Tyr Phe
 1               5                  10              


<210> 163
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 163
Cys Ala Val Asn Ile Val Gly Thr Gln Gly Gly Ser Glu Lys Leu Val
 1               5                  10                  15      
Phe
    


<210> 164
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 164
Cys Ala Leu Ser Pro Leu Asn Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  15  


<210> 165
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 165
Cys Ala Leu Ser Pro Leu Asn Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  15  


<210> 166
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 166
Cys Ala Ala Ser Arg Lys Asp Arg Thr Ala Ser Lys Leu Thr Phe
 1               5                  10                  15  


<210> 167
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 167
Cys Ala Ala Ser Met Gly Leu Asn Ser Gly Tyr Ala Leu Asn Phe
 1               5                  10                  15  


<210> 168
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 168
Cys Ala Glu Asn Arg Gly Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 169
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 169
Cys Ala Glu Met Met Asn Ser Gly Tyr Ser Thr Leu Thr Phe
 1               5                  10                  


<210> 170
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 170
Cys Ala Met Arg Asp Leu Tyr Ser Gly Ala Gly Ser Tyr Gln Leu Thr
 1               5                  10                  15      
Phe
    


<210> 171
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 171
Cys Ala Val Pro Val Tyr Asn Thr Asp Lys Leu Ile Phe
 1               5                  10              


<210> 172
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 172
Ala Thr Asp Ala Gly Tyr Asn Gln Gly Gly Lys Leu Ile
 1               5                  10              


<210> 173
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 173
Cys Ala Ala Ser Lys Ala Ser Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  


<210> 174
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 174
Cys Ala Ser Ser Arg Gly Gly Gly Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  15  


<210> 175
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 175
Cys Ala Leu Ser Asp Val Gly Tyr Gln Lys Val Thr Phe
 1               5                  10              


<210> 176
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 176
Cys Ala Val Gly Met Gly Tyr Gln Lys Val Thr Phe
 1               5                  10          


<210> 177
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 177
Cys Ala Val Glu Asp Leu Gly Ser Gly Ala Gly Ser Tyr Gln Leu Thr
 1               5                  10                  15      
Phe
    


<210> 178
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 178
Cys Ala Leu Glu Gly Met Gly Gly Tyr Asn Lys Leu Ile Phe
 1               5                  10                  


<210> 179
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 179
Cys Ala Tyr Arg Ser Tyr Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10                  


<210> 180
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 180
Cys Ala Tyr Arg Ser Tyr Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10                  


<210> 181
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 181
Cys Val Val Ile Pro Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  


<210> 182
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 182
Cys His His Gly Gly Ser Gln Gly Asn Leu Ile Phe
 1               5                  10          


<210> 183
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 183
Cys Val Val Asn Lys Tyr Pro Leu Phe Asp Ser Gly Gly Ser Asn Tyr
 1               5                  10                  15      
Lys Leu Thr Phe
            20  


<210> 184
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 184
Cys Ile Val Arg Val Asp Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 185
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 185
Cys Ala Val Ser Ala Pro Asp Ser Trp Gly Lys Leu Gln Phe
 1               5                  10                  


<210> 186
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 186
Cys Ala Val Asn Arg Tyr Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10                  15  


<210> 187
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 187
Cys Ala Val Arg Ala Val Leu Ser Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10                  15      


<210> 188
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 188
Cys Ala Tyr Arg Asn Arg Gly Thr Leu Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  15      


<210> 189
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 189
Cys Ala Val Ser Ser Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10              


<210> 190
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 190
Cys Ala Val Asp Gly Ser Gly Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  


<210> 191
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 191
Cys Ala Val Gly Lys Thr Gly Phe Gln Lys Leu Val Phe
 1               5                  10              


<210> 192
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 192
Cys Ala Leu Lys Ala Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10              


<210> 193
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 193
Cys Ala Leu Pro Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10              


<210> 194
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 194
Cys Ala Val Ile Pro Phe Gly Gly Asn Ala Gly Lys Ser Thr Phe
 1               5                  10                  15  


<210> 195
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 195
Cys Ala Thr Ala Ile Ile Ser Asn Phe Gly Asn Glu Lys Leu Thr Phe
 1               5                  10                  15      


<210> 196
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 196
Cys Ala Thr Ala Ile Ile Ser Asn Phe Gly Asn Glu Lys Leu Thr Phe
 1               5                  10                  15      


<210> 197
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 197
Cys Ala Leu Ile Ser Ser Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10                  


<210> 198
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 198
Cys Ala Gln Arg Ser Gly Gly Tyr Asn Lys Leu Ile Phe
 1               5                  10              


<210> 199
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 199
Cys Val Val Asn Ile Glu Ala Asp Trp Asp Thr Gly Arg Arg Ala Leu
 1               5                  10                  15      
Thr Phe
        


<210> 200
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 200
Cys Ala Met Arg Glu Ala Tyr Asn Thr Asn Ala Gly Lys Ser Thr Phe
 1               5                  10                  15      


<210> 201
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 201
Cys Ala Met Arg Glu Ala Tyr Asn Thr Asn Ala Gly Lys Ser Thr Phe
 1               5                  10                  15      


<210> 202
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 202
Cys Ala Val Arg Gly Ile Ile Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10                  15  


<210> 203
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 203
Cys Ala Val Asn Val Asn Gln Phe Tyr Phe
 1               5                  10  


<210> 204
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 204
Cys Ala Val Arg Pro Asn Asp Tyr Lys Leu Ser Phe
 1               5                  10          


<210> 205
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 205
Cys Leu Val Val Asp Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10                  


<210> 206
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 206
Cys Ala Leu Ser Asp Leu Arg Gly Phe Gln Lys Leu Val Phe
 1               5                  10                  


<210> 207
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 207
Cys Ala Val Asn Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10          


<210> 208
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 208
Cys Ala Leu Arg Ala Asn Ala Arg Leu Met Phe
 1               5                  10      


<210> 209
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 209
Cys Ala Val Asn Leu Ala Gly Thr Ala Leu Ile Phe
 1               5                  10          


<210> 210
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 210
Cys Ala Ala Arg Arg Tyr Asn Phe Asn Lys Phe Tyr Phe
 1               5                  10              


<210> 211
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 211
Cys Ala Leu Ser Gly Ala Leu Asn Asn Ala Gly Asn Met Leu Thr Phe
 1               5                  10                  15      


<210> 212
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 212
Cys Ala Leu Ser Gly Ala Leu Asn Asn Ala Gly Asn Met Leu Thr Phe
 1               5                  10                  15      


<210> 213
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 213
Cys Ala Met Ser Pro Trp Gly Leu Asn Asn Asp Met Arg Phe
 1               5                  10                  


<210> 214
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 214
Cys Ala Val Gln Ala Lys Asn Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  15  


<210> 215
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 215
Cys Ala Ser Arg Ser Asn Asp Tyr Lys Leu Ser Phe
 1               5                  10          


<210> 216
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 216
Cys Ala Ile Trp Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10          


<210> 217
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 217
Cys Ala Val Asn Ser Asn Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  


<210> 218
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 218
Cys Ala Ala Arg Lys Ser Ala Gly Lys Ser Thr Phe
 1               5                  10          


<210> 219
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 219
Cys Ala Leu Val Thr Thr Asp Ser Trp Gly Lys Leu Gln Phe
 1               5                  10                  


<210> 220
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 220
Cys Ala Thr Ala Leu Tyr Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10                  15  


<210> 221
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 221
Cys Val Val Asn Thr Tyr Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10                  15  


<210> 222
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 222
Cys Ala Val Arg Glu Thr Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10                  


<210> 223
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 223
Cys Ala Gly Pro Arg Gly Asn Glu Lys Leu Thr Phe
 1               5                  10          


<210> 224
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 224
Cys Ala Val Gly Ala Trp Asn Asn Asn Ala Arg Leu Met Phe
 1               5                  10                  


<210> 225
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 225
Cys Ala Glu Thr Gln Ser Thr Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  15  


<210> 226
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 226
Cys Ala Ala Thr Phe Pro Pro Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10                  15  


<210> 227
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 227
Cys Ala Val Gly Glu Ser Asn Tyr Gln Leu Ile Trp
 1               5                  10          


<210> 228
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 228
Cys Val Val Ser Asp Arg Gly Ser Thr Leu Gly Arg Leu Tyr Phe
 1               5                  10                  15  


<210> 229
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 229
Cys Val Val Ser Asp Arg Gly Ser Thr Leu Gly Arg Leu Tyr Phe
 1               5                  10                  15  


<210> 230
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 230
Cys Val Val Ser Asp Arg Gly Ser Thr Leu Gly Arg Leu Tyr Phe
 1               5                  10                  15  


<210> 231
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 231
Cys Val Val Ser Asp Arg Gly Ser Thr Leu Gly Arg Leu Tyr Phe
 1               5                  10                  15  


<210> 232
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 232
Cys Val Val Asn Arg Tyr Ser Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10                  15  


<210> 233
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 233
Cys Ala Val Thr Leu Asn Thr Asn Ala Gly Lys Ser Thr Phe
 1               5                  10                  


<210> 234
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 234
Cys Ser Ala Arg Asp Leu Arg Glu Thr Asn Glu Lys Leu Phe Phe
 1               5                  10                  15  


<210> 235
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 235
Cys Ser Ala Arg Asp Gly Pro Thr Asn Glu Lys Leu Phe Phe
 1               5                  10                  


<210> 236
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 236
Cys Ala Ser Arg Leu Arg Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 237
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 237
Cys Ala Ser Ser Met Gly Gly Ala Leu Glu Lys Leu Phe Phe
 1               5                  10                  


<210> 238
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 238
Cys Ala Ser Ser Leu Arg Ala Asn Pro Gly Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 239
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 239
Cys Ala Ser Ser Leu Ala Arg Gly Thr Leu Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 240
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 240
Cys Ala Ile Ser Ala Glu Thr Leu Asn Glu Lys Leu Phe Phe
 1               5                  10                  


<210> 241
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 241
Cys Ala Ser Ser Pro Gln Gln Val Leu Gly Glu Ala Phe Phe
 1               5                  10                  


<210> 242
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 242
Cys Ala Ile Arg Glu Asp Arg Asn Asn Tyr Gly Tyr Thr Phe
 1               5                  10                  


<210> 243
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 243
Cys Ala Ser Ser Pro Arg Gly Gly Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 244
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 244
Cys Ala Ser Ser Arg Gly Arg Gly Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 245
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 245
Cys Ala Ser Ser Lys Gly Thr Gly Val Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 246
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 246
Cys Ala Ser Ser Arg Thr Asn Glu Lys Leu Phe Phe
 1               5                  10          


<210> 247
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 247
Cys Ala Ser Ser Leu Ala Arg Gly Thr Leu Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 248
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 248
Cys Ala Ser Ser Glu Glu Gln Gly Ala Ile Ala Phe Phe
 1               5                  10              


<210> 249
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 249
Cys Ala Ser Ser Leu Thr Ser Gly Leu Lys Lys Gln Tyr Phe
 1               5                  10                  


<210> 250
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 250
Cys Ala Ser Ser Glu Ser Gly Gly Leu Gly Gly Tyr Thr Phe
 1               5                  10                  


<210> 251
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 251
Cys Ala Ser Ser Ala Gly Asn Thr Ile Tyr Phe
 1               5                  10      


<210> 252
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 252
Cys Ala Ser Leu Lys Ala Thr Asp Thr Gln Tyr Phe
 1               5                  10          


<210> 253
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 253
Cys Ala Ser Ser Arg Gly Gly Gly Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  15  


<210> 254
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 254
Cys Ala Ser Gly Asp Arg Gly Ala Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 255
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 255
Cys Ala Ser Arg Asp Leu Gln Gly Gly Arg Asn Tyr Gly Tyr Thr Phe
 1               5                  10                  15      


<210> 256
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 256
Cys Ala Ser Arg Asp Leu Gln Gly Gly Arg Asn Tyr Gly Tyr Thr Phe
 1               5                  10                  15      


<210> 257
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 257
Cys Ala Ser Ser Ala Gly Ser Glu Ala Phe Phe
 1               5                  10      


<210> 258
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 258
Cys Ala Ser Ser Phe Asp Ser Ser Gly Ala Asn Val Leu Thr Phe
 1               5                  10                  15  


<210> 259
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 259
Cys Ala Ser Ser Leu Ala Asn Ser Gly Ala Asn Val Leu Thr Phe
 1               5                  10                  15  


<210> 260
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 260
Cys Ala Ser Ser Leu Leu Gly Arg Ser Asn Glu Gln Phe Phe
 1               5                  10                  


<210> 261
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 261
Cys Ala Ser Ser Leu Leu Gln Thr Asn Tyr Gly Tyr Thr Phe
 1               5                  10                  


<210> 262
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 262
Cys Ala Ser Ser Leu Ser Ala Ile Arg Asp Arg Gly Thr Asp Thr Gln
 1               5                  10                  15      
Tyr Phe
        


<210> 263
<211> 18
<212> PRT
<213> Homo sapiens

<220> 

<400> 263
Cys Ala Ser Ser Leu Thr Ala Gly Leu Ala Ser Thr Tyr Asn Glu Gln
 1               5                  10                  15      
Phe Phe
        


<210> 264
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 264
Cys Ala Ser Ser Pro Asp Arg Gly Arg Thr Gly Glu Leu Phe Phe
 1               5                  10                  15  


<210> 265
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 265
Cys Ala Ser Ser Pro Pro Ala Gln Gly Asn Ser Pro Leu His Phe
 1               5                  10                  15  


<210> 266
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 266
Cys Ala Ser Ser Pro Arg Gly Gln Glu Gly Tyr Thr Phe
 1               5                  10              


<210> 267
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 267
Cys Ala Ser Ser Pro Arg Thr Arg His Tyr Glu Gln Phe Phe
 1               5                  10                  


<210> 268
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 268
Cys Ala Ser Ser Pro Thr Gly Asn Ser Asn Gln Pro Gln His Phe
 1               5                  10                  15  


<210> 269
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 269
Cys Ala Ser Ser Gln Asp Leu Ala Gly Val Arg Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 270
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 270
Cys Ala Ser Ser Gln Asp Trp Thr Gly Thr Ser Leu Gly Asn Glu Gln
 1               5                  10                  15      
Phe Phe
        


<210> 271
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 271
Cys Ala Ser Ser Gln Gly Lys Thr Glu Ala Phe Phe
 1               5                  10          


<210> 272
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 272
Cys Ala Ser Ser Gln His Gln Arg Thr Gly Gly Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 273
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 273
Cys Ala Ser Ser Gln Val Gly Gln Gly Thr Asn Glu Lys Leu Phe Phe
 1               5                  10                  15      


<210> 274
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 274
Cys Ala Ala Ser Pro Leu Ser Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10                  15  


<210> 275
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 275
Cys Ala Ser Ser Arg Thr Thr Gly Ala Asp Pro Gly Asn Thr Ile Tyr
 1               5                  10                  15      
Phe
    


<210> 276
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 276
Cys Ala Ser Ser Ser Val Gly Ser Tyr Glu Gln Tyr Phe
 1               5                  10              


<210> 277
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 277
Cys Ala Ser Ser Val Gly Ser Ser Asn Gln Pro Gln His Phe
 1               5                  10                  


<210> 278
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 278
Cys Ala Ser Ser Val Gly Ser Ser Asn Gln Pro Gln His Phe
 1               5                  10                  


<210> 279
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 279
Cys Ala Leu Gly Glu Leu Pro Ile Lys Ala Ala Gly Asn Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 280
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 280
Cys Ala Ser Ser Trp Leu Glu Glu Asp Ser Leu Ser Gly Gly Tyr Gly
 1               5                  10                  15      
Tyr Thr Phe
            


<210> 281
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 281
Cys Ala Ser Thr Leu Leu Gly Ser Gly Ala Asn Val Leu Thr Phe
 1               5                  10                  15  


<210> 282
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 282
Cys Ser Ala Arg Ala Thr Gly Gly Ala Gly Gly Thr Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 283
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 283
Cys Ala Ser Ser Gly Val Met Gly Leu Asn Gln Pro Gln His Phe
 1               5                  10                  15  


<210> 284
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 284
Cys Ala Ser Ser Val Glu Gly Gln Gly Arg Tyr Glu Gln Phe Phe
 1               5                  10                  15  


<210> 285
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 285
Cys Ala Ser Ser Asp Glu Thr Gly Gly Thr Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15      


<210> 286
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 286
Cys Ser Val Phe Asp Trp Asp Arg Gly Pro Gly Glu Leu Phe Phe
 1               5                  10                  15  


<210> 287
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 287
Cys Ala Ser Ser Met Thr Ser Gly Gln Ala Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 288
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 288
Cys Ser Ala Ile Arg Thr Ser Gly Thr Gln Pro Tyr Glu Gln Tyr Phe
 1               5                  10                  15      


<210> 289
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 289
Cys Ser Val Asp Glu Asp Ser Gly Asn Asp Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 290
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 290
Cys Ala Thr Asp Ala Tyr Arg Arg Phe Gly Asn Glu Lys Leu Thr Phe
 1               5                  10                  15      


<210> 291
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 291
Cys Ala Ser Ser Leu Phe Gly Tyr Arg Gln Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 292
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 292
Cys Ala Ser Ser Leu Gly Gly Ser Ser Asn Gln Pro Gln His Phe
 1               5                  10                  15  


<210> 293
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 293
Cys Ala Ser Ser Pro Leu Met Gly Gly Pro Gly Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 294
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 294
Cys Ala Ser Ser Gln Asp Tyr Asn Glu Gln Phe Phe
 1               5                  10          


<210> 295
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 295
Cys Ala Ser Ser Tyr Leu Leu Ala Gly Ser Met Asn Thr Glu Ala Phe
 1               5                  10                  15      
Phe
    


<210> 296
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 296
Cys Ala Ser Ser Pro Arg Thr Ser Gly Ser Asp Glu Gln Phe Phe
 1               5                  10                  15  


<210> 297
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 297
Cys Ala Ser Ser Gln Asp Thr Gly Leu Trp Thr Glu Ala Phe Phe
 1               5                  10                  15  


<210> 298
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 298
Cys Ser Ala Arg Ala Glu Gly Gly Pro Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 299
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 299
Cys Ala Ser Ser Trp Thr Gly Gly Ala Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 300
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 300
Cys Ala Ser Ser Pro Arg Pro Leu Thr Tyr Glu Gln Tyr Phe
 1               5                  10                  


<210> 301
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 301
Cys Ser Ala Arg Pro Gln Gly Phe Ser Ser Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 302
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 302
Cys Ala Ser Ser Leu Asn Asn Pro Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 303
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 303
Cys Ala Ser Ser Tyr Gly Thr Val Asn Ser Pro Leu His Phe
 1               5                  10                  


<210> 304
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 304
Cys Ala Ser Ser Leu Pro Gly Gly Ala Gly Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 305
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 305
Cys Ala Ser Ser Gln Asp Phe Cys Ser Asp Val Met Asn Thr Glu Ala
 1               5                  10                  15      
Phe Phe
        


<210> 306
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 306
Cys Ala Ser Arg Asp Arg Gly Gly Gly Glu Lys Leu Phe Phe
 1               5                  10                  


<210> 307
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 307
Cys Ala Ser Ser Asp Pro Pro Gly Leu Ala Gly Ser Leu Asn Glu Gln
 1               5                  10                  15      
Phe Phe
        


<210> 308
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 308
Cys Ala Ser Ser Asp Pro Pro Ser Ser Gly Gly Arg Glu Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 309
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 309
Cys Ala Ser Ser Leu Arg Glu Gly Leu Glu Ala Thr Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 310
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 310
Cys Ala Ser Ser Pro Gly His Arg Asp Asp Gly Tyr Thr Phe
 1               5                  10                  


<210> 311
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 311
Cys Ala Ser Ser Met Thr Ser Gly Val Ser Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 312
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 312
Cys Ala Ser Ser Pro Ile Ile Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  


<210> 313
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 313
Cys Ala Val Ala Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10          


<210> 314
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 314
Cys Val Val Ile Pro Ala Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  15  


<210> 315
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 315
Cys Ala Leu Ser Pro Asn Asp Tyr Lys Leu Ser Phe
 1               5                  10          


<210> 316
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 316
Cys Ala Leu Ser Pro Asn Asp Tyr Lys Leu Ser Phe
 1               5                  10          


<210> 317
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 317
Cys Val Val Asn Lys Gly Asn Thr Pro Leu Val Phe
 1               5                  10          


<210> 318
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 318
Cys Ala Val Ile Ala Ser Gly Asn Thr Pro Leu Val Phe
 1               5                  10              


<210> 319
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 319
Cys Ala Gly Ala Glu Ser Gly Ala Asn Ala Gly Lys Ser Thr Phe
 1               5                  10                  15  


<210> 320
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 320
Cys Ala Ile Leu Ser Gly Gly Tyr Asn Lys Leu Ile Phe
 1               5                  10              


<210> 321
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 321
Cys Ala Met Arg Asp Pro Phe Asp Arg Gly Ser Thr Leu Gly Arg Leu
 1               5                  10                  15      
Tyr Phe
        


<210> 322
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 322
Cys Ala Met Arg Asp Pro Phe Asp Arg Gly Ser Thr Leu Gly Arg Leu
 1               5                  10                  15      
Tyr Phe
        


<210> 323
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 323
Cys Ala Leu Asp Ile Pro Glu Ala Gly Asn Met Leu Thr Phe
 1               5                  10                  


<210> 324
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 324
Cys Ala Val Arg Asp Lys Gly Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10                  15  


<210> 325
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 325
Cys Ala Tyr Arg Ser Gly Glu Thr Ser Gly Ser Arg Leu Thr Phe
 1               5                  10                  15  


<210> 326
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 326
Cys Ala Ala Thr Gly Gly Gly Ala Asp Gly Leu Thr Phe
 1               5                  10              


<210> 327
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 327
Cys Ala Ala Lys Ser Ser Tyr Lys Leu Ile Phe
 1               5                  10      


<210> 328
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 328
Cys Ala Val Gly Arg Tyr Ser Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  15      


<210> 329
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 329
Cys Ala Leu Ser Ile Ser Gly Gly Ser Tyr Ile Pro Thr Phe
 1               5                  10                  


<210> 330
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 330
Cys Ala Met Lys Thr Gln Gly Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  15  


<210> 331
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 331
Cys Ala Met Arg Gly Asn Thr Asp Lys Leu Ile Phe
 1               5                  10          


<210> 332
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 332
Cys Ala Leu Ser Asp Arg Ser Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  15      


<210> 333
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 333
Cys Ala Ala Ser Leu Thr His Gly Gln Asn Phe Val Phe
 1               5                  10              


<210> 334
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 334
Cys Ala Gly Gly Val Tyr Gly Asn Asn Arg Leu Ala Phe
 1               5                  10              


<210> 335
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 335
Cys Ala Ala Ser Arg Ala Gly Phe Gln Lys Leu Val Phe
 1               5                  10              


<210> 336
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 336
Cys Val Val Asn Ser Arg Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10                  


<210> 337
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 337
Cys Ala Trp Arg Thr Gly Ala Asn Ser Lys Leu Thr Phe
 1               5                  10              


<210> 338
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 338
Cys Leu Val Gly Ala Pro Ile Ser Gly Gly Tyr Asn Lys Leu Ile Phe
 1               5                  10                  15      


<210> 339
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 339
Cys Leu Val Gly Ala Pro Ile Ser Gly Gly Tyr Asn Lys Leu Ile Phe
 1               5                  10                  15      


<210> 340
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 340
Cys Ala Pro Arg Val Gly Ser Tyr Ile Pro Thr Phe
 1               5                  10          


<210> 341
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 341
Cys Ala Val Arg Asp Ser Gly Asn Thr Pro Leu Val Phe
 1               5                  10              


<210> 342
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 342
Cys Ala Leu Ser Ala Ser Trp Thr Ala Gly Asn Lys Leu Thr Phe
 1               5                  10                  15  


<210> 343
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 343
Cys Ala Val Arg Phe Pro Gly Asn Gln Phe Tyr Phe
 1               5                  10          


<210> 344
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 344
Cys Ala Val Arg His Asn Gly Asn Gln Phe Tyr Phe
 1               5                  10          


<210> 345
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 345
Cys Ala Val Arg Asp Ser Met Asp Ser Ser Tyr Lys Leu Ile Phe
 1               5                  10                  15  


<210> 346
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 346
Cys Ala Val Arg Asp Asn Thr Gly Phe Gln Lys Leu Val Phe
 1               5                  10                  


<210> 347
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 347
Cys Ala Leu Ser Glu Ala Arg Thr Asp Thr Gly Asn Gln Phe Tyr Phe
 1               5                  10                  15      


<210> 348
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 348
Cys Ala Ala Ser Met Lys Tyr Gly Asn Lys Leu Val Phe
 1               5                  10              


<210> 349
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 349
Cys Ala Ala Ser Met Lys Tyr Gly Asn Lys Leu Val Phe
 1               5                  10              


<210> 350
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 350
Cys Ala Leu Ser Glu Ala Arg Ser Asn Asp Tyr Lys Leu Ser Phe
 1               5                  10                  15  


<210> 351
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 351
Cys Ala Leu Ser Glu Ala Arg Ser Asn Asp Tyr Lys Leu Ser Phe
 1               5                  10                  15  


<210> 352
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 352
Cys Ala Leu Ser Glu Ala Arg Thr Asp Thr Gly Asn Gln Phe Tyr Phe
 1               5                  10                  15      


<210> 353
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 353
Cys Ala Val Asn Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr Phe
 1               5                  10                  15  


<210> 354
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 354
Cys Ala Ala Ser Ile Ile Ala Arg Leu Met Phe
 1               5                  10      


<210> 355
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 355
Cys Ala Gly Thr Ala Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10              


<210> 356
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 356
Cys Ala Val Arg Met Asn Thr Gly Phe Gln Lys Leu Val Phe
 1               5                  10                  


<210> 357
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 357
Cys Ala Leu Ser Glu Ala Arg Gly Ser Asp Gly Gln Lys Leu Leu Phe
 1               5                  10                  15      


<210> 358
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 358
Cys Ala Met Arg Leu His Asn Asn Asn Asp Met Arg Phe
 1               5                  10              


<210> 359
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 359
Cys Ala Met Ser Asn Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr Phe
 1               5                  10                  15      


<210> 360
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 360
Cys Ala Val Ser Gly Asn Thr Pro Leu Val Phe
 1               5                  10      


<210> 361
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 361
Cys Ala Tyr Arg Ser Pro Ala Arg Gln Leu Thr Phe
 1               5                  10          


<210> 362
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 362
Cys Ala Met Ser Ala Leu Gly Asn Phe Gly Asn Glu Lys Leu Thr Phe
 1               5                  10                  15      


<210> 363
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 363
Cys Ala Val Ser Phe Thr Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 364
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 364
Cys Ala Val Ser Phe Thr Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 365
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 365
Cys Ala Val Ser Gly Gly Ser Gln Gly Asn Leu Ile Phe
 1               5                  10              


<210> 366
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 366
Cys Gly Thr Glu Gln Asn Ser Gly Gly Ser Asn Tyr Lys Leu Thr Phe
 1               5                  10                  15      


<210> 367
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 367
Cys Ala Leu Arg Gly Asn Thr Gly Gly Phe Lys Thr Ile Phe
 1               5                  10                  


<210> 368
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 368
Cys Ala Val Ser Asp Asn Asn Ala Arg Leu Met Phe
 1               5                  10          


<210> 369
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 369
Cys Ala Val Ser Asp Gln Gly Ser Gly Tyr Ser Thr Leu Thr Phe
 1               5                  10                  15  


<210> 370
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 370
Cys Ala Trp Asp Pro Leu Asp Ser Asn Tyr Gln Leu Ile Trp
 1               5                  10                  


<210> 371
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 371
Cys Ala Met Arg Glu Arg Glu Ser Gly Asn Thr Pro Leu Val Phe
 1               5                  10                  15  


<210> 372
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 372
Cys Ala Val Glu Asn Ala Gly Asn Met Leu Thr Phe
 1               5                  10          


<210> 373
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 373
Cys Gly Glu Asn Asn Ala Gly Asn Met Leu Thr Phe
 1               5                  10          


<210> 374
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 374
Cys Val Leu Pro Gly Val Gly Thr Ser Tyr Gly Lys Leu Thr Phe
 1               5                  10                  15  


<210> 375
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 375
Cys Ala Val Asn Ile Arg Tyr Asn Thr Asp Lys Leu Ile Phe
 1               5                  10                  


<210> 376
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 376
Cys Ala Val Asn Ile Arg Tyr Asn Thr Asp Lys Leu Ile Phe
 1               5                  10                  


<210> 377
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 377
Cys Ala Val Val Ala Asp Ser Asn Tyr Gln Leu Ile Trp
 1               5                  10              


<210> 378
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 378
Cys Ala Ala Ala Ser Asn Asp Tyr Lys Leu Ser Phe
 1               5                  10          


<210> 379
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 379
Cys Ala Phe Lys Arg Glu Thr Ser Gly Ser Arg Leu Thr Phe
 1               5                  10                  


<210> 380
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 380
Cys Ala Ala Thr Pro Gly Gly Ala Asp Gly Leu Thr Phe
 1               5                  10              


<210> 381
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 381
Cys Ala Val Ser Asn Ser Gly Tyr Ala Leu Asn Phe
 1               5                  10          


<210> 382
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 382
Cys Ala Ala Ser Tyr Gly Asn Lys Leu Val Phe
 1               5                  10      


<210> 383
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 383
Cys Ala Ala Ser Gln Tyr Asp Tyr Lys Leu Ser Phe
 1               5                  10          


<210> 384
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 384
Cys Ala Leu Ser Ala Ser Ser Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10                  15  


<210> 385
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 385
Cys Ala Ala Asn Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10          


<210> 386
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 386
Cys Ala Ala Ser Thr Gly Gly Gly Asn Lys Leu Thr Phe
 1               5                  10              


<210> 387
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 387
Phe Phe Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr Phe
 1               5                  10              


<210> 388
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 388
Cys Ala Ala Ser Lys Thr Tyr Gly Gln Asn Phe Val Phe
 1               5                  10              


<210> 389
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 389
Cys Ala Ala Thr Asn Phe Asn Lys Phe Tyr Phe
 1               5                  10      


<210> 390
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 390
Cys Ala Ala Ser Ile Gly Gly Tyr Gln Lys Val Thr Phe
 1               5                  10              


<210> 391
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 391
Cys Ala Ala Ser Thr Arg Gly Ser Thr Leu Gly Arg Leu Tyr Phe
 1               5                  10                  15  


<210> 392
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 392
Cys Ala Leu Gly Lys Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10              


<210> 393
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 393
Cys Ala Ala Lys Gly Gly Gly Ala Asp Gly Leu Thr Phe
 1               5                  10              


<210> 394
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 394
Cys Ala Ala Ser Thr Arg Arg Gly Thr Gly Asn Gln Phe Tyr Phe
 1               5                  10                  15  


<210> 395
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 395
Cys Ala Ala Ser Gly Gly Ser Ser Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  15  


<210> 396
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 396
Cys Ala Ala Ser Gly Asn Tyr Gly Gly Ser Gln Gly Asn Leu Ile Phe
 1               5                  10                  15      


<210> 397
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 397
Cys Ala Ala Ser Gly Asn Tyr Gly Gly Ser Gln Gly Asn Leu Ile Phe
 1               5                  10                  15      


<210> 398
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 398
Cys Ala Glu Thr Arg Asn Ser Gly Asn Thr Pro Leu Val Phe
 1               5                  10                  


<210> 399
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 399
Cys Ala Leu His Ser Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  


<210> 400
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 400
Cys Ala Leu Ser Glu Val Ser Ala Gly Ala Asn Ser Lys Leu Thr Phe
 1               5                  10                  15      


<210> 401
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 401
Cys Ala Val Gly Glu Tyr Gly Asn Lys Leu Val Phe
 1               5                  10          


<210> 402
<211> 13
<212> PRT
<213> Homo sapiens

<220> 

<400> 402
Cys Ala Ala Leu Asn Asn Ala Gly Asn Met Leu Thr Phe
 1               5                  10              


<210> 403
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 403
Cys Ala Val Asp Val Glu Thr Ser Gly Ser Arg Leu Thr Phe
 1               5                  10                  


<210> 404
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 404
Cys Ala Leu Ser Glu Ala Thr Gln Gly Gly Ser Glu Lys Leu Val Phe
 1               5                  10                  15      


<210> 405
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 405
Cys Ala Ser Ser Pro Arg Asp Gly Ser Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15      


<210> 406
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 406
Cys Ala Ser Ser Pro Arg Asp Gly Ser Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15      


<210> 407
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 407
Cys Ala Val Ser Thr Thr Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 408
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 408
Cys Ser Ala Arg Gly Pro Thr Ala His Gly Tyr Thr Phe
 1               5                  10              


<210> 409
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 409
Cys Ala Ile Ser Asp Ser Leu Gly Ala Thr Glu Ala Phe Phe
 1               5                  10                  


<210> 410
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 410
Cys Ala Ser Lys Gly Pro Gly Thr Val Ile Arg Ala Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 411
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 411
Cys Ala Ser Lys Arg Ala Ser Met Asn Thr Glu Ala Phe Phe
 1               5                  10                  


<210> 412
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 412
Cys Ala Ser Ser Ala Glu Thr Gln Tyr Phe
 1               5                  10  


<210> 413
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 413
Cys Val Val Glu Val Ser Gly Asn Thr Pro Leu Val Phe
 1               5                  10              


<210> 414
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 414
Cys Ala Ser Ser Phe Glu Ser Arg Ala Phe Phe
 1               5                  10      


<210> 415
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 415
Cys Ala Ser Ser Leu Leu Ala Gly Asp Asn Glu Gln Phe Phe
 1               5                  10                  


<210> 416
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 416
Cys Ala Ser Ser Leu Asn Arg Met Ala Tyr Glu Gln Tyr Phe
 1               5                  10                  


<210> 417
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 417
Cys Ala Ser Ser Leu Val Ala Ser Gly Ala Val Gln Glu Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 418
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 418
Cys Ala Ser Ser Thr Thr Arg Gly Gln Gly Val Arg Arg Asn Thr Gly
 1               5                  10                  15      
Glu Leu Phe Phe
            20  


<210> 419
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 419
Cys Ala Ser Ser Ala Pro Leu Asn Arg Asp Ala Glu Ala Phe Phe
 1               5                  10                  15  


<210> 420
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 420
Cys Ala Ser Ser Asp Gly Thr Gly Pro Tyr Gly Tyr Thr Phe
 1               5                  10                  


<210> 421
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 421
Cys Ala Ser Ser Phe Arg Gln Gly Glu Gln Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 422
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 422
Cys Ala Ser Ser Ile Ser Asn Thr Gly Glu Leu Phe Phe
 1               5                  10              


<210> 423
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 423
Cys Ala Ser Ser Leu His Arg Ala Arg Ser Gly Asn Thr Ile Tyr Phe
 1               5                  10                  15      


<210> 424
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 424
Cys Ala Ser Ser Pro Pro Ala Gly Asp Arg Leu Thr Ser Gly Ala Asn
 1               5                  10                  15      
Val Leu Thr Phe
            20  


<210> 425
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 425
Cys Ala Ser Ser Pro Pro Gly Leu Gly Glu Gln Tyr Phe
 1               5                  10              


<210> 426
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 426
Cys Ala Ser Ser Pro Pro Gly Leu Gly Glu Gln Tyr Phe
 1               5                  10              


<210> 427
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 427
Cys Ala Ser Ser Pro Pro Pro Gly Gly Asn Ser Pro Leu His Phe
 1               5                  10                  15  


<210> 428
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 428
Cys Ala Ser Ser Tyr Ser Tyr Pro Gly Gln Gly Asn Glu Lys Leu Phe
 1               5                  10                  15      
Phe
    


<210> 429
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 429
Cys Ala Thr Gly Leu Ala Ala Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  


<210> 430
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 430
Cys Ala Val Thr Gly Gly Phe Lys Thr Ile Phe
 1               5                  10      


<210> 431
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 431
Cys Ala Thr Ser Asp Leu Gln Met Gly Ala Ser Arg Glu Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 432
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 432
Cys Ala Trp Arg Leu Thr Gly Gly Ser Gly Asn Thr Ile Tyr Phe
 1               5                  10                  15  


<210> 433
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 433
Cys Ala Trp Arg Leu Thr Gly Gly Ser Gly Asn Thr Ile Tyr Phe
 1               5                  10                  15  


<210> 434
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 434
Cys Ser Ala Arg Ala Thr Ala Ser Gly Ala Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15      


<210> 435
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 435
Cys Ser Val Asn Arg Gly Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 436
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 436
Cys Ser Val Asn Arg Gly Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 437
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 437
Cys Ala Ser Arg Ala Ser Leu Pro Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 438
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 438
Cys Ala Ser Ser Thr Lys Gly Gln Gly Ala Ser Glu Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 439
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 439
Cys Ala Ser Ser Glu Gly Tyr Gly Tyr Thr Phe
 1               5                  10      


<210> 440
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 440
Cys Ala Gly Pro Gln Asp Pro Met Asp Ser Asn Tyr Gln Leu Ile Trp
 1               5                  10                  15      


<210> 441
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 441
Cys Ala Ser Ser Leu Val Val Arg Val Asp Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 442
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 442
Cys Ala Val Gln Ala Gly Ser Lys Gly Asn Ala Gly Asn Met Leu Thr
 1               5                  10                  15      
Phe
    


<210> 443
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 443
Cys Ala Ser Ser Gln Val Ala Gly Val Tyr Glu Gln Phe Phe
 1               5                  10                  


<210> 444
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 444
Cys Ala Ile Ser Glu Ser Asp Arg Arg Arg Asp Pro Asn Tyr Gly Tyr
 1               5                  10                  15      
Thr Phe
        


<210> 445
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 445
Cys Ala Ser Ser Arg Thr Gly Leu Thr Thr Glu Ala Phe Phe
 1               5                  10                  


<210> 446
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 446
Cys Ala Ser Ser Pro Glu Gly Arg Glu Thr Gln Tyr Phe
 1               5                  10              


<210> 447
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 447
Cys Ala Thr Ser Arg Asp Arg Leu Gln Gly Ala Arg Asn Glu Gln Phe
 1               5                  10                  15      
Phe
    


<210> 448
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 448
Cys Ala Ser Ser Val Gly Met Asp Pro Gly Leu Gly Tyr Asn Glu Gln
 1               5                  10                  15      
Phe Phe
        


<210> 449
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 449
Cys Ala Ser Ser His Thr Asp Gly Tyr Glu Gln Tyr Phe
 1               5                  10              


<210> 450
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 450
Cys Ala Ser Ile Ala Ser Arg Tyr Asn Gln Pro Gln His Phe
 1               5                  10                  


<210> 451
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 451
Cys Ala Ser Ser Leu Ala Arg Tyr Asn Glu Lys Leu Phe Phe
 1               5                  10                  


<210> 452
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 452
Cys Ala Ser Ser Leu Gly Leu Leu Gly Ser Ser Tyr Asn Glu Gln Phe
 1               5                  10                  15      
Phe
    


<210> 453
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 453
Cys Ala Ser Ser Glu Gly Trp Gly Val Pro Ser Tyr Glu Gln Tyr Phe
 1               5                  10                  15      


<210> 454
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 454
Cys Ala Ser Ser Ile Ala Gly Gly Asn Glu Gln Phe Phe
 1               5                  10              


<210> 455
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 455
Cys Ala Ser Ser His Ser Thr Ser Gly Arg Ala Gly Asn Glu Gln Phe
 1               5                  10                  15      
Phe
    


<210> 456
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 456
Cys Ala Ser Ser Gln Val Gly Pro Ser Gly Gly Ala Lys Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 457
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 457
Cys Ala Ser Ser Pro Pro Thr Gly Trp Gly Gly Tyr Thr Phe
 1               5                  10                  


<210> 458
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 458
Cys Ala Ser Ser Leu Phe Gly Gln Gly Ser Glu Gln Tyr Phe
 1               5                  10                  


<210> 459
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 459
Cys Ala Ser Ser Glu Ala Val Ala Gly Leu Arg Asn Thr Ile Tyr Phe
 1               5                  10                  15      


<210> 460
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 460
Cys Ala Ser Ser Gln Gly Ser Tyr Gly Tyr Thr Phe
 1               5                  10          


<210> 461
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 461
Cys Ala Ser Ser Trp Thr Ala Asn Gln Pro Gln His Phe
 1               5                  10              


<210> 462
<211> 13
<212> PRT
<213> Homo Sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 462
Cys Ser Ala Arg Arg Thr Ser Gly Asn Glu Gln Phe Phe
 1               5                  10              


<210> 463
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 463
Cys Ala Ser Ser Val Val Gly Ile Ala Ala Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 464
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 464
Cys Ala Ser Trp Thr Val Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10              


<210> 465
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 465
Cys Ala Ser Ser Leu Gln Pro Pro Gly Thr Ser Thr Glu Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 466
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 466
Cys Ala Ser Arg Gly Thr Gly Thr Ser Gly Pro Gly Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 467
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 467
Cys Ala Leu Ser Tyr Gly Gly Phe Lys Thr Ile Phe
 1               5                  10          


<210> 468
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 468
Cys Ala Ser Ser Ser Ile Gln Gly Ser Gly Ser Gly Gln Pro Gln His
 1               5                  10                  15      
Phe
    


<210> 469
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 469
Gly Gly Thr Gly Thr Ala Ser Lys Leu Thr Phe
 1               5                  10      


<210> 470
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 470
Cys Ala Ser Ser Tyr Ser Thr Gly Tyr Thr Phe
 1               5                  10      


<210> 471
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 471
Cys Ala Ser Ser Thr Arg Leu Ala Gly Asp Glu Gln Phe Phe
 1               5                  10                  


<210> 472
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 472
Cys Ala Ser Ser Val Ser Gly Ser Thr Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 473
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 473
Cys Ser Val Phe His Arg Gly Glu Thr Gln Tyr Phe
 1               5                  10          


<210> 474
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 474
Cys Ser Ala Thr Ser Gly Thr Met Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 475
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 475
Cys Ala Ser Ser Ser Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10          


<210> 476
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 476
Cys Ala Ser Ser Arg Ser Ser Tyr Glu Gln Tyr Phe
 1               5                  10          


<210> 477
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 477
Cys Ser Ala Arg Glu Gly Thr Ser Asp Asp Glu Gln Tyr Phe
 1               5                  10                  


<210> 478
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 478
Cys Ser Val Glu Arg Gly Ser Leu Gln Glu Thr Gln Tyr Phe
 1               5                  10                  


<210> 479
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 479
Cys Ala Ser Ser Ser Tyr Arg Gly Thr Tyr Glu Gln Tyr Phe
 1               5                  10                  


<210> 480
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 480
Cys Ala Ser Ser Leu Arg Gln Gly Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 481
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 481
Cys Ala Ser Ser Leu Glu Gly Ala Ser Tyr Glu Gln Tyr Phe
 1               5                  10                  


<210> 482
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 482
Cys Ala Ser Ser Val Ala Ser Asn Glu Gln Phe Phe
 1               5                  10          


<210> 483
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 483
Cys Ala Ser Ser Ser Ser Asp Arg Gly Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 484
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 484
Cys Ala Ser Ser Pro Arg Leu Ala Gly Glu Ile Thr Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 485
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 485
Cys Ala Ser Ser Ser Gly Leu Ala Gln Gln Tyr Phe
 1               5                  10          


<210> 486
<211> 22
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 486
Cys Ala Ser Ser Leu Trp Ala Ser Gly Arg Asp Ser Ser Phe Ser Gly
 1               5                  10                  15      
Ala Asn Val Leu Thr Phe
            20          


<210> 487
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 487
Cys Ala Ser Ser Pro Gly Ala Asp Asp Asn Glu Gln Phe Phe
 1               5                  10                  


<210> 488
<211> 22
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 488
Cys Ala Ser Ser Leu Lys Phe Glu Ser Arg Glu Arg Gly Gln Gly Ser
 1               5                  10                  15      
Gly Glu Thr Gln Tyr Phe
            20          


<210> 489
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 489
Cys Ala Ser Ser Leu Gly Leu Ala Ser Gly Thr Leu Tyr Asn Glu Gln
 1               5                  10                  15      
Phe Phe
        


<210> 490
<211> 13
<212> PRT
<213> Homo sapiens

<220> 

<400> 490
Cys Ala Gly Gly Arg Phe Gly Ala Asn Val Leu Thr Phe
 1               5                  10              


<210> 491
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 491
Cys Ala Ser Ser Ile Gly Ala Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 492
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 492
Cys Ala Ser Ser Pro Leu Gly Asn Gln Pro Gln His Phe
 1               5                  10              


<210> 493
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 493
Cys Ala Ser Ser Leu Ser Arg Gly Gly Ala Asn Ile Gln Tyr Phe
 1               5                  10                  15  


<210> 494
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 494
Cys Ala Cys Ser Glu Ser Leu Ala Gly Gly Lys Gln Phe Phe
 1               5                  10                  


<210> 495
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 495
Cys Ser Ala Arg Ala Leu Ala Gly Ala Arg Asn Asn Glu Gln Phe Phe
 1               5                  10                  15      


<210> 496
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 496
Cys Ala Ser Ser Leu Leu Ala Gly Val Gly Lys Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 497
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 497
Cys Ala Leu Ser Gly Gly Asp Ser Ser Tyr Lys Leu Ile Phe
 1               5                  10                  


<210> 498
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 498
Cys Ala Ala Leu Ile Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10              


<210> 499
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 499
Cys Ala Ala Leu Ile Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10              


<210> 500
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 500
Cys Ala Val Asp Arg Gly Ser Thr Leu Gly Arg Leu Tyr Phe
 1               5                  10                  


<210> 501
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 501
Cys Ala Ala Ser Val Tyr Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 502
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 502
Cys Ala Ala Ser Ser Ser Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 503
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 503
Cys Ala Ser Ser Leu Ala Asp Arg Val Asn Thr Glu Ala Phe Phe
 1               5                  10                  15  


<210> 504
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 504
Cys Ala Ser Thr Tyr His Gly Thr Gly Tyr Phe
 1               5                  10      


<210> 505
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 505
Cys Ala Ser Thr Tyr His Gly Thr Gly Tyr Phe
 1               5                  10      


<210> 506
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 506
Cys Ala Ser Ser Gln Ile Arg Glu Thr Gln Tyr Phe
 1               5                  10          


<210> 507
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 507
Cys Ala Ser Arg Pro Arg Arg Asp Asn Glu Gln Phe Phe
 1               5                  10              


<210> 508
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 508
Cys Ala Ser Arg Pro Arg Asp Pro Val Thr Gln Tyr Phe
 1               5                  10              


<210> 509
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 509
Cys Ala Ser Ser Phe Arg Gly Gly Gly Asn Pro Tyr Glu Gln Tyr Phe
 1               5                  10                  15      


<210> 510
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 510
Cys Ala Val Gly Ala Gly Tyr Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10                  15      


<210> 511
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 511
Cys Ala Ser Thr Leu Leu Trp Gly Gly Asp Ser Tyr Glu Gln Tyr Phe
 1               5                  10                  15      


<210> 512
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 512
Cys Ala Glu Arg Leu Tyr Gly Asn Asn Arg Leu Ala Phe
 1               5                  10              


<210> 513
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 513
Cys Ala Ser Ser Phe Thr Tyr Asn Glu Gln Phe Phe
 1               5                  10          


<210> 514
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 514
Cys Ala Ala Ala Gly Asn Gln Phe Tyr Phe
 1               5                  10  


<210> 515
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 515
Cys Ala Trp Ser Ala Gln Gly Glu Thr Gln Tyr Phe
 1               5                  10          


<210> 516
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 516
Cys Ala Ala Ser Gly Ala Asn Ser Gly Tyr Ala Leu Asn Phe
 1               5                  10                  


<210> 517
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 517
Cys Ala Ser Ser Leu Gly Thr Gly Thr Gly Val Tyr Glu Gln Tyr Phe
 1               5                  10                  15      


<210> 518
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 518
Cys Ala Val Arg Asp Met Arg Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  15      


<210> 519
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 519
Cys Ala Ser Ser Ser Gln Gly Gln Gly Lys Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 520
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 520
Cys Ala Glu Asn Arg Ser Asp Tyr Lys Leu Ser Phe
 1               5                  10          


<210> 521
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 521
Cys Ala Ser Lys Tyr Asn Arg Gly Glu Gln Pro Gln His Phe
 1               5                  10                  


<210> 522
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 522
Cys Ala Val Lys Leu Gln Gly Gly Ser Glu Lys Leu Val Phe
 1               5                  10                  


<210> 523
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 523
Cys Ala Ser Ser Leu Gly Val Thr Gly Glu Leu Phe Phe
 1               5                  10              


<210> 524
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 524
Cys Ala Val Gln Ala Gly Asn Ala Gly Asn Met Leu Thr Phe
 1               5                  10                  


<210> 525
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 525
Cys Ala Ser Ser Leu Ala Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 526
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 526
Cys Ala Ala Ser Ile Gly Gly Gly Gly Ser Tyr Ile Pro Thr Phe
 1               5                  10                  15  


<210> 527
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 527
Cys Ala Ser Ser Leu Val Gly Gly Arg Val Asp Trp Arg Glu Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 528
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 528
Cys Ala Thr Asp Ser Ser Ser Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10                  15  


<210> 529
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 529
Cys Ala Ser Ser Val Asn Arg Gly His Asn Thr Glu Ala Phe Phe
 1               5                  10                  15  


<210> 530
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 530
Cys Ala Met Glu Gly Gly Arg Tyr Asn Thr Pro Leu Val Phe
 1               5                  10                  


<210> 531
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 531
Cys Ala Trp Met Gly Gly Tyr Asn Glu Gln Phe Phe
 1               5                  10          


<210> 532
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 532
Cys Ala Glu Ser Thr Ser Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10                  


<210> 533
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 533
Cys Ala Ser Ser Ser Gln Gly Ala Asn Tyr Gly Tyr Thr Phe
 1               5                  10                  


<210> 534
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 534
Cys Ala Ala Ser Glu Pro Asp Lys Leu Ile Phe
 1               5                  10      


<210> 535
<211> 2
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 535
Asn Ala
 1      


<210> 536
<211> 2
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 536
Asn Ala
 1      


<210> 537
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 537
Cys Ala Ser Ser Gln Glu Val Gly Thr Val Pro Asn Gln Pro Gln His
 1               5                  10                  15      
Phe
    


<210> 538
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 538
Cys Ala Gly Gln Thr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10          


<210> 539
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 539
Cys Ala Ser Ser Phe Gly Ser Ser Tyr Tyr Gly Tyr Thr Phe
 1               5                  10                  


<210> 540
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 540
Cys Ile Leu Arg Asp Thr Ile Ser Asn Phe Gly Asn Glu Lys Thr Phe
 1               5                  10                  15      


<210> 541
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 541
Cys Ala Ser Ser Leu Ala Leu Gly Gln Gly Asn Gln Gln Phe Phe
 1               5                  10                  15  


<210> 542
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 542
Cys Ala Val Glu Asp Leu Asn Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  15  


<210> 543
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 543
Cys Ala Ser Ser Glu Gly Val Thr Ala Pro Gly Leu Ala Gly Pro Tyr
 1               5                  10                  15      
Glu Gln Tyr Phe
            20  


<210> 544
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 544
Cys Val Val Ser Asp Arg Gly Ser Thr Leu Gly Arg Leu Tyr Phe
 1               5                  10                  15  


<210> 545
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 545
Cys Ser Ala Lys Gly Gln Pro Arg Gly Ala Phe Phe
 1               5                  10          


<210> 546
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 546
Cys Ala Leu Ser Ala Glu Ala Gly Gly Phe Lys Thr Ile Phe
 1               5                  10                  


<210> 547
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 547
ggagctggag tctcccagtc ccccagtaac aaggtcacag agaagggaaa ggatgtagag 60
ctcaggtgtg atccaatttc aggtcatact gccctttact ggtaccgaca gagcctgggg 120
cagggcctgg agtttttaat ttacttccaa ggcaacagtg caccagacaa atcagggctg 180
cccagtgatc gcttctctgc agagaggact gggggatccg tctccactct gacgatccag 240
cgcacacagc aggaggactc ggccgtgtat ctctgtgcca gcagcttagg gcgacagggc 300
gctggctaca ccttcggttc ggggaccagg ttaaccgttg tag                   343

<210> 548
<211> 346
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 548
gctcagaagg taactcaagc gcagactgaa atttctgtgg tggagaagga ggatgtgacc 60
ttggactgtg tgtatgaaac ccgtgatact acttattact tattctggta caagcaacca 120
ccaagtggag aattggtttt ccttattcgt cggaactctt ttgatgagca aaatgaaata 180
agtggtcggt attcttggaa cttccagaaa tccaccagtt ccttcaactt caccatcaca 240
gcctcacaag tcgtggactc agcagtatac ttctgtgctc tgagccgggg tactggaggc 300
ttcaaaacta tctttggagc aggaacaaga ctatttgtta aagcaa                346

<210> 549
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 549
gaacctgaag tcacccagac tcccagccat caggtcacac agatgggaca ggaagtgatc 60
ttgcgctgtg tccccatctc taatcactta tacttctatt ggtacagaca aatcttgggg 120
cagaaagtcg agtttctggt ttccttttat aataatgaaa tctcagagaa gtctgaaata 180
ttcgatgatc aattctcagt tgaaaggcct gatggatcaa atttcactct gaagatccgg 240
tccacaaagc tggaggactc agccatgtac ttctgtgcca gcagtggagt cggagcctac 300
gagcagtact tcgggccggg caccaggctc acggtcacag                       340

<210> 550
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 550
gctcagaagg taactcaagc gcagactgaa atttctgtgg tggagaagga ggatgtgacc 60
ttggactgtg tgtatgaaac ccgtgatact acttattact tattctggta caagcaacca 120
ccaagtggag aattggtttt ccttattcgt cggaactctt ttgatgagca aaatgaaata 180
agtggtcggt attcttggaa cttccagaaa tccaccagtt ccttcaactt caccatcaca 240
gcctcacaag tcgtggactc agcagtatac ttctgtgctc tgagagggga tagcagctat 300
aaattgatct tcgggagtgg gaccagactg ctggtcaggc ctg                   343

<210> 551
<211> 352
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 551
gatgctggag ttatccagtc accccggcac gaggtgacag agatgggaca agaagtgact 60
ctgagatgta aaccaatttc aggacacgac taccttttct ggtacagaca gaccatgatg 120
cggggactgg agttgctcat ttactttaac aacaacgttc cgatagatga ttcagggatg 180
cccgaggatc gattctcagc taagatgcct aatgcatcat tctccactct gaagatccag 240
ccctcagaac ccagggactc agctgtgtac ttctgtgcca gcagttccct caaagcggga 300
gggggggaca atgagcagtt cttcgggcca gggacacggc tcaccgtgct ag         352

<210> 552
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 552
gcccagtctg tgacccagct tgacagccaa gtccctgtct ttgaagaagc ccctgtggag 60
ctgaggtgca actactcatc gtctgtttca gtgtatctct tctggtatgt gcaatacccc 120
aaccaaggac tccagcttct cctgaagtat ttatcaggat ccaccctggt taaaggcatc 180
aacggttttg aggctgaatt taacaagagt caaacttcct tccacttgag gaaaccctca 240
gtccatataa gcgacacggc tgagtacttc tgtgctgtga gtgaaagagg cttcaacaaa 300
ttttactttg gatctgggac caaactcaat gtaaaaccaa                       340

<210> 553
<211> 352
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 553
gatactggag tctcccagga ccccagacac aagatcacaa agaggggaca gaatgtaact 60
ttcaggtgtg atccaatttc tgaacacaac cgcctttatt ggtaccgaca gaccctgggg 120
cagggcccag agtttctgac ttacttccag aatgaagctc aactagaaaa atcaaggctg 180
ctcagtgatc ggttctctgc agagaggcct aagggatctt tctccacctt ggagatccag 240
cgcacagagc agggggactc ggccatgtat ctctgtgcca gccccccgcc aggaacagga 300
gtattccaag agacccagta cttcgggcca ggcacgcggc tcctggtgct cg         352

<210> 554
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 554
gctcagaagg taactcaagc gcagactgaa atttctgtgg tggagaagga ggatgtgacc 60
ttggactgtg tgtatgaaac ccgtgatact acttattact tattctggta caagcaacca 120
ccaagtggag aattggtttt ccttattcgt cggaactctt ttgatgagca aaatgaaata 180
agtggtcggt attcttggaa cttccagaaa tccaccagtt ccttcaactt caccatcaca 240
gcctcacaag tcgtggactc agcagtatac ttctgtgctc tgaactatgg aggcttcaaa 300
actatctttg gagcaggaac aagactattt gttaaagcaa                       340

<210> 555
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 555
gagactggag tcacccaaag tcccacacac ctgatcaaaa cgagaggaca gcaagtgact 60
ctgagatgct cttctcagtc tgggcacaac actgtgtcct ggtaccaaca ggccctgggt 120
caggggcccc agtttatctt tcagtattat agggaggaag agaatggcag aggaaacttc 180
cctcctagat tctcaggtct ccagttccct aattatagct ctgagctgaa tgtgaacgcc 240
ttggagctgg acgactcggc cctgtatctc tgtgccagca gctttaaaca ggggaacggg 300
gagctgtttt ttggagaagg ctctaggctg accgtactgg                       340

<210> 556
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 556
gctcagtcag tggctcagcc ggaagatcag gtcaacgttg ctgaagggaa tcctctgact 60
gtgaaatgca cctattcagt ctctggaaac ccttatcttt tttggtatgt tcaatacccc 120
aaccgaggcc tccagttcct tctgaaatac atcacagggg ataacctggt taaaggcagc 180
tatggctttg aagctgaatt taacaagagc caaacctcct tccacctgaa gaaaccatct 240
gcccttgtga gcgactccgc tttgtacttc tgtgctgtga gagacatgga cggaggaaag 300
cttatcttcg gacagggaac ggagttatct gtgaaaccca                       340

<210> 557
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 557
gaagctggag ttgcccagtc tcccagatat aagattatag agaaaaggca gagtgtggct 60
ttttggtgca atcctatatc tggccatgct accctttact ggtaccagca gatcctggga 120
cagggcccaa agcttctgat tcagtttcag aataacggtg tagtggatga ttcacagttg 180
cctaaggatc gattttctgc agagaggctc aaaggagtag actccactct caagatccaa 240
cctgcaaagc ttgaggactc ggccgtgtat ctctgtgcca gcagcttaga tcccttcaca 300
gatacgcagt attttggccc aggcacccgg ctgacagtgc tcg                   343

<210> 558
<211> 352
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 558
gctcagacag tcactcagtc tcaaccagag atgtctgtgc aggaggcaga gaccgtgacc 60
ctgagctgca catatgacac cagtgagagt gattattatt tattctggta caagcagcct 120
cccagcaggc agatgattct cgttattcgc caagaagctt ataagcaaca gaatgcaaca 180
gagaatcgtt tctctgtgaa cttccagaaa gcagccaaat ccttcagtct caagatctca 240
gactcacagc tgggggatgc cgcgatgtat ttctgtgctt ataggttgaa ttatggtggt 300
gctacaaaca agctcatctt tggaactggc actctgcttg ctgtccagcc aa         352

<210> 559
<211> 325
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 559
aaggaccaag tgtttcagcc ttccacagtg gcatcttcag agggagctgt ggtggaaatc 60
ttctgtaatc actctgtgtc caatgcttac aacttcttct ggtaccttca cttcccggga 120
tgtgcaccaa gactccttgt taaaggctca aagccttctc agcagggacg atacaacatg 180
acctatgaac ggttctcttc atcgctgctc atcctccagg tgcgggaggc agatgctgct 240
gtttactact gtgctgtgga gttgggctct ggcaacacag gcaaactaat ctttgggcaa 300
gggacaactt tacaagtaaa accag                                       325

<210> 560
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 560
gaagctggag tggttcagtc tcccagatat aagattatag agaaaaaaca gcctgtggct 60
ttttggtgca atcctatttc tggccacaat accctttact ggtacctgca gaacttggga 120
cagggcccgg agcttctgat tcgatatgag aatgaggaag cagtagacga ttcacagttg 180
cctaaggatc gattttctgc agagaggctc aaaggagtag actccactct caagatccag 240
cctgcagagc ttggggactc ggccgtgtat ctctgtgcca gcagcgcccg acaaaacacc 300
ggggagctgt tttttggaga aggctctagg ctgaccgtac tgg                   343

<210> 561
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 561
agtgctgtca tctctcaaaa gccaagcagg gatatctgtc aacgtggaac ctccctgacg 60
atccagtgtc aagtcgatag ccaagtcacc atgatgttct ggtaccgtca gcaacctgga 120
cagagcctga cactgatcgc aactgcaaat cagggctctg aggccacata tgagagtgga 180
tttgtcattg acaagtttcc catcagccgc ccaaacctaa cattctcaac tctgactgtg 240
agcaacatga gccctgaaga cagcagcata tatctctgca gcgtggaccg gcagggtggc 300
tacgagcagt acttcgggcc gggcaccagg ctcacggtca cag                   343

<210> 562
<211> 352
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 562
gcccagtcag tgacccagcc tgacatccac atcactgtct ctgaaggagc ctcactggag 60
ttgagatgta actattccta tggggcaaca ccttatctct tctggtatgt ccagtccccc 120
ggccaaggcc tccagctgct cctgaagtac ttttcaggag acactctggt tcaaggcatt 180
aaaggctttg aggctgaatt taagaggagt caatcttcct tcaatctgag gaaaccctct 240
gtgcattgga gtgatgctgc tgagtacttc tgtgctgtgg gccctccgct ttatggagga 300
agccaaggaa atctcatctt tggaaaaggc actaaactct ctgttaaacc aa         352

<210> 563
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 563
gaagctgaag ttgcccagtc ccccagatat aagattacag agaaaagcca ggctgtggct 60
ttttggtgtg atcctatttc tggccatgct accctttact ggtaccggca gatcctggga 120
cagggcccgg agcttctggt tcaatttcag gatgagagtg tagtagatga ttcacagttg 180
cctaaggatc gattttctgc agagaggctc aaaggagtag actccactct caagatccag 240
cctgcagagc ttggggactc ggccatgtat ctctgtgcca gcagcccggg acactataat 300
tcacccctcc actttgggaa cgggaccagg ctcactgtga cag                   343

<210> 564
<211> 334
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 564
gatgctaaga ccacccagcc cccctccatg gattgcgctg aaggaagagc tgcaaacctg 60
ccttgtaatc actctaccat cagtggaaat gagtatgtgt attggtatcg acagattcac 120
tcccaggggc cacagtatat cattcatggt ctaaaaaaca atgaaaccaa tgaaatggcc 180
tctctgatca tcacagaaga cagaaagtcc agcaccttga tcctgcccca cgctacgctg 240
agagacactg ctgtgtacta ttgcatcgtc agagtcgctg aggcaggaac tgctctgatc 300
tttgggaagg gaaccacctt atcagtgagt tcca                             334

<210> 565
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 565
gatgtgaaag taacccagag ctcgagatat ctagtcaaaa ggacgggaga gaaagttttt 60
ctggaatgtg tccaggatat ggaccatgaa aatatgttct ggtatcgaca agacccaggt 120
ctggggctac ggctgatcta tttctcatat gatgttaaaa tgaaagaaaa aggagatatt 180
cctgaggggt acagtgtctc tagagagaag aaggagcgct tctccctgat tctggagtcc 240
gccagcacca accagacatc tatgtacctc tgtgccagca gccgaccggg acagttgaac 300
actgaagctt tctttggaca aggcaccaga ctcacagttg tag                   343

<210> 566
<211> 334
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 566
gcccagtcgg tgacccagct tggcagccac gtctctgtct ctgaaggagc cctggttctg 60
ctgaggtgca actactcatc gtctgttcca ccatatctct tctggtatgt gcaatacccc 120
aaccaaggac tccagcttct cctgaagtac acatcagcgg ccaccctggt taaaggcatc 180
aacggttttg aggctgaatt taagaagagt gaaacctcct tccacctgac gaaaccctca 240
gcccatatga gcgacgcggc tgagtacttc tgtgctgtga gtgagagagg aaagcttatc 300
ttcggacagg gaacggagtt atctgtgaaa ccca                             334

<210> 567
<211> 334
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 567
atactgaacg tggaacaaag tcctcagtca ctgcatgttc aggagggaga cagcaccaat 60
ttcacctgca gcttcccttc cagcaatttt tatgccttac actggtacag atgggaaact 120
gcaaaaagcc ccgaggcctt gtttgtaatg actttaaatg gggatgaaaa gaagaaagga 180
cgaataagtg ccactcttaa taccaaggag ggttacagct atttgtacat caaaggatcc 240
cagcctgaag actcagccac atacctctgt gcctttattt caggaaacac acctcttgtc 300
tttggaaagg gcacaagact ttctgtgatt gcaa                             334

<210> 568
<211> 346
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 568
gatgtgaaag taacccagag ctcgagatat ctagtcaaaa ggacgggaga gaaagttttt 60
ctggaatgtg tccaggatat ggaccatgaa aatatgttct ggtatcgaca agacccaggt 120
ctggggctac ggctgatcta tttctcatat gatgttaaaa tgaaagaaaa aggagatatt 180
cctgaggggt acagtgtctc tagagagaag aaggagcgct tctccctgat tctggagtcc 240
gccagcacca accagacatc tatgtacctc tgtgccagca gtttatgggg aggactaatg 300
aacactgaag ctttctttgg acaaggcacc agactcacag ttgtag                346

<210> 569
<211> 328
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 569
gaagaccagg tgacgcagag tcccgaggcc ctgagactcc aggagggaga gagtagcagt 60
ctcaactgca gttacacagt cagcggttta agagggctgt tctggtatag gcaagatcct 120
gggaaaggcc ctgaattcct cttcaccctg tattcagctg gggaagaaaa ggagaaagaa 180
aggctaaaag ccacattaac aaagaaggaa agctttctgc acatcacagc ccctaaacct 240
gaagactcag ccacttatct ctgtgctgcc gccgccgagg gaggaaagct tatcttcgga 300
cagggaacgg agttatctgt gaaaccca                                    328

<210> 570
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 570
gatgctggag ttatccagtc accccgccat gaggtgacag agatgggaca agaagtgact 60
ctgagatgta aaccaatttc aggccacaac tcccttttct ggtacagaca gaccatgatg 120
cggggactgg agttgctcat ttactttaac aacaacgttc cgatagatga ttcagggatg 180
cccgaggatc gattctcagc taagatgcct aatgcatcat tctccactct gaagatccag 240
ccctcagaac ccagggactc agctgtgtac ttctgtgcca gcagttttct ggcaggcaat 300
cagccccagc attttggtga tgggactcga ctctccatcc tag                   343

<210> 571
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 571
gaccagcaag ttaagcaaaa ttcaccatcc ctgagcgtcc aggaaggaag aatttctatt 60
ctgaactgtg actatactaa cagcatgttt gattatttcc tatggtacaa aaaataccct 120
gctgaaggtc ctacattcct gatatctata agttccatta aggataaaaa tgaagatgga 180
agattcactg ttttcttaaa caaaagtgcc aagcacctct ctctgcacat tgtgccctcc 240
cagcctggag actctgcagt gtacttctgt gcagcaagcg aggctggagc caatagtaag 300
ctgacatttg gaaaaggaat aactctgagt gttagaccag                       340

<210> 572
<211> 340
<212> DNA
<213> homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 572
gatgctggag ttatccagtc accccgccat gaggtgacag agatgggaca agaagtgact 60
ctgagatgta aaccaatttc aggccacaac tcccttttct ggtacagaca gaccatgatg 120
cggggactgg agttgctcat ttactttaac aacaacgttc cgatagatga ttcagggatg 180
cccgaggatc gattctcagc taagatgcct aatgcatcat tctccactct gaagatccag 240
ccctcagaac ccagggactc agctgtgtac ttctgtgcca gcagatttgg acaggcgtat 300
ggctacacct tcggttcggg gaccaggtta accgttgtag                       340

<210> 573
<211> 334
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 573
ggtcaacagc tgaatcagag tcctcaatct atgtttatcc aggaaggaga agatgtctcc 60
atgaactgca cttcttcaag catatttaac acctggctat ggtacaagca ggaccctggg 120
gaaggtcctg tcctcttgat agccttatat aaggctggtg aattgacctc aaatggaaga 180
ctgactgctc agtttggtat aaccagaaag gacagcttcc tgaatatctc agcatccata 240
cctagtgatg taggcatcta cttctgtgct agtagtggag gtagcaacta taaactgaca 300
tttggaaaag gaactctctt aaccgtgaat ccaa                             334

<210> 574
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 574
agtgctgtca tctctcaaaa gccaagcagg gatatctgtc aacgtggaac ctccctgacg 60
atccagtgtc aagtcgatag ccaagtcacc atgatgttct ggtaccgtca gcaacctgga 120
cagagcctga cactgatcgc aactgcaaat cagggctctg aggccacata tgagagtgga 180
tttgtcattg acaagtttcc catcagccgc ccaaacctaa cattctcaac tctgactgtg 240
agcaacatga gccctgaaga cagcagcata tatctctgca gcgtgagcgc ggacactaac 300
tatggctaca ccttcggttc ggggaccagg ttaaccgttg tag                   343

<210> 575
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 575
ggagagaatg tggagcagca tccttcaacc ctgagtgtcc aggagggaga cagcgctgtt 60
atcaagtgta cttattcaga cagtgcctca aactacttcc cttggtataa gcaagaactt 120
ggaaaaggac ctcagcttat tatagacatt cgttcaaatg tgggcgaaaa gaaagaccaa 180
cgaattgctg ttacattgaa caagacagcc aaacatttct ccctgcacat cacagagacc 240
caacctgaag actcggctgt ctacttctgt gcagcaagtg ataccggcac tgccagtaaa 300
ctcacctttg ggactggaac aagacttcag gtcacgctcg                       340

<210> 576
<211> 361
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 576
ggtgctgtcg tctctcaaca tccgagctgg gttatctgta agagtggaac ctctgtgaag 60
atcgagtgcc gttccctgga ctttcaggcc acaactatgt tttggtatcg tcagttcccg 120
aaacagagtc tcatgctgat ggcaacttcc aatgagggct ccaaggccac atacgagcaa 180
ggcgtcgaga aggacaagtt tctcatcaac catgcaagcc tgaccttgtc cactctgaca 240
gtgaccagtg cccatcctga agacagcagc ttctacatct gcagtgctag aggattcggg 300
gggttgggcg caactaatga aaaactgttt tttggcagtg gaacccagct ctctgtcttg 360
g                                                                 361

<210> 577
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 577
gcccagtcgg tgacccagct tggcagccac gtctctgtct ctgaaggagc cctggttctg 60
ctgaggtgca actactcatc gtctgttcca ccatatctct tctggtatgt gcaatacccc 120
aaccaaggac tccagcttct cctgaagtac acatcagcgg ccaccctggt taaaggcatc 180
aacggttttg aggctgaatt taagaagagt gaaacctcct tccacctgac gaaaccctca 240
gcccatatga gcgacgcggc tgagtacttc tgtgctgtga gtgattatac tggaggcttc 300
aaaactatct ttggagcagg aacaagacta tttgttaaag caa                   343

<210> 578
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 578
gacgctggag tcacccaaag tcccacacac ctgatcaaaa cgagaggaca gcaagtgact 60
ctgagatgct ctcctaagtc tgggcatgac actgtgtcct ggtaccaaca ggccctgggt 120
caggggcccc agtttatctt tcagtattat gaggaggaag agagacagag aggcaacttc 180
cctgatcgat tctcaggtca ccagttccct aactatagct ctgagctgaa tgtgaacgcc 240
ttgttgctgg gggactcggc cctctatctc tgtgccagca gcggatcgac gggcacagat 300
acgcagtatt ttggcccagg cacccggctg acagtgctcg                       340

<210> 579
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 579
Cys Ala Ser Ser Leu Gly Arg Gln Gly Ala Gly Tyr Thr Phe
 1               5                  10                  


<210> 580
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 580
Cys Ala Leu Ser Arg Gly Thr Gly Gly Phe Lys Thr Ile Phe
 1               5                  10                  


<210> 581
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 581
Cys Ala Ser Ser Gly Val Gly Ala Tyr Glu Gln Tyr Phe
 1               5                  10              


<210> 582
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 582
Cys Ala Leu Arg Gly Asp Ser Ser Tyr Lys Leu Ile Phe
 1               5                  10              


<210> 583
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 583
Cys Ala Ser Ser Ser Leu Lys Ala Gly Gly Gly Asp Asn Glu Gln Phe
 1               5                  10                  15      
Phe
    


<210> 584
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 584
Cys Ala Val Ser Glu Arg Gly Phe Asn Lys Phe Tyr Phe
 1               5                  10              


<210> 585
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 585
Cys Ala Ser Pro Pro Pro Gly Thr Gly Val Phe Gln Glu Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 586
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 586
Cys Ala Leu Asn Tyr Gly Gly Phe Lys Thr Ile Phe
 1               5                  10          


<210> 587
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 587
Cys Ala Ser Ser Phe Lys Gln Gly Asn Gly Glu Leu Phe Phe
 1               5                  10                  


<210> 588
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 588
Cys Ala Val Arg Asp Met Asp Gly Gly Lys Leu Ile Phe
 1               5                  10              


<210> 589
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 589
Cys Ala Ser Ser Leu Asp Pro Phe Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 590
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 590
Cys Ala Tyr Arg Leu Asn Tyr Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10                  15      


<210> 591
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 591
Cys Ala Val Glu Leu Gly Ser Gly Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  15  


<210> 592
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 592
Cys Ala Ser Ser Ala Arg Gln Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  


<210> 593
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 593
Cys Ser Val Asp Arg Gln Gly Gly Tyr Glu Gln Tyr Phe
 1               5                  10              


<210> 594
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 594
Cys Ala Val Gly Pro Pro Leu Tyr Gly Gly Ser Gln Gly Asn Leu Ile
 1               5                  10                  15      
Phe
    


<210> 595
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 595
Cys Ala Ser Ser Pro Gly His Tyr Asn Ser Pro Leu His Phe
 1               5                  10                  


<210> 596
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 596
Cys Ile Val Arg Val Ala Glu Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  


<210> 597
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 597
Cys Ala Ser Ser Arg Pro Gly Gln Leu Asn Thr Glu Ala Phe Phe
 1               5                  10                  15  


<210> 598
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 598
Cys Ala Val Ser Glu Arg Gly Lys Leu Ile Phe
 1               5                  10      


<210> 599
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 599
Cys Ala Phe Ile Ser Gly Asn Thr Pro Leu Val Phe
 1               5                  10          


<210> 600
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 600
Cys Ala Ser Ser Leu Trp Gly Gly Leu Met Asn Thr Glu Ala Phe Phe
 1               5                  10                  15      


<210> 601
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 601
Cys Ala Ala Ala Ala Glu Gly Gly Lys Leu Ile Phe
 1               5                  10          


<210> 602
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 602
Cys Ala Ser Ser Phe Leu Ala Gly Asn Gln Pro Gln His Phe
 1               5                  10                  


<210> 603
<211> 14
<212> PRT
<213> Homo sapiiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 603
Cys Ala Ala Ser Glu Ala Gly Ala Asn Ser Lys Leu Thr Phe
 1               5                  10                  


<210> 604
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 604
Cys Ala Ser Arg Phe Gly Gln Ala Tyr Gly Tyr Thr Phe
 1               5                  10              


<210> 605
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 605
Cys Ala Ser Ser Gly Gly Ser Asn Tyr Lys Leu Thr Phe
 1               5                  10              


<210> 606
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 606
Cys Ser Val Ser Ala Asp Thr Asn Tyr Gly Tyr Thr Phe
 1               5                  10              


<210> 607
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 607
Cys Ala Ala Ser Asp Thr Gly Thr Ala Ser Lys Leu Thr Phe
 1               5                  10                  


<210> 608
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 608
Cys Ser Ala Arg Gly Phe Gly Gly Leu Gly Ala Thr Asn Glu Lys Leu
 1               5                  10                  15      
Phe Phe
        


<210> 609
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 609
Cys Ala Val Ser Asp Tyr Thr Gly Gly Phe Lys Thr Ile Phe
 1               5                  10                  


<210> 610
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 610
Cys Ala Ser Ser Gly Ser Thr Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 611
<211> 364
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 611
gatactggag tctcccagga ccccagacac aagatcacaa agaggggaca gaatgtaact 60
ttcaggtgtg atccaatttc tgaacacaac cgcctttatt ggtaccgaca gaccctgggg 120
cagggcccag agtttctgac ttacttccag aatgaagctc aactagaaaa atcaaggctg 180
ctcagtgatc ggttctctgc agagaggcct aagggatctt tctccacctt ggagatccag 240
cgcacagagc agggggactc ggccatgtat ctctgtgcca gcagcttaat tccttttctg 300
gcgggagtat tagctaacta caatgagcag ttcttcgggc cagggacacg gctcaccgtg 360
ctag                                                              364

<210> 612
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 612
ggaaattcag tgacccagat ggaagggcca gtgactctct cagaagaggc cttcctgact 60
ataaactgca cgtacacagc cacaggatac ccttcccttt tctggtatgt ccaatatcct 120
ggagaaggtc tacagctcct cctgaaagcc acgaaggctg atgacaaggg aagcaacaaa 180
ggttttgaag ccacataccg taaagaaacc acttctttcc acttggagaa aggctcagtt 240
caagtgtcag actcagcggt gtacttctgt gctctgagta atgacatgga atatggaaac 300
aaactggtct ttggcgcagg aaccattctg agagtcaagt cct                   343

<210> 613
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 613
aaggctggag tcactcaaac tccaagatat ctgatcaaaa cgagaggaca gcaagtgaca 60
ctgagctgct cccctatctc tgggcatagg agtgtatcct ggtaccaaca gaccccagga 120
cagggccttc agttcctctt tgaatacttc agtgagacac agagaaacaa aggaaacttc 180
cctggtcgat tctcagggcg ccagttctct aactctcgct ctgagatgaa tgtgagcacc 240
ttggagctgg gggactcggc cctttatctt tgcgccagca gcttatccgg gaatagcaat 300
cagccccagc attttggtga tgggactcga ctctccatcc tag                   343

<210> 614
<211> 334
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 614
atactgaacg tggaacaaag tcctcagtca ctgcatgttc aggagggaga cagcaccaat 60
ttcacctgca gcttcccttc cagcaatttt tatgccttac actggtacag atgggaaact 120
gcaaaaagcc ccgaggcctt gtttgtaatg actttaaatg gggatgaaaa gaagaaagga 180
cgaataagtg ccactcttaa taccaaggag ggttacagct atttgtacat caaaggatcc 240
cagcctgaag actcagccac atacctctgt gcctttggtg gtgctacaaa caagctcatc 300
tttggaactg gcactctgct tgctgtccag ccaa                             334

<210> 615
<211> 337
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 615
tctcagacta ttcatcaatg gccagcgacc ctggtgcagc ctgtgggcag cccgctctct 60
ctggagtgca ctgtggaggg aacatcaaac cccaacctat actggtaccg acaggctgca 120
ggcaggggcc tccagctgct cttctactcc gttggtattg gccagatcag ctctgaggtg 180
ccccagaatc tctcagcctc cagaccccag gaccggcagt tcatcctgag ttctaagaag 240
ctccttctca gtgactctgg cttctatctc tgtgcctgga gtgtacgtgg ggatcagccc 300
cagcattttg gtgatgggac tcgactctcc atcctag                          337

<210> 616
<211> 331
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 616
gaagaccagg tgacgcagag tcccgaggcc ctgagactcc aggagggaga gagtagcagt 60
ctcaactgca gttacacagt cagcggttta agagggctgt tctggtatag gcaagatcct 120
gggaaaggcc ctgaattcct cttcaccctg tattcagctg gggaagaaaa ggagaaagaa 180
aggctaaaag ccacattaac aaagaaggaa agctttctgc acatcacagc ccctaaacct 240
gaagactcag ccacttatct ctgtgctgtg ctttatggcg gatctgaaaa gctggtcttt 300
ggaaagggaa cgaaactgac agtaaaccca t                                331

<210> 617
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 617
aaggctggag tcactcaaac tccaagatat ctgatcaaaa cgagaggaca gcaagtgaca 60
ctgagctgct cccctatctc tgggcatagg agtgtatcct ggtaccaaca gaccccagga 120
cagggccttc agttcctctt tgaatacttc agtgagacac agagaaacaa aggaaacttc 180
cctggtcgat tctcagggcg ccagttctct aactctcgct ctgagatgaa tgtgagcacc 240
ttggagctgg gggactcggc cctttatctt tgcgccagca gacccgggac cataaatcaa 300
gagacccagt acttcgggcc aggcacgcgg ctcctggtgc tcg                   343

<210> 618
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 618
ggagagagtg tggggctgca tcttcctacc ctgagtgtcc aggagggtga caactctatt 60
atcaactgtg cttattcaaa cagcgcctca gactacttca tttggtacaa gcaagaatct 120
ggaaaaggtc ctcaattcat tatagacatt cgttcaaata tggacaaaag gcaaggccaa 180
agagtcaccg ttttattgaa taagacagtg aaacatctct ctctgcaaat tgcagctact 240
caacctggag actcagctgt ctacttttgt gcagagaata aggtttcaga tggccagaag 300
ctgctctttg caagggggac catgttaaag gtggatctta                       340

<210> 619
<211> 346
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 619
ggtgctggag tctcccagac ccccagtaac aaggtcacag agaagggaaa atatgtagag 60
ctcaggtgtg atccaatttc aggtcatact gccctttact ggtaccgaca aagcctgggg 120
cagggcccag agtttctaat ttacttccaa ggcacgggtg cggcagatga ctcagggctg 180
cccaacgatc ggttctttgc agtcaggcct gagggatccg tctctactct gaagatccag 240
cgcacagagc ggggggactc agccgtgtat ctctgtgcca gcagctcaaa cccgcgggat 300
aactatggct acaccttcgg ttcggggacc aggttaaccg ttgtag                346

<210> 620
<211> 328
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 620
cttgctaaga ccacccagcc catctccatg gactcatatg aaggacaaga agtgaacata 60
acctgtagcc acaacaacat tgctacaaat gattatatca cgtggtacca acagtttccc 120
agccaaggac cacgatttat tattcaagga tacaagacaa aagttacaaa cgaagtggcc 180
tccctgttta tccctgccga cagaaagtcc agcactctga gcctgccccg ggtttccctg 240
agcgacactg ctgtgtacta ctgcctcgtg ggggaatatg gaaacaagct ggtctttggc 300
gcaggaacca ttctgagagt caagtcct                                    328

<210> 621
<211> 346
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 621
gatgctggag ttatccagtc accccgccat gaggtgacag agatgggaca agaagtgact 60
ctgagatgta aaccaatttc aggccacaac tcccttttct ggtacagaca gaccatgatg 120
cggggactgg agttgctcat ttactttaac aacaacgttc cgatagatga ttcagggatg 180
cccgaggatc gattctcagc taagatgcct aatgcatcat tctccactct gaagatccag 240
ccctcagaac ccagggactc agctgtgtac ttctgtgcca gcaaattccc gtggggggct 300
gtcggggagc tgttttttgg agaaggctct aggctgaccg tactgg                346

<210> 622
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 622
ggagagaatg tggagcagca tccttcaacc ctgagtgtcc aggagggaga cagcgctgtt 60
atcaagtgta cttattcaga cagtgcctca aactacttcc cttggtataa gcaagaactt 120
ggaaaaggac ctcagcttat tatagacatt cgttcaaatg tgggcgaaaa gaaagaccaa 180
cgaattgctg ttacattgaa caagacagcc aaacatttct ccctgcacat cacagagacc 240
caacctgaag actcggctgt ctacttctgt gcagcaagta aagggtctag caacacaggc 300
aaactaatct ttgggcaagg gacaacttta caagtaaaac cag                   343

<210> 623
<211> 349
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 623
gatgctggaa tcacccagag cccaagacac aaggtcacag agacaggaac accagtgact 60
ctgagatgtc accagactga gaaccaccgc tatatgtact ggtatcgaca agacccgggg 120
catgggctga ggctgatcca ttactcatat ggtgttaaag atactgacaa aggagaagtc 180
tcagatggct atagtgtctc tagatcaaag acagaggatt tcctcctcac tctggagtcc 240
gctaccagct cccagacatc tgtgtacttc tgtgccatca ccccgggaca gggggcgaag 300
ggtggagaga cccagtactt cgggccaggc acgcggctcc tggtgctcg             349

<210> 624
<211> 346
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 624
gctcagacag tcactcagtc tcaaccagag atgtctgtgc aggaggcaga gaccgtgacc 60
ctgagctgca catatgacac cagtgagagt gattattatt tattctggta caagcagcct 120
cccagcaggc agatgattct cgttattcgc caagaagctt ataagcaaca gaatgcaaca 180
gagaatcgtt tctctgtgaa cttccagaaa gcagccaaat ccttcagtct caagatctca 240
gactcacagc tgggggatgc cgcgatgtat ttctgtgctt accgggggtc taaccaggga 300
ggaaagctta tcttcggaca gggaacggag ttatctgtga aaccca                346

<210> 625
<211> 355
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 625
ggagctggag tctcccagtc ccccagtaac aaggtcacag agaagggaaa ggatgtagag 60
ctcaggtgtg atccaatttc aggtcatact gccctttact ggtaccgaca gagcctgggg 120
cagggcctgg agtttttaat ttacttccaa ggcaacagtg caccagacaa atcagggctg 180
cccagtgatc gcttctctgc agagaggact gggggatccg tctccactct gacgatccag 240
cgcacacagc aggaggactc ggccgtgtat ctctgtgcca gcagctaccg tttgatgggt 300
agcgggagta gggagaccca gtacttcggg ccaggcacgc ggctcctggt gctcg      355

<210> 626
<211> 334
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 626
ggaaattcag tgacccagat ggaagggcca gtgactctct cagaagaggc cttcctgact 60
ataaactgca cgtacacagc cacaggatac ccttcccttt tctggtatgt ccaatatcct 120
ggagaaggtc tacagctcct cctgaaagcc acgaaggctg atgacaaggg aagcaacaaa 180
ggttttgaag ccacataccg taaagaaacc acttctttcc acttggagaa aggctcagtt 240
caagtgtcag actcagcggt gtacttctgt gctctgcacg gaggaagcta catacctaca 300
tttggaagag gaaccagcct tattgttcat ccgt                             334

<210> 627
<211> 343
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 627
ggagattcag tgacccagat ggaagggcca gtgactctct cagaagaggc cttcctgact 60
ataaactgca cgtacacagc cacaggatac ccttcccttt tctggtatgt ccaatatcct 120
ggagaaggtc tacagctcct cctgaaagcc acgaaggctg atgacaaggg aagcaacaaa 180
ggttttgaag ccacataccg taaggaaacc acttctttcc acttggagaa aggctcagtt 240
caagtgtcag actcagcggt gtacttctgt gctctgagtg atcggggaac cagtggctct 300
aggttgacct ttggggaagg aacacagctc acagtgaatc ctg                   343

<210> 628
<211> 346
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 628
ggagctggag tctcccagtc ccccagtaac aaggtcacag agaagggaaa ggatgtagag 60
ctcaggtgtg atccaatttc aggtcatact gccctttact ggtaccgaca gagcctgggg 120
cagggcctgg agtttttaat ttacttccaa ggcaacagtg caccagacaa atcagggctg 180
cccagtgatc gcttctctgc agagaggact gggggatccg tctccactct gacgatccag 240
cgcacacagc aggaggactc ggccgtgtat ctctgtgcca gcagccgatg gacagggggc 300
aattacgagc agtacttcgg gccgggcacc aggctcacgg tcacag                346

<210> 629
<211> 346
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 629
ggagagaatg tggagcagca tccttcaacc ctgagtgtcc aggagggaga cagcgctgtt 60
atcaagtgta cttattcaga cagtgcctca aactacttcc cttggtataa gcaagaactt 120
ggaaaaagac ctcagcttat tatagacatt cgttcaaatg tgggcgaaaa gaaagaccaa 180
cgaattgctg ttacattgaa caagacagcc aaacatttct ccctgcacat cacagagacc 240
caacctgaag actcggctgt ctacttctgt gcagcaagta ggggaggctc tagcaacaca 300
ggcaaactaa tctttgggca agggacaact ttacaagtaa aaccag                346

<210> 630
<211> 346
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 630
gatgctggaa tcacccagag cccaagacac aaggtcacag agacaggaac accagtgact 60
ctgagatgtc accagactga gaaccaccgc tatatgtact ggtatcgaca agacccgggg 120
catgggctga ggctgatcca ttactcatat ggtgttaaag atactgacaa aggagaagtc 180
tcagatggct atagtgtctc tagatcaaag acagaggatt tcctcctcac tctggagtcc 240
gctaccagct cccagacatc tgtgtacttc tgtgccatcg ggacagggcc aacccgcggt 300
acctacgagc agtacttcgg gccgggcacc aggctcacgg tcacag                346

<210> 631
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 631
gcccagtcag tgacccagcc tgacatccac atcactgtct ctgaaggagc ctcactggag 60
ttgagatgta actattccta tggggcaaca ccttatctct tctggtatgt ccagtccccc 120
ggccaaggcc tccagctgct cctgaagtac ttttcaggag acactctggt tcaaggcatt 180
aaaggctttg aggctgaatt taagaggagt caatcttcct tcaatctgag gaaaccctct 240
gtgcattgga gtgatgctgc tgagtacttc tgtgctgtgg gtgcgggtaa caatgccaga 300
ctcatgtttg gagatggaac tcagctggtg gtgaagccca                       340

<210> 632
<211> 340
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 632
gaacctgaag tcacccagac tcccagccat caggtcacac agatgggaca ggaagtgatc 60
ttgcgctgtg tccccatctc taatcactta tacttctatt ggtacagaca aatcttgggg 120
cagaaagtcg agtttctggt ttccttttat aataatgaaa tctcagagaa gtctgaaata 180
ttcgatgatc aattctcagt tgaaaggcct gatggatcaa atttcactct gaagatccgg 240
tccacaaagc tggaggactc agccatgtac ttctgtgccg gagcccagcg ggctaatgaa 300
aaactgtttt ttggcagtgg aacccagctc tctgtcttgg                       340

<210> 633
<211> 328
<212> DNA
<213> Homo sapiens

<220> 
<223> TCR alpha and beta chain V region of TCR that
      specifically recognizes antigen associated with
      pathogenesis of autoimmune, allergic, or
      inflammatory condition

<400> 633
cggaaggagg tggagcagga tcctggaccc ttcaatgttc cagagggagc cactgtcgct 60
ttcaactgta cttacagcaa cagtgcttct cagtctttct tctggtacag acaggattgc 120
aggaaagaac ctaagttgct gatgtccgta tactccagtg gtaatgaaga tggaaggttt 180
acagcacagc tcaatagagc cagccagtat atttccctgc tcatcagaga ctccaagctc 240
agtgattcag ccacctacct ctgtgtggtg aacggaggaa gctacatacc tacatttgga 300
agaggaacca gccttattgt tcatccgt                                    328

<210> 634
<211> 21
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 634
Cys Ala Ser Ser Leu Ile Pro Phe Leu Ala Gly Val Leu Ala Asn Tyr
 1               5                  10                  15      
Asn Glu Gln Phe Phe
            20      


<210> 635
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 635
Cys Ala Leu Ser Asn Asp Met Glu Tyr Gly Asn Lys Leu Val Phe
 1               5                  10                  15  


<210> 636
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 636
Cys Ala Ser Ser Leu Ser Gly Asn Ser Asn Gln Pro Gln His Phe
 1               5                  10                  15  


<210> 637
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 637
Cys Ala Phe Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10          


<210> 638
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 638
Cys Ala Trp Ser Val Arg Gly Asp Gln Pro Gln His Phe
 1               5                  10              


<210> 639
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 639
Cys Ala Val Leu Tyr Gly Gly Ser Glu Lys Leu Val Phe
 1               5                  10              


<210> 640
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 640
Cys Ala Ser Arg Pro Gly Thr Ile Asn Gln Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 641
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 641
Cys Ala Glu Asn Lys Val Ser Asp Gly Gln Lys Leu Leu Phe
 1               5                  10                  


<210> 642
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 642
Cys Ala Ser Ser Ser Asn Pro Arg Asp Asn Tyr Gly Tyr Thr Phe
 1               5                  10                  15  


<210> 643
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 643
Cys Leu Val Gly Glu Tyr Gly Asn Lys Leu Val Phe
 1               5                  10          


<210> 644
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 644
Cys Ala Ser Lys Phe Pro Trp Gly Ala Val Gly Glu Leu Phe Phe
 1               5                  10                  15  


<210> 645
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 645
Cys Ala Ala Ser Lys Gly Ser Ser Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  15  


<210> 646
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 646
Cys Ala Ile Thr Pro Gly Gln Gly Ala Lys Gly Gly Glu Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 647
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 647
Cys Ala Tyr Arg Gly Ser Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10                  


<210> 648
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 648
Cys Ala Ser Ser Tyr Arg Leu Met Gly Ser Gly Ser Arg Glu Thr Gln
 1               5                  10                  15      
Tyr Phe
        


<210> 649
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 649
Cys Ala Leu His Gly Gly Ser Tyr Ile Pro Thr Phe
 1               5                  10          


<210> 650
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 650
Cys Ala Leu Ser Asp Arg Gly Thr Ser Gly Ser Arg Leu Thr Phe
 1               5                  10                  15  


<210> 651
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 651
Cys Ala Ser Ser Arg Trp Thr Gly Gly Asn Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 652
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 652
Cys Ala Ala Ser Arg Gly Gly Ser Ser Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  15      


<210> 653
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 653
Cys Ala Ile Gly Thr Gly Pro Thr Arg Gly Thr Tyr Glu Gln Tyr Phe
 1               5                  10                  15      


<210> 654
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 654
Cys Ala Val Gly Ala Gly Asn Asn Ala Arg Leu Met Phe
 1               5                  10              


<210> 655
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 655
Cys Ala Gly Ala Gln Arg Ala Asn Glu Lys Leu Phe Phe
 1               5                  10              


<210> 656
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> junction sequence of TCR that specifically
      recognizes antigen associated with pathogenesis of
      autoimmune, allergic, or inflammatory condition

<400> 656
Cys Val Val Asn Gly Gly Ser Tyr Ile Pro Thr Phe
 1               5                  10          


<210> 657
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 657
Arg Arg Phe Glu Tyr Asp Asp Pro Arg Phe Leu Arg Leu Leu Asp Leu
 1               5                  10                  15      
Ala Gln Glu Gly
            20  


<210> 658
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 658
Ala Gly Met Val Thr Thr Ser Thr Thr Leu Ala Trp Gly Leu Leu Leu
 1               5                  10                  15      
Met Ile Leu His
            20  


<210> 659
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 659
Thr Leu Ala Trp Gly Leu Leu Leu Met Ile Leu His Pro Asp Val Gln
 1               5                  10                  15      
Arg Arg Val Gln
            20  


<210> 660
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 660
Thr Thr Leu Ile Thr Asn Leu Ser Ser Val Leu Lys Asp Glu Ala Val
 1               5                  10                  15      
Trp Glu Lys Pro
            20  


<210> 661
<211> 52
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 661
Leu Ala Trp Thr Pro Val Val Val Leu Asn Gly Leu Ala Ala Val Arg
 1               5                  10                  15      
Glu Ala Leu Val Thr His Gly Glu Asp Thr Ala Asp Arg Pro Pro Val
            20                  25                  30          
Pro Ile Thr Gln Ile Leu Gly Phe Gly Pro Arg Ser Gln Gly Val Phe
        35                  40                  45              
Leu Ala Arg Tyr
    50          


<210> 662
<211> 36
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 662
Leu Leu Asp Lys Ala Val Ser Asn Val Ile Ala Ser Leu Thr Cys Gly
 1               5                  10                  15      
Arg Arg Phe Glu Tyr Asp Asp Pro Arg Phe Leu Arg Leu Leu Asp Leu
            20                  25                  30          
Ala Gln Glu Gly
        35      


<210> 663
<211> 44
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 663
Ser Gly Phe Leu Arg Glu Val Leu Asn Ala Val Pro Val Leu Leu His
 1               5                  10                  15      
Ile Pro Ala Leu Ala Gly Lys Val Leu Arg Phe Gln Lys Ala Phe Leu
            20                  25                  30          
Thr Gln Leu Asp Glu Leu Leu Thr Glu His Arg Met
        35                  40                  


<210> 664
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 664
Lys Ala Lys Gly Asn Pro Glu Ser Ser Phe Asn Asp Glu Asn Leu Arg
 1               5                  10                  15      
Ile Val Val Ala
            20  


<210> 665
<211> 44
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 665
Ala Gly Met Val Thr Thr Ser Thr Thr Leu Ala Trp Gly Leu Leu Leu
 1               5                  10                  15      
Met Ile Leu His Pro Asp Val Gln Arg Arg Val Gln Gln Glu Ile Asp
            20                  25                  30          
Asp Val Ile Gly Gln Val Arg Arg Pro Glu Met Gly
        35                  40                  


<210> 666
<211> 36
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 666
Met Thr Ser Arg Asp Ile Glu Val Gln Gly Phe Arg Ile Pro Lys Gly
 1               5                  10                  15      
Thr Thr Leu Ile Thr Asn Leu Ser Ser Val Leu Lys Asp Glu Ala Val
            20                  25                  30          
Trp Glu Lys Pro
        35      


<210> 667
<211> 28
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 667
Trp Glu Lys Pro Phe Arg Phe His Pro Glu His Phe Leu Asp Ala Gln
 1               5                  10                  15      
Gly His Phe Val Lys Pro Glu Ala Phe Leu Pro Phe
            20                  25              


<210> 668
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 668
Arg Leu Leu Asp Leu Ala Glu Gly Leu
 1               5                  


<210> 669
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 669
Gly Leu Glu Ala Leu Val Pro Leu Ala Val
 1               5                  10  


<210> 670
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 670
Lys Ala Phe Leu Thr Gln Leu Asp Glu Leu
 1               5                  10  


<210> 671
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 671
Thr Thr Leu Ile Thr Asn Leu Ser Ser Val
 1               5                  10  


<210> 672
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 672
Leu Leu Asp Lys Ala Val Ser Asn Val Ile
 1               5                  10  


<210> 673
<211> 8
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 673
Asp Pro Ala Gln Pro Pro Arg Asp
 1               5              


<210> 674
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 674
Arg Arg Phe Glu Tyr Asp Asp Pro Arg Phe Leu Arg Leu Leu Asp Leu
 1               5                  10                  15      
Ala Gln Glu Gly
            20  


<210> 675
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 675
Glu Leu Leu Thr Glu His Arg Met Thr Trp Asp Pro Ala Gln Pro Pro
 1               5                  10                  15      
Arg Asp Leu Thr
            20  


<210> 676
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 676
Pro Arg Asp Leu Thr Glu Ala Phe Leu Ala Glu Met Glu Lys Ala Lys
 1               5                  10                  15      
Gly Asn Pro Glu
            20  


<210> 677
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 677
Gln Arg Arg Val Gln Gln Glu Ile Asp Asp Val Ile Gly Gln Val Arg
 1               5                  10                  15      
Arg Pro Glu Met
            20  


<210> 678
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 678
Gly Met Thr His Met Thr Ser Arg Asp Ile Glu Val Gln Gly Phe Arg
 1               5                  10                  15      
Ile Pro Lys Gly
            20  


<210> 679
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2".

<400> 679
Glu His Phe Leu Asp Ala Gln Gly His Phe Val Lys Pro Glu Ala Phe
 1               5                  10                  15      
Leu Pro Phe Ser
            20  


<210> 680
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 680
Glu His Arg Met Thr Trp Asp Pro Ala Gln Pro Pro Arg
 1               5                  10              


<210> 681
<211> 31
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 681
Met Ile Leu His Pro Asp Val Gln Arg Arg Val Gln Gln Glu Ile Asp
 1               5                  10                  15      
Asp Val Ile Gly Gln Val Arg Arg Pro Glu Met Gly Asp Gln Ala
            20                  25                  30      


<210> 682
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 682
Gly Val Thr His Met Thr Ser Arg Asp Ile Glu Val Gln Gly Phe Arg
 1               5                  10                  15      
Ile
    


<210> 683
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 683
Glu Lys Pro Phe Arg Phe His Pro Glu His Phe Leu Asp Ala Gln Gly
 1               5                  10                  15      
His Phe Val Lys
            20  


<210> 684
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 684
Glu His Arg Met Thr Trp Asp Pro Ala Gln Pro Pro Arg
 1               5                  10              


<210> 685
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for a
      CYP2D6 antigen associated with autoimmune
      hepatitis type 2

<400> 685
Glu Tyr Asp Asp Pro Arg Phe Leu Arg Leu Leu Asp Leu Ala Gln Glu
 1               5                  10                  15      
Gly Leu Lys Glu Glu Ser Gly
            20              


<210> 686
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 686
Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu
 1               5                  10                  


<210> 687
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 687
Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu
 1               5                  10                  


<210> 688
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 688
Lys Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp
 1               5                  10                  


<210> 689
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 689
Lys Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp
 1               5                  10                  


<210> 690
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 690
Lys Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp
 1               5                  10                  


<210> 691
<211> 1011
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 691
Ile Ala Leu Ala Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp Glu
 1               5                  10                  15      
Leu Glu Arg Ile Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp
            20                  25                  30          
Arg Ile Glu Lys Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala
        35                  40                  45              
Asp Leu Asp Lys Ile Gly Leu His Ser Asp Ser Gln Glu Glu Leu Trp
    50                  55                  60                  
Met Phe Val Arg Lys Lys Leu Met Met Glu Gln Glu Asn Gly Asn Leu
65                  70                  75                  80  
Arg Gly Ser Pro Gly Pro Lys Gly Asp Met Gly Ser Pro Gly Pro Lys
                85                  90                  95      
Gly Asp Arg Gly Phe Pro Gly Thr Pro Gly Ile Pro Gly Pro Leu Gly
            100                 105                 110         
His Pro Gly Pro Gln Gly Pro Lys Gly Gln Lys Gly Ser Val Gly Asp
        115                 120                 125             
Pro Gly Met Glu Gly Pro Met Gly Gln Arg Gly Arg Glu Gly Pro Met
    130                 135                 140                 
Gly Pro Arg Gly Glu Ala Gly Pro Pro Gly Ser Gly Glu Lys Gly Glu
145                 150                 155                 160 
Arg Gly Ala Ala Gly Glu Pro Gly Pro His Gly Pro Pro Gly Val Pro
                165                 170                 175     
Gly Ser Val Gly Pro Lys Gly Ser Ser Gly Ser Pro Gly Pro Gln Gly
            180                 185                 190         
Pro Pro Gly Pro Val Gly Leu Gln Gly Leu Arg Gly Glu Val Gly Leu
        195                 200                 205             
Pro Gly Val Lys Gly Asp Lys Gly Pro Met Gly Pro Pro Gly Pro Lys
    210                 215                 220                 
Gly Asp Gln Gly Glu Lys Gly Pro Arg Gly Leu Thr Gly Glu Pro Gly
225                 230                 235                 240 
Met Arg Gly Leu Pro Gly Ala Val Gly Glu Pro Gly Ala Lys Gly Ala
                245                 250                 255     
Met Gly Pro Ala Gly Pro Asp Gly His Gln Gly Pro Arg Gly Glu Gln
            260                 265                 270         
Gly Leu Thr Gly Met Pro Gly Ile Arg Gly Pro Pro Gly Pro Ser Gly
        275                 280                 285             
Asp Pro Gly Lys Pro Gly Leu Thr Gly Pro Gln Gly Pro Gln Gly Leu
    290                 295                 300                 
Pro Gly Thr Pro Gly Arg Pro Gly Ile Lys Gly Glu Pro Gly Ala Pro
305                 310                 315                 320 
Gly Lys Ile Val Thr Ser Glu Gly Ser Ser Met Leu Thr Val Pro Gly
                325                 330                 335     
Pro Pro Gly Pro Pro Gly Ala Met Gly Pro Pro Gly Pro Pro Gly Ala
            340                 345                 350         
Pro Gly Pro Ala Gly Pro Ala Gly Leu Pro Gly His Gln Glu Val Leu
        355                 360                 365             
Asn Leu Gln Gly Pro Pro Gly Pro Pro Gly Pro Arg Gly Pro Pro Gly
    370                 375                 380                 
Pro Ser Ile Pro Gly Pro Pro Gly Pro Arg Gly Pro Pro Gly Glu Gly
385                 390                 395                 400 
Leu Pro Gly Pro Pro Gly Pro Pro Gly Ser Phe Leu Ser Asn Ser Glu
                405                 410                 415     
Thr Phe Leu Ser Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro Lys
            420                 425                 430         
Gly Asp Gln Gly Pro Pro Gly Pro Arg Gly His Gln Gly Glu Gln Gly
        435                 440                 445             
Leu Pro Gly Phe Ser Thr Ser Gly Ser Ser Ser Phe Gly Leu Asn Leu
    450                 455                 460                 
Gln Gly Pro Pro Gly Pro Pro Gly Pro Gln Gly Pro Lys Gly Asp Lys
465                 470                 475                 480 
Gly Asp Pro Gly Val Pro Gly Ala Leu Gly Ile Pro Ser Gly Pro Ser
                485                 490                 495     
Glu Gly Gly Ser Ser Ser Thr Met Tyr Val Ser Gly Pro Pro Gly Pro
            500                 505                 510         
Pro Gly Pro Pro Gly Pro Pro Gly Ser Ile Ser Ser Ser Gly Gln Glu
        515                 520                 525             
Ile Gln Gln Tyr Ile Ser Glu Tyr Met Gln Ser Asp Ser Ile Arg Ser
    530                 535                 540                 
Tyr Leu Ser Gly Val Gln Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly
545                 550                 555                 560 
Pro Val Thr Thr Ile Thr Gly Glu Thr Phe Asp Tyr Ser Glu Leu Ala
                565                 570                 575     
Ser His Val Val Ser Tyr Leu Arg Thr Ser Gly Tyr Gly Val Ser Leu
            580                 585                 590         
Phe Ser Ser Ser Ile Ser Ser Glu Asp Ile Leu Ala Val Leu Gln Arg
        595                 600                 605             
Asp Asp Val Arg Gln Tyr Leu Arg Gln Tyr Leu Met Gly Pro Arg Gly
    610                 615                 620                 
Pro Pro Gly Pro Pro Gly Ala Ser Gly Asp Gly Ser Leu Leu Ser Leu
625                 630                 635                 640 
Asp Tyr Ala Glu Leu Ser Ser Arg Ile Leu Ser Tyr Met Ser Ser Ser
                645                 650                 655     
Gly Ile Ser Ile Gly Leu Pro Gly Pro Pro Gly Pro Pro Gly Leu Pro
            660                 665                 670         
Gly Thr Ser Tyr Glu Glu Leu Leu Ser Leu Leu Arg Gly Ser Glu Phe
        675                 680                 685             
Arg Gly Ile Val Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Ile Pro
    690                 695                 700                 
Gly Asn Val Trp Ser Ser Ile Ser Val Glu Asp Leu Ser Ser Tyr Leu
705                 710                 715                 720 
His Thr Ala Gly Leu Ser Phe Ile Pro Gly Pro Pro Gly Pro Pro Gly
                725                 730                 735     
Pro Pro Gly Pro Arg Gly Pro Pro Gly Val Ser Gly Ala Leu Ala Thr
            740                 745                 750         
Tyr Ala Ala Glu Asn Ser Asp Ser Phe Arg Ser Glu Leu Ile Ser Tyr
        755                 760                 765             
Leu Thr Ser Pro Asp Val Arg Ser Phe Ile Val Gly Pro Pro Gly Pro
    770                 775                 780                 
Pro Gly Pro Gln Gly Pro Pro Gly Asp Ser Arg Leu Leu Ser Thr Asp
785                 790                 795                 800 
Ala Ser His Ser Arg Gly Ser Ser Ser Ser Ser His Ser Ser Ser Val
                805                 810                 815     
Arg Arg Gly Ser Ser Tyr Ser Ser Ser Met Ser Thr Gly Gly Gly Gly
            820                 825                 830         
Ala Gly Ser Leu Gly Ala Gly Gly Ala Phe Gly Glu Ala Ala Gly Asp
        835                 840                 845             
Arg Gly Pro Tyr Gly Thr Asp Ile Gly Pro Gly Gly Gly Tyr Gly Ala
    850                 855                 860                 
Ala Ala Glu Gly Gly Met Tyr Ala Gly Asn Gly Gly Leu Leu Gly Ala
865                 870                 875                 880 
Asp Phe Ala Gly Asp Leu Asp Tyr Asn Glu Leu Ala Val Arg Val Ser
                885                 890                 895     
Glu Ser Met Gln Arg Gln Gly Leu Leu Gln Gly Met Ala Tyr Thr Val
            900                 905                 910         
Gln Gly Pro Pro Gly Gln Pro Gly Pro Gln Gly Pro Pro Gly Ile Ser
        915                 920                 925             
Lys Val Phe Ser Ala Tyr Ser Asn Val Thr Ala Asp Leu Met Asp Phe
    930                 935                 940                 
Phe Gln Thr Tyr Gly Ala Ile Gln Gly Pro Pro Gly Gln Lys Glu Met
945                 950                 955                 960 
Gly Thr Pro Gly Pro Lys Gly Asp Arg Gly Pro Ala Gly Pro Pro Gly
                965                 970                 975     
His Pro Gly Pro Pro Gly Pro Arg Gly His Lys Gly Glu Lys Gly Asp
            980                 985                 990         
Lys Gly Asp Gln Val Tyr Ala Gly Arg Arg Arg Arg Arg Ser Ile Ala
        995                 1000                1005            
Val Lys Pro
    1010    


<210> 692
<211> 321
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 692
Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp Glu Leu Glu Arg Ile
 1               5                  10                  15      
Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu Lys
            20                  25                  30          
Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp Leu Asp Lys
        35                  40                  45              
Ile Gly Leu His Ser Asp Ser Gln Glu Glu Leu Trp Met Phe Val Arg
    50                  55                  60                  
Lys Lys Leu Met Met Glu Gln Glu Asn Gly Asn Leu Arg Gly Ser Pro
65                  70                  75                  80  
Gly Pro Lys Gly Asp Met Gly Ser Pro Gly Pro Lys Gly Asp Arg Gly
                85                  90                  95      
Phe Pro Gly Thr Pro Gly Ile Pro Gly Pro Leu Gly His Pro Gly Pro
            100                 105                 110         
Gln Gly Pro Lys Gly Gln Lys Gly Ser Val Gly Asp Pro Gly Met Glu
        115                 120                 125             
Gly Pro Met Gly Gln Arg Gly Arg Glu Gly Pro Met Gly Pro Arg Gly
    130                 135                 140                 
Glu Ala Gly Pro Pro Gly Ser Gly Glu Lys Gly Glu Arg Gly Ala Ala
145                 150                 155                 160 
Gly Glu Pro Gly Pro His Gly Pro Pro Gly Val Pro Gly Ser Val Gly
                165                 170                 175     
Pro Lys Gly Ser Ser Gly Ser Pro Gly Pro Gln Gly Pro Pro Gly Pro
            180                 185                 190         
Val Gly Leu Gln Gly Leu Arg Gly Glu Val Gly Leu Pro Gly Val Lys
        195                 200                 205             
Gly Asp Lys Gly Pro Met Gly Pro Pro Gly Pro Lys Gly Asp Gln Gly
    210                 215                 220                 
Glu Lys Gly Pro Arg Gly Leu Thr Gly Glu Pro Gly Met Arg Gly Leu
225                 230                 235                 240 
Pro Gly Ala Val Gly Glu Pro Gly Ala Lys Gly Ala Met Gly Pro Ala
                245                 250                 255     
Gly Pro His Gln Gly Pro Arg Gly Glu Gln Gly Leu Thr Gly Met Pro
            260                 265                 270         
Gly Ile Arg Gly Pro Pro Gly Pro Ser Gly Asp Pro Gly Lys Pro Gly
        275                 280                 285             
Leu Thr Gly Pro Gln Gly Pro Gln Gly Leu Pro Gly Thr Pro Gly Arg
    290                 295                 300                 
Pro Gly Ile Lys Gly Glu Pro Gly Ala Pro Gly Lys Ile Val Thr Ser
305                 310                 315                 320 
Glu
    


<210> 693
<211> 70
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 693
Trp Leu Leu Gly Leu Leu Leu Thr Trp Leu Leu Leu Leu Gly Leu Leu
 1               5                  10                  15      
Phe Gly Leu Ile Ala Leu Ala Glu Glu Val Arg Lys Leu Lys Ala Arg
            20                  25                  30          
Val Asp Glu Leu Glu Arg Ile Arg Arg Ser Ile Leu Pro Tyr Gly Asp
        35                  40                  45              
Ser Met Asp Arg Ile Glu Lys Asp Arg Leu Gln Gly Met Ala Pro Ala
    50                  55                  60                  
Ala Gly Ala Asp Leu Asp
65                  70  


<210> 694
<211> 31
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 694
Lys Ile Gly Leu His Ser Asp Ser Gln Glu Glu Leu Trp Met Phe Val
 1               5                  10                  15      
Arg Lys Lys Leu Met Met Glu Gln Glu Asn Gly Asn Leu Arg Gly
            20                  25                  30      


<210> 695
<211> 417
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 695
Thr Thr Ile Thr Gly Glu Thr Phe Asp Tyr Ser Glu Leu Ala Ser His
 1               5                  10                  15      
Val Val Ser Tyr Leu Arg Thr Ser Gly Tyr Gly Val Ser Leu Phe Ser
            20                  25                  30          
Ser Ser Ile Ser Ser Glu Asp Ile Leu Ala Val Leu Gln Arg Asp Asp
        35                  40                  45              
Val Arg Gln Tyr Leu Arg Gln Tyr Leu Met Gly Pro Arg Gly Pro Pro
    50                  55                  60                  
Gly Pro Pro Gly Ala Ser Gly Asp Gly Ser Leu Leu Ser Leu Asp Tyr
65                  70                  75                  80  
Ala Glu Leu Ser Ser Arg Ile Leu Ser Tyr Met Ser Ser Ser Gly Ile
                85                  90                  95      
Ser Ile Gly Leu Pro Gly Pro Pro Gly Pro Pro Gly Leu Pro Gly Thr
            100                 105                 110         
Ser Tyr Glu Glu Leu Leu Ser Leu Leu Arg Gly Ser Glu Phe Arg Gly
        115                 120                 125             
Ile Val Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Ile Pro Gly Asn
    130                 135                 140                 
Val Trp Ser Ser Ile Ser Val Glu Asp Leu Ser Ser Tyr Leu His Thr
145                 150                 155                 160 
Ala Gly Leu Ser Phe Ile Pro Gly Pro Pro Gly Pro Pro Gly Pro Pro
                165                 170                 175     
Gly Pro Arg Gly Pro Pro Gly Val Ser Gly Ala Leu Ala Thr Tyr Ala
            180                 185                 190         
Ala Glu Asn Ser Asp Ser Phe Arg Ser Glu Leu Ile Ser Tyr Leu Thr
        195                 200                 205             
Ser Pro Asp Val Arg Ser Phe Ile Val Gly Pro Pro Gly Pro Pro Gly
    210                 215                 220                 
Pro Gln Gly Pro Pro Gly Asp Ser Arg Leu Leu Ser Thr Asp Ala Ser
225                 230                 235                 240 
His Ser Arg Gly Ser Ser Ser Ser Ser His Ser Ser Ser Val Arg Arg
                245                 250                 255     
Gly Ser Ser Tyr Ser Ser Ser Met Ser Thr Gly Gly Gly Gly Ala Gly
            260                 265                 270         
Ser Leu Gly Ala Gly Gly Ala Phe Gly Glu Ala Ala Gly Asp Arg Gly
        275                 280                 285             
Pro Tyr Gly Thr Asp Ile Gly Pro Gly Gly Gly Tyr Gly Ala Ala Ala
    290                 295                 300                 
Glu Gly Gly Met Tyr Ala Gly Asn Gly Gly Leu Leu Gly Ala Asp Phe
305                 310                 315                 320 
Ala Gly Asp Leu Asp Tyr Asn Glu Leu Ala Val Val Ser Glu Ser Met
                325                 330                 335     
Gln Arg Gln Gly Leu Leu Gln Gly Met Ala Tyr Thr Val Gln Gly Pro
            340                 345                 350         
Pro Gly Gln Pro Gly Pro Gln Gly Pro Pro Gly Ile Ser Lys Val Phe
        355                 360                 365             
Ser Ala Tyr Ser Asn Val Thr Ala Asp Leu Met Asp Phe Phe Gln Thr
    370                 375                 380                 
Tyr Gly Ala Ile Gln Gly Pro Pro Gly Gln Lys Gly Glu Met Gly Thr
385                 390                 395                 400 
Pro Gly Pro Lys Gly Asp Arg Gly Pro Ala Gly Pro Pro Gly His Pro
                405                 410                 415     
Gly
    


<210> 696
<211> 114
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 696
Glu Gly Gly Met Tyr Ala Gly Asn Gly Gly Leu Leu Gly Ala Asp Phe
 1               5                  10                  15      
Ala Gly Asp Leu Asp Tyr Asn Glu Leu Ala Val Arg Val Ser Glu Ser
            20                  25                  30          
Met Gln Arg Gln Gly Leu Leu Gln Gly Met Ala Tyr Thr Val Gln Gly
        35                  40                  45              
Pro Pro Gly Gln Pro Gly Pro Gln Gly Pro Pro Gly Ile Ser Lys Val
    50                  55                  60                  
Phe Ser Ala Tyr Ser Asn Val Thr Ala Asp Leu Met Asp Phe Phe Gln
65                  70                  75                  80  
Thr Tyr Gly Ala Ile Gln Gly Pro Pro Gly Gln Lys Gly Glu Met Gly
                85                  90                  95      
Thr Pro Gly Pro Lys Gly Asp Arg Gly Pro Ala Gly Pro Pro Gly His
            100                 105                 110         
Pro Gly
        


<210> 697
<211> 769
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 697
Asp Phe Glu Met Thr Val Lys Glu Cys Gln His Ser Gly Glu Leu Ser
 1               5                  10                  15      
Ser Arg Asn Thr Gly His Leu His Pro Thr Pro Arg Ser Pro Leu Leu
            20                  25                  30          
Arg Trp Thr Gln Glu Pro Gln Pro Leu Glu Glu Lys Trp Gln His Arg
        35                  40                  45              
Val Val Glu Gln Ile Pro Lys Glu Val Gln Phe Gln Pro Pro Gly Ala
    50                  55                  60                  
Pro Leu Glu Lys Glu Lys Ser Gln Gln Cys Tyr Ser Glu Tyr Phe Ser
65                  70                  75                  80  
Gln Thr Ser Thr Glu Leu Gln Ile Thr Phe Asp Glu Thr Asn Pro Ile
                85                  90                  95      
Thr Arg Leu Ser Glu Ile Glu Lys Ile Arg Asp Gln Ala Leu Asn Asn
            100                 105                 110         
Ser Arg Pro Pro Val Arg Tyr Gln Asp Asn Ala Cys Glu Met Glu Leu
        115                 120                 125             
Val Lys Val Leu Thr Pro Leu Glu Ile Ala Lys Asn Lys Gln Tyr Asp
    130                 135                 140                 
Met His Thr Glu Val Thr Thr Leu Lys Gln Glu Lys Asn Pro Val Pro
145                 150                 155                 160 
Ser Ala Glu Glu Trp Met Leu Glu Gly Cys Arg Ala Ser Gly Gly Leu
                165                 170                 175     
Lys Lys Gly Asp Phe Leu Lys Lys Gly Leu Glu Pro Glu Thr Phe Gln
            180                 185                 190         
Asn Phe Asp Gly Asp His Ala Cys Ser Val Arg Asp Asp Glu Phe Lys
        195                 200                 205             
Phe Gln Gly Leu Arg His Thr Val Thr Ala Arg Gln Leu Val Glu Ala
    210                 215                 220                 
Lys Leu Leu Asp Met Arg Thr Ile Glu Gln Leu Arg Leu Gly Leu Lys
225                 230                 235                 240 
Thr Val Glu Glu Val Gln Lys Thr Leu Asn Lys Phe Leu Thr Lys Ala
                245                 250                 255     
Thr Ser Ile Ala Gly Leu Tyr Leu Glu Ser Thr Lys Glu Lys Ile Ser
            260                 265                 270         
Phe Ala Ser Ala Ala Glu Arg Ile Ile Ile Asp Lys Met Val Ala Leu
        275                 280                 285             
Ala Phe Leu Glu Ala Gln Ala Ala Thr Gly Phe Ile Ile Asp Pro Ile
    290                 295                 300                 
Ser Gly Gln Thr Tyr Ser Val Glu Asp Ala Val Leu Lys Gly Val Val
305                 310                 315                 320 
Asp Pro Glu Phe Arg Ile Arg Leu Leu Glu Ala Glu Lys Ala Ala Val
                325                 330                 335     
Gly Tyr Ser Tyr Ser Ser Lys Thr Leu Ser Val Phe Gln Ala Met Glu
            340                 345                 350         
Asn Arg Met Leu Asp Arg Gln Lys Gly Lys His Ile Leu Glu Ala Gln
        355                 360                 365             
Ile Ala Ser Gly Gly Val Ile Asp Pro Val Arg Gly Ile Arg Val Pro
    370                 375                 380                 
Pro Glu Ile Ala Leu Gln Gln Gly Leu Leu Asn Asn Ala Ile Leu Gln
385                 390                 395                 400 
Phe Leu His Glu Pro Ser Ser Asn Thr Arg Val Phe Pro Asn Pro Asn
                405                 410                 415     
Asn Lys Gln Ala Leu Tyr Tyr Ser Glu Leu Leu Arg Met Cys Val Phe
            420                 425                 430         
Asp Val Glu Ser Gln Cys Phe Leu Phe Pro Phe Gly Glu Arg Asn Ile
        435                 440                 445             
Ser Asn Leu Asn Val Lys Lys Thr His Arg Ile Ser Val Val Asp Thr
    450                 455                 460                 
Lys Thr Gly Ser Glu Leu Thr Val Tyr Glu Ala Phe Gln Arg Asn Leu
465                 470                 475                 480 
Ile Glu Lys Ser Ile Tyr Leu Glu Leu Ser Gly Gln Gln Tyr Gln Trp
                485                 490                 495     
Lys Glu Ala Met Phe Phe Glu Ser Tyr Gly His Ser Ser His Met Leu
            500                 505                 510         
Thr Asp Thr Lys Thr Gly Leu His Phe Asn Ile Asn Glu Ala Ile Glu
        515                 520                 525             
Gln Gly Thr Ile Asp Lys Ala Leu Val Lys Lys Tyr Gln Glu Gly Leu
    530                 535                 540                 
Ile Thr Leu Thr Glu Leu Ala Asp Ser Leu Leu Ser Arg Leu Val Pro
545                 550                 555                 560 
Lys Lys Asp Leu His Ser Pro Val Ala Gly Tyr Trp Leu Thr Ala Ser
                565                 570                 575     
Gly Glu Arg Ile Ser Val Leu Lys Ala Ser Arg Arg Asn Leu Val Asp
            580                 585                 590         
Arg Ile Thr Ala Leu Arg Cys Leu Glu Ala Gln Val Ser Thr Gly Gly
        595                 600                 605             
Ile Ile Asp Pro Leu Thr Gly Lys Lys Tyr Arg Val Ala Glu Ala Leu
    610                 615                 620                 
His Arg Gly Leu Val Asp Glu Gly Phe Ala Gln Gln Leu Arg Gln Cys
625                 630                 635                 640 
Glu Leu Val Ile Thr Gly Ile Gly His Pro Ile Thr Asn Lys Met Met
                645                 650                 655     
Ser Val Val Glu Ala Val Asn Ala Asn Ile Ile Asn Lys Glu Met Gly
            660                 665                 670         
Ile Arg Cys Leu Glu Phe Gln Tyr Leu Thr Gly Gly Leu Ile Glu Pro
        675                 680                 685             
Gln Val His Ser Arg Leu Ser Ile Glu Glu Ala Leu Gln Val Gly Ile
    690                 695                 700                 
Ile Asp Val Leu Ile Ala Thr Lys Leu Lys Asp Gln Lys Ser Tyr Val
705                 710                 715                 720 
Arg Asn Ile Ile Cys Pro Gln Thr Lys Arg Lys Leu Thr Tyr Lys Glu
                725                 730                 735     
Ala Leu Glu Lys Ala Asp Phe Asp Phe His Thr Gly Leu Lys Leu Leu
            740                 745                 750         
Glu Val Ser Glu Pro Leu Met Thr Gly Ile Ser Ser Leu Tyr Tyr Ser
        755                 760                 765             
Ser
    


<210> 698
<211> 573
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 698
Asp His Ala Cys Ser Val Arg Asp Asp Glu Phe Lys Phe Gln Gly Leu
 1               5                  10                  15      
Arg His Thr Val Thr Ala Arg Gln Leu Val Glu Ala Lys Leu Leu Asp
            20                  25                  30          
Met Arg Thr Ile Glu Gln Leu Arg Leu Gly Leu Lys Thr Val Glu Glu
        35                  40                  45              
Val Gln Lys Thr Leu Asn Lys Phe Leu Thr Lys Ala Thr Ser Ile Ala
    50                  55                  60                  
Gly Leu Tyr Leu Glu Ser Thr Lys Glu Lys Ile Ser Phe Ala Ser Ala
65                  70                  75                  80  
Ala Glu Arg Ile Ile Ile Asp Lys Met Val Ala Leu Ala Phe Leu Glu
                85                  90                  95      
Ala Gln Ala Ala Thr Gly Phe Ile Ile Asp Pro Ile Ser Gly Gln Thr
            100                 105                 110         
Tyr Ser Val Glu Asp Ala Val Leu Lys Gly Val Val Asp Pro Glu Phe
        115                 120                 125             
Arg Ile Arg Leu Leu Glu Ala Glu Lys Ala Ala Val Gly Tyr Ser Tyr
    130                 135                 140                 
Ser Ser Lys Thr Leu Ser Val Phe Gln Ala Met Glu Asn Arg Met Leu
145                 150                 155                 160 
Asp Arg Gln Lys Gly Lys His Ile Leu Glu Ala Gln Ile Ala Ser Gly
                165                 170                 175     
Gly Val Ile Asp Pro Val Arg Gly Ile Arg Val Pro Pro Glu Ile Ala
            180                 185                 190         
Leu Gln Gln Gly Leu Leu Asn Asn Ala Ile Leu Gln Phe Leu His Glu
        195                 200                 205             
Pro Ser Ser Asn Thr Arg Val Phe Pro Asn Pro Asn Asn Lys Gln Ala
    210                 215                 220                 
Leu Tyr Tyr Ser Glu Leu Leu Arg Met Cys Val Phe Asp Val Glu Ser
225                 230                 235                 240 
Gln Cys Phe Leu Phe Pro Phe Gly Glu Arg Asn Ile Ser Asn Leu Asn
                245                 250                 255     
Val Lys Lys Thr His Arg Ile Ser Val Val Asp Thr Lys Thr Gly Ser
            260                 265                 270         
Glu Leu Thr Val Tyr Glu Ala Phe Gln Arg Asn Leu Ile Glu Lys Ser
        275                 280                 285             
Ile Tyr Leu Glu Leu Ser Gly Gln Gln Tyr Gln Trp Lys Glu Ala Met
    290                 295                 300                 
Phe Phe Glu Ser Tyr Gly His Ser Ser His Met Leu Thr Asp Thr Lys
305                 310                 315                 320 
Thr Gly Leu His Phe Asn Ile Asn Glu Ala Ile Glu Gln Gly Thr Ile
                325                 330                 335     
Asp Lys Ala Leu Val Lys Lys Tyr Gln Glu Gly Leu Ile Thr Leu Thr
            340                 345                 350         
Glu Leu Ala Asp Ser Leu Leu Ser Arg Leu Val Pro Lys Lys Asp Leu
        355                 360                 365             
His Ser Pro Val Ala Gly Tyr Trp Leu Thr Ala Ser Gly Glu Arg Ile
    370                 375                 380                 
Ser Val Leu Lys Ala Ser Arg Arg Asn Leu Val Asp Arg Ile Thr Ala
385                 390                 395                 400 
Leu Arg Cys Leu Glu Ala Gln Val Ser Thr Gly Gly Ile Ile Asp Pro
                405                 410                 415     
Leu Thr Gly Lys Lys Tyr Arg Val Ala Glu Ala Leu His Arg Gly Leu
            420                 425                 430         
Val Asp Glu Gly Phe Ala Gln Gln Leu Arg Gln Cys Glu Leu Val Ile
        435                 440                 445             
Thr Gly Ile Gly His Pro Ile Thr Asn Lys Met Met Ser Val Val Glu
    450                 455                 460                 
Ala Val Asn Ala Asn Ile Ile Asn Lys Glu Met Gly Ile Arg Cys Leu
465                 470                 475                 480 
Glu Phe Gln Tyr Leu Thr Gly Gly Leu Ile Glu Pro Gln Val His Ser
                485                 490                 495     
Arg Leu Ser Ile Glu Glu Ala Leu Gln Val Gly Ile Ile Asp Val Leu
            500                 505                 510         
Ile Ala Thr Lys Leu Lys Asp Gln Lys Ser Tyr Val Arg Asn Ile Ile
        515                 520                 525             
Cys Pro Gln Thr Lys Arg Lys Leu Thr Tyr Lys Glu Ala Leu Glu Lys
    530                 535                 540                 
Ala Asp Phe Asp Phe His Thr Gly Leu Lys Leu Leu Glu Val Ser Glu
545                 550                 555                 560 
Pro Leu Met Thr Gly Ile Ser Ser Leu Tyr Tyr Ser Ser
                565                 570             


<210> 699
<211> 1307
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 699
Met His Ser Ser Ser Tyr Ser Tyr Arg Ser Ser Asp Ser Val Phe Ser
 1               5                  10                  15      
Asn Thr Thr Ser Thr Arg Thr Ser Leu Asp Ser Asn Glu Asn Leu Leu
            20                  25                  30          
Leu Val His Cys Gly Pro Thr Leu Ile Asn Ser Cys Ile Ser Phe Gly
        35                  40                  45              
Ser Glu Ser Phe Asp Gly His Arg Leu Glu Met Leu Gln Gln Ile Ala
    50                  55                  60                  
Asn Arg Val Gln Arg Asp Ser Val Ile Cys Glu Asp Lys Leu Ile Leu
65                  70                  75                  80  
Ala Gly Asn Ala Leu Gln Ser Asp Ser Lys Arg Leu Glu Ser Gly Val
                85                  90                  95      
Gln Phe Gln Asn Glu Ala Glu Ile Ala Gly Tyr Ile Leu Glu Cys Glu
            100                 105                 110         
Asn Leu Leu Arg Gln His Val Ile Asp Val Gln Ile Leu Ile Asp Gly
        115                 120                 125             
Lys Tyr Tyr Gln Ala Asp Gln Leu Val Gln Arg Val Ala Lys Leu Arg
    130                 135                 140                 
Asp Glu Ile Met Ala Leu Arg Asn Glu Cys Ser Ser Val Tyr Ser Lys
145                 150                 155                 160 
Gly Arg Ile Leu Thr Thr Glu Gln Thr Lys Leu Met Ile Ser Gly Ile
                165                 170                 175     
Thr Gln Ser Leu Asn Ser Gly Phe Ala Gln Thr Leu His Pro Ser Leu
            180                 185                 190         
Thr Ser Gly Leu Thr Gln Ser Leu Thr Pro Ser Leu Thr Ser Ser Ser
        195                 200                 205             
Met Thr Ser Gly Leu Ser Ser Gly Met Thr Ser Arg Leu Thr Pro Ser
    210                 215                 220                 
Val Thr Pro Ala Tyr Thr Pro Gly Phe Pro Ser Gly Leu Val Pro Asn
225                 230                 235                 240 
Phe Ser Ser Gly Val Glu Pro Asn Ser Leu Gln Thr Leu Lys Leu Met
                245                 250                 255     
Gln Ile Arg Lys Pro Leu Leu Lys Ser Ser Leu Leu Asp Gln Asn Leu
            260                 265                 270         
Thr Glu Glu Glu Ile Asn Met Lys Phe Val Gln Asp Leu Leu Asn Trp
        275                 280                 285             
Val Asp Glu Met Gln Val Gln Leu Asp Arg Thr Glu Trp Gly Ser Asp
    290                 295                 300                 
Leu Pro Ser Val Glu Ser His Leu Glu Asn His Lys Asn Val His Arg
305                 310                 315                 320 
Ala Ile Glu Glu Phe Glu Ser Ser Leu Lys Glu Ala Lys Ile Ser Glu
                325                 330                 335     
Ile Gln Met Thr Ala Pro Leu Lys Leu Thr Tyr Ala Glu Lys Leu His
            340                 345                 350         
Arg Leu Glu Ser Gln Tyr Ala Lys Leu Leu Asn Thr Ser Arg Asn Gln
        355                 360                 365             
Glu Arg His Leu Asp Thr Leu His Asn Phe Val Ser Arg Ala Thr Asn
    370                 375                 380                 
Glu Leu Ile Trp Leu Asn Glu Lys Glu Glu Glu Glu Val Ala Tyr Asp
385                 390                 395                 400 
Trp Ser Glu Arg Asn Thr Asn Ile Ala Arg Lys Lys Asp Tyr His Ala
                405                 410                 415     
Glu Leu Met Arg Glu Leu Asp Gln Lys Glu Glu Asn Ile Lys Ser Val
            420                 425                 430         
Gln Glu Ile Ala Glu Gln Leu Leu Leu Glu Asn His Pro Ala Arg Leu
        435                 440                 445             
Thr Ile Glu Ala Tyr Arg Ala Ala Met Gln Thr Gln Trp Ser Trp Ile
    450                 455                 460                 
Leu Gln Leu Cys Gln Cys Val Glu Gln His Ile Lys Glu Asn Thr Ala
465                 470                 475                 480 
Tyr Phe Glu Phe Phe Asn Asp Ala Lys Glu Ala Thr Asp Tyr Leu Arg
                485                 490                 495     
Asn Leu Lys Asp Ala Ile Gln Arg Lys Tyr Ser Cys Asp Arg Ser Ser
            500                 505                 510         
Ser Ile His Lys Leu Glu Asp Leu Val Gln Glu Ser Met Glu Glu Lys
        515                 520                 525             
Glu Glu Leu Leu Gln Tyr Lys Ser Thr Ile Ala Asn Leu Met Gly Lys
    530                 535                 540                 
Ala Lys Thr Ile Ile Gln Leu Lys Pro Arg Asn Ser Asp Cys Pro Leu
545                 550                 555                 560 
Lys Thr Ser Ile Pro Ile Lys Ala Ile Cys Asp Tyr Arg Gln Ile Glu
                565                 570                 575     
Ile Thr Ile Tyr Lys Asp Asp Glu Cys Val Leu Ala Asn Asn Ser His
            580                 585                 590         
Arg Ala Lys Trp Lys Val Ile Ser Pro Thr Gly Asn Glu Ala Met Val
        595                 600                 605             
Pro Ser Val Cys Phe Thr Val Pro Pro Pro Asn Lys Glu Ala Val Asp
    610                 615                 620                 
Leu Ala Asn Arg Ile Glu Gln Gln Tyr Gln Asn Val Leu Thr Leu Trp
625                 630                 635                 640 
His Glu Ser His Ile Asn Met Lys Ser Val Val Ser Trp His Tyr Leu
                645                 650                 655     
Ile Asn Glu Ile Asp Arg Ile Arg Ala Ser Asn Val Ala Ser Ile Lys
            660                 665                 670         
Thr Met Leu Pro Gly Glu His Gln Gln Val Leu Ser Asn Leu Gln Ser
        675                 680                 685             
Arg Phe Glu Asp Phe Leu Glu Asp Ser Gln Glu Ser Gln Val Phe Ser
    690                 695                 700                 
Gly Ser Asp Ile Thr Gln Leu Glu Lys Glu Val Asn Val Cys Lys Gln
705                 710                 715                 720 
Tyr Tyr Gln Glu Leu Leu Lys Ser Ala Glu Arg Glu Glu Gln Glu Glu
                725                 730                 735     
Ser Val Tyr Asn Leu Tyr Ile Ser Glu Val Arg Asn Ile Arg Leu Arg
            740                 745                 750         
Leu Glu Asn Cys Glu Asp Arg Leu Ile Arg Gln Ile Arg Thr Pro Leu
        755                 760                 765             
Glu Arg Asp Asp Leu His Glu Ser Val Phe Arg Ile Thr Glu Gln Glu
    770                 775                 780                 
Lys Leu Lys Lys Glu Leu Glu Arg Leu Lys Asp Asp Leu Gly Thr Ile
785                 790                 795                 800 
Thr Asn Lys Cys Glu Glu Phe Phe Ser Gln Ala Ala Ala Ser Ser Ser
                805                 810                 815     
Val Pro Thr Leu Arg Ser Glu Leu Asn Val Val Leu Gln Asn Met Asn
            820                 825                 830         
Gln Val Tyr Ser Met Ser Ser Thr Tyr Ile Asp Lys Leu Lys Thr Val
        835                 840                 845             
Asn Leu Val Leu Lys Asn Thr Gln Ala Ala Glu Ala Leu Val Lys Leu
    850                 855                 860                 
Tyr Glu Thr Lys Leu Cys Glu Glu Glu Ala Val Ile Ala Asp Lys Asn
865                 870                 875                 880 
Asn Ile Glu Asn Leu Ile Ser Thr Leu Lys Gln Trp Arg Ser Glu Val
                885                 890                 895     
Asp Glu Lys Arg Gln Val Phe His Ala Leu Glu Asp Glu Leu Gln Lys
            900                 905                 910         
Ala Lys Ala Ile Ser Asp Glu Met Phe Lys Thr Tyr Lys Glu Arg Asp
        915                 920                 925             
Leu Asp Phe Asp Trp His Lys Glu Lys Ala Asp Gln Leu Val Glu Arg
    930                 935                 940                 
Trp Gln Asn Val His Val Gln Ile Asp Asn Arg Leu Arg Asp Leu Glu
945                 950                 955                 960 
Gly Ile Gly Lys Ser Leu Lys Tyr Tyr Arg Asp Thr Tyr His Pro Leu
                965                 970                 975     
Asp Asp Trp Ile Gln Gln Val Glu Thr Thr Gln Arg Lys Ile Gln Glu
            980                 985                 990         
Asn Gln Pro Glu Asn Ser Lys Thr Leu Ala Thr Gln Leu Asn Gln Gln
        995                 1000                1005            
Lys Met Leu Val Ser Glu Ile Glu Met Lys Gln Ser Lys Met Asp Glu
    1010                1015                1020                
Cys Gln Lys Tyr Ala Glu Gln Tyr Ser Ala Thr Val Lys Asp Tyr Glu
1025                1030                1035               1040 
Leu Gln Thr Met Thr Tyr Arg Ala Met Val Asp Ser Gln Gln Lys Ser
                1045                1050                1055    
Pro Val Lys Arg Arg Arg Met Gln Ser Ser Ala Asp Leu Ile Ile Gln
            1060                1065                1070        
Glu Phe Met Asp Leu Arg Thr Arg Tyr Thr Ala Leu Val Thr Leu Met
        1075                1080                1085            
Thr Gln Tyr Ile Lys Phe Ala Gly Asp Ser Leu Lys Arg Leu Glu Glu
    1090                1095                1100                
Glu Glu Ile Lys Arg Cys Lys Glu Thr Ser Glu His Gly Ala Tyr Ser
1105                1110                1115               1120 
Asp Leu Leu Gln Arg Gln Lys Ala Thr Val Leu Glu Asn Ser Lys Leu
                1125                1130                1135    
Thr Gly Lys Ile Ser Glu Leu Glu Arg Met Val Ala Glu Leu Lys Lys
            1140                1145                1150        
Gln Lys Ser Arg Val Glu Glu Glu Leu Pro Lys Val Arg Glu Ala Ala
        1155                1160                1165            
Glu Asn Glu Leu Arg Lys Gln Gln Arg Asn Val Glu Asp Ile Ser Leu
    1170                1175                1180                
Gln Lys Ile Arg Ala Glu Ser Glu Ala Lys Gln Tyr Arg Arg Glu Leu
1185                1190                1195               1200 
Glu Thr Ile Val Arg Glu Lys Glu Ala Ala Glu Arg Glu Leu Glu Arg
                1205                1210                1215    
Val Arg Gln Leu Thr Ile Glu Ala Glu Ala Lys Arg Ala Ala Val Glu
            1220                1225                1230        
Glu Asn Leu Leu Asn Phe Arg Asn Gln Leu Glu Glu Asn Thr Phe Thr
        1235                1240                1245            
Arg Arg Thr Leu Glu Asp His Leu Lys Arg Lys Asp Leu Ser Leu Asn
    1250                1255                1260                
Asp Leu Glu Gln Gln Lys Asn Lys Leu Met Glu Glu Leu Arg Arg Lys
1265                1270                1275               1280 
Arg Asp Asn Glu Glu Glu Leu Leu Lys Leu Ile Lys Gln Met Glu Lys
                1285                1290                1295    
Asp Leu Ala Phe Gln Lys Gln Val Ala Glu Lys
            1300                1305        


<210> 700
<211> 73
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 700
Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp Glu Leu Glu Arg Ile
 1               5                  10                  15      
Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu Lys
            20                  25                  30          
Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp Leu Asp Lys
        35                  40                  45              
Ile Gly Leu His Ser Asp Ser Gln Glu Glu Leu Trp Met Phe Val Arg
    50                  55                  60                  
Lys Lys Leu Met Met Glu Gln Glu Asn
65                  70              


<210> 701
<211> 45
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 701
Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp Glu Leu Glu Arg Ile
 1               5                  10                  15      
Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu Lys
            20                  25                  30          
Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp
        35                  40                  45  


<210> 702
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 702
Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu
 1               5                  10                  


<210> 703
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 703
Lys Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp
 1               5                  10                  


<210> 704
<211> 78
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 704
Ala Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp Glu Leu Glu Arg
 1               5                  10                  15      
Ile Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu
            20                  25                  30          
Lys Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp Leu Asp
        35                  40                  45              
Lys Ile Gly Leu His Ser Asp Ser Gln Glu Glu Leu Trp Met Phe Val
    50                  55                  60                  
Arg Lys Lys Leu Met Met Glu Gln Glu Asn Gly Asn Leu Arg
65                  70                  75              


<210> 705
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 705
Lys Ala Arg Val Asp Glu Leu Glu Arg Ile Arg Arg Ser Ile Leu
 1               5                  10                  15  


<210> 706
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 706
Leu Glu Arg Ile Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met
 1               5                  10                  15  


<210> 707
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 707
Ile Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile
 1               5                  10                  15  


<210> 708
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 708
His Ser Asp Ser Gln Glu Glu Leu Trp Met Phe Val Arg Lys Lys
 1               5                  10                  15  


<210> 709
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 709
Glu Leu Trp Met Phe Val Arg Lys Lys Leu Met Met Glu Gln Glu
 1               5                  10                  15  


<210> 710
<211> 946
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 710
Leu Ile Ala Leu Ala Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp
 1               5                  10                  15      
Glu Leu Glu Arg Ile Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met
            20                  25                  30          
Asp Arg Ile Glu Lys Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly
        35                  40                  45              
Ala Asp Leu Asp Lys Ile Gly Leu His Ser Asp Ser Gln Glu Glu Leu
    50                  55                  60                  
Trp Met Phe Val Arg Lys Lys Leu Met Met Glu Gln Glu Asn Gly Asn
65                  70                  75                  80  
Leu Arg Gly Ser Pro Gly Pro Lys Gly Asp Met Gly Ser Pro Gly Pro
                85                  90                  95      
Lys Gly Asp Arg Gly Phe Pro Gly Thr Pro Gly Ile Pro Gly Pro Leu
            100                 105                 110         
Gly His Pro Gly Pro Gln Gly Pro Lys Gly Gln Lys Gly Ser Val Gly
        115                 120                 125             
Asp Pro Gly Met Glu Gly Pro Met Gly Gln Arg Gly Arg Glu Gly Pro
    130                 135                 140                 
Met Gly Pro Arg Gly Glu Ala Gly Pro Pro Gly Ser Gly Glu Lys Gly
145                 150                 155                 160 
Glu Arg Gly Ala Ala Gly Glu Pro Gly Pro His Gly Pro Pro Gly Val
                165                 170                 175     
Pro Gly Ser Val Gly Pro Lys Gly Ser Ser Gly Ser Pro Gly Pro Gln
            180                 185                 190         
Gly Pro Pro Gly Pro Val Gly Leu Gln Gly Leu Arg Gly Glu Val Gly
        195                 200                 205             
Leu Pro Gly Val Lys Gly Asp Lys Gly Pro Met Gly Pro Pro Gly Pro
    210                 215                 220                 
Lys Gly Asp Gln Gly Glu Lys Gly Pro Arg Gly Leu Thr Gly Glu Pro
225                 230                 235                 240 
Gly Met Arg Gly Leu Pro Gly Ala Val Gly Glu Pro Gly Ala Lys Gly
                245                 250                 255     
Ala Met Gly Pro Ala Gly Pro Asp Gly His Gln Gly Pro Arg Gly Glu
            260                 265                 270         
Gln Gly Leu Thr Gly Met Pro Gly Ile Arg Gly Pro Pro Gly Pro Ser
        275                 280                 285             
Gly Asp Pro Gly Lys Pro Gly Leu Thr Gly Pro Gln Gly Pro Gln Gly
    290                 295                 300                 
Leu Pro Gly Thr Pro Gly Arg Pro Gly Ile Lys Gly Glu Pro Gly Ala
305                 310                 315                 320 
Pro Gly Lys Ile Val Thr Ser Glu Gly Ser Ser Met Leu Thr Val Pro
                325                 330                 335     
Gly Pro Pro Gly Pro Pro Gly Ala Met Gly Pro Pro Gly Pro Pro Gly
            340                 345                 350         
Ala Pro Gly Pro Ala Gly Pro Ala Gly Leu Pro Gly His Gln Glu Val
        355                 360                 365             
Leu Asn Leu Gln Gly Pro Pro Gly Pro Pro Gly Pro Arg Gly Pro Pro
    370                 375                 380                 
Gly Pro Ser Ile Pro Gly Pro Pro Gly Pro Arg Gly Pro Pro Gly Glu
385                 390                 395                 400 
Gly Leu Pro Gly Pro Pro Gly Pro Pro Gly Ser Phe Leu Ser Asn Ser
                405                 410                 415     
Glu Thr Phe Leu Ser Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro
            420                 425                 430         
Lys Gly Asp Gln Gly Pro Pro Gly Pro Arg Gly His Gln Gly Glu Gln
        435                 440                 445             
Gly Leu Pro Gly Phe Ser Thr Ser Gly Ser Ser Ser Phe Gly Leu Asn
    450                 455                 460                 
Leu Gln Gly Pro Pro Gly Pro Pro Gly Pro Gln Gly Pro Lys Gly Asp
465                 470                 475                 480 
Lys Gly Asp Pro Gly Val Pro Gly Ala Leu Gly Ile Pro Ser Gly Pro
                485                 490                 495     
Ser Glu Gly Gly Ser Ser Ser Thr Met Tyr Val Ser Gly Pro Pro Gly
            500                 505                 510         
Pro Pro Gly Pro Pro Gly Pro Pro Gly Ser Ile Ser Ser Ser Gly Gln
        515                 520                 525             
Glu Ile Gln Gln Tyr Ile Ser Glu Tyr Met Gln Ser Asp Ser Ile Arg
    530                 535                 540                 
Ser Tyr Leu Ser Gly Val Gln Gly Pro Pro Gly Pro Pro Gly Pro Pro
545                 550                 555                 560 
Gly Pro Val Thr Thr Ile Thr Gly Glu Thr Phe Asp Tyr Ser Glu Leu
                565                 570                 575     
Ala Ser His Val Val Ser Tyr Leu Arg Thr Ser Gly Tyr Gly Val Ser
            580                 585                 590         
Leu Phe Ser Ser Ser Ile Ser Ser Glu Asp Ile Leu Ala Val Leu Gln
        595                 600                 605             
Arg Asp Asp Val Arg Gln Tyr Leu Arg Gln Tyr Leu Met Gly Pro Arg
    610                 615                 620                 
Gly Pro Pro Gly Pro Pro Gly Ala Ser Gly Asp Gly Ser Leu Leu Ser
625                 630                 635                 640 
Leu Asp Tyr Ala Glu Leu Ser Ser Arg Ile Leu Ser Tyr Met Ser Ser
                645                 650                 655     
Ser Gly Ile Ser Ile Gly Leu Pro Gly Pro Pro Gly Pro Pro Gly Leu
            660                 665                 670         
Pro Gly Thr Ser Tyr Glu Glu Leu Leu Ser Leu Leu Arg Gly Ser Glu
        675                 680                 685             
Phe Arg Gly Ile Val Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Ile
    690                 695                 700                 
Pro Gly Asn Val Trp Ser Ser Ile Ser Val Glu Asp Leu Ser Ser Tyr
705                 710                 715                 720 
Leu His Thr Ala Gly Leu Ser Phe Ile Pro Gly Pro Pro Gly Pro Pro
                725                 730                 735     
Gly Pro Pro Gly Pro Arg Gly Pro Pro Gly Val Ser Gly Ala Leu Ala
            740                 745                 750         
Thr Tyr Ala Ala Glu Asn Ser Asp Ser Phe Arg Ser Glu Leu Ile Ser
        755                 760                 765             
Tyr Leu Thr Ser Pro Asp Val Arg Ser Phe Ile Val Gly Pro Pro Gly
    770                 775                 780                 
Pro Pro Gly Pro Gln Gly Pro Pro Gly Asp Ser Arg Leu Leu Ser Thr
785                 790                 795                 800 
Asp Ala Ser His Ser Arg Gly Ser Ser Ser Ser Ser His Ser Ser Ser
                805                 810                 815     
Val Arg Arg Gly Ser Ser Tyr Ser Ser Ser Met Ser Thr Gly Gly Gly
            820                 825                 830         
Gly Ala Gly Ser Leu Gly Ala Gly Gly Ala Phe Gly Glu Ala Ala Gly
        835                 840                 845             
Asp Arg Gly Pro Tyr Gly Thr Asp Ile Gly Pro Gly Gly Gly Tyr Gly
    850                 855                 860                 
Ala Ala Ala Glu Gly Gly Met Tyr Ala Gly Asn Gly Gly Leu Leu Gly
865                 870                 875                 880 
Ala Asp Phe Ala Gly Asp Leu Asp Tyr Asn Glu Leu Ala Val Arg Val
                885                 890                 895     
Ser Glu Ser Met Gln Arg Gln Gly Leu Leu Gln Gly Met Ala Tyr Thr
            900                 905                 910         
Val Gln Gly Pro Pro Gly Gln Pro Gly Pro Gln Gly Pro Pro Gly Ile
        915                 920                 925             
Ser Lys Val Phe Ser Ala Tyr Ser Asn Val Thr Ala Asp Leu Met Asp
    930                 935                 940                 
Phe Phe
945     


<210> 711
<211> 1013
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 711
Leu Ile Ala Leu Ala Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp
 1               5                  10                  15      
Glu Leu Glu Arg Ile Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met
            20                  25                  30          
Asp Arg Ile Glu Lys Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly
        35                  40                  45              
Ala Asp Leu Asp Lys Ile Gly Leu His Ser Asp Ser Gln Glu Glu Leu
    50                  55                  60                  
Trp Met Phe Val Arg Lys Lys Leu Met Met Glu Gln Glu Asn Gly Asn
65                  70                  75                  80  
Leu Arg Gly Ser Pro Gly Pro Lys Gly Asp Met Gly Ser Pro Gly Pro
                85                  90                  95      
Lys Gly Asp Arg Gly Phe Pro Gly Thr Pro Gly Ile Pro Gly Pro Leu
            100                 105                 110         
Gly His Pro Gly Pro Gln Gly Pro Lys Gly Gln Lys Gly Ser Val Gly
        115                 120                 125             
Asp Pro Gly Met Glu Gly Pro Met Gly Gln Arg Gly Arg Glu Gly Pro
    130                 135                 140                 
Met Gly Pro Arg Gly Glu Ala Gly Pro Pro Gly Ser Gly Glu Lys Gly
145                 150                 155                 160 
Glu Arg Gly Ala Ala Gly Glu Pro Gly Pro His Gly Pro Pro Gly Val
                165                 170                 175     
Pro Gly Ser Val Gly Pro Lys Gly Ser Ser Gly Ser Pro Gly Pro Gln
            180                 185                 190         
Gly Pro Pro Gly Pro Val Gly Leu Gln Gly Leu Arg Gly Glu Val Gly
        195                 200                 205             
Leu Pro Gly Val Lys Gly Asp Lys Gly Pro Met Gly Pro Pro Gly Pro
    210                 215                 220                 
Lys Gly Asp Gln Gly Glu Lys Gly Pro Arg Gly Leu Thr Gly Glu Pro
225                 230                 235                 240 
Gly Met Arg Gly Leu Pro Gly Ala Val Gly Glu Pro Gly Ala Lys Gly
                245                 250                 255     
Ala Met Gly Pro Ala Gly Pro Asp Gly His Gln Gly Pro Arg Gly Glu
            260                 265                 270         
Gln Gly Leu Thr Gly Met Pro Gly Ile Arg Gly Pro Pro Gly Pro Ser
        275                 280                 285             
Gly Asp Pro Gly Lys Pro Gly Leu Thr Gly Pro Gln Gly Pro Gln Gly
    290                 295                 300                 
Leu Pro Gly Thr Pro Gly Arg Pro Gly Ile Lys Gly Glu Pro Gly Ala
305                 310                 315                 320 
Pro Gly Lys Ile Val Thr Ser Glu Gly Ser Ser Met Leu Thr Val Pro
                325                 330                 335     
Gly Pro Pro Gly Pro Pro Gly Ala Met Gly Pro Pro Gly Pro Pro Gly
            340                 345                 350         
Ala Pro Gly Pro Ala Gly Pro Ala Gly Leu Pro Gly His Gln Glu Val
        355                 360                 365             
Leu Asn Leu Gln Gly Pro Pro Gly Pro Pro Gly Pro Arg Gly Pro Pro
    370                 375                 380                 
Gly Pro Ser Ile Pro Gly Pro Pro Gly Pro Arg Gly Pro Pro Gly Glu
385                 390                 395                 400 
Gly Leu Pro Gly Pro Pro Gly Pro Pro Gly Ser Phe Leu Ser Asn Ser
                405                 410                 415     
Glu Thr Phe Leu Ser Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro
            420                 425                 430         
Lys Gly Asp Gln Gly Pro Pro Gly Pro Arg Gly His Gln Gly Glu Gln
        435                 440                 445             
Gly Leu Pro Gly Phe Ser Thr Ser Gly Ser Ser Ser Phe Gly Leu Asn
    450                 455                 460                 
Leu Gln Gly Pro Pro Gly Pro Pro Gly Pro Gln Gly Pro Lys Gly Asp
465                 470                 475                 480 
Lys Gly Asp Pro Gly Val Pro Gly Ala Leu Gly Ile Pro Ser Gly Pro
                485                 490                 495     
Ser Glu Gly Gly Ser Ser Ser Thr Met Tyr Val Ser Gly Pro Pro Gly
            500                 505                 510         
Pro Pro Gly Pro Pro Gly Pro Pro Gly Ser Ile Ser Ser Ser Gly Gln
        515                 520                 525             
Glu Ile Gln Gln Tyr Ile Ser Glu Tyr Met Gln Ser Asp Ser Ile Arg
    530                 535                 540                 
Ser Tyr Leu Ser Gly Val Gln Gly Pro Pro Gly Pro Pro Gly Pro Pro
545                 550                 555                 560 
Gly Pro Val Thr Thr Ile Thr Gly Glu Thr Phe Asp Tyr Ser Glu Leu
                565                 570                 575     
Ala Ser His Val Val Ser Tyr Leu Arg Thr Ser Gly Tyr Gly Val Ser
            580                 585                 590         
Leu Phe Ser Ser Ser Ile Ser Ser Glu Asp Ile Leu Ala Val Leu Gln
        595                 600                 605             
Arg Asp Asp Val Arg Gln Tyr Leu Arg Gln Tyr Leu Met Gly Pro Arg
    610                 615                 620                 
Gly Pro Pro Gly Pro Pro Gly Ala Ser Gly Asp Gly Ser Leu Leu Ser
625                 630                 635                 640 
Leu Asp Tyr Ala Glu Leu Ser Ser Arg Ile Leu Ser Tyr Met Ser Ser
                645                 650                 655     
Ser Gly Ile Ser Ile Gly Leu Pro Gly Pro Pro Gly Pro Pro Gly Leu
            660                 665                 670         
Pro Gly Thr Ser Tyr Glu Glu Leu Leu Ser Leu Leu Arg Gly Ser Glu
        675                 680                 685             
Phe Arg Gly Ile Val Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Ile
    690                 695                 700                 
Pro Gly Asn Val Trp Ser Ser Ile Ser Val Glu Asp Leu Ser Ser Tyr
705                 710                 715                 720 
Leu His Thr Ala Gly Leu Ser Phe Ile Pro Gly Pro Pro Gly Pro Pro
                725                 730                 735     
Gly Pro Pro Gly Pro Arg Gly Pro Pro Gly Val Ser Gly Ala Leu Ala
            740                 745                 750         
Thr Tyr Ala Ala Glu Asn Ser Asp Ser Phe Arg Ser Glu Leu Ile Ser
        755                 760                 765             
Tyr Leu Thr Ser Pro Asp Val Arg Ser Phe Ile Val Gly Pro Pro Gly
    770                 775                 780                 
Pro Pro Gly Pro Gln Gly Pro Pro Gly Asp Ser Arg Leu Leu Ser Thr
785                 790                 795                 800 
Asp Ala Ser His Ser Arg Gly Ser Ser Ser Ser Ser His Ser Ser Ser
                805                 810                 815     
Val Arg Arg Gly Ser Ser Tyr Ser Ser Ser Met Ser Thr Gly Gly Gly
            820                 825                 830         
Gly Ala Gly Ser Leu Gly Ala Gly Gly Ala Phe Gly Glu Ala Ala Gly
        835                 840                 845             
Asp Arg Gly Pro Tyr Gly Thr Asp Ile Gly Pro Gly Gly Gly Tyr Gly
    850                 855                 860                 
Ala Ala Ala Glu Gly Gly Met Tyr Ala Gly Asn Gly Gly Leu Leu Gly
865                 870                 875                 880 
Ala Asp Phe Ala Gly Asp Leu Asp Tyr Asn Glu Leu Ala Val Arg Val
                885                 890                 895     
Ser Glu Ser Met Gln Arg Gln Gly Leu Leu Gln Gly Met Ala Tyr Thr
            900                 905                 910         
Val Gln Gly Pro Pro Gly Gln Pro Gly Pro Gln Gly Pro Pro Gly Ile
        915                 920                 925             
Ser Lys Val Phe Ser Ala Tyr Ser Asn Val Thr Ala Asp Leu Met Asp
    930                 935                 940                 
Phe Phe Gln Thr Tyr Gly Ala Ile Gln Gly Pro Pro Gly Gln Lys Gly
945                 950                 955                 960 
Glu Met Gly Thr Pro Gly Pro Lys Gly Asp Arg Gly Pro Ala Gly Pro
                965                 970                 975     
Pro Gly His Pro Gly Pro Pro Gly Pro Arg Gly His Lys Gly Glu Lys
            980                 985                 990         
Gly Asp Lys Gly Asp Gln Val Tyr Ala Gly Arg Arg Arg Arg Arg Ser
        995                 1000                1005            
Ile Ala Val Lys Pro
    1010            


<210> 712
<211> 323
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 712
Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp Glu Leu Glu Arg Ile
 1               5                  10                  15      
Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu Lys
            20                  25                  30          
Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp Leu Asp Lys
        35                  40                  45              
Ile Gly Leu His Ser Asp Ser Gln Glu Glu Leu Trp Met Phe Val Arg
    50                  55                  60                  
Lys Lys Leu Met Met Glu Gln Glu Asn Gly Asn Leu Arg Gly Ser Pro
65                  70                  75                  80  
Gly Pro Lys Gly Asp Met Gly Ser Pro Gly Pro Lys Gly Asp Arg Gly
                85                  90                  95      
Phe Pro Gly Thr Pro Gly Ile Pro Gly Pro Leu Gly His Pro Gly Pro
            100                 105                 110         
Gln Gly Pro Lys Gly Gln Lys Gly Ser Val Gly Asp Pro Gly Met Glu
        115                 120                 125             
Gly Pro Met Gly Gln Arg Gly Arg Glu Gly Pro Met Gly Pro Arg Gly
    130                 135                 140                 
Glu Ala Gly Pro Pro Gly Ser Gly Glu Lys Gly Glu Arg Gly Ala Ala
145                 150                 155                 160 
Gly Glu Pro Gly Pro His Gly Pro Pro Gly Val Pro Gly Ser Val Gly
                165                 170                 175     
Pro Lys Gly Ser Ser Gly Ser Pro Gly Pro Gln Gly Pro Pro Gly Pro
            180                 185                 190         
Val Gly Leu Gln Gly Leu Arg Gly Glu Val Gly Leu Pro Gly Val Lys
        195                 200                 205             
Gly Asp Lys Gly Pro Met Gly Pro Pro Gly Pro Lys Gly Asp Gln Gly
    210                 215                 220                 
Glu Lys Gly Pro Arg Gly Leu Thr Gly Glu Pro Gly Met Arg Gly Leu
225                 230                 235                 240 
Pro Gly Ala Val Gly Glu Pro Gly Ala Lys Gly Ala Met Gly Pro Ala
                245                 250                 255     
Gly Pro Asp Gly His Gln Gly Pro Arg Gly Glu Gln Gly Leu Thr Gly
            260                 265                 270         
Met Pro Gly Ile Arg Gly Pro Pro Gly Pro Ser Gly Asp Pro Gly Lys
        275                 280                 285             
Pro Gly Leu Thr Gly Pro Gln Gly Pro Gln Gly Leu Pro Gly Thr Pro
    290                 295                 300                 
Gly Arg Pro Gly Ile Lys Gly Glu Pro Gly Ala Pro Gly Lys Ile Val
305                 310                 315                 320 
Thr Ser Glu
            


<210> 713
<211> 101
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 713
Trp Leu Leu Gly Leu Leu Leu Thr Trp Leu Leu Leu Leu Gly Leu Leu
 1               5                  10                  15      
Phe Gly Leu Ile Ala Leu Ala Glu Glu Val Arg Lys Leu Lys Ala Arg
            20                  25                  30          
Val Asp Glu Leu Glu Arg Ile Arg Arg Ser Ile Leu Pro Tyr Gly Asp
        35                  40                  45              
Ser Met Asp Arg Ile Glu Lys Asp Arg Leu Gln Gly Met Ala Pro Ala
    50                  55                  60                  
Ala Gly Ala Asp Leu Asp Lys Ile Gly Leu His Ser Asp Ser Gln Glu
65                  70                  75                  80  
Glu Leu Trp Met Phe Val Arg Lys Lys Leu Met Met Glu Gln Glu Asn
                85                  90                  95      
Gly Asn Leu Arg Gly
            100     


<210> 714
<211> 298
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 714
Val Thr Ser Glu Gly Ser Ser Met Leu Thr Val Pro Gly Pro Pro Gly
 1               5                  10                  15      
Pro Pro Gly Ala Met Gly Pro Pro Gly Pro Pro Gly Ala Pro Gly Pro
            20                  25                  30          
Ala Gly Pro Ala Gly Leu Pro Gly His Gln Glu Val Leu Asn Leu Gln
        35                  40                  45              
Gly Pro Pro Gly Pro Pro Gly Pro Arg Gly Pro Pro Gly Pro Ser Ile
    50                  55                  60                  
Pro Gly Pro Pro Gly Pro Arg Gly Pro Pro Gly Glu Gly Leu Pro Gly
65                  70                  75                  80  
Pro Pro Gly Pro Pro Gly Ser Phe Leu Ser Asn Ser Glu Thr Phe Leu
                85                  90                  95      
Ser Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro Lys Gly Asp Gln
            100                 105                 110         
Gly Pro Pro Gly Pro Arg Gly His Gln Gly Glu Gln Gly Leu Pro Gly
        115                 120                 125             
Phe Ser Thr Ser Gly Ser Ser Ser Phe Gly Leu Asn Leu Gln Gly Pro
    130                 135                 140                 
Pro Gly Pro Pro Gly Pro Gln Gly Pro Lys Gly Asp Lys Gly Asp Pro
145                 150                 155                 160 
Gly Val Pro Gly Ala Leu Gly Ile Pro Ser Gly Pro Ser Glu Gly Gly
                165                 170                 175     
Ser Ser Ser Thr Met Tyr Val Ser Gly Pro Pro Gly Pro Pro Gly Pro
            180                 185                 190         
Pro Gly Pro Pro Gly Ser Ile Ser Ser Ser Gly Gln Glu Ile Gln Gln
        195                 200                 205             
Tyr Ile Ser Glu Tyr Met Gln Ser Asp Ser Ile Arg Ser Tyr Leu Ser
    210                 215                 220                 
Gly Val Gln Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro Val Thr
225                 230                 235                 240 
Thr Ile Thr Gly Glu Thr Phe Asp Tyr Ser Glu Leu Ala Ser His Val
                245                 250                 255     
Val Ser Tyr Leu Arg Thr Ser Gly Tyr Gly Val Ser Leu Phe Ser Ser
            260                 265                 270         
Ser Ile Ser Ser Glu Asp Ile Leu Ala Val Leu Gln Arg Asp Asp Val
        275                 280                 285             
Arg Gln Tyr Leu Arg Gln Tyr Leu Met Gly
    290                 295             


<210> 715
<211> 418
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 715
Thr Thr Ile Thr Gly Glu Thr Phe Asp Tyr Ser Glu Leu Ala Ser His
 1               5                  10                  15      
Val Val Ser Tyr Leu Arg Thr Ser Gly Tyr Gly Val Ser Leu Phe Ser
            20                  25                  30          
Ser Ser Ile Ser Ser Glu Asp Ile Leu Ala Val Leu Gln Arg Asp Asp
        35                  40                  45              
Val Arg Gln Tyr Leu Arg Gln Tyr Leu Met Gly Pro Arg Gly Pro Pro
    50                  55                  60                  
Gly Pro Pro Gly Ala Ser Gly Asp Gly Ser Leu Leu Ser Leu Asp Tyr
65                  70                  75                  80  
Ala Glu Leu Ser Ser Arg Ile Leu Ser Tyr Met Ser Ser Ser Gly Ile
                85                  90                  95      
Ser Ile Gly Leu Pro Gly Pro Pro Gly Pro Pro Gly Leu Pro Gly Thr
            100                 105                 110         
Ser Tyr Glu Glu Leu Leu Ser Leu Leu Arg Gly Ser Glu Phe Arg Gly
        115                 120                 125             
Ile Val Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Ile Pro Gly Asn
    130                 135                 140                 
Val Trp Ser Ser Ile Ser Val Glu Asp Leu Ser Ser Tyr Leu His Thr
145                 150                 155                 160 
Ala Gly Leu Ser Phe Ile Pro Gly Pro Pro Gly Pro Pro Gly Pro Pro
                165                 170                 175     
Gly Pro Arg Gly Pro Pro Gly Val Ser Gly Ala Leu Ala Thr Tyr Ala
            180                 185                 190         
Ala Glu Asn Ser Asp Ser Phe Arg Ser Glu Leu Ile Ser Tyr Leu Thr
        195                 200                 205             
Ser Pro Asp Val Arg Ser Phe Ile Val Gly Pro Pro Gly Pro Pro Gly
    210                 215                 220                 
Pro Gln Gly Pro Pro Gly Asp Ser Arg Leu Leu Ser Thr Asp Ala Ser
225                 230                 235                 240 
His Ser Arg Gly Ser Ser Ser Ser Ser His Ser Ser Ser Val Arg Arg
                245                 250                 255     
Gly Ser Ser Tyr Ser Ser Ser Met Ser Thr Gly Gly Gly Gly Ala Gly
            260                 265                 270         
Ser Leu Gly Ala Gly Gly Ala Phe Gly Glu Ala Ala Gly Asp Arg Gly
        275                 280                 285             
Pro Tyr Gly Thr Asp Ile Gly Pro Gly Gly Gly Tyr Gly Ala Ala Ala
    290                 295                 300                 
Glu Gly Gly Met Tyr Ala Gly Asn Gly Gly Leu Leu Gly Ala Asp Phe
305                 310                 315                 320 
Ala Gly Asp Leu Asp Tyr Asn Glu Leu Ala Val Arg Val Ser Glu Ser
                325                 330                 335     
Met Gln Arg Gln Gly Leu Leu Gln Gly Met Ala Tyr Thr Val Gln Gly
            340                 345                 350         
Pro Pro Gly Gln Pro Gly Pro Gln Gly Pro Pro Gly Ile Ser Lys Val
        355                 360                 365             
Phe Ser Ala Tyr Ser Asn Val Thr Ala Asp Leu Met Asp Phe Phe Gln
    370                 375                 380                 
Thr Tyr Gly Ala Ile Gln Gly Pro Pro Gly Gln Lys Gly Glu Met Gly
385                 390                 395                 400 
Thr Pro Gly Pro Lys Gly Asp Arg Gly Pro Ala Gly Pro Pro Gly His
                405                 410                 415     
Pro Gly
        


<210> 716
<211> 1307
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 716
Met His Ser Ser Ser Tyr Ser Tyr Arg Ser Ser Asp Ser Val Phe Ser
 1               5                  10                  15      
Asn Thr Thr Ser Thr Arg Thr Ser Leu Asp Ser Asn Glu Asn Leu Leu
            20                  25                  30          
Leu Val His Cys Gly Pro Thr Leu Ile Asn Ser Cys Ile Ser Phe Gly
        35                  40                  45              
Ser Glu Ser Phe Asp Gly His Arg Leu Glu Met Leu Gln Gln Ile Ala
    50                  55                  60                  
Asn Arg Val Gln Arg Asp Ser Val Ile Cys Glu Asp Lys Leu Ile Leu
65                  70                  75                  80  
Ala Gly Asn Ala Leu Gln Ser Asp Ser Lys Arg Leu Glu Ser Gly Val
                85                  90                  95      
Gln Phe Gln Asn Glu Ala Glu Ile Ala Gly Tyr Ile Leu Glu Cys Glu
            100                 105                 110         
Asn Leu Leu Arg Gln His Val Ile Asp Val Gln Ile Leu Ile Asp Gly
        115                 120                 125             
Lys Tyr Tyr Gln Ala Asp Gln Leu Val Gln Arg Val Ala Lys Leu Arg
    130                 135                 140                 
Asp Glu Ile Met Ala Leu Arg Asn Glu Cys Ser Ser Val Tyr Ser Lys
145                 150                 155                 160 
Gly Arg Ile Leu Thr Thr Glu Gln Thr Lys Leu Met Ile Ser Gly Ile
                165                 170                 175     
Thr Gln Ser Leu Asn Ser Gly Phe Ala Gln Thr Leu His Pro Ser Leu
            180                 185                 190         
Thr Ser Gly Leu Thr Gln Ser Leu Thr Pro Ser Leu Thr Ser Ser Ser
        195                 200                 205             
Met Thr Ser Gly Leu Ser Ser Gly Met Thr Ser Arg Leu Thr Pro Ser
    210                 215                 220                 
Val Thr Pro Ala Tyr Thr Pro Gly Phe Pro Ser Gly Leu Val Pro Asn
225                 230                 235                 240 
Phe Ser Ser Gly Val Glu Pro Asn Ser Leu Gln Thr Leu Lys Leu Met
                245                 250                 255     
Gln Ile Arg Lys Pro Leu Leu Lys Ser Ser Leu Leu Asp Gln Asn Leu
            260                 265                 270         
Thr Glu Glu Glu Ile Asn Met Lys Phe Val Gln Asp Leu Leu Asn Trp
        275                 280                 285             
Val Asp Glu Met Gln Val Gln Leu Asp Arg Thr Glu Trp Gly Ser Asp
    290                 295                 300                 
Leu Pro Ser Val Glu Ser His Leu Glu Asn His Lys Asn Val His Arg
305                 310                 315                 320 
Ala Ile Glu Glu Phe Glu Ser Ser Leu Lys Glu Ala Lys Ile Ser Glu
                325                 330                 335     
Ile Gln Met Thr Ala Pro Leu Lys Leu Thr Tyr Ala Glu Lys Leu His
            340                 345                 350         
Arg Leu Glu Ser Gln Tyr Ala Lys Leu Leu Asn Thr Ser Arg Asn Gln
        355                 360                 365             
Glu Arg His Leu Asp Thr Leu His Asn Phe Val Ser Arg Ala Thr Asn
    370                 375                 380                 
Glu Leu Ile Trp Leu Asn Glu Lys Glu Glu Glu Glu Val Ala Tyr Asp
385                 390                 395                 400 
Trp Ser Glu Arg Asn Thr Asn Ile Ala Arg Lys Lys Asp Tyr His Ala
                405                 410                 415     
Glu Leu Met Arg Glu Leu Asp Gln Lys Glu Glu Asn Ile Lys Ser Val
            420                 425                 430         
Gln Glu Ile Ala Glu Gln Leu Leu Leu Glu Asn His Pro Ala Arg Leu
        435                 440                 445             
Thr Ile Glu Ala Tyr Arg Ala Ala Met Gln Thr Gln Trp Ser Trp Ile
    450                 455                 460                 
Leu Gln Leu Cys Gln Cys Val Glu Gln His Ile Lys Glu Asn Thr Ala
465                 470                 475                 480 
Tyr Phe Glu Phe Phe Asn Asp Ala Lys Glu Ala Thr Asp Tyr Leu Arg
                485                 490                 495     
Asn Leu Lys Asp Ala Ile Gln Arg Lys Tyr Ser Cys Asp Arg Ser Ser
            500                 505                 510         
Ser Ile His Lys Leu Glu Asp Leu Val Gln Glu Ser Met Glu Glu Lys
        515                 520                 525             
Glu Glu Leu Leu Gln Tyr Lys Ser Thr Ile Ala Asn Leu Met Gly Lys
    530                 535                 540                 
Ala Lys Thr Ile Ile Gln Leu Lys Pro Arg Asn Ser Asp Cys Pro Leu
545                 550                 555                 560 
Lys Thr Ser Ile Pro Ile Lys Ala Ile Cys Asp Tyr Arg Gln Ile Glu
                565                 570                 575     
Ile Thr Ile Tyr Lys Asp Asp Glu Cys Val Leu Ala Asn Asn Ser His
            580                 585                 590         
Arg Ala Lys Trp Lys Val Ile Ser Pro Thr Gly Asn Glu Ala Met Val
        595                 600                 605             
Pro Ser Val Cys Phe Thr Val Pro Pro Pro Asn Lys Glu Ala Val Asp
    610                 615                 620                 
Leu Ala Asn Arg Ile Glu Gln Gln Tyr Gln Asn Val Leu Thr Leu Trp
625                 630                 635                 640 
His Glu Ser His Ile Asn Met Lys Ser Val Val Ser Trp His Tyr Leu
                645                 650                 655     
Ile Asn Glu Ile Asp Arg Ile Arg Ala Ser Asn Val Ala Ser Ile Lys
            660                 665                 670         
Thr Met Leu Pro Gly Glu His Gln Gln Val Leu Ser Asn Leu Gln Ser
        675                 680                 685             
Arg Phe Glu Asp Phe Leu Glu Asp Ser Gln Glu Ser Gln Val Phe Ser
    690                 695                 700                 
Gly Ser Asp Ile Thr Gln Leu Glu Lys Glu Val Asn Val Cys Lys Gln
705                 710                 715                 720 
Tyr Tyr Gln Glu Leu Leu Lys Ser Ala Glu Arg Glu Glu Gln Glu Glu
                725                 730                 735     
Ser Val Tyr Asn Leu Tyr Ile Ser Glu Val Arg Asn Ile Arg Leu Arg
            740                 745                 750         
Leu Glu Asn Cys Glu Asp Arg Leu Ile Arg Gln Ile Arg Thr Pro Leu
        755                 760                 765             
Glu Arg Asp Asp Leu His Glu Ser Val Phe Arg Ile Thr Glu Gln Glu
    770                 775                 780                 
Lys Leu Lys Lys Glu Leu Glu Arg Leu Lys Asp Asp Leu Gly Thr Ile
785                 790                 795                 800 
Thr Asn Lys Cys Glu Glu Phe Phe Ser Gln Ala Ala Ala Ser Ser Ser
                805                 810                 815     
Val Pro Thr Leu Arg Ser Glu Leu Asn Val Val Leu Gln Asn Met Asn
            820                 825                 830         
Gln Val Tyr Ser Met Ser Ser Thr Tyr Ile Asp Lys Leu Lys Thr Val
        835                 840                 845             
Asn Leu Val Leu Lys Asn Thr Gln Ala Ala Glu Ala Leu Val Lys Leu
    850                 855                 860                 
Tyr Glu Thr Lys Leu Cys Glu Glu Glu Ala Val Ile Ala Asp Lys Asn
865                 870                 875                 880 
Asn Ile Glu Asn Leu Ile Ser Thr Leu Lys Gln Trp Arg Ser Glu Val
                885                 890                 895     
Asp Glu Lys Arg Gln Val Phe His Ala Leu Glu Asp Glu Leu Gln Lys
            900                 905                 910         
Ala Lys Ala Ile Ser Asp Glu Met Phe Lys Thr Tyr Lys Glu Arg Asp
        915                 920                 925             
Leu Asp Phe Asp Trp His Lys Glu Lys Ala Asp Gln Leu Val Glu Arg
    930                 935                 940                 
Trp Gln Asn Val His Val Gln Ile Asp Asn Arg Leu Arg Asp Leu Glu
945                 950                 955                 960 
Gly Ile Gly Lys Ser Leu Lys Tyr Tyr Arg Asp Thr Tyr His Pro Leu
                965                 970                 975     
Asp Asp Trp Ile Gln Gln Val Glu Thr Thr Gln Arg Lys Ile Gln Glu
            980                 985                 990         
Asn Gln Pro Glu Asn Ser Lys Thr Leu Ala Thr Gln Leu Asn Gln Gln
        995                 1000                1005            
Lys Met Leu Val Ser Glu Ile Glu Met Lys Gln Ser Lys Met Asp Glu
    1010                1015                1020                
Cys Gln Lys Tyr Ala Glu Gln Tyr Ser Ala Thr Val Lys Asp Tyr Glu
1025                1030                1035               1040 
Leu Gln Thr Met Thr Tyr Arg Ala Met Val Asp Ser Gln Gln Lys Ser
                1045                1050                1055    
Pro Val Lys Arg Arg Arg Met Gln Ser Ser Ala Asp Leu Ile Ile Gln
            1060                1065                1070        
Glu Phe Met Asp Leu Arg Thr Arg Tyr Thr Ala Leu Val Thr Leu Met
        1075                1080                1085            
Thr Gln Tyr Ile Lys Phe Ala Gly Asp Ser Leu Lys Arg Leu Glu Glu
    1090                1095                1100                
Glu Glu Ile Lys Arg Cys Lys Glu Thr Ser Glu His Gly Ala Tyr Ser
1105                1110                1115               1120 
Asp Leu Leu Gln Arg Gln Lys Ala Thr Val Leu Glu Asn Ser Lys Leu
                1125                1130                1135    
Thr Gly Lys Ile Ser Glu Leu Glu Arg Met Val Ala Glu Leu Lys Lys
            1140                1145                1150        
Gln Lys Ser Arg Val Glu Glu Glu Leu Pro Lys Val Arg Glu Ala Ala
        1155                1160                1165            
Glu Asn Glu Leu Arg Lys Gln Gln Arg Asn Val Glu Asp Ile Ser Leu
    1170                1175                1180                
Gln Lys Ile Arg Ala Glu Ser Glu Ala Lys Gln Tyr Arg Arg Glu Leu
1185                1190                1195               1200 
Glu Thr Ile Val Arg Glu Lys Glu Ala Ala Glu Arg Glu Leu Glu Arg
                1205                1210                1215    
Val Arg Gln Leu Thr Ile Glu Ala Glu Ala Lys Arg Ala Ala Val Glu
            1220                1225                1230        
Glu Asn Leu Leu Asn Phe Arg Asn Gln Leu Glu Glu Asn Thr Phe Thr
        1235                1240                1245            
Arg Arg Thr Leu Glu Asp His Leu Lys Arg Lys Asp Leu Ser Leu Asn
    1250                1255                1260                
Asp Leu Glu Gln Gln Lys Asn Lys Leu Met Glu Glu Leu Arg Arg Lys
1265                1270                1275               1280 
Arg Asp Asn Glu Glu Glu Leu Leu Lys Leu Ile Lys Gln Met Glu Lys
                1285                1290                1295    
Asp Leu Ala Phe Gln Lys Gln Val Ala Glu Lys
            1300                1305        


<210> 717
<211> 769
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 717
Asp Phe Glu Met Thr Val Lys Glu Cys Gln His Ser Gly Glu Leu Ser
 1               5                  10                  15      
Ser Arg Asn Thr Gly His Leu His Pro Thr Pro Arg Ser Pro Leu Leu
            20                  25                  30          
Arg Trp Thr Gln Glu Pro Gln Pro Leu Glu Glu Lys Trp Gln His Arg
        35                  40                  45              
Val Val Glu Gln Ile Pro Lys Glu Val Gln Phe Gln Pro Pro Gly Ala
    50                  55                  60                  
Pro Leu Glu Lys Glu Lys Ser Gln Gln Cys Tyr Ser Glu Tyr Phe Ser
65                  70                  75                  80  
Gln Thr Ser Thr Glu Leu Gln Ile Thr Phe Asp Glu Thr Asn Pro Ile
                85                  90                  95      
Thr Arg Leu Ser Glu Ile Glu Lys Ile Arg Asp Gln Ala Leu Asn Asn
            100                 105                 110         
Ser Arg Pro Pro Val Arg Tyr Gln Asp Asn Ala Cys Glu Met Glu Leu
        115                 120                 125             
Val Lys Val Leu Thr Pro Leu Glu Ile Ala Lys Asn Lys Gln Tyr Asp
    130                 135                 140                 
Met His Thr Glu Val Thr Thr Leu Lys Gln Glu Lys Asn Pro Val Pro
145                 150                 155                 160 
Ser Ala Glu Glu Trp Met Leu Glu Gly Cys Arg Ala Ser Gly Gly Leu
                165                 170                 175     
Lys Lys Gly Asp Phe Leu Lys Lys Gly Leu Glu Pro Glu Thr Phe Gln
            180                 185                 190         
Asn Phe Asp Gly Asp His Ala Cys Ser Val Arg Asp Asp Glu Phe Lys
        195                 200                 205             
Phe Gln Gly Leu Arg His Thr Val Thr Ala Arg Gln Leu Val Glu Ala
    210                 215                 220                 
Lys Leu Leu Asp Met Arg Thr Ile Glu Gln Leu Arg Leu Gly Leu Lys
225                 230                 235                 240 
Thr Val Glu Glu Val Gln Lys Thr Leu Asn Lys Phe Leu Thr Lys Ala
                245                 250                 255     
Thr Ser Ile Ala Gly Leu Tyr Leu Glu Ser Thr Lys Glu Lys Ile Ser
            260                 265                 270         
Phe Ala Ser Ala Ala Glu Arg Ile Ile Ile Asp Lys Met Val Ala Leu
        275                 280                 285             
Ala Phe Leu Glu Ala Gln Ala Ala Thr Gly Phe Ile Ile Asp Pro Ile
    290                 295                 300                 
Ser Gly Gln Thr Tyr Ser Val Glu Asp Ala Val Leu Lys Gly Val Val
305                 310                 315                 320 
Asp Pro Glu Phe Arg Ile Arg Leu Leu Glu Ala Glu Lys Ala Ala Val
                325                 330                 335     
Gly Tyr Ser Tyr Ser Ser Lys Thr Leu Ser Val Phe Gln Ala Met Glu
            340                 345                 350         
Asn Arg Met Leu Asp Arg Gln Lys Gly Lys His Ile Leu Glu Ala Gln
        355                 360                 365             
Ile Ala Ser Gly Gly Val Ile Asp Pro Val Arg Gly Ile Arg Val Pro
    370                 375                 380                 
Pro Glu Ile Ala Leu Gln Gln Gly Leu Leu Asn Asn Ala Ile Leu Gln
385                 390                 395                 400 
Phe Leu His Glu Pro Ser Ser Asn Thr Arg Val Phe Pro Asn Pro Asn
                405                 410                 415     
Asn Lys Gln Ala Leu Tyr Tyr Ser Glu Leu Leu Arg Met Cys Val Phe
            420                 425                 430         
Asp Val Glu Ser Gln Cys Phe Leu Phe Pro Phe Gly Glu Arg Asn Ile
        435                 440                 445             
Ser Asn Leu Asn Val Lys Lys Thr His Arg Ile Ser Val Val Asp Thr
    450                 455                 460                 
Lys Thr Gly Ser Glu Leu Thr Val Tyr Glu Ala Phe Gln Arg Asn Leu
465                 470                 475                 480 
Ile Glu Lys Ser Ile Tyr Leu Glu Leu Ser Gly Gln Gln Tyr Gln Trp
                485                 490                 495     
Lys Glu Ala Met Phe Phe Glu Ser Tyr Gly His Ser Ser His Met Leu
            500                 505                 510         
Thr Asp Thr Lys Thr Gly Leu His Phe Asn Ile Asn Glu Ala Ile Glu
        515                 520                 525             
Gln Gly Thr Ile Asp Lys Ala Leu Val Lys Lys Tyr Gln Glu Gly Leu
    530                 535                 540                 
Ile Thr Leu Thr Glu Leu Ala Asp Ser Leu Leu Ser Arg Leu Val Pro
545                 550                 555                 560 
Lys Lys Asp Leu His Ser Pro Val Ala Gly Tyr Trp Leu Thr Ala Ser
                565                 570                 575     
Gly Glu Arg Ile Ser Val Leu Lys Ala Ser Arg Arg Asn Leu Val Asp
            580                 585                 590         
Arg Ile Thr Ala Leu Arg Cys Leu Glu Ala Gln Val Ser Thr Gly Gly
        595                 600                 605             
Ile Ile Asp Pro Leu Thr Gly Lys Lys Tyr Arg Val Ala Glu Ala Leu
    610                 615                 620                 
His Arg Gly Leu Val Asp Glu Gly Phe Ala Gln Gln Leu Arg Gln Cys
625                 630                 635                 640 
Glu Leu Val Ile Thr Gly Ile Gly His Pro Ile Thr Asn Lys Met Met
                645                 650                 655     
Ser Val Val Glu Ala Val Asn Ala Asn Ile Ile Asn Lys Glu Met Gly
            660                 665                 670         
Ile Arg Cys Leu Glu Phe Gln Tyr Leu Thr Gly Gly Leu Ile Glu Pro
        675                 680                 685             
Gln Val His Ser Arg Leu Ser Ile Glu Glu Ala Leu Gln Val Gly Ile
    690                 695                 700                 
Ile Asp Val Leu Ile Ala Thr Lys Leu Lys Asp Gln Lys Ser Tyr Val
705                 710                 715                 720 
Arg Asn Ile Ile Cys Pro Gln Thr Lys Arg Lys Leu Thr Tyr Lys Glu
                725                 730                 735     
Ala Leu Glu Lys Ala Asp Phe Asp Phe His Thr Gly Leu Lys Leu Leu
            740                 745                 750         
Glu Val Ser Glu Pro Leu Met Thr Gly Ile Ser Ser Leu Tyr Tyr Ser
        755                 760                 765             
Ser
    


<210> 718
<211> 573
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 718
Asp His Ala Cys Ser Val Arg Asp Asp Glu Phe Lys Phe Gln Gly Leu
 1               5                  10                  15      
Arg His Thr Val Thr Ala Arg Gln Leu Val Glu Ala Lys Leu Leu Asp
            20                  25                  30          
Met Arg Thr Ile Glu Gln Leu Arg Leu Gly Leu Lys Thr Val Glu Glu
        35                  40                  45              
Val Gln Lys Thr Leu Asn Lys Phe Leu Thr Lys Ala Thr Ser Ile Ala
    50                  55                  60                  
Gly Leu Tyr Leu Glu Ser Thr Lys Glu Lys Ile Ser Phe Ala Ser Ala
65                  70                  75                  80  
Ala Glu Arg Ile Ile Ile Asp Lys Met Val Ala Leu Ala Phe Leu Glu
                85                  90                  95      
Ala Gln Ala Ala Thr Gly Phe Ile Ile Asp Pro Ile Ser Gly Gln Thr
            100                 105                 110         
Tyr Ser Val Glu Asp Ala Val Leu Lys Gly Val Val Asp Pro Glu Phe
        115                 120                 125             
Arg Ile Arg Leu Leu Glu Ala Glu Lys Ala Ala Val Gly Tyr Ser Tyr
    130                 135                 140                 
Ser Ser Lys Thr Leu Ser Val Phe Gln Ala Met Glu Asn Arg Met Leu
145                 150                 155                 160 
Asp Arg Gln Lys Gly Lys His Ile Leu Glu Ala Gln Ile Ala Ser Gly
                165                 170                 175     
Gly Val Ile Asp Pro Val Arg Gly Ile Arg Val Pro Pro Glu Ile Ala
            180                 185                 190         
Leu Gln Gln Gly Leu Leu Asn Asn Ala Ile Leu Gln Phe Leu His Glu
        195                 200                 205             
Pro Ser Ser Asn Thr Arg Val Phe Pro Asn Pro Asn Asn Lys Gln Ala
    210                 215                 220                 
Leu Tyr Tyr Ser Glu Leu Leu Arg Met Cys Val Phe Asp Val Glu Ser
225                 230                 235                 240 
Gln Cys Phe Leu Phe Pro Phe Gly Glu Arg Asn Ile Ser Asn Leu Asn
                245                 250                 255     
Val Lys Lys Thr His Arg Ile Ser Val Val Asp Thr Lys Thr Gly Ser
            260                 265                 270         
Glu Leu Thr Val Tyr Glu Ala Phe Gln Arg Asn Leu Ile Glu Lys Ser
        275                 280                 285             
Ile Tyr Leu Glu Leu Ser Gly Gln Gln Tyr Gln Trp Lys Glu Ala Met
    290                 295                 300                 
Phe Phe Glu Ser Tyr Gly His Ser Ser His Met Leu Thr Asp Thr Lys
305                 310                 315                 320 
Thr Gly Leu His Phe Asn Ile Asn Glu Ala Ile Glu Gln Gly Thr Ile
                325                 330                 335     
Asp Lys Ala Leu Val Lys Lys Tyr Gln Glu Gly Leu Ile Thr Leu Thr
            340                 345                 350         
Glu Leu Ala Asp Ser Leu Leu Ser Arg Leu Val Pro Lys Lys Asp Leu
        355                 360                 365             
His Ser Pro Val Ala Gly Tyr Trp Leu Thr Ala Ser Gly Glu Arg Ile
    370                 375                 380                 
Ser Val Leu Lys Ala Ser Arg Arg Asn Leu Val Asp Arg Ile Thr Ala
385                 390                 395                 400 
Leu Arg Cys Leu Glu Ala Gln Val Ser Thr Gly Gly Ile Ile Asp Pro
                405                 410                 415     
Leu Thr Gly Lys Lys Tyr Arg Val Ala Glu Ala Leu His Arg Gly Leu
            420                 425                 430         
Val Asp Glu Gly Phe Ala Gln Gln Leu Arg Gln Cys Glu Leu Val Ile
        435                 440                 445             
Thr Gly Ile Gly His Pro Ile Thr Asn Lys Met Met Ser Val Val Glu
    450                 455                 460                 
Ala Val Asn Ala Asn Ile Ile Asn Lys Glu Met Gly Ile Arg Cys Leu
465                 470                 475                 480 
Glu Phe Gln Tyr Leu Thr Gly Gly Leu Ile Glu Pro Gln Val His Ser
                485                 490                 495     
Arg Leu Ser Ile Glu Glu Ala Leu Gln Val Gly Ile Ile Asp Val Leu
            500                 505                 510         
Ile Ala Thr Lys Leu Lys Asp Gln Lys Ser Tyr Val Arg Asn Ile Ile
        515                 520                 525             
Cys Pro Gln Thr Lys Arg Lys Leu Thr Tyr Lys Glu Ala Leu Glu Lys
    530                 535                 540                 
Ala Asp Phe Asp Phe His Thr Gly Leu Lys Leu Leu Glu Val Ser Glu
545                 550                 555                 560 
Pro Leu Met Thr Gly Ile Ser Ser Leu Tyr Tyr Ser Ser
                565                 570             


<210> 719
<211> 45
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 719
Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp Glu Leu Glu Arg Ile
 1               5                  10                  15      
Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu Lys
            20                  25                  30          
Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp
        35                  40                  45  


<210> 720
<211> 73
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 720
Glu Glu Val Arg Lys Leu Lys Ala Arg Val Asp Glu Leu Glu Arg Ile
 1               5                  10                  15      
Arg Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu Lys
            20                  25                  30          
Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp Leu Asp Lys
        35                  40                  45              
Ile Gly Leu His Ser Asp Ser Gln Glu Glu Leu Trp Met Phe Val Arg
    50                  55                  60                  
Lys Lys Leu Met Met Glu Gln Glu Asn
65                  70              


<210> 721
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 721
Ser Asp Ser Gln Glu Glu Leu Trp Met Phe Val Arg Lys Lys
 1               5                  10                  


<210> 722
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope recognized by specific TCR for
      an antigen associated with bullous pemphigoid

<400> 722
Trp Met Phe Val Arg Lys Lys Leu Met Met Glu Gln Glu Asn Gly Asn
 1               5                  10                  15      
Leu Arg Gly
            


<210> 723
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR".

<400> 723
Thr Asn Phe Lys Tyr Asn Tyr Ser Val Ile Glu Gly Gly Pro Ile
 1               5                  10                  15  


<210> 724
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 724
Ile Leu Lys Ile Ser Asn Lys Tyr His Thr Lys Gly Asp His
 1               5                  10                  


<210> 725
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 725
Asp Thr Leu Glu Lys Ile Ser Asn Glu Ile Lys Ile Val Ala Thr Pro
 1               5                  10                  15      


<210> 726
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 726
Ile Leu Lys Ile Ser Asn Lys Tyr His Thr Lys Gly Asp His
 1               5                  10                  


<210> 727
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 727
Ile Leu Lys Ile Ser Asn Lys Tyr His Thr Lys Gly Asp His
 1               5                  10                  


<210> 728
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 728
Thr Asn Phe Lys Tyr Asn Tyr Ser Val Ile Glu Gly Gly Pro Ile
 1               5                  10                  15  


<210> 729
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 729
Asp Thr Leu Glu Lys Ile Ser Asn Glu Ile Lys Ile Val Ala Thr Pro
 1               5                  10                  15      


<210> 730
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 730
Asp Thr Leu Glu Lys Ile Ser Asn Glu Ile Lys Ile Val Ala Thr Pro
 1               5                  10                  15      


<210> 731
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 731
Asp Thr Leu Glu Lys Ile Ser Asn Glu Ile Lys Ile Val Ala Thr Pro
 1               5                  10                  15      


<210> 732
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 732
Thr Asn Phe Lys Tyr Asn Tyr Ser Val Ile Glu Gly Gly Pro Ile
 1               5                  10                  15  


<210> 733
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 733
Ile Leu Lys Ile Ser Asn Lys Tyr His Thr Lys Gly Asp His
 1               5                  10                  


<210> 734
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 734
Thr Asn Phe Lys Tyr Asn Tyr Ser Val Ile Glu Gly Gly Pro Ile
 1               5                  10                  15  


<210> 735
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> ntigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 735
Asp Thr Leu Glu Lys Ile Ser Asn Glu Ile Lys Ile Val Ala Thr Pro
 1               5                  10                  15      


<210> 736
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR".

<400> 736
Thr Asn Phe Lys Tyr Asn Tyr Ser Val Ile Glu Gly Gly Pro Ile
 1               5                  10                  15  


<210> 737
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 737
Ile Leu Lys Ile Ser Asn Lys Tyr His Thr Lys Gly Asp His
 1               5                  10                  


<210> 738
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 738
Thr Asn Phe Lys Tyr Asn Tyr Ser Val Ile Glu Gly Gly Pro Ile
 1               5                  10                  15  


<210> 739
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 739
Thr Asn Phe Lys Tyr Asn Tyr Ser Val Ile Glu Gly Gly Pro
 1               5                  10                  


<210> 740
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 740
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 741
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 741
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 742
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 742
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 743
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 743
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 744
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 744
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 745
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 745
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 746
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 746
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 747
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 747
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 748
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 748
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 749
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 749
Pro Gln Pro Glu Leu Pro Tyr Pro Gln Pro Glu
 1               5                  10      


<210> 750
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 750
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 751
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 751
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 752
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 752
Gln Leu Gln Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  10          


<210> 753
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 753
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 754
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR"

<400> 754
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 755
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 755
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 756
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 756
Gln Leu Gln Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  10          


<210> 757
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 757
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 758
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 758
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 759
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 759
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 760
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 760
Gln Leu Gln Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  10          


<210> 761
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 761
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 762
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 762
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 763
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 763
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 764
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 764
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 765
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 765
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 766
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 766
Pro Phe Pro Gln Pro Glu Leu Pro Tyr
 1               5                  


<210> 767
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 767
Pro Gln Pro Glu Leu Pro Tyr Pro Gln
 1               5                  


<210> 768
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 768
Pro Gln Pro Glu Leu Pro Tyr Pro Gln
 1               5                  


<210> 769
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 769
Pro Gln Pro Glu Leu Pro Tyr Pro Gln
 1               5                  


<210> 770
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 770
Pro Gln Pro Glu Leu Pro Tyr Pro Gln
 1               5                  


<210> 771
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR"

<400> 771
Pro Gln Pro Glu Leu Pro Tyr Pro Gln
 1               5                  


<210> 772
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 772
Pro Gln Pro Glu Leu Pro Tyr Pro Gln
 1               5                  


<210> 773
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 773
Pro Gln Pro Glu Leu Pro Tyr Pro Gln
 1               5                  


<210> 774
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 774
Pro Gln Pro Glu Leu Pro Tyr Pro Gln
 1               5                  


<210> 775
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 775
Pro Gln Pro Glu Leu Pro Tyr Pro Gln
 1               5                  


<210> 776
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 776
Pro Gln Gln Pro Phe Pro Gln Pro Glu Gln Pro Phe Pro
 1               5                  10              


<210> 777
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 777
Pro Gln Gln Pro Phe Pro Gln Pro Glu Gln Pro Phe Pro
 1               5                  10              


<210> 778
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 778
Pro Gln Gln Pro Phe Pro Gln Pro Glu Gln Pro Phe Pro
 1               5                  10              


<210> 779
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 779
Pro Gln Gln Pro Phe Pro Gln Pro Glu Gln Pro Phe Pro
 1               5                  10              


<210> 780
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 780
Val His Phe Phe Lys Asn Ile Val Thr Pro Arg Thr Pro Gly
 1               5                  10                  


<210> 781
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 781
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 782
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 782
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 783
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 783
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 784
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 784
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 785
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 785
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 786
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 786
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 787
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 787
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 788
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 788
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 789
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 789
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 790
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 790
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 791
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 791
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 792
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 792
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 793
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 793
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 794
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 794
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 795
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 795
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 796
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 796
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 797
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 797
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 798
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 798
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 799
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 799
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 800
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 800
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 801
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 801
Leu Ser Arg Phe Ser Trp Gly Ala Glu Gly Gln Arg Pro Gly Phe Gly
 1               5                  10                  15      
Tyr Gly Gly
            


<210> 802
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 802
Glu Lys Pro Lys Val Glu Ala Tyr Lys Ala Ala Ala Ala Pro Ala
 1               5                  10                  15  


<210> 803
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 803
Glu Lys Pro Lys Val Glu Ala Tyr Lys Ala Ala Ala Ala Pro Ala
 1               5                  10                  15  


<210> 804
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 804
Glu Lys Pro Lys Val Glu Ala Tyr Lys Ala Ala Ala Ala Pro Ala
 1               5                  10                  15  


<210> 805
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 805
Glu Lys Pro Lys Val Glu Ala Tyr Lys Ala Ala Ala Ala Pro Ala
 1               5                  10                  15  


<210> 806
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 806
Glu Lys Pro Lys Val Glu Ala Tyr Lys Ala Ala Ala Ala Pro Ala
 1               5                  10                  15  


<210> 807
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TC

<400> 807
Glu Lys Pro Lys Val Glu Ala Tyr Lys Ala Ala Ala Ala Pro Ala
 1               5                  10                  15  


<210> 808
<211> 43
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 808
Glu Lys Pro Lys Val Glu Ala Tyr Lys Ala Ala Ala Ala Pro Ala Glu
 1               5                  10                  15      
Lys Pro Lys Val Glu Ala Tyr Lys Ala Ala Ala Ala Pro Ala Pro Lys
            20                  25                  30          
Val Glu Ala Tyr Lys Ala Ala Ala Ala Pro Ala
        35                  40              


<210> 809
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 809
Thr Val Tyr Gly Ala Phe Asp Pro Leu Leu Ala Val Ala Asp
 1               5                  10                  


<210> 810
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 810
Asn Phe Phe Arg Met Val Ile Ser Asn Pro Ala Ala Thr
 1               5                  10              


<210> 811
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 811
Asn Phe Phe Arg Met Val Ile Ser Asn Pro Ala Ala Thr
 1               5                  10              


<210> 812
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 812
Gln Leu Tyr His Phe Leu Gln Ile Pro Thr His Glu Glu His Leu Phe
 1               5                  10                  15      
Tyr Val Leu Ser
            20  


<210> 813
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 813
Lys Trp Cys Ala Asn Pro Asp Trp Ile His Ile Asp Thr Thr Pro Phe
 1               5                  10                  15      
Ala Gly Leu Val
            20  


<210> 814
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 814
Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly
 1               5                  10                  15  


<210> 815
<211> 7
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 815
Leu Ala Leu Glu Gly Ser Leu
 1               5          


<210> 816
<211> 7
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 816
Leu Ala Leu Glu Gly Ser Leu
 1               5          


<210> 817
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 817
Ala Glu Asp Leu Gln Val Gly Gln Val Glu
 1               5                  10  


<210> 818
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 818
Ala Glu Asp Leu Gln Val Gly Gln Val Glu
 1               5                  10  


<210> 819
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 819
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 820
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 820
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 821
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 821
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 822
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 822
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 823
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 823
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 824
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 824
Ala Gly Ser Leu Gln Pro Leu Ala Leu Glu
 1               5                  10  


<210> 825
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 825
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 826
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 826
Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly
 1               5                  10                  15  


<210> 827
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 827
Gln Val Glu Leu Gly Gly Gly Pro Gly Ala Gly
 1               5                  10      


<210> 828
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 828
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 829
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 829
Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser
 1               5                  10  


<210> 830
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 830
Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser
 1               5                  10  


<210> 831
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 831
Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser
 1               5                  10  


<210> 832
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR"

<400> 832
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 833
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 833
Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly
 1               5                  10                  15  


<210> 834
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 834
Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly
 1               5                  10                  15  


<210> 835
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 835
Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu
 1               5                  10      


<210> 836
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 836
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 837
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 837
Gly Ala Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys
 1               5                  10                  15      
Arg
    


<210> 838
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 838
Ala Gly Ser Leu Gln Pro Leu Ala Leu
 1               5                  


<210> 839
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 839
Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly
 1               5                  10                  15  


<210> 840
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 840
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 841
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 841
Val Glu Leu Gly Gly Gly Pro Gly Ala
 1               5                  


<210> 842
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 842
Gln Pro Leu Ala Leu Glu Gly Ser Leu
 1               5                  


<210> 843
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR"

<400> 843
Gln Pro Leu Ala Leu Glu Gly Ser Leu
 1               5                  


<210> 844
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 844
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 845
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 845
Gly Ala Gly Ser Leu Gln Pro Leu Ala Leu
 1               5                  10  


<210> 846
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 846
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 847
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 847
Gln Pro Leu Ala Leu Glu Gly Ser Leu
 1               5                  


<210> 848
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 848
Val Glu Leu Gly Gly Gly Pro Gly Ala
 1               5                  


<210> 849
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 849
Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly
 1               5                  10                  15  


<210> 850
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 850
Gln Val Glu Leu Gly Gly Gly Pro Gly
 1               5                  


<210> 851
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 851
Gln Val Glu Leu Gly Gly Gly Pro Gly Ala Gly
 1               5                  10      


<210> 852
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 852
Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln
 1               5                  10                  15  


<210> 853
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 853
Val Glu Leu Gly Gly Gly Pro Gly Ala Gly
 1               5                  10  


<210> 854
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 854
Val Glu Leu Gly Gly Gly Pro Gly Ala
 1               5                  


<210> 855
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 855
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 856
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 856
Leu Val Glu Ala Leu Tyr Leu Val Cys Gly
 1               5                  10  


<210> 857
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 857
Pro Gly Ala Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln
 1               5                  10                  15      
Lys Arg Gly
            


<210> 858
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 858
Glu Asp Leu Gln Val Gly Gln Val Glu Leu Gly Gly
 1               5                  10          


<210> 859
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<221> CONFLICT       
<222> (0)...(0)
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 859
Pro Gly Ala Gly Ser Leu Gln Pro Leu Ala Leu Glu
 1               5                  10          


<210> 860
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 860
Ala Gly Ser Leu Gln Pro Leu Ala Leu
 1               5                  


<210> 861
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 861
Ala Gly Ser Leu Gln Pro Leu Ala Leu
 1               5                  


<210> 862
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 862
Ala Gly Ser Leu Gln Pro Leu Ala Leu
 1               5                  


<210> 863
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 863
Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15      
Ile Val
        


<210> 864
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 864
Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln
 1               5                  10          


<210> 865
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 865
Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln
 1               5                  10  


<210> 866
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 866
Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln
 1               5                  10  


<210> 867
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 867
Met Ala Leu Trp Met Arg Leu Leu Pro Leu Leu Ala Leu Leu Ala
 1               5                  10                  15  


<210> 868
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 868
Met Ala Leu Trp Met Arg Leu Leu Pro Leu Leu Ala Leu Leu Ala
 1               5                  10                  15  


<210> 869
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 869
Met Ala Leu Trp Met Arg Leu Leu Pro Leu Leu Ala Leu Leu Ala
 1               5                  10                  15  


<210> 870
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 870
Met Ala Leu Trp Met Arg Leu Leu Pro Leu Leu Ala Leu Leu Ala
 1               5                  10                  15  


<210> 871
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 871
Cys Ala Ala Lys Thr Gly Tyr Ser Ser Ala Ser Lys Ile Ile Phe
 1               5                  10                  15  


<210> 872
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 872
Cys Ala Ala Ser Met Gly Leu Asn Ser Gly Tyr Ala Leu Asn Phe
 1               5                  10                  15  


<210> 873
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 873
Cys Ala Ala Ser Arg Lys Asp Arg Thr Ala Ser Lys Leu Thr Phe
 1               5                  10                  15  


<210> 874
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 874
Cys Ala Glu Met Met Asn Ser Gly Tyr Ser Thr Leu Thr Phe
 1               5                  10                  


<210> 875
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 875
Cys Ala Glu Asn Arg Gly Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 876
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 876
Cys Ala Leu Glu Ser Leu Leu Leu Ile Lys Glu Thr Ser Gly Ser Arg
 1               5                  10                  15      
Leu Thr Phe
            


<210> 877
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 877
Cys Ala Leu Arg Val Tyr Asn Phe Asn Lys Phe Tyr Phe
 1               5                  10              


<210> 878
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 878
Cys Ala Leu Ser Pro Leu Asn Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  15  


<210> 879
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 879
Cys Ala Leu Ser Pro Leu Asn Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  15  


<210> 880
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 880
Cys Ala Met Gly Glu Thr Gly Gly Pro Lys Thr Ile Phe
 1               5                  10              


<210> 881
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 881
Cys Ala Met Arg Asp Leu Tyr Ser Gly Ala Gly Ser Tyr Gln Leu Thr
 1               5                  10                  15      
Phe
    


<210> 882
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 882
Cys Ala Pro Pro Pro Arg Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 883
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 883
Cys Ala Val Asn Ile Val Gly Thr Gln Gly Gly Ser Glu Lys Leu Val
 1               5                  10                  15      
Phe
    


<210> 884
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 884
Cys Ala Val Asn Thr Gly Phe Gln Lys Leu Val Phe
 1               5                  10          


<210> 885
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 885
Cys Ala Val Pro Val Tyr Asn Thr Asp Lys Leu Ile Phe
 1               5                  10              


<210> 886
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 886
Cys Ala Val Arg Gly Gly Gly Ala Asp Gly Leu Thr Phe
 1               5                  10              


<210> 887
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 887
Cys Ala Ala Asp Glu Phe Val Arg Asn Tyr Gly Gly Ala Thr Asn Lys
 1               5                  10                  15      
Leu Ile Phe
            


<210> 888
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> :  CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 888
Cys Ala Gly Asp Ser Gly Tyr Ala Leu Asn
 1               5                  10  


<210> 889
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 889
Cys Ala Leu Ser Glu Leu Ser Ile Gln Gly Ala Gln Lys Leu Val
 1               5                  10                  15  


<210> 890
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 890
Cys Ala Leu Ser Glu Ser Gly Ala Asn Ser Lys Leu Thr
 1               5                  10              


<210> 891
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 891
Cys Ala Val Arg Asp Pro Leu Tyr Asn Phe Asn Lys Phe Tyr
 1               5                  10                  


<210> 892
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 892
Cys Ile Glu Tyr Asn Phe Asn Lys Phe Tyr
 1               5                  10  


<210> 893
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 893
Cys Ile Val Pro Ala Asn Thr Gly Gly Phe Lys Thr Ile
 1               5                  10              


<210> 894
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 894
Cys Leu Val Gly Gly Gly Ala Asp Gly Leu Thr
 1               5                  10      


<210> 895
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 895
Cys Leu Val Gly His Gly Ser Ser Asn Thr Gly Lys Leu Ile
 1               5                  10                  


<210> 896
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> :  CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 896
Cys Val Val Asn Ser Trp Ala Gly Asn Gln Phe Tyr
 1               5                  10          


<210> 897
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 897
Ile Val Tyr Gly Gly Phe Lys Thr Ile
 1               5                  


<210> 898
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 898
Cys Ala Ala Pro Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10              


<210> 899
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 899
Cys Ala Ala Ser Ala Asn Tyr Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10                  15      


<210> 900

<400> 900
 000

<210> 901
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 901
Cys Ala Phe Ile Gly Gly Ser Asn Tyr Lys Leu Thr Phe
 1               5                  10              


<210> 902
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 902
Cys Ala Gly Pro Ser Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10              


<210> 903
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 903
Cys Ala Gly Pro Tyr Asn Thr Asp Lys Leu Ile Phe
 1               5                  10          


<210> 904
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 904
Cys Ala Met Arg Glu Gly Trp Gln Ala Gly Asn Thr Leu Ile Phe
 1               5                  10                  15  


<210> 905
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 905
Cys Ala Val Glu Leu Gly Asp Ser Trp Gly Lys Phe Gln Phe
 1               5                  10                  


<210> 906
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 906
Cys Ala Val Gly Ala Gly Ser Asn Tyr Gln Leu Ile Trp
 1               5                  10              


<210> 907
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 907
Cys Ala Val Gly Trp Glu Asp Gly Thr Ala Ser Lys Leu Thr Phe
 1               5                  10                  15  


<210> 908
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 908
Cys Ala Val Lys Phe Ala Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 909
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 909
Cys Ala Val Gln Ala Asp Gly Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  


<210> 910
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 910
Cys Ala Val Thr Leu Gly Gly Gly Ser Glu Lys Leu Val Phe
 1               5                  10                  


<210> 911
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 911
Cys Ala Tyr Arg Ser Gly Tyr Met Glu Tyr Gly Asn Lys Leu Val
 1               5                  10                  15  


<210> 912
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 912
Cys Leu Val Ala Gly Ala Gly Gly Tyr Asn Lys Leu Ile Phe
 1               5                  10                  


<210> 913
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 913
Cys Leu Val Gly Asp Gly Gly Ser Phe Ser Gly Gly Tyr Asn Lys Leu
 1               5                  10                  15      
Ile Phe
        


<210> 914
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 914
Cys Leu Val Gly Asp Asn Asp Tyr Lys Leu Ser Phe
 1               5                  10          


<210> 915
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 915
Cys Ala Met Arg Glu Gly Arg Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  15      


<210> 916
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 916
Cys Ala Met Arg Glu Gly Arg Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  15      


<210> 917
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 917
Cys Ala Met Ser Val Leu Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 918
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 918
Cys Ala Met Ser Val Leu Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 919
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 919
Cys Ala Val Gly Arg Gly Gly Ser Gln Gly Asn Leu Ile Phe
 1               5                  10                  


<210> 920
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 920
Cys Ile Ala Phe Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10          


<210> 921
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 921
Cys Ile Val Leu Gly Gly Ala Asp Gly Leu Thr Phe
 1               5                  10          


<210> 922
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 922
Cys Ile Val Trp Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10              


<210> 923
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 923
Cys Leu Val Gly Glu Ala Ala Gly Asn Lys Leu Thr Phe
 1               5                  10              


<210> 924
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 924
Cys Ala Glu Ser Arg Tyr Ser Gly Tyr Ser Thr Leu Thr Phe
 1               5                  10                  


<210> 925
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 925
Cys Ala Leu Ser Glu Tyr Gly Asn Lys Leu Val Phe
 1               5                  10          


<210> 926
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 926
Cys Ala Val Val Asp Ala Ser Ser Lys Leu Ile Phe
 1               5                  10          


<210> 927
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 927
Cys Leu Val Gly Gly Tyr Asn Asn Asn Asp Met Arg Phe
 1               5                  10              


<210> 928
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 928
Cys Ala Leu Ser Gly Gly Asp Ser Ser Tyr Lys Leu Ile Phe
 1               5                  10                  


<210> 929
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 929
Phe Cys Ala Glu Ala Gln Lys Gly Gln Lys Leu Leu Phe Ala Arg Gly
 1               5                  10                  15      
Thr Met Leu Lys Val Asp Leu
            20              


<210> 930
<211> 27
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 930
Phe Cys Ala Val Ile Ser Ile Ser Ser Gly Ser Ala Arg Gln Leu Thr
 1               5                  10                  15      
Phe Gly Ser Gly Thr Gln Leu Thr Val Leu Pro
            20                  25          


<210> 931
<211> 21
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 931
Phe Cys Ala Val Met His Asn Asp Met Arg Phe Gly Ala Gly Thr Arg
 1               5                  10                  15      
Leu Thr Val Lys Pro
            20      


<210> 932

<400> 932
 000

<210> 933
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 933
Leu Cys Ala Ala Tyr Gly Ser Ser Asn Thr Gly Lys Leu Ile Phe Gly
 1               5                  10                  15      
Gln Gly Thr Thr Leu Gln Val Lys Pro
            20                  25  


<210> 934
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 934
Leu Cys Ala Val Gln Ala Asn Asn Tyr Gly Gln Asn Phe Val Phe Gly
 1               5                  10                  15      
Pro Gly Thr Arg Leu Ser Val Leu Pro
            20                  25  


<210> 935
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 935
Leu Cys Ala Val Gln Ala Asn Asn Tyr Gly Gln Asn Phe Val Phe Gly
 1               5                  10                  15      
Pro Gly Thr Arg Leu Ser Val Leu Pro
            20                  25  


<210> 936
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 936
Leu Cys Ala Val Gln Ala Asn Asn Tyr Gly Gln Asn Phe Val Phe Gly
 1               5                  10                  15      
Pro Gly Thr Arg Leu Ser Val Leu Pro
            20                  25  


<210> 937
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 937
Leu Cys Ala Val Gln Gly Ala Gly Gly Tyr Gln Lys Val Thr Phe Gly
 1               5                  10                  15      
Ile Gly Thr Lys Leu Gln Val Ile Pro
            20                  25  


<210> 938
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 938
Leu Cys Ala Val Arg Lys Glu Thr Ser Gly Ser Arg Leu Thr Phe Gly
 1               5                  10                  15      
Glu Gly Thr Gln Leu Thr Val Asn Pro
            20                  25  


<210> 939
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 939
Leu Cys Ala Val Tyr Thr Gly Ala Asn Ser Lys Leu Thr Phe Gly Lys
 1               5                  10                  15      
Gly Ile Thr Leu Ser Val Arg Pro
            20                  


<210> 940
<211> 2
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 940
Asn Asp
 1      


<210> 941
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 941
Tyr Cys Ile Leu Arg Gly Arg Thr Ser Tyr Asp Lys Val Ile Phe Gly
 1               5                  10                  15      
Pro Gly Thr Ser Leu Ser Val Ile Pro
            20                  25  


<210> 942
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 942
Tyr Cys Ile Leu Arg Gly Arg Thr Ser Tyr Asp Lys Val Ile Phe Gly
 1               5                  10                  15      
Pro Gly Thr Ser Leu Ser Val Ile Pro
            20                  25  


<210> 943
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 943
Tyr Cys Ile Leu Arg Gly Arg Thr Ser Tyr Asp Lys Val Ile Phe Gly
 1               5                  10                  15      
Pro Gly Thr Ser Leu Ser Val Ile Pro
            20                  25  


<210> 944
<211> 27
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 944
Tyr Cys Ile Val Arg Pro Ser His Asn Thr Asn Ala Gly Lys Ser Thr
 1               5                  10                  15      
Phe Gly Asp Gly Thr Thr Leu Thr Val Lys Pro
            20                  25          


<210> 945
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 945
Tyr Cys Ile Val Arg Val Val Asp Tyr Gly Gln Asn Phe Val Phe Gly
 1               5                  10                  15      
Pro Gly Thr Arg Leu Ser Val Leu Pro
            20                  25  


<210> 946
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 946
Tyr Cys Thr Val Tyr Gly Gly Ala Thr Asn Lys Leu Ile Phe Gly Thr
 1               5                  10                  15      
Gly Thr Leu Leu Ala Val Gln Pro
            20                  


<210> 947
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 947
Tyr Cys Thr Val Tyr Gly Gly Ala Thr Asn Lys Leu Ile Phe Gly Thr
 1               5                  10                  15      
Gly Thr Leu Leu Ala Val Gln Pro
            20                  


<210> 948
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 948
Tyr Cys Thr Val Tyr Gly Gly Ala Thr Asn Lys Leu Ile Phe Gly Thr
 1               5                  10                  15      
Gly Thr Leu Leu Ala Val Gln Pro
            20                  


<210> 949
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 949
Tyr Cys Thr Val Tyr Gly Gly Ala Thr Asn Lys Leu Ile Phe Gly Thr
 1               5                  10                  15      
Gly Thr Leu Leu Ala Val Gln Pro
            20                  


<210> 950
<211> 29
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 950
Tyr Phe Cys Ala Ala Ser Ser Phe Gly Asn Glu Lys Leu Thr Phe Gly
 1               5                  10                  15      
Thr Gly Thr Arg Leu Thr Ile Ile Pro Asn Ile Gln Asn
            20                  25                  


<210> 951
<211> 28
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 951
Tyr Phe Cys Ala Thr Asp Ala Gly Gly Gln Asn Phe Val Phe Gly Pro
 1               5                  10                  15      
Gly Thr Arg Leu Ser Val Leu Pro Tyr Ile Gln Asn
            20                  25              


<210> 952
<211> 30
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 952
Tyr Phe Cys Ala Thr Asp Ala Thr Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  15      
Gly Thr Gly Thr Arg Leu Lys Val Leu Ala Asn Ile Gln Asn
            20                  25                  30  


<210> 953
<211> 28
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 953
Tyr Phe Cys Ala Thr Asp Gly Asn Gly Asn Gln Phe Tyr Phe Gly Thr
 1               5                  10                  15      
Gly Thr Ser Leu Thr Val Ile Pro Asn Ile Gln Asn
            20                  25              


<210> 954
<211> 29
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 954
Tyr Phe Cys Ala Thr Asp Ser Gly Gly Ser Tyr Ile Pro Thr Phe Gly
 1               5                  10                  15      
Arg Gly Thr Ser Leu Ile Val His Pro Tyr Ile Gln Asn
            20                  25                  


<210> 955
<211> 29
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 955
Tyr Phe Cys Ala Thr Asp Thr Gly Gly Ser Tyr Ile Pro Thr Phe Gly
 1               5                  10                  15      
Arg Gly Thr Ser Leu Ile Val His Pro Tyr Ile Gln Asn
            20                  25                  


<210> 956
<211> 30
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 956
Tyr Phe Cys Ala Thr Asp Thr Thr Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  15      
Gly Thr Gly Thr Arg Leu Lys Val Leu Ala Asn Ile Gln Asn
            20                  25                  30  


<210> 957
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 957
Cys Ala Gly His Ser Ile Ile Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10                  15  


<210> 958
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 958
Cys Ala Leu Ser Glu Glu Gly Gly Gly Ala Asn Ser Lys Leu Thr
 1               5                  10                  15  


<210> 959
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 959
Cys Ala Leu Ser Glu Asn Arg Gly Gly Thr Ala Ser Lys Leu Thr
 1               5                  10                  15  


<210> 960
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 960
Cys Ala Ala Thr Arg Thr Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 961
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 961
Cys Ala Val Glu Asp Leu Asn Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  15  


<210> 962
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 962
Ala Ala Ser Lys Ala Ser Asn Thr Gly Lys Leu Ile
 1               5                  10          


<210> 963
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 963
Cys Ala Ala Ala Leu Ser Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  15  


<210> 964
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 964
Cys Ala Ala Ala Leu Ser Gly Ala Gly Ser Tyr Gln Leu Thr Phe
 1               5                  10                  15  


<210> 965
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 965
Cys Ala Ala Arg Asn Ala Gly Asn Asn Arg Lys Leu Ile Trp
 1               5                  10                  


<210> 966
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 966
Cys Ala Ala Arg Asn Ala Gly Asn Asn Arg Lys Leu Ile Trp
 1               5                  10                  


<210> 967
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 967
Cys Ala Ala Ser Ser Ser Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 968
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 968
Cys Ala Ala Ser Val Ser Gly Gly Ser Asn Tyr Lys Leu Thr Phe
 1               5                  10                  15  


<210> 969
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 969
Cys Ala Ala Ser Val Tyr Ala Gly Gly Thr Ser Tyr Gly Lys Leu Thr
 1               5                  10                  15      
Phe
    


<210> 970
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 970
Cys Ala Glu Asn Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10          


<210> 971
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 971
Cys Ala Glu Ser Pro Asn Ala Gly Asn Asn Arg Lys Leu Ile Trp
 1               5                  10                  15  


<210> 972
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 972
Cys Ala Gly Gly Phe Ser Asp Gly Gln Lys Leu Leu Phe
 1               5                  10              


<210> 973
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 973
Cys Ala Gly Gly Pro Arg Arg Gly Ser Thr Leu Gly Arg Leu Tyr Phe
 1               5                  10                  15      


<210> 974
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 974
Cys Ala Ile Leu Ser Gly Gly Tyr Asn Lys Leu Ile Phe
 1               5                  10              


<210> 975
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 975
Cys Ala Leu Lys Tyr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10          


<210> 976
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 976
Cys Ala Leu Arg Asn Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10              


<210> 977
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 977
Cys Ala Leu Ser Gly Arg Gly Ser Glu Lys Leu Val Phe
 1               5                  10              


<210> 978
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 978
Cys Ala Leu Ser Gly Arg Gly Ser Glu Lys Leu Val Phe
 1               5                  10              


<210> 979
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 979
Cys Ala Leu Ser Arg Ala Gly Thr Gly Asn Gln Phe Tyr Phe
 1               5                  10                  


<210> 980
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 980
Cys Ala Leu Tyr Asn Asn Asn Asp Met Arg Phe
 1               5                  10      


<210> 981
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 981
Cys Ala Thr Ala Tyr Gly Gln Asn Phe Val Phe
 1               5                  10      


<210> 982
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 982
Cys Ala Thr Asp Ala Gly Tyr Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10                  15  


<210> 983
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 983
Cys Ala Thr Gly Pro Ile Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10                  


<210> 984
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 984
Cys Ala Thr Tyr Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10          


<210> 985
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 985
Cys Ala Val Asp Gly Ser Gly Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  


<210> 986
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 986
Cys Ala Val Ile Glu Thr Ser Gly Ser Arg Leu Thr Phe
 1               5                  10              


<210> 987
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 987
Cys Ala Val Lys Arg Thr Gly Gly Ser Tyr Ile Pro Thr Phe
 1               5                  10                  


<210> 988
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 988
Cys Ala Val Pro Asn Asn Asn Asp Met Arg Phe
 1               5                  10      


<210> 989
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 989
Cys Ala Val Gln Ala Gly Gly Asn Asn Arg Leu Ala Phe
 1               5                  10              


<210> 990
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 990
Cys Ala Val Arg Gly Asp Asn Asn Ala Arg Leu Met Phe
 1               5                  10              


<210> 991
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 991
Cys Ala Val Arg Gly Asp Asn Asn Ala Arg Leu Met Phe
 1               5                  10              


<210> 992
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 992
Cys Ala Val Ser Asp Lys Ala Ala Gly Asn Lys Leu Thr Phe
 1               5                  10                  


<210> 993
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 993
Cys Ala Val Thr Pro Lys Ser Gly Tyr Ser Thr Leu Thr Phe
 1               5                  10                  


<210> 994
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 994
Cys Ala Tyr Arg Ser Leu Ser Thr Gly Thr Ala Ser Lys Leu Thr Phe
 1               5                  10                  15      


<210> 995
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 995
Cys Gly Thr Glu Lys Pro Gly Ser Gly Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  15      


<210> 996
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 996
Cys Ile Ala Ile Tyr Asn Phe Asn Lys Phe Tyr Phe
 1               5                  10          


<210> 997
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 997
Cys Ile Val Arg Val Asp Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10                  


<210> 998
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 998
Cys Ile Val Arg Val Glu Ile Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10                  15  


<210> 999
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 999
Cys Ile Val Arg Val Glu Ile Gln Gly Ala Gln Lys Leu Val Phe
 1               5                  10                  15  


<210> 1000
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1000
Cys Ile Val Arg Val Ser Ser Ala Tyr Tyr Asn Gln Gly Gly Lys Leu
 1               5                  10                  15      
Ile Phe
        


<210> 1001
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1001
Cys Ile Val Arg Val Val Thr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10                  


<210> 1002
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1002
Cys Ile Val Ser His Asn Ala Gly Asn Met Leu Thr Phe
 1               5                  10              


<210> 1003
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1003
Cys Leu Val Gly Asp Phe Gly Ser Ala Arg Gln Leu Thr Phe
 1               5                  10                  


<210> 1004
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1004
Cys Leu Val Gly Asp Ser Leu Asn Thr Asn Ala Gly Lys Ser Thr Phe
 1               5                  10                  15      


<210> 1005
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1005
Cys Leu Val Gly Asp Ser Leu Asn Thr Asn Ala Gly Lys Ser Thr Phe
 1               5                  10                  15      


<210> 1006
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1006
Cys Val Ile Ser Pro Pro Gly Arg Arg Ala Leu Thr Phe
 1               5                  10              


<210> 1007
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1007
Cys Val Val Lys Ser Thr Gly Gly Phe Lys Thr Ile Phe
 1               5                  10              


<210> 1008
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1008
Cys Val Val Asn Pro Thr Asp Asp Tyr Lys Leu Ser Phe
 1               5                  10              


<210> 1009
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1009
Cys Val Val Asn Pro Thr Asp Asp Tyr Lys Leu Ser Phe
 1               5                  10              


<210> 1010
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1010
Cys Val Val Asn Pro Thr Asp Asp Tyr Lys Leu Ser Phe
 1               5                  10              


<210> 1011
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1011
Cys Val Val Asn Val Arg Gly Ser Thr Leu Gly Arg Leu Tyr Phe
 1               5                  10                  15  


<210> 1012
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1012
Cys Val Val Ser Ala Ala Gly Gly Gly Gly Ala Asp Gly Leu Thr Phe
 1               5                  10                  15      


<210> 1013
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1013
Cys Val Val Ser Ala Lys Ala Ala Gly Asn Lys Leu Thr Phe
 1               5                  10                  


<210> 1014
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1014
Cys Val Val Ser Ala Lys Ala Ala Gly Asn Lys Leu Thr Phe
 1               5                  10                  


<210> 1015
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1015
Tyr Phe Cys Ala Asp Ala Gly Gly Thr Ser Tyr Lys Leu Phe Gly Gln
 1               5                  10                  15      
Gly Thr Ile Leu
            20  


<210> 1016
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1016
Tyr Phe Cys Ala Val Gly Ala Leu Ala Gly Thr Ala Ser Lys Leu Thr
 1               5                  10                  15      
Phe Gly Thr Gly Thr Arg Leu
            20              


<210> 1017
<211> 22
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1017
Tyr Phe Cys Ala Val Val Asn Met Asp Ser Asn Tyr Gln Leu Ile Trp
 1               5                  10                  15      
Gly Ala Gly Thr Lys Leu
            20          


<210> 1018
<211> 22
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1018
Tyr Tyr Cys Ile Pro Gly Ser Glu Glu Tyr Gly Asn Lys Leu Val Phe
 1               5                  10                  15      
Gly Ala Gly Thr Ile Leu
            20          


<210> 1019
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1019
Tyr Cys Ile Val Arg Ile Tyr Asn Gln Gly Gly Lys Leu Ile Phe Gly
 1               5                  10                  15      
Gln Gly Thr Glu Leu Ser Val Lys Pro
            20                  25  


<210> 1020
<211> 30
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1020
Tyr Phe Cys Ala Glu Met Arg Pro His Asn Asn Asn Asp Met Arg Phe
 1               5                  10                  15      
Gly Ala Gly Thr Arg Leu Thr Val Lys Pro Asn Ile Gln Asn
            20                  25                  30  


<210> 1021
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1021
Cys Ala Ser Ser Leu Arg Ala Asn Pro Gly Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 1022
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1022
Cys Ala Ser Ser Arg Thr Asn Glu Lys Leu Phe Phe
 1               5                  10          


<210> 1023
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1023
Cys Ala Ser Ser Lys Gly Thr Gly Val Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 1024
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1024
Cys Ala Ser Ser Glu Glu Gln Gly Ala Ile Ala Phe Phe
 1               5                  10              


<210> 1025
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1025
Cys Ala Ser Ser Leu Ala Arg Gly Thr Leu Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 1026
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1026
Cys Ala Ser Ser Met Gly Gly Ala Leu Glu Lys Leu Phe Phe
 1               5                  10                  


<210> 1027
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1027
Cys Ala Ser Ser Pro Gln Gln Val Leu Gly Glu Ala Phe Phe
 1               5                  10                  


<210> 1028
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1028
Cys Ala Ser Ser Pro Arg Gly Gly Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 1029
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1029
Cys Ala Ser Ser Arg Gly Arg Gly Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 1030
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1030
Cys Ser Ala Arg Asp Leu Arg Glu Thr Asn Glu Lys Leu Phe Phe
 1               5                  10                  15  


<210> 1031
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1031
Cys Ala Ser Ser Leu Thr Ser Gly Leu Lys Lys Gln Tyr Phe
 1               5                  10                  


<210> 1032
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1032
Cys Ala Ile Ser Ala Glu Thr Leu Asn Glu Lys Leu Phe Phe
 1               5                  10                  


<210> 1033
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1033
Cys Ala Ile Arg Glu Asp Arg Asn Asn Tyr Gly Tyr Thr Phe
 1               5                  10                  


<210> 1034
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1034
Cys Ser Ala Arg Asp Gly Pro Thr Asn Glu Lys Leu Phe Phe
 1               5                  10                  


<210> 1035
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1035
Cys Ala Ser Ser Glu Ser Gly Gly Leu Gly Gly Tyr Thr Phe
 1               5                  10                  


<210> 1036
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1036
Cys Ala Ser Arg Leu Arg Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1037
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1037
Cys Ala Ser Ser Leu Ala Arg Gly Thr Leu Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 1038
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1038
Cys Ala Thr Ser Ser Arg Met Gly Gly Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1039
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1039
Cys Ala Ser Ser Ile Val Asp Arg Gly Gly Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 1040
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1040
Cys Ala Ser Ser Leu Arg Ala Trp Glu Thr Gln Tyr Phe
 1               5                  10              


<210> 1041
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1041
Cys Ala Ser Ser Gln Gly Gly Asp Arg Gly Glu Ser Glu Ala Phe
 1               5                  10                  15  


<210> 1042
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1042
Cys Ala Ser Arg Pro Val Ala Gly Leu Pro His Phe
 1               5                  10          


<210> 1043
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1043
Cys Ala Ser Ser Phe Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 1044
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1044
Cys Ala Ser Ser Val Arg Thr Leu Asp Thr Gly Glu Leu Phe
 1               5                  10                  


<210> 1045
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1045
Cys Ala Ser Ser Leu Arg Trp Gly Asp Gly Gly Lys Leu Phe
 1               5                  10                  


<210> 1046
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1046
Cys Ala Ser Ser Leu Gly Tyr Gly Val Ser Thr Gly Glu Leu Phe
 1               5                  10                  15  


<210> 1047
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1047
Cys Ala Ser Ser Leu Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 1048
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1048
Cys Ser Val Ala Ala Leu Ala Gly Phe Gln Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 1049
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1049
Cys Ala Ser Ser Leu Asn Trp Asp Thr Glu Ala Phe Phe
 1               5                  10              


<210> 1050
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1050
Cys Ala Ser Ser Ile Asn Ala Leu Val Gly Glu Gln Phe Phe
 1               5                  10                  


<210> 1051
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1051
Cys Ser Ala Arg Glu Pro Asp Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  


<210> 1052
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1052
Cys Ala Ser Ser Pro Thr Ala Leu Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 1053
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1053
Cys Ala Ser Ser Leu Ala Ser Ala Gly Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 1054
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1054
Cys Ala Ser Ser Leu Asp Gly Leu Thr Asn Thr Glu Ala Phe Phe
 1               5                  10                  15  


<210> 1055
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1055
Cys Ser Ala Gly Gln Gly Gly Thr Gly Glu Leu Phe Phe
 1               5                  10              


<210> 1056
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1056
Cys Ala Ser Ser Leu Glu Gly Gln Gly Ala Ser Glu Gln Phe Phe
 1               5                  10                  15  


<210> 1057
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1057
Cys Ser Ala Ser Arg Trp Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1058
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1058
Cys Ala Ser Ser Pro Ala Phe Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1059
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1059
Cys Ser Ala Tyr Arg Thr Trp Asp Gln Glu Thr Gln Tyr Phe
 1               5                  10                  


<210> 1060
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1060
Cys Ala Ser Ser Phe Ser Pro Ala Gly Ser Glu Ala Phe Phe
 1               5                  10                  


<210> 1061
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1061
Cys Ser Val Ser Gly Gly Pro Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1062
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1062
Cys Ala Ser Ser Gln Gly Leu Ala Gly Val Gln Glu Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 1063
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1063
Cys Ser Ala Gly Val Gly Gly Gln Glu Thr Gln Tyr Phe
 1               5                  10              


<210> 1064
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1064
Cys Ser Val Gly Gln Thr Asp Ser Pro Leu His Phe
 1               5                  10          


<210> 1065
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1065
Cys Ala Ser Ser Phe Pro Gln Val Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1066
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1066
Cys Ala Ser Ser Phe Pro Gln Val Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1067
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1067
Cys Ala Ser Ser His Val Asp Arg Gly Gly Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 1068
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1068
Cys Ala Ser Ser His Val Asp Arg Gly Gly Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 1069
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1069
Cys Ala Ser Ser Gln Tyr Gln Ser Leu Val Arg Gly Asn Asn Glu Gln
 1               5                  10                  15      
Phe Phe
        


<210> 1070
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1070
Cys Ala Ser Ser Phe Arg Ala Leu Ala Ala Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 1071
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1071
Cys Ala Ser Ser Phe Arg Phe Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 1072
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1072
Cys Ala Ser Ser Val Arg Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10              


<210> 1073
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1073
Cys Ala Ser Ser Ile Arg Thr Ser Gly Asp His Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 1074
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1074
Cys Ser Ala Phe Pro Gly Gly Asp Thr Glu Ala Phe Phe
 1               5                  10              


<210> 1075
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1075
Cys Ala Ser Ser Tyr Val Gly Gly Asp Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 1076
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1076
Cys Ser Ala Thr Leu Gly Gly Asp Tyr Gly Tyr Thr Phe
 1               5                  10              


<210> 1077
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1077
Cys Ser Ala Gln Leu Ala Gly Gly Gly Gly Asp Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 1078
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1078
Cys Ala Ser Ser Leu Ala Asp Arg Val Asn Thr Glu Ala Phe Phe
 1               5                  10                  15  


<210> 1079
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1079
Cys Ala Ser Ser Gly Gly Ser Gly Arg Gly Glu Gln Tyr Phe Gly Pro
 1               5                  10                  15      
Gly Thr Arg Leu Thr Val Thr
            20              


<210> 1080
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1080
Cys Ala Ser Ser Leu Glu Gly Thr Val Val Thr Gly Glu Leu Phe Phe
 1               5                  10                  15      
Gly Glu Gly Ser Arg Leu Thr Val Leu
            20                  25  


<210> 1081
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1081
Cys Ala Ser Arg Thr Gly Thr Gly Arg Ala Ser Thr Glu Ala Phe Phe
 1               5                  10                  15      
Gly Gln Gly Thr Arg Leu Thr Val Val
            20                  25  


<210> 1082
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1082
Cys Ser Ala Ser Glu Gly Thr Ser Gly Asn Pro Thr Gly Leu Phe Phe
 1               5                  10                  15      
Gly Glu Gly Ser Arg Leu Thr Val Leu
            20                  25  


<210> 1083
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1083
Cys Ala Trp Ser Ala Pro Gly Thr Ala Tyr Thr Glu Ala Phe Phe Gly
 1               5                  10                  15      
Gln Gly Thr Arg Leu Thr Val Val
            20                  


<210> 1084
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1084
Cys Ala Ser Ser Gln Gly Pro Ser Gly Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  15      
Gly Glu Gly Ser Arg Leu Thr Val Leu
            20                  25  


<210> 1085
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1085
Cys Ala Ser Ser Gln Gly Pro Ser Gly Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  15      
Gly Glu Gly Ser Arg Leu Thr Val Leu
            20                  25  


<210> 1086
<211> 25
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1086
Cys Ala Ser Ser Gln Gly Pro Ser Gly Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  15      
Gly Glu Gly Ser Arg Leu Thr Val Leu
            20                  25  


<210> 1087
<211> 21
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1087
Cys Ala Ser Ser Glu Trp Ala Ser Gly Tyr Thr Phe Gly Ser Gly Thr
 1               5                  10                  15      
Arg Leu Thr Val Val
            20      


<210> 1088
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1088
Cys Ala Ser Ser Ser Gly Ser Gln Ala Ala Tyr Glu Gln Tyr Phe Gly
 1               5                  10                  15      
Pro Gly Thr Arg Leu Thr Val Thr
            20                  


<210> 1089
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1089
Cys Ala Ser Arg Gly Asn Arg Ala Pro Ser Tyr Glu Gln Tyr Phe Gly
 1               5                  10                  15      
Pro Gly Thr Arg Leu Thr Val Thr
            20                  


<210> 1090
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1090
Cys Ser Ala Lys Pro Gly Thr Gly Val Gly Glu Asp Leu
 1               5                  10              


<210> 1091
<211> 26
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1091
Cys Ala Ser Ser Gln Gly Ser Gly Gly Gly Val Thr Gly Glu Leu Phe
 1               5                  10                  15      
Phe Gly Glu Gly Ser Arg Leu Thr Val Leu
            20                  25      


<210> 1092
<211> 26
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1092
Cys Ala Ser Ser Gln Gly Ser Gly Gly Gly Val Thr Gly Glu Leu Phe
 1               5                  10                  15      
Phe Gly Glu Gly Ser Arg Leu Thr Val Leu
            20                  25      


<210> 1093
<211> 26
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1093
Cys Ala Ser Ser Gln Gly Ser Gly Gly Gly Val Thr Gly Glu Leu Phe
 1               5                  10                  15      
Phe Gly Glu Gly Ser Arg Leu Thr Val Leu
            20                  25      


<210> 1094
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1094
Cys Ala Ser Ser Arg Gly Thr Ile Leu Gly Asn Glu Gln Phe Phe Gly
 1               5                  10                  15      
Pro Gly Thr Arg Leu Thr Val Leu
            20                  


<210> 1095
<211> 24
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1095
Cys Ser Ala Lys Lys Gly Thr Ser Trp Lys Asp Thr Gln Tyr Phe Gly
 1               5                  10                  15      
Pro Gly Thr Arg Leu Thr Val Leu
            20                  


<210> 1096
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1096
Cys Ser Ala Arg Gly Gly Ser Tyr Asn Ser Pro Leu His Phe Gly Asn
 1               5                  10                  15      
Gly Thr Arg Leu Thr Val Thr
            20              


<210> 1097
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1097
Cys Ser Ala Arg Gly Gly Ser Tyr Asn Ser Pro Leu His Phe Gly Asn
 1               5                  10                  15      
Gly Thr Arg Leu Thr Val Thr
            20              


<210> 1098
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1098
Cys Ser Ala Arg Gly Gly Ser Tyr Asn Ser Pro Leu His Phe Gly Asn
 1               5                  10                  15      
Gly Thr Arg Leu Thr Val Thr
            20              


<210> 1099
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1099
Cys Ser Ala Arg Gly Gly Ser Tyr Asn Ser Pro Leu His Phe Gly Asn
 1               5                  10                  15      
Gly Thr Arg Leu Thr Val Thr
            20              


<210> 1100
<211> 27
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1100
Tyr Leu Cys Ala Thr Ser Ala Leu Gly Asp Thr Gln Tyr Phe Gly Pro
 1               5                  10                  15      
Gly Thr Arg Leu Thr Val Leu Glu Asp Leu Lys
            20                  25          


<210> 1101
<211> 30
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1101
Tyr Leu Cys Ala Ser Ser Thr Asp Trp Ser Ser Tyr Asn Glu Gln Phe
 1               5                  10                  15      
Phe Gly Pro Gly Thr Arg Leu Thr Val Leu Glu Asp Leu Lys
            20                  25                  30  


<210> 1102
<211> 31
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1102
Tyr Ile Cys Ser Ala Arg Asp Leu Thr Ser Gly Ser Leu Asn Glu Gln
 1               5                  10                  15      
Phe Phe Gly Pro Gly Thr Arg Leu Thr Val Leu Glu Asp Leu Lys
            20                  25                  30      


<210> 1103
<211> 30
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1103
Tyr Leu Cys Ala Ser Ser Ile Arg His Arg Thr Asn Thr Glu Ala Phe
 1               5                  10                  15      
Phe Gly Gln Gly Thr Arg Leu Thr Val Val Glu Asp Leu Asn
            20                  25                  30  


<210> 1104
<211> 30
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1104
Tyr Leu Cys Ser Ala Trp Pro Ser Gly Gln Gly Thr Tyr Gly Tyr Thr
 1               5                  10                  15      
Phe Gly Ser Gly Thr Arg Leu Thr Val Val Glu Asp Leu Asn
            20                  25                  30  


<210> 1105
<211> 29
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1105
Tyr Leu Cys Ala Ser Arg Thr Ser Gly Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15      
Gly Pro Gly Thr Arg Leu Thr Val Leu Glu Asp Leu Lys
            20                  25                  


<210> 1106
<211> 31
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1106
Tyr Ile Cys Ser Ala Arg Asp Leu Thr Ser Gly Ala Asn Asn Glu Gln
 1               5                  10                  15      
Phe Phe Gly Pro Gly Thr Arg Leu Thr Val Leu Glu Asp Leu Lys
            20                  25                  30      


<210> 1107
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1107
Cys Ala Ser Gly Arg Ser Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10              


<210> 1108
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1108
Ala Ser Ser Leu Ala Gly Gly Ala Asn Ser Pro Leu His
 1               5                  10              


<210> 1109
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1109
Ala Ser Ser Leu Val Gly Gly Pro Ser Ser Glu Ala Phe
 1               5                  10              


<210> 1110
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1110
Cys Ala Ser Ser Pro Trp Gly Ala Gly Gly Thr Asp Thr Gln Tyr
 1               5                  10                  15  


<210> 1111
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1111
Cys Ala Ser Ser Leu Ala Leu Gly Gln Gly Asn Gln Gln Phe Phe
 1               5                  10                  15  


<210> 1112
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1112
Ala Ser Leu Lys Ala Thr Asp Thr Gln Tyr
 1               5                  10  


<210> 1113
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1113
Cys Ala Ser Arg Leu Asp Pro Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1114
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1114
Cys Ala Ser Arg Leu Asp Pro Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1115
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1115
Cys Ala Ser Ser Phe Arg Gly Leu Gly Gly Gly Thr Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 1116
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1116
Cys Ala Ser Ser Phe Arg Gly Leu Gly Gly Gly Thr Asp Thr Gln Tyr
 1               5                  10                  15      
Phe
    


<210> 1117
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1117
Cys Ala Ser Arg Pro Arg Asp Pro Val Thr Gln Tyr Phe
 1               5                  10              


<210> 1118
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1118
Cys Ala Ser Arg Ala Lys Ala Gly Gly Thr Gly Glu Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 1119
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1119
Cys Ala Ser Arg Pro Arg Arg Asp Asn Glu Gln Phe Phe
 1               5                  10              


<210> 1120
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1120
Cys Ala Ser Ser Ser Phe Trp Arg Gln Phe Asp Gln Pro Gln His Phe
 1               5                  10                  15      


<210> 1121
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1121
Cys Ala Ser Ser Ile Gly Pro Thr Gln Pro Gln His Phe
 1               5                  10              


<210> 1122
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1122
Cys Ser Ala Arg Thr Glu Ala Tyr Glu Gln Tyr Phe
 1               5                  10          


<210> 1123
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1123
Cys Ala Ser Ser Gly Gly Gly Ser Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1124
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1124
Cys Ala Ser Ser Ala Glu Thr Gln Tyr Phe
 1               5                  10  


<210> 1125
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1125
Cys Ala Ser Ser Pro Thr Thr Gly Gly Asp Glu Ala Phe Phe
 1               5                  10                  


<210> 1126
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1126
Cys Ala Ser Ser Leu Tyr Gly Gly Asp Glu Ala Phe Phe
 1               5                  10              


<210> 1127
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1127
Cys Ala Ser Ser Thr Arg Thr Gly Gln Gly Gly Asn Glu Gln Tyr Phe
 1               5                  10                  15      


<210> 1128
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1128
Cys Ala Ser Ser Thr Arg Thr Gly Gln Gly Gly Asn Glu Gln Tyr Phe
 1               5                  10                  15      


<210> 1129
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1129
Cys Ala Ser Ser Leu Gly Leu Arg Gly Glu Asn Ile Gln Tyr Phe
 1               5                  10                  15  


<210> 1130
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1130
Cys Ala Ile Ser Glu Ser Ala Ser Gly Gly Ala Phe Ile Gly Asn Glu
 1               5                  10                  15      
Gln Phe Phe
            


<210> 1131
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1131
Cys Ala Ser Ser Arg Gly Gly Gly Asn Thr Gly Glu Leu Phe Phe
 1               5                  10                  15  


<210> 1132
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1132
Cys Ala Ser Ser Ala Gly Asn Thr Ile Tyr Phe
 1               5                  10      


<210> 1133
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1133
Cys Ala Ser Ser Tyr Ala Trp Gly Arg Ala Thr Glu Ala Phe Phe
 1               5                  10                  15  


<210> 1134
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1134
Cys Ala Thr Gln Gly Val Gly Glu Asn Thr Glu Ala Phe Phe
 1               5                  10                  


<210> 1135
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1135
Cys Ala Ser Ser Gln Asp Leu Ala Gly Val Arg Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 1136
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1136
Cys Ser Ala Arg Asp Gln Gln Arg Val Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1137
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1137
Cys Ala Ser Ser Ser Phe Trp Gly Ser Asp Thr Gly Glu Leu Phe Phe
 1               5                  10                  15      


<210> 1138
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1138
Cys Ala Ser Leu Leu Val Ala Gly Ala Asn Val Leu Thr Phe
 1               5                  10                  


<210> 1139
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1139
Cys Ala Ser Ser Leu Glu Arg Asp Gly Tyr Thr Phe
 1               5                  10          


<210> 1140
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1140
Cys Ala Ser Ser Pro Ile Ile Trp Gly Thr Gly Glu Leu Phe Phe
 1               5                  10                  15  


<210> 1141
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1141
Cys Ala Ser Ser Pro Ile Ile Trp Gly Thr Gly Glu Leu Phe Phe
 1               5                  10                  15  


<210> 1142
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1142
Cys Ala Ser Arg Gly Thr Val Ser Tyr Asn Glu Gln Phe Phe
 1               5                  10                  


<210> 1143
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1143
Cys Ser Ala Arg Asp Leu Ala Ile Pro Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1144
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1144
Cys Ala Ser Ser Ser Gly Pro Thr Gly Ser Pro Leu His Phe
 1               5                  10                  


<210> 1145
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1145
Cys Ser Ala Arg Asp Gly Ala Arg Gly Glu Lys Leu Phe Phe
 1               5                  10                  


<210> 1146
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1146
Cys Ala Ser Ser Leu Glu Ala Ser Ser Tyr Asn Ser Pro Leu His Phe
 1               5                  10                  15      


<210> 1147
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1147
Cys Ala Ser Ser Leu Thr Ala Gly Leu Ala Ser Thr Tyr Asn Glu Gln
 1               5                  10                  15      
Phe Phe
        


<210> 1148
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1148
Cys Ala Ser Ser Leu Gly Pro Gly Gln Arg Glu Thr Gln Tyr Phe
 1               5                  10                  15  


<210> 1149
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1149
Cys Ala Ser Ser Ser Pro Gly Thr Glu Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 1150
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1150
Cys Ala Ser Ser Pro Arg Ala Asn Thr Asp Thr Gln Tyr Phe
 1               5                  10                  


<210> 1151
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1151
Cys Ala Ser Ser Leu Glu Arg Glu Thr Gln Tyr Phe
 1               5                  10          


<210> 1152
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1152
Cys Ala Ser Ser Leu Glu Arg Glu Thr Gln Tyr Phe
 1               5                  10          


<210> 1153
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1153
Cys Ala Ser Ser Phe Trp Gly Tyr Asn Glu Gln Phe Phe
 1               5                  10              


<210> 1154
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1154
Cys Ser Val Glu Asp Arg Asn Thr Gly Glu Leu Phe Phe
 1               5                  10              


<210> 1155
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1155
Cys Ala Ser Ser Trp Ser Ser Ile Gly Asn Gln Pro Gln His Phe
 1               5                  10                  15  


<210> 1156
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1156
Cys Ala Ser Ser Ser Gly Thr Ser Ala Gly Thr Gly Glu Leu Phe Phe
 1               5                  10                  15      


<210> 1157
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1157
Cys Ser Ala Gly Gly Leu Ala Gly Ala Ser Gln Glu Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 1158
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1158
Cys Ser Ala Arg Ser Leu Ala Ser Gly Gly Pro Asp Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 1159
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1159
Cys Ser Ala Arg Ser Leu Ala Ser Gly Gly Pro Asp Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 1160
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1160
Cys Ser Ala Arg Ser Leu Ala Ser Gly Gly Pro Asp Thr Gln Tyr Phe
 1               5                  10                  15      


<210> 1161
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1161
Cys Ser Val Leu Phe Arg Asp Arg Arg Thr Glu Ala Phe Phe
 1               5                  10                  


<210> 1162
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1162
Cys Ala Ser Ser Val Asp Pro Gly Val Tyr Asn Glu Gln Phe Phe
 1               5                  10                  15  


<210> 1163
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1163
Cys Ala Ser Ser Leu Ala Gly Thr Asp His Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 1164
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1164
Cys Ala Ser Ser Leu Ala Gly Thr Asp His Tyr Glu Gln Tyr Phe
 1               5                  10                  15  


<210> 1165
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1165
Cys Ala Ser Ser Leu Ala Thr Ser Gly Gly Gly Ser Asp Thr Gln Tyr
 1               5                  10                  15      
Phe Gly Pro Gly Thr Arg Leu
            20              


<210> 1166
<211> 22
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1166
Cys Ser Val Glu Ala Thr Arg Ala Asp Thr Gln Tyr Phe Gly Pro Gly
 1               5                  10                  15      
Thr Arg Leu Thr Val Leu
            20          


<210> 1167
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1167
Cys Ala Ser Ser Leu Ala Thr Ser Gly Gly Gly Ser Asp Thr Gln Tyr
 1               5                  10                  15      
Phe Gly Pro Gly Thr Arg Leu
            20              


<210> 1168
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1168
Cys Ala Ser Ser Leu Ala Thr Ser Gly Gly Gly Ser Asp Thr Gln Tyr
 1               5                  10                  15      
Phe Gly Pro Gly Thr Arg Leu
            20              


<210> 1169
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1169
Cys Ser Ala Ser Ile Gly Thr Gly Ala Asp Thr Gln Tyr Phe Gly Pro
 1               5                  10                  15      
Gly Thr Arg Leu Thr Val Leu
            20              


<210> 1170
<211> 23
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1170
Cys Ala Ser Arg Ser Pro Gly Ser Asn Tyr Gly Tyr Thr Phe Gly Ser
 1               5                  10                  15      
Gly Thr Arg Leu Thr Val Val
            20              


<210> 1171
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1171
Arg Arg Phe Glu Tyr Asp Asp Pro Arg Phe Leu Arg Leu Leu Asp Leu
 1               5                  10                  15      
Ala Gln Glu Gly
            20  


<210> 1172
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1172
Ala Gly Met Val Thr Thr Ser Thr Thr Leu Ala Trp Gly Leu Leu Leu
 1               5                  10                  15      
Met Ile Leu His
            20  


<210> 1173
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1173
Thr Leu Ala Trp Gly Leu Leu Leu Met Ile Leu His Pro Asp Val Gln
 1               5                  10                  15      
Arg Arg Val Gln
            20  


<210> 1174
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder
      and recognized by specific TCR

<400> 1174
Thr Thr Leu Ile Thr Asn Leu Ser Ser Val Leu Lys Asp Glu Ala Val
 1               5                  10                  15      
Trp Glu Lys Pro
            20  


<210> 1175
<211> 52
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1175
Leu Ala Trp Thr Pro Val Val Val Leu Asn Gly Leu Ala Ala Val Arg
 1               5                  10                  15      
Glu Ala Leu Val Thr His Gly Glu Asp Thr Ala Asp Arg Pro Pro Val
            20                  25                  30          
Pro Ile Thr Gln Ile Leu Gly Phe Gly Pro Arg Ser Gln Gly Val Phe
        35                  40                  45              
Leu Ala Arg Tyr
    50          


<210> 1176
<211> 36
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder
      and recognized by specific TCR

<400> 1176
Leu Leu Asp Lys Ala Val Ser Asn Val Ile Ala Ser Leu Thr Cys Gly
 1               5                  10                  15      
Arg Arg Phe Glu Tyr Asp Asp Pro Arg Phe Leu Arg Leu Leu Asp Leu
            20                  25                  30          
Ala Gln Glu Gly
        35      


<210> 1177
<211> 44
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1177
Ser Gly Phe Leu Arg Glu Val Leu Asn Ala Val Pro Val Leu Leu His
 1               5                  10                  15      
Ile Pro Ala Leu Ala Gly Lys Val Leu Arg Phe Gln Lys Ala Phe Leu
            20                  25                  30          
Thr Gln Leu Asp Glu Leu Leu Thr Glu His Arg Met
        35                  40                  


<210> 1178
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1178
Lys Ala Lys Gly Asn Pro Glu Ser Ser Phe Asn Asp Glu Asn Leu Arg
 1               5                  10                  15      
Ile Val Val Ala
            20  


<210> 1179
<211> 44
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1179
Ala Gly Met Val Thr Thr Ser Thr Thr Leu Ala Trp Gly Leu Leu Leu
 1               5                  10                  15      
Met Ile Leu His Pro Asp Val Gln Arg Arg Val Gln Gln Glu Ile Asp
            20                  25                  30          
Asp Val Ile Gly Gln Val Arg Arg Pro Glu Met Gly
        35                  40                  


<210> 1180
<211> 36
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder
      and recognized by specific TCR

<400> 1180
Met Thr Ser Arg Asp Ile Glu Val Gln Gly Phe Arg Ile Pro Lys Gly
 1               5                  10                  15      
Thr Thr Leu Ile Thr Asn Leu Ser Ser Val Leu Lys Asp Glu Ala Val
            20                  25                  30          
Trp Glu Lys Pro
        35      


<210> 1181
<211> 28
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1181
Trp Glu Lys Pro Phe Arg Phe His Pro Glu His Phe Leu Asp Ala Gln
 1               5                  10                  15      
Gly His Phe Val Lys Pro Glu Ala Phe Leu Pro Phe
            20                  25              


<210> 1182
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1182
Arg Leu Leu Asp Leu Ala Glu Gly Leu
 1               5                  


<210> 1183
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1183
Gly Leu Glu Ala Leu Val Pro Leu Ala Val
 1               5                  10  


<210> 1184
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1184
Lys Ala Phe Leu Thr Gln Leu Asp Glu Leu
 1               5                  10  


<210> 1185
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1185
Thr Thr Leu Ile Thr Asn Leu Ser Ser Val
 1               5                  10  


<210> 1186
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1186
Leu Leu Asp Lys Ala Val Ser Asn Val Ile
 1               5                  10  


<210> 1187
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1187
Ser Glu Val Glu Asp Val Ile Pro Glu Gly Trp Lys Ala Asp Thr Ser
 1               5                  10                  15      
Tyr Glu Ala Lys
            20  


<210> 1188
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1188
Glu Glu Pro Ile Ala Pro Tyr His Phe Asp Leu Ser Gly His Ala Phe
 1               5                  10                  15      
Gly Ser Met Ala
            20  


<210> 1189
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223>  antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1189
Ser Glu Phe Glu Asp Val Ile Pro Glu Gly Trp Lys Ala Asp Thr Ser
 1               5                  10                  15      
Tyr Ser Ala Lys
            20  


<210> 1190
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder
      and recognized by specific TCR

<400> 1190
Glu Glu Pro Ile Ala Pro Tyr His Phe Asp Leu Ser Gly His Ala Phe
 1               5                  10                  15      
Gly Ser Met Ala
            20  


<210> 1191
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1191
Glu Glu Pro Ile Ala Pro Tyr His Phe Asp Leu Ser Gly His Ala Phe
 1               5                  10                  15      
Gly Ala Met Ala
            20  


<210> 1192
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1192
Thr Glu Ala Glu Asp Val Ile Pro Glu Gly Trp Lys Ala Asp Thr Ser
 1               5                  10                  15      
Tyr Glu Ser Lys
            20  


<210> 1193
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1193
Glu Glu Pro Ile Ala Ala Tyr His Phe Asp Leu Ser Gly Lys Ala Phe
 1               5                  10                  15      
Gly Ala Met Ala
            20  


<210> 1194
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1194
Gly Glu Ala Glu Asp Val Ile Pro Glu Gly Trp Lys Ala Asp Thr Ala
 1               5                  10                  15      
Tyr Ala Ser Lys
            20  


<210> 1195
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1195
Ala Ala Tyr Lys Ile Ala Ala Thr Ala Ala Asn Ala Ala
 1               5                  10              


<210> 1196
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder
      and recognized by specific TCR

<400> 1196
Glu Ser Tyr Lys Phe Ile Pro Thr Leu Glu Ala Ala Val
 1               5                  10              


<210> 1197
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1197
Ala Ala Phe Arg Ile Ala Ala Thr Ala Ala Asn Ala Ala
 1               5                  10              


<210> 1198
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1198
Glu Ala Tyr Lys Phe Ile Pro Ser Leu Glu Thr Ala Val
 1               5                  10              


<210> 1199
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1199
Ala Ala Phe Arg Thr Ala Ala Thr Ala Ala Asp Ala Ala
 1               5                  10              


<210> 1200
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1200
Glu Ser Tyr Lys Phe Ile Pro Ala Leu Glu Ala Ala Val
 1               5                  10              


<210> 1201
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1201
Ala Ala Tyr Arg Thr Ala Ala Thr Ala Ala Asn Ala Ala
 1               5                  10              


<210> 1202
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1202
Asp Ser Tyr Lys Phe Ile Pro Thr Leu Val Ala Ala Val
 1               5                  10              


<210> 1203
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1203
Ala Ala Phe Lys Ile Ala Ala Thr Ala Ala Asn Ser Ala
 1               5                  10              


<210> 1204
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder
      and recognized by specific TCR

<400> 1204
Glu Thr Tyr Lys Phe Ile Pro Ser Leu Glu Ala Ala Val
 1               5                  10              


<210> 1205
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1205
Ala Ala Phe Lys Val Ala Ala Thr Ala Ala Asn Ala Ala
 1               5                  10              


<210> 1206
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1206
Glu Ser Tyr Lys Phe Ile Pro Ala Leu Glu Ala Ala Val
 1               5                  10              


<210> 1207
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1207
Ala Ala Phe Lys Val Ala Ala Thr Ala Ala Asn Ala Ala
 1               5                  10              


<210> 1208
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1208
Asp Thr Tyr Lys Ser Ile Pro Ser Leu Glu Ala Ala Val
 1               5                  10              


<210> 1209
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1209
Ala Arg Gln Gln Trp Glu Leu Gln Gly Asp Arg Arg Cys Gln Ser
 1               5                  10                  15  


<210> 1210
<211> 11
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1210
Ala Asn Leu Arg Pro Cys Glu Gln His Leu Met
 1               5                  10      


<210> 1211
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1211
Ser Gln Leu Glu Arg Ala Asn Leu Arg Pro Cys Glu Gln
 1               5                  10              


<210> 1212
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1212
Phe Glu Asn Asn Gln Arg Cys Met Cys Glu Ala Leu Gln
 1               5                  10              


<210> 1213
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1213
Arg Arg Pro Phe Tyr Ser Asn Ala Pro Leu Glu Ile Tyr Val Gln
 1               5                  10                  15  


<210> 1214
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1214
Gln Ala Arg Gln Leu Lys Asn Asn Asn Pro Phe Lys Phe Phe Val
 1               5                  10                  15  


<210> 1215
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1215
Glu Phe Leu Ala Gln Ala Phe Gln Val Asp Asp Arg Gln Ile Val
 1               5                  10                  15  


<210> 1216
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1216
Arg Ser Ile Leu Pro Tyr Gly Asp Ser Met Asp Arg Ile Glu
 1               5                  10                  


<210> 1217
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1217
Lys Asp Arg Leu Gln Gly Met Ala Pro Ala Ala Gly Ala Asp
 1               5                  10                  


<210> 1218
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1218
Ile Ser Arg Ile Tyr Val Ser Ile Asp Val Thr Leu Gln Gln Leu Glu
 1               5                  10                  15      
Ser

<210> 1219
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1219
Arg Asn Thr Arg Asn Leu Thr Tyr Ile Asp Pro Asp Ala Leu Lys Glu
 1               5                  10                  15      


<210> 1220
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1220
Gly Ile Phe Asn Thr Gly Leu Lys Met Phe Pro Asp Leu Thr Lys Val
 1               5                  10                  15      
Tyr Ser Thr
            


<210> 1221
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1221
His Ile Glu Ile Arg Asn Thr Arg Asn Leu Thr Tyr Ile Asp
 1               5                  10                  


<210> 1222
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1222
Gly Leu Lys Met Phe Pro Asp Leu Thr Lys Val Tyr Ser Thr
 1               5                  10                  


<210> 1223
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1223
Ile Ser Arg Ile Tyr Val Ser Ile Asp Val Thr Leu Gln Gln Leu Glu
 1               5                  10                  15      
Ser

<210> 1224
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1224
Ser Leu Ser Phe Leu His Leu Thr Arg Ala Asp Leu Ser Tyr Pro Ser
 1               5                  10                  15      
His Cys Cys
            


<210> 1225
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<221> CONFLICT       
<222> (0)...(0)
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1225
Glu Asn Gly Glu Trp Ala Ile Asp Phe Cys Pro Gly Val Ile Arg Arg
 1               5                  10                  15      
His His Gly
            


<210> 1226
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1226
Glu Asn Gly Glu Trp Ala Ile Asp Phe Cys Pro Gly Val Ile Arg Arg
 1               5                  10                  15      
His His Gly
            


<210> 1227
<211> 9
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1227
Thr Trp Thr Tyr Asp Gly Ser Val Val
 1               5                  


<210> 1228
<211> 41
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1228
Val Lys Lys Ile His Ile Pro Ser Glu Lys Ile Trp Arg Pro Asp Leu
 1               5                  10                  15      
Val Leu Tyr Asn Asn Ala Asp Gly Asp Phe Ala Ile Val Lys Phe Thr
            20                  25                  30          
Lys Val Leu Leu Gln Tyr Thr Gly His
        35                  40      


<210> 1229
<211> 30
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1229
Asp Glu Gln Asn Cys Ser Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly
 1               5                  10                  15      
Ser Val Val Ala Ile Asn Pro Glu Ser Asp Gln Pro Asp Leu
            20                  25                  30  


<210> 1230
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1230
Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly Ser Val Val Ala Ile Asn
 1               5                  10                  15      
Pro Glu Ser Asp
            20  


<210> 1231
<211> 41
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1231
Val Lys Lys Ile His Ile Pro Ser Glu Lys Ile Trp Arg Pro Asp Leu
 1               5                  10                  15      
Val Leu Tyr Asn Asn Ala Asp Gly Asp Phe Ala Ile Val Lys Phe Thr
            20                  25                  30          
Lys Val Leu Leu Gln Tyr Thr Gly His
        35                  40      


<210> 1232
<211> 36
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1232
Pro Asn Trp Val Arg Lys Val Phe Ile Asp Thr Ile Pro Asn Ile Met
 1               5                  10                  15      
Phe Phe Ser Thr Met Lys Arg Pro Ser Arg Glu Lys Gln Asp Lys Lys
            20                  25                  30          
Ile Phe Thr Glu
        35      


<210> 1233
<211> 41
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1233
Val Lys Lys Ile His Ile Pro Ser Glu Lys Ile Trp Arg Pro Asp Leu
 1               5                  10                  15      
Val Leu Tyr Asn Asn Ala Asp Gly Asp Phe Ala Ile Val Lys Phe Thr
            20                  25                  30          
Lys Val Leu Leu Gln Tyr Thr Gly His
        35                  40      


<210> 1234
<211> 30
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1234
Asp Glu Gln Asn Cys Ser Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly
 1               5                  10                  15      
Ser Val Val Ala Ile Asn Pro Glu Ser Asp Gln Pro Asp Leu
            20                  25                  30  


<210> 1235
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1235
Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly Ser Val Val Ala Ile Asn
 1               5                  10                  15      
Pro Glu Ser Asp
            20  


<210> 1236
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1236
Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly Ser Val Val Ala Ile Asn
 1               5                  10                  15      
Pro Glu Ser Asp
            20  


<210> 1237
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1237
Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly Ser Val Val
 1               5                  10              


<210> 1238
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1238
Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly Ser Val Val
 1               5                  10              


<210> 1239
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1239
Pro Leu Phe Ser His Leu Gln Asn Glu Gln Trp Val Asp
 1               5                  10              


<210> 1240
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1240
Pro Leu Phe Ser His Leu Gln Asn Glu Gln Trp Val Asp
 1               5                  10              


<210> 1241
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1241
Pro Leu Phe Ser His Leu Gln Asn Glu Gln Trp Val Asp
 1               5                  10              


<210> 1242
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1242
Pro Leu Phe Ser His Leu Gln Asn Glu Gln Trp Val Asp
 1               5                  10              


<210> 1243
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1243
Val Arg Lys Val Phe Leu Arg Leu Leu Pro Gln Leu Leu Arg Met His
 1               5                  10                  15      
Val Arg Pro Leu
            20  


<210> 1244
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1244
Val Arg Lys Val Phe Leu Arg Leu Leu Pro Gln Leu Leu Arg Met His
 1               5                  10                  15      
Val Arg Pro Leu
            20  


<210> 1245
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1245
Val Arg Lys Val Phe Leu Arg Leu Leu Pro Gln Leu Leu Arg Met His
 1               5                  10                  15      
Val Arg Pro Leu
            20  


<210> 1246
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1246
Gln Ile Val Thr Thr Asn Val Arg Leu Lys Gln Gln Trp Val Asp Tyr
 1               5                  10                  15      
Asn Leu Lys Trp
            20  


<210> 1247
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1247
Ser Thr His Val Met Pro Asn Trp Val Arg Lys Val Phe Ile Asp Thr
 1               5                  10                  15      
Ile Pro Asn
            


<210> 1248
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1248
Gln Ile Val Thr Thr Asn Val Arg Leu Lys Gln Gln Trp Val Asp Tyr
 1               5                  10                  15      
Asn Leu Lys Trp
            20  


<210> 1249
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1249
Ser Thr His Val Met Pro Asn Trp Val Arg Lys Val Phe Ile Asp Thr
 1               5                  10                  15      
Ile Pro Asn
            


<210> 1250
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1250
Ser Thr His Val Met Pro Asn Trp Val Arg Lys Val Phe Ile Asp Thr
 1               5                  10                  15      
Ile Pro Asn
            


<210> 1251
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1251
Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly Ser Val Val Ala Ile Asn
 1               5                  10                  15      
Pro Glu Ser Asp
            20  


<210> 1252
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1252
Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly Ser Val Val
 1               5                  10              


<210> 1253
<211> 36
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1253
Pro Asn Trp Val Arg Lys Val Phe Ile Asp Thr Ile Pro Asn Ile Met
 1               5                  10                  15      
Phe Phe Ser Thr Met Lys Arg Pro Ser Arg Glu Lys Gln Asp Lys Lys
            20                  25                  30          
Ile Phe Thr Glu
        35      


<210> 1254
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1254
Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly Ser Val Val
 1               5                  10              


<210> 1255
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1255
Met Lys Leu Gly Thr Trp Thr Tyr Asp Gly Ser Val Val
 1               5                  10              


<210> 1256
<211> 8
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1256
Trp Thr Tyr Asp Gly Ser Val Val
 1               5              


<210> 1257
<211> 10
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1257
Asp Leu Arg Asn Lys Ile Leu Thr Ala Thr
 1               5                  10  


<210> 1258
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1258
Val Arg Ala Leu Glu Glu Ala Asn Thr Glu Leu Glu Val Lys Ile
 1               5                  10                  15  


<210> 1259
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1259
Ala Asn Ile Leu Leu Gln Ile Asp Asn Ala Arg Leu Ala Ala Asp
 1               5                  10                  15  


<210> 1260
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1260
Met Gln Ala Leu Glu Ile Glu Leu Gln Ser Gln Leu Ser Met Lys
 1               5                  10                  15  


<210> 1261
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1261
Glu Asn Arg Tyr Cys Val Gln Leu Ser Gln Ile Gln Gly Leu Ile
 1               5                  10                  15  


<210> 1262
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1262
Ser Thr Arg Tyr Thr Leu Asp Phe Asp Arg Ala Gln Arg Ala Cys Leu
 1               5                  10                  15      
Gln

<210> 1263
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1263
Asp Ala Gly Trp Leu Ala Asp Gln Thr Val Arg Tyr Pro Ile His Thr
 1               5                  10                  15

<210> 1264
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1264
Ser Ala Gly Trp Leu Ala Asp Arg Ser Val Arg Tyr Pro Ile Ser Lys
 1               5                  10                  15

<210> 1265
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1265
Gly Tyr Glu Gln Cys Asp Ala Gly Trp Leu Arg Asp Gln Thr Val Arg
 1               5                  10                  15      
Tyr Pro Ile Val
            20

<210> 1266
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1266
Asp Val Tyr Cys Phe Val Asp Arg Leu Glu Gly Glu Val Phe Phe Ala
 1               5                  10                  15

<210> 1267
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1267
Glu Val Phe Phe Ala Thr Arg Leu Glu Gln Phe Thr Phe Gln Glu
 1               5                  10                  15

<210> 1268
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1268
Lys Cys Tyr Ala Gly Trp Leu Ala Asp Gly Ser Leu Arg Tyr Pro Ile
 1               5                  10                  15      
Val

<210> 1269
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1269
Asn Ser Pro Phe Cys Leu Glu Arg Thr Pro Leu Gly Ser Pro Asp Pro
 1               5                  10                  15      
Ala

<210> 1270
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 11
<223> Xaa = Any Amino Acid

<400> 1270
Asp Ala Gly Trp Leu Ala Asp Gln Thr Val Xaa Tyr Pro Ile His Thr
 1               5                  10                  15

<210> 1271
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline
      

<220> 
<223> X = citrulline
      

<220> 
<221> VARIANT        
<222> 7, 12
<223> Xaa = Any Amino Acid

<400> 1271
Asp Glu Phe Pro Gly Val Xaa Thr Tyr Gly Ile Xaa Asp Thr Asn Glu
 1               5                  10                  15      
Thr Tyr Asp Val
            20

<210> 1272
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 8, 11
<223> Xaa = Any Amino Acid

<400> 1272
Ser Ala Gly Trp Leu Ala Asp Xaa Ser Val Xaa Tyr Pro Ile Ser Lys
 1               5                  10                  15

<210> 1273
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 7, 12
<223> Xaa = Any Amino Acid

<400> 1273
Gly Val Val Phe His Tyr Xaa Pro Gly Pro Thr Xaa Tyr Ser Leu Thr
 1               5                  10                  15      
Phe

<210> 1274
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 11, 16
<223> Xaa = Any Amino Acid

<400> 1274
Gly Tyr Glu Gln Cys Asp Ala Gly Trp Leu Xaa Asp Gln Thr Val Xaa
 1               5                  10                  15      
Tyr Pro Ile Val
            20 

<210> 1275
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 4, 9
<223> Xaa = Any Amino Acid

<400> 1275
Pro Gly Val Xaa Thr Tyr Gly Val Xaa Pro Ser Thr Glu Thr Tyr Asp
 1               5                  10                  15      
Val Tyr

<210> 1276
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 8
<223> Xaa = Any Amino Acid

<400> 1276
Asp Val Tyr Cys Phe Val Asp Xaa Leu Glu Gly Glu Val Phe Phe Ala
 1               5                  10                  15

<210> 1277
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 7
<223> Xaa = Any Amino Acid

<400> 1277
Glu Val Phe Phe Ala Thr Xaa Leu Glu Gln Phe Thr Phe Gln Glu
 1               5                  10                  15

<210> 1278
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 13
<223> Xaa = Any Amino Acid

<400> 1278
Lys Cys Tyr Ala Gly Trp Leu Ala Asp Gly Ser Leu Xaa Tyr Pro Ile
 1               5                  10                  15      
Val

<210> 1279
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 8
<223> Xaa = Any Amino Acid

<400> 1279
Asn Ser Pro Phe Cys Leu Glu Xaa Thr Pro Leu Gly Ser Pro Asp Pro
 1               5                  10                  15      
Ala

<210> 1280
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1280
Met Lys Pro Val Gln Lys Val Leu Glu Asp Ser Asp
 1               5                  10

<210> 1281
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1281
Glu Arg Arg Leu Phe Asn Leu Asp Val Pro Glu Ser Arg Arg
 1               5                  10 

<210> 1282
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1282
Gly Lys Leu Tyr Gly Ile Arg Asp Val Arg Ser Thr Arg Asp Arg
 1               5                  10                  15

<210> 1283
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1283
Ala Thr Ile Lys Ala Glu Phe Val Arg Ala Glu Thr Pro Tyr Met
 1               5                  10                  15

<210> 1284
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1284
Gly Lys Leu Tyr Gly Ile Arg Asp Val Arg Ser Thr Arg Asp Arg
 1               5                  10                  15 

<210> 1285
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 13
<223> Xaa = Any Amino Acid

<400> 1285
Glu Arg Arg Leu Phe Asn Leu Asp Val Pro Glu Ser Xaa Arg
 1               5                  10

<210> 1286
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 7, 10
<223> Xaa = Any Amino Acid

<400> 1286
Gly Lys Leu Tyr Gly Ile Xaa Asp Val Xaa Ser Thr Arg Asp Arg
 1               5                  10                  15

<210> 1287
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223>  X = citrulline

<220> 
<221> VARIANT        
<222> 1, 14
<223> Xaa = Any Amino Acid

<400> 1287
Xaa Cys Ile Leu Pro Ala Thr Ile Lys Ala Glu Phe Val Xaa Ala Glu
 1               5                  10                  15      
Thr Pro Tyr Met
            20 

<210> 1288
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 1, 12, 15
<223> Xaa = Any Amino Acid

<400> 1288
Xaa Cys Ile Leu Pro Gly Lys Leu Tyr Gly Ile Xaa Asp Val Xaa Ser
 1               5                  10                  15      
Thr Arg Asp Arg
            20

<210> 1289
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1289
Ala Gly Phe Lys Gly Glu Gln Gly Pro Lys Gly Glu Pro
 1               5                  10              

<210> 1290
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 5
<223> Xaa = Any Amino Acid

<400> 1290
Ala Pro Gly Asn Xaa Gly Phe Pro Gly Gln Asp Leu Ala Gly
 1               5                  10                  

<210> 1291
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1291
Gly Tyr Arg Ala Arg Pro Ala Lys Ala Ala Ala Thr
 1               5                  10          

<210> 1292
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 7
<223> Xaa = Any Amino Acid

<400> 1292
Tyr Ala Glu Tyr His Phe Xaa Val Gly Ser Glu Ala Glu Gly Tyr
 1               5                  10                  15  

<210> 1293
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1293
Gly His Trp Thr Ser Glu Ser Ser Val Ser Gly Ser Thr
 1               5                  10              

<210> 1294
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 6
<223> Xaa = Any Amino Acid

<400> 1294
Gln Asp Phe Thr Asn Xaa Ile Asn Lys Leu Lys Asn Ser
 1               5                  10              

<210> 1295
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 7
<223> Xaa = Any Amino Acid

<400> 1295
Gly Gly Gly Tyr Arg Ala Xaa Pro Ala Lys Ala Ala Ala Thr Gln
 1               5                  10                  15  


<210> 1296
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 1, 7, 10
<223> Xaa = Any Amino Acid

<400> 1296
Xaa Phe Gly Tyr Arg Ala Xaa Pro Ala Xaa Ala Ala Ala Thr
 1               5                  10

<210> 1297
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1297
Met Ala Gln Gly Thr Leu Ile Arg Val Thr Pro Glu Gln Pro Thr His
 1               5                  10                  15      
Ala

<210> 1298
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1298
Ala Ser Pro Gly Val Val Val Asp Ile Ala His Ser Pro Pro Ala Lys
 1               5                  10                  15      
Lys Lys

<210> 1299
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1299
Leu Thr Met Lys Ala Ala Ser Gly Ser Thr Gly Asp Gln Lys Val Gln
 1               5                  10                  15

<210> 1300
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1300
Ile Ser Tyr Tyr Gly Pro Lys Thr Pro Pro Val Lys
 1               5                  10

<210> 1301
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1301
Ile Gly Tyr Ile Gln Ala Pro His Lys Thr Leu Pro Val Val Phe
 1               5                  10                  15

<210> 1302
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1302
Arg Gly Pro Gln Thr Gly Gly Ile Ser Gly Leu Asp
 1               5                  10

<210> 1303
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1303
Gln Ala Leu Gln Asp Phe Leu Ser Ala Gln Gln Val Gln Ala Pro Val
 1               5                  10                  15      
Lys

<210> 1304
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1304
Val Gly His Val Asp Glu Phe Leu Ser Phe Val Pro Ala Pro Asp Arg
 1               5                  10                  15      
Lys Gly

<210> 1305
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1305
Gly Val Tyr Ala Thr Arg Ser Ser Ala Val Arg Leu Arg Ser Ser Val
 1               5                  10                  15      
Pro Gly Val Arg
            20

<210> 1306
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1306
Ser Ser Leu Asn Leu Arg Glu Thr Asn Leu Asp Ser Leu
 1               5                  10 

<210> 1307
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 7, 12
<223> Xaa = Any Amino Acid

<400> 1307
Gly Gly Val Tyr Ala Thr Xaa Ser Ser Ala Val Xaa Leu Arg Ser
 1               5                  10                  15

<210> 1308
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 6, 11, 13
<223> Xaa = Any Amino Acid

<400> 1308
Gly Val Tyr Ala Thr Xaa Ser Ser Ala Val Xaa Leu Xaa Ser Ser Val
 1               5                  10                  15      
Pro Gly Val Arg
            20

<210> 1309
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 6
<223> Xaa = Any Amino Acid

<400> 1309
Ser Ser Leu Asn Leu Xaa Glu Thr Asn Leu Asp Ser Leu
 1               5                  10 

<210> 1310
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1310
Thr Ser Lys Gly Leu Phe Arg Ala Ala Val Pro Ser Gly Ala Ser
 1               5                  10                  15 

<210> 1311
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1311
Val Ile Gly Met Asp Val Ala Ala Ser Glu Phe Phe Arg Ser Gly
 1               5                  10                  15 

<210> 1312
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1312
Lys Ala Lys Phe Ala Gly Arg Asn Phe Arg Asn Pro Leu Ala Lys
 1               5                  10                  15

<210> 1313
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1313
Lys Arg Ile Ala Lys Ala Val Asn Glu Lys Ser Cys Asn Cys Leu
 1               5                  10                  15 

<210> 1314
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1314
Met Ser Ile Leu Lys Ile His Ala Arg Glu Ile Phe Asp Ser Arg
 1               5                  10                  15

<210> 1315
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1315
Lys Arg Ile Ala Lys Ala Val Asn Glu Lys Ser Cys Asn Cys Leu
 1               5                  10                  15

<210> 1316
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1316
Ile Phe Asp Ser Arg Gly Asn Pro Thr Val Glu Val Asp Leu Phe
 1               5                  10                  15 

<210> 1317
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1317
Lys Arg Ile Ala Lys Ala Val Asn Glu Lys Ser Cys Asn Cys Leu
 1               5                  10                  15

<210> 1318
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 7
<223> Xaa = Any Amino Acid

<400> 1318
Thr Ser Lys Gly Leu Phe Xaa Ala Ala Val Pro Ser Gly Ala Ser
 1               5                  10                  15

<210> 1319
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 13
<223> Xaa = Any Amino Acid

<400> 1319
Val Ile Gly Met Asp Val Ala Ala Ser Glu Phe Phe Xaa Ser Gly
 1               5                  10                  15

<210> 1320
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 7, 10
<223> Xaa = Any Amino Acid

<400> 1320
Lys Ala Lys Phe Ala Gly Xaa Asn Phe Xaa Asn Pro Leu Ala Lys
 1               5                  10                  15 

<210> 1321
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = Any Amino Acid

<400> 1321
Lys Xaa Ile Ala Lys Ala Val Asn Glu Lys Ser Cys Asn Cys Leu
 1               5                  10                  15

<210> 1322
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 5
<223> Xaa = Any Amino Acid

<400> 1322
Ile Phe Asp Ser Xaa Gly Asn Pro Thr Val Glu Asp Val Leu Phe
 1               5                  10                  15

<210> 1323
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = Any Amino Acid

<400> 1323
Lys Xaa Ile Ala Lys Ala Val Asn Glu Lys Ser Cys Asn Cys Leu
 1               5                  10                  15 

<210> 1324
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 5
<223> Xaa = Any Amino Acid

<400> 1324
Ile Phe Asp Ser Xaa Gly Asn Pro Thr Val Glu Val Asp Leu Phe
 1               5                  10                  15

<210> 1325
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = Any Amino Acid

<400> 1325
Lys Xaa Ile Ala Lys Ala Val Asn Glu Lys Ser Cys Asn Cys Leu
 1               5                  10                  15

<210> 1326
<211> 19
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1326
Trp Val Pro Leu Glu Ile Met Ile Lys Phe Asn Arg Leu Asn Arg Leu
 1               5                  10                  15      
Thr Thr Asp

<210> 1327
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1327
Phe Asn Arg Leu Asn Arg Leu Thr Thr Asp Phe Asn Val Ile Val Glu
 1               5                  10                  15      
Ala Leu

<210> 1328
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1328
Gln Glu Ala Lys Gln Lys Leu Glu Glu Asp Ala Glu Met Lys Ser Leu
 1               5                  10                  15      
Glu Glu

<210> 1329
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1329
Glu Ala Leu Lys Lys Ile Ile Glu Asp Gln Gln Glu Ser Leu Asn Lys
 1               5                  10                  15      
Trp Lys

<210> 1330
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1330
Lys Gly Ser Ile Phe Val Val Phe Asp Ser Ile Glu Ser Ala Lys Lys
 1               5                  10                  15      
Phe Val

<210> 1331
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1331
Ser Val Lys Leu Val Arg Phe Leu Met Lys Leu Ser His Glu Thr
 1               5                  10                  15

<210> 1332
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1332
Glu Pro Val Gln Leu Glu Thr Leu Ser Ile Arg Gly Asn Asn Ile
 1               5                  10                  15

<210> 1333
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1333
Tyr Val Val Lys Ser Phe Asp Arg Ser Thr Lys Val Ile Asp Phe His
 1               5                  10                  15      
Tyr Pro Asn Glu
            20

<210> 1334
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1334
Ala Met Met Ile Ala Arg Phe Lys Met Phe Pro Glu Val Lys Glu Lys
 1               5                  10                  15      
Gly

<210> 1335
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1335
Met Ala Ser Pro Gly Ser Gly Phe Trp Ser Phe Gly Ser Glu Asp Gly
 1               5                  10                  15      
Ser Gly Asp Ser
            20 

<210> 1336
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1336
Cys Ala Cys Asp Gln Lys Pro Cys Ser Cys Ser Lys Val Asp Val Asn
 1               5                  10                  15      
Tyr Ala Phe Leu
            20 

<210> 1337
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1337
Arg Pro Thr Leu Ala Phe Leu Gln Asp Val Met Asn Ile Leu Leu Gln
 1               5                  10                  15      
Tyr Val Val Lys
            20

<210> 1338
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1338
Asp Val Met Asn Ile Leu Leu Gln Tyr Val Val Lys Ser Phe Asp Arg
 1               5                  10                  15      
Ser Thr Lys Val
            20 

<210> 1339
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1339
Asn Thr Asn Met Phe Thr Tyr Glu Ile Ala Pro Val Phe Val Leu Leu
 1               5                  10                  15      
Glu Tyr Val Thr
            20 

<210> 1340
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1340
Lys Gly Met Ala Ala Leu Pro Arg Leu Ile Ala Phe Thr Ser Glu His
 1               5                  10                  15      
Ser His Phe Ser
            20 

<210> 1341
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1341
Leu Ile Ala Phe Thr Ser Glu His Ser His Phe Ser Leu Lys Lys Gly
 1               5                  10                  15      
Ala Ala Ala Leu
            20

<210> 1342
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1342
Asp Ser Val Ile Leu Ile Lys Cys Asp Glu Arg Gly Lys Met Ile Pro
 1               5                  10                  15      
Ser Asp Leu Glu
            20

<210> 1343
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1343
Asp Glu Arg Gly Lys Met Ile Pro Ser Asp Leu Glu Arg Arg Ile Leu
 1               5                  10                  15      
Glu Ala Lys Gln
            20 

<210> 1344
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1344
Glu Ala Lys Gln Lys Gly Phe Val Pro Phe Leu Val Ser Ala Thr Ala
 1               5                  10                  15      
Gly Thr Thr Val
            20

<210> 1345
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1345
Ile Cys Lys Lys Tyr Lys Ile Trp Met His Val Asp Ala Ala Trp Gly
 1               5                  10                  15      
Gly Gly Leu Leu
            20 

<210> 1346
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1346
Gly Gly Leu Leu Met Ser Arg Lys His Lys Trp Lys Leu Ser Gly Val
 1               5                  10                  15      
Glu Arg Ala Asn
            20

<210> 1347
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1347
His Lys Trp Lys Leu Ser Gly Val Glu Arg Ala Asn Ser Val Thr Trp
 1               5                  10                  15      
Asn Pro His Lys
            20

<210> 1348
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1348
Tyr Asp Leu Ser Tyr Asp Thr Gly Asp Lys Ala Leu Gln Cys Gly Arg
 1               5                  10                  15      
His Val Asp Val
            20

<210> 1349
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1349
Lys Cys Leu Glu Leu Ala Glu Tyr Leu Tyr Asn Ile Ile Lys Asn Arg
 1               5                  10                  15      
Glu Gly Tyr Glu
            20

<210> 1350
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1350
Val Ser Tyr Gln Pro Leu Gly Asp Lys Val Asn Phe Phe Arg Met Val
 1               5                  10                  15      
Ile Ser Asn Pro
            20

<210> 1351
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1351
Lys Val Asn Phe Phe Arg Met Val Ile Ser Asn Pro Ala Ala Thr His
 1               5                  10                  15      
Gln Asp Ile Asp
            20

<210> 1352
<211> 28
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1352
Leu Ala Lys Glu Trp Gln Ala Leu Cys Ala Tyr Gln Ala Glu Pro Asn
 1               5                  10                  15      
Thr Cys Ala Thr Ala Gln Gly Glu Gly Asn Ile Lys
            20                  25

<210> 1353
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1353
Gly Ala Ser Ser Ser Leu Ser Pro Leu Gln Ala Glu Leu Leu Pro
 1               5                  10                  15

<210> 1354
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1354
Phe Gln Asp Ser Gly Leu Leu Tyr Leu Ala Gln Glu Leu Pro Ala
 1               5                  10                  15

<210> 1355
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1355
Arg Ser Asp Tyr Ile Asn Ala Ser Pro Ile Ile Glu His Asp Pro Arg
 1               5                  10                  15      
Met

<210> 1356
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1356
Asp Gln Phe Glu Phe Ala Leu Thr Ala Val Ala Glu Glu Val Asn Ala
 1               5                  10                  15

<210> 1357
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1357
Gln Glu Pro Ser Gln Leu Ile Ser Leu Glu Glu Glu Asn Gln Arg
 1               5                  10                  15

<210> 1358
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1358
Leu Tyr His Phe Leu Gln Ile Pro Thr His Glu Glu His Leu Phe
 1               5                  10                  15

<210> 1359
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1359
Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe
 1               5                  10

<210> 1360
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1360
Gly Leu Ser Gly Leu Glu Leu Asp Gly Met Ala Glu Leu Met Ala
 1               5                  10                  15

<210> 1361
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1361
Ala Lys Met Tyr Ala Phe Thr Leu Glu Ser Val Glu Leu Gln Gln
 1               5                  10                  15

<210> 1362
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1362
Val Arg Arg Glu Ile Ala Lys Ala Leu Ser Lys Ser Phe Thr Met His
 1               5                  10                  15      
Ser Leu Thr Ile
            20

<210> 1363
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 6, 11
<223> Xaa = Any Amino Acid

<400> 1363
Ile Val Phe His Tyr Xaa Ala Ile Ser Thr Xaa Tyr Thr Leu Asp Phe
 1               5                  10                  15

<210> 1364
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 6
<223> Xaa = Any Amino Acid

<400> 1364
Ser Ser Leu Asn Leu Xaa Glu Thr Asn Leu Asp Ser Leu
 1               5                  10

<210> 1365
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = Any Amino Acid

<400> 1365
Lys Xaa Ile Ala Lys Ala Val Asn Glu Lys Ser Cys Asn Cys Leu
 1               5                  10                  15

<210> 1366
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 9
<223> Xaa = Any Amino Acid

<400> 1366
Ala Thr Ile Lys Ala Glu Phe Val Xaa Ala Glu Thr Pro Tyr Met
 1               5                  10                  15

<210> 1367
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 9
<223> Xaa = Any Amino Acid

<400> 1367
Ala Thr Ile Lys Ala Glu Phe Val Xaa Ala Glu Thr Pro Tyr Met
 1               5                  10                  15

<210> 1368
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 11, 16
<223> Xaa = Any Amino Acid

<400> 1368
Gly Tyr Glu Gln Cys Asp Ala Gly Trp Leu Xaa Asp Gln Thr Val Xaa
 1               5                  10                  15      
Tyr Pro Ile Val
            20

<210> 1369
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 4, 9
<223> Xaa = Any Amino Acid

<400> 1369
Pro Gly Val Xaa Thr Tyr Gly Val Xaa Pro Ser Thr Glu Thr Tyr Asp
 1               5                  10                  15      
Val Tyr

<210> 1370
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 13
<223> Xaa = Any Amino Acid

<400> 1370
Lys Cys Tyr Ala Gly Trp Leu Ala Asp Gly Ser Leu Xaa Tyr Pro Ile
 1               5                  10                  15      
Val

<210> 1371
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1371
Gln Leu Tyr His Phe Leu Gln Ile Pro Thr His Glu Glu His Leu Phe
 1               5                  10                  15      
Tyr Val Leu Ser
            20

<210> 1372
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1372
Lys Trp Cys Ala Asn Pro Asp Trp Ile His Ile Asp Thr Thr Pro Phe
 1               5                  10                  15      
Ala Gly Leu Val
            20

<210> 1373
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1373
Gln Leu Tyr His Phe Leu Gln Ile Pro Thr His Glu Glu His Leu Phe
 1               5                  10                  15      
Tyr Val Leu Ser
            20

<210> 1374
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1374
Gln Leu Tyr His Phe Leu Gln Ile Pro Thr His Glu Glu His Leu Phe
 1               5                  10                  15      
Tyr Val Leu Ser
            20

<210> 1375
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1375
Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15

<210> 1376
<211> 20
<212> PRT
<213> Homo sapiens

<220> 
<223> antigenic epitope associated with a disorder and
      recognized by specific TCR

<400> 1376
Ile Arg Tyr Phe Ile Leu Pro Asp Ser Leu Pro Leu Asp Thr Leu Leu
 1               5                  10                  15      
Val Asp Val Glu
            20

<210> 1377
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1377
Cys Ala Leu Ser Asn Asp Met Glu Tyr Gly Asn Lys Leu Val Phe
 1               5                  10                  15

<210> 1378
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1378
Cys Ala Phe Gly Gly Ala Thr Asn Lys Leu Ile Phe
 1               5                  10

<210> 1379
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1379
Cys Ala Val Leu Tyr Gly Gly Ser Glu Lys Leu Val Phe
 1               5                  10

<210> 1380
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1380
Cys Ala Glu Asn Lys Val Ser Asp Gly Gln Lys Leu Leu Phe
 1               5                  10

<210> 1381
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1381
Cys Leu Val Gly Glu Tyr Gly Asn Lys Leu Val Phe
 1               5                  10 

<210> 1382
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1382
Cys Ala Ala Ser Lys Gly Ser Ser Asn Thr Gly Lys Leu Ile Phe
 1               5                  10                  15

<210> 1383
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1383
Cys Ala Tyr Arg Gly Ser Asn Gln Gly Gly Lys Leu Ile Phe
 1               5                  10

<210> 1384
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1384
Cys Ala Leu His Gly Gly Ser Tyr Ile Pro Thr Phe
 1               5                  10

<210> 1385
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1385
Cys Ala Ala Thr Arg Thr Ser Gly Thr Tyr Lys Tyr Ile Phe
 1               5                  10

<210> 1386
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1386
Cys Ala Val Glu Asp Leu Asn Gln Ala Gly Thr Ala Leu Ile Phe
 1               5                  10                  15

<210> 1387
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1387
Cys Ala Gly Gln Thr Gly Ala Asn Asn Leu Phe Phe
 1               5                  10

<210> 1388
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1388
Cys Ile Leu Arg Asp Thr Ile Ser Asn Phe Gly Asn Glu Lys Thr Phe
 1               5                  10                  15

<210> 1389
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1389
Cys Val Val Ser Val Lys Ala Ala Gly Asn Lys Leu Thr Phe
 1               5                  10 

<210> 1390
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 alpha of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1390
Cys Ala Leu Ser Ala Glu Ala Gly Gly Phe Lys Thr Ile Phe
 1               5                  10                  


<210> 1391
<211> 21
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1391
Cys Ala Ser Ser Leu Ile Pro Phe Leu Ala Gly Val Leu Ala Asn Tyr
 1               5                  10                  15      
Asn Glu Gln Phe Phe
            20 

<210> 1392
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1392
Cys Ala Ser Ser Leu Ser Gly Asn Ser Asn Gln Pro Gln His Phe
 1               5                  10                  15

<210> 1393
<211> 13
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1393
Cys Ala Trp Ser Val Arg Gly Asp Gln Pro Gln His Phe
 1               5                  10

<210> 1394
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1394
Cys Ala Ser Arg Pro Gly Thr Ile Asn Gln Glu Thr Gln Tyr Phe
 1               5                  10                  15

<210> 1395
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1395
Cys Ala Ser Ser Ser Asn Pro Arg Asp Asn Tyr Gly Tyr Thr Phe
 1               5                  10                  15

<210> 1396
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1396
Cys Ala Ser Lys Phe Pro Trp Gly Ala Val Gly Glu Leu Phe Phe
 1               5                  10                  15

<210> 1397
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1397
Cys Ala Ile Thr Pro Gly Gln Gly Ala Lys Gly Gly Glu Thr Gln Tyr
 1               5                  10                  15      
Phe

<210> 1398
<211> 18
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1398
Cys Ala Ser Ser Tyr Arg Leu Met Gly Ser Gly Ser Arg Glu Thr Gln
 1               5                  10                  15      
Tyr Phe

<210> 1399
<211> 16
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1399
Cys Ala Ser Ser Pro Trp Gly Ala Gly Gly Thr Asp Thr Gln Tyr Phe
 1               5                  10                  15

<210> 1400
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1400
Cys Ala Ser Ser Leu Ala Leu Gly Gln Gly Asn Gln Gln Phe Phe
 1               5                  10                  15

<210> 1401
<211> 17
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1401
Cys Ala Ser Ser Gln Glu Val Gly Thr Val Pro Asn Gln Pro Gln His
 1               5                  10                  15      
Phe

<210> 1402
<211> 14
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1402
Cys Ala Ser Ser Phe Gly Ser Ser Tyr Tyr Gly Tyr Thr Phe
 1               5                  10

<210> 1403
<211> 15
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1403
Cys Ala Ser Ser Gln Thr Gly Thr Asp Gly Tyr Glu Gln Phe Phe
 1               5                  10                  15

<210> 1404
<211> 12
<212> PRT
<213> Homo sapiens

<220> 
<223> CDR3 beta of TCR that specifically recognizes
      antigen associated with a disorder

<400> 1404
Cys Ser Ala Lys Gly Gln Pro Arg Gly Ala Phe Phe
 1               5                  10

<210> 1405
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<223> gRNA_1  (human TRAC editing)

<400> 1405
tctctcagct ggtacacggc                                             20

<210> 1406
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<223> gRNA_4 (human TRAC editing)

<400> 1406
gagaatcaaa atcggtgaat                                             20

<210> 1407
<211> 6508
<212> DNA
<213> Artificial Sequence

<220> 
<223> AAV FOXP3 ex1.MND-LNGFRki (FOXP3 editing)

<400> 1407
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtagc 1020
ggccgcatca cttgccagga ctgttacaat agcctcctca ctagccccac tcacagcagc 1080
cagatgaatc ttttgagtcc atgcctagtc actggggcaa aataggactc cgaggagaaa 1140
gtccgagacc agctccggca agatgagcaa acacagcctg tgcagggtgc agggagggct 1200
agaggcctga ggcttgaaac agctctcaag tggaggggga aacaaccatt gccctcatag 1260
aggacacatc cacaccaggg ctgtgctagc gtgggcaggc aagccaggtg ctggacctct 1320
gcacgtgggg catgtgtggg tatgtacatg tacctgtgtt cttggtgtgt gtgtgtgtgt 1380
gtgtgtgtgt gtgtgtctag agctggggtg caactatggg gcccctcggg acatgtccca 1440
gccaatgcct gctttgacca gaggagtgtc cacgtggctc aggtggtcga gtatctcata 1500
ccgccctagc acacgtgtga ctcctttccc ctattgtcta cgcagcctgc ccttggacaa 1560
ggacccgatg cccaacccca ggcctggcaa gccctcggcc ccttccttgg cccttggccc 1620
atccccacgc gtaggaacag agaaacagga gaatatgggc caaacaggat atctgtggta 1680
agcagttcct gccccggctc agggccaaga acagttggaa cagcagaata tgggccaaac 1740
aggatatctg tggtaagcag ttcctgcccc ggctcagggc caagaacaga tggtccccag 1800
atgcggtccc gccctcagca gtttctagag aaccatcaga tgtttccagg gtgccccaag 1860
gacctgaaat gaccctgtgc cttatttgaa ctaaccaatc agttcgcttc tcgcttctgt 1920
tcgcgcgctt ctgctccccg agctctatat aagcagagct cgtttagtga accgtcagat 1980
cgcctggaga cgccatccac gctgttttga cttccataga aggatctcga ggccaccatg 2040
ggggcaggtg ccaccggacg agccatggac gggccgcgcc tgctgctgtt gctgcttctg 2100
ggggtgtccc ttggaggtgc caaggaggca tgccccacag gcctgtacac acacagcggt 2160
gagtgctgca aagcctgcaa cctgggcgag ggtgtggccc agccttgtgg agccaaccag 2220
accgtgtgtg agccctgcct ggacagcgtg acgttctccg acgtggtgag cgcgaccgag 2280
ccgtgcaagc cgtgcaccga gtgcgtgggg ctccagagca tgtcggcgcc gtgcgtggag 2340
gccgacgacg ccgtgtgccg ctgcgcctac ggctactacc aggatgagac gactgggcgc 2400
tgcgaggcgt gccgcgtgtg cgaggcgggc tcgggcctcg tgttctcctg ccaggacaag 2460
cagaacaccg tgtgcgagga gtgccccgac ggcacgtatt ccgacgaggc caaccacgtg 2520
gacccgtgcc tgccctgcac cgtgtgcgag gacaccgagc gccagctccg cgagtgcaca 2580
cgctgggccg acgccgagtg cgaggagatc cctggccgtt ggattacacg gtccacaccc 2640
ccagagggct cggacagcac agcccccagc acccaggagc ctgaggcacc tccagaacaa 2700
gacctcatag ccagcacggt ggcaggtgtg gtgaccacag tgatgggcag ctcccagccc 2760
gtggtgaccc gaggcaccac cgacaacctc atccctgtct attgctccat cctggctgct 2820
gtggttgtgg gtcttgtggc ctacatagcc ttcaagaggg gaagcggagc gactaacttc 2880
agcctgctga agcaggccgg agatgtggag gaaaaccctg gaccgatgcc caaccccagg 2940
cctggcaagc cctcggcccc ttccttggcc cttggcccat ctcctggtgc atcgcccagc 3000
tggagggctg cccctaaagc aagcgacctg ctgggggccc ggggcccggg tggcacgttc 3060
cagggccgag atcttcgagg cggggcccat gcctcctctt cttccttgaa ccccatgcca 3120
ccatcgcagc tgcaggtgag gccctgggcc caggatgggg caggcagggt ggggtacctg 3180
gacctacagg tgccgacctt tactgtggca ctgggcggga ggggggctgg ctggggcaca 3240
ggaagtggtt tctgggtccc aggcaagtct gtgacttatg cagatgttgc agggccaaga 3300
aaatccccac ctgccaggcc tcagagattg gaggctctcc ccgacctccc aatccctgtc 3360
tcaggagagg aggaggccgt attgtagtcc catgagcata gctatgtgtc cccatcccca 3420
tgtgacaaga gaagaggact ggggccaagt aggtgaggtg acagggctga ggccagctct 3480
gcaacttatt agctgtttga tctttaaaaa gttactcgat ctccatgagc ctcagtttcc 3540
atacgtgtaa aagggggatg atcatagcat ctaccatgtg ggcttgcagg atcctacgta 3600
gataagtagc atggcgggtt aatcattaac tacaaggaac ccctagtgat ggagttggcc 3660
actccctctc tgcgcgctcg ctcgctcact gaggccgggc gaccaaaggt cgcccgacgc 3720
ccgggctttg cccgggcggc ctcagtgagc gagcgagcgc gccagctggc gtaatagcga 3780
agaggcccgc accgatcgcc cttcccaaca gttgcgcagc ctgaatggcg aatggcgatt 3840
ccgttgcaat ggctggcggt aatattgttc tggatattac cagcaaggcc gatagtttga 3900
gttcttctac tcaggcaagt gatgttatta ctaatcaaag aagtattgcg acaacggtta 3960
atttgcgtga tggacagact cttttactcg gtggcctcac tgattataaa aacacttctc 4020
aggattctgg cgtaccgttc ctgtctaaaa tccctttaat cggcctcctg tttagctccc 4080
gctctgattc taacgaggaa agcacgttat acgtgctcgt caaagcaacc atagtacgcg 4140
ccctgtagcg gcgcattaag cgcggcgggt gtggtggtta cgcgcagcgt gaccgctaca 4200
cttgccagcg ccctagcgcc cgctcctttc gctttcttcc cttcctttct cgccacgttc 4260
gccggctttc cccgtcaagc tctaaatcgg gggctccctt tagggttccg atttagtgct 4320
ttacggcacc tcgaccccaa aaaacttgat tagggtgatg gttcacgtag tgggccatcg 4380
ccctgataga cggtttttcg ccctttgacg ttggagtcca cgttctttaa tagtggactc 4440
ttgttccaaa ctggaacaac actcaaccct atctcggtct attcttttga tttataaggg 4500
attttgccga tttcggccta ttggttaaaa aatgagctga tttaacaaaa atttaacgcg 4560
aattttaaca aaatattaac gtttacaatt taaatatttg cttatacaat cttcctgttt 4620
ttggggcttt tctgattatc aaccggggta catatgattg acatgctagt tttacgatta 4680
ccgttcatcg attctcttgt ttgctccaga ctctcaggca atgacctgat agcctttgta 4740
gagacctctc aaaaatagct accctctccg gcatgaattt atcagctaga acggttgaat 4800
atcatattga tggtgatttg actgtctccg gcctttctca cccgtttgaa tctttaccta 4860
cacattactc aggcattgca tttaaaatat atgagggttc taaaaatttt tatccttgcg 4920
ttgaaataaa ggcttctccc gcaaaagtat tacagggtca taatgttttt ggtacaaccg 4980
atttagcttt atgctctgag gctttattgc ttaattttgc taattctttg ccttgcctgt 5040
atgatttatt ggatgttgga atcgcctgat gcggtatttt ctccttacgc atctgtgcgg 5100
tatttcacac cgcatatggt gcactctcag tacaatctgc tctgatgccg catagttaag 5160
ccagccccga cacccgccaa cacccgctga cgcgccctga cgggcttgtc tgctcccggc 5220
atccgcttac agacaagctg tgaccgtctc cgggagctgc atgtgtcaga ggttttcacc 5280
gtcatcaccg aaacgcgcga gacgaaaggg cctcgtgata cgcctatttt tataggttaa 5340
tgtcatgata ataatggttt cttagacgtc aggtggcact tttcggggaa atgtgcgcgg 5400
aacccctatt tgtttatttt tctaaataca ttcaaatatg tatccgctca tgagacaata 5460
accctgataa atgcttcaat aatattgaaa aaggaagagt atgagtattc aacatttccg 5520
tgtcgccctt attccctttt ttgcggcatt ttgccttcct gtttttgctc acccagaaac 5580
gctggtgaaa gtaaaagatg ctgaagatca gttgggtgca cgagtgggtt acatcgaact 5640
ggatctcaac agcggtaaga tccttgagag ttttcgcccc gaagaacgtt ttccaatgat 5700
gagcactttt aaagttctgc tatgtggcgc ggtattatcc cgtattgacg ccgggcaaga 5760
gcaactcggt cgccgcatac actattctca gaatgacttg gttgagtact caccagtcac 5820
agaaaagcat cttacggatg gcatgacagt aagagaatta tgcagtgctg ccataaccat 5880
gagtgataac actgcggcca acttacttct gacaacgatc ggaggaccga aggagctaac 5940
cgcttttttg cacaacatgg gggatcatgt aactcgcctt gatcgttggg aaccggagct 6000
gaatgaagcc ataccaaacg acgagcgtga caccacgatg cctgtagcaa tggcaacaac 6060
gttgcgcaaa ctattaactg gcgaactact tactctagct tcccggcaac aattaataga 6120
ctggatggag gcggataaag ttgcaggacc acttctgcgc tcggcccttc cggctggctg 6180
gtttattgct gataaatctg gagccggtga gcgtgggtct cgcggtatca ttgcagcact 6240
ggggccagat ggtaagccct cccgtatcgt agttatctac acgacgggga gtcaggcaac 6300
tatggatgaa cgaaatagac agatcgctga gataggtgcc tcactgatta agcattggta 6360
actgtcagac caagtttact catatatact ttagattgat ttaaaacttc atttttaatt 6420
taaaaggatc taggtgaaga tcctttttga taatctcatg accaaaatcc cttaacgtga 6480
gttttcgttc cactgagcgt cagacccc                                    6508

<210> 1408
<211> 13
<212> PRT
<213> Artificial Sequence

<220> 
<223> target epitope for TCR

<220> 
<223> X is citrulline

<220> 
<221> VARIANT        
<222> 6
<223> Xaa = Any Amino Acid

<400> 1408
Ser Ser Leu Asn Leu Xaa Glu Thr Asn Leu Asp Ser Leu
 1               5                  10

<210> 1409
<211> 16
<212> PRT
<213> Artificial sequence

<220> 
<223> target epitope for TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 6, 11
<223> Xaa = Any Amino Acid

<400> 1409
Ile Val Phe His Tyr Xaa Ala Ile Ser Thr Xaa Tyr Thr Leu Asp Phe
 1               5                  10                  15

<210> 1410
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> target epitope for TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 11, 16
<223> Xaa = Any Amino Acid

<400> 1410
Gly Tyr Glu Gln Cys Asp Ala Gly Trp Leu Xaa Asp Gln Thr Val Xaa
 1               5                  10                  15      
Tyr Pro Ile Val
            20

<210> 1411
<211> 18
<212> PRT
<213> Artificial Sequence

<220> 
<223> target epitope for TCR

<220> 
<223> X = citrulline

<220> 
<223> X = citrulline

<220> 
<221> VARIANT        
<222> 4, 9
<223> Xaa = Any Amino Acid

<400> 1411
Pro Gly Val Xaa Thr Tyr Gly Val Xaa Pro Ser Thr Glu Thr Tyr Asp
 1               5                  10                  15      
Val Tyr

<210> 1412
<211> 17
<212> PRT
<213> Artificial Sequence

<220> 
<223> target epitope for TCR

<220> 
<223> X is citrulline

<220> 
<221> VARIANT        
<222> 13
<223> Xaa = Any Amino Acid

<400> 1412
Lys Cys Tyr Ala Gly Trp Leu Ala Asp Gly Ser Leu Xaa Tyr Pro Ile
 1               5                  10                  15      
Val

<210> 1413
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> target epitope for TCR

<220> 
<223> X is citrulline

<220> 
<221> VARIANT        
<222> 9
<223> Xaa = Any Amino Acid

<400> 1413
Ala Thr Ile Lys Ala Glu Phe Val Xaa Ala Glu Thr Pro Tyr Met
 1               5                  10                  15

<210> 1414
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> target epitope for TCR

<220> 
<223> X is citrulline

<220> 
<221> VARIANT        
<222> 9
<223> Xaa = Any Amino Acid

<400> 1414
Ala Thr Ile Lys Ala Glu Phe Val Xaa Ala Glu Thr Pro Tyr Met
 1               5                  10                  15

<210> 1415
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> target epitope for TCR

<220> 
<223> X is citrulline

<220> 
<221> VARIANT        
<222> 2
<223> Xaa = Any Amino Acid

<400> 1415
Lys Xaa Ile Ala Lys Ala Val Asn Glu Lys Ser Cys Asn Cys Leu
 1               5                  10                  15

<210> 1416
<211> 8914
<212> DNA
<213> Artificial Sequence

<220> 
<223> lentiviral vector expressing A2CAR.P2A and
      truncated LNGFR

<400> 1416
agcttaatgt agtcttatgc aatactcttg tagtcttgca acatggtaac gatgagttag 60
caacatgcct tacaaggaga gaaaaagcac cgtgcatgcc gattggtgga agtaaggtgg 120
tacgatcgtg ccttattagg aaggcaacag acgggtctga catggattgg acgaaccact 180
gaattgccgc attgcagaga tattgtattt aagtgcctag ctcgatacaa taaacgggtc 240
tctctggtta gaccagatct gagcctggga gctctctggc taactaggga acccactgct 300
taagcctcaa taaagcttgc cttgagtgct tcaagtagtg tgtgcccgtc tgttgtgtga 360
ctctggtaac tagagatccc tcagaccctt ttagtcagtg tggaaaatct ctagcagtgg 420
cgcccgaaca gggacctgaa agcgaaaggg aaaccagagc tctctcgacg caggactcgg 480
cttgctgaag cgcgcacggc aagaggcgag gggcggcgac tggtgagtac gccaaaaatt 540
ttgactagcg gaggctagaa ggagagagat gggtgcgaga gcgtcagtat taagcggggg 600
agaattagat cgcgatggga aaaaattcgg ttaaggccag ggggaaagaa aaaatataaa 660
ttaaaacata tagtatgggc aagcagggag ctagaacgat tcgcagttaa tcctggcctg 720
ttagaaacat cagaaggctg tagacaaata ctgggacagc tacaaccatc ccttcagaca 780
ggatcagaag aacttagatc attatataat acagtagcaa ccctctattg tgtgcatcaa 840
aggatagaga taaaagacac caaggaagct ttagacaaga tagaggaaga gcaaaacaaa 900
agtaagacca ccgcacagca agcggacgct gatcttcaga cctggaggag gagatatgag 960
ggacaattgg agaagtgaat tatataaata taaagtagta aaaattgaac cattaggagt 1020
agcacccacc aaggcaaaga gaagagtggt gcagagagaa aaaagagcag tgggaatagg 1080
agctttgttc cttgggttct tgggagcagc aggaagcact atgggcgcag cctcaatgac 1140
gctgacggta caggccagac aattattgtc tggtatagtg cagcagcaga acaatttgct 1200
gagggctatt gaggcgcaac agcatctgtt gcaactcaca gtctggggca tcaagcagct 1260
ccaggcaaga atcctggctg tggaaagata cctaaaggat caacagctcc tggggatttg 1320
gggttgctct ggaaaactca tttgcaccac tgctgtgcct tggaatgcta gttggagtaa 1380
taaatctctg gaacagattt ggaatcacac gacctggatg gagtgggaca gagaaattaa 1440
caattacaca agcttaatac actccttaat tgaagaatcg caaaaccagc aagaaaagaa 1500
tgaacaagaa ttattggaat tagataaatg ggcaagtttg tggaattggt ttaacataac 1560
aaattggctg tggtatataa aattattcat aatgatagta ggaggcttgg taggtttaag 1620
aatagttttt gctgtacttt ctatagtgaa tagagttagg cagggatatt caccattatc 1680
gtttcagacc cacctcccaa ccccgagggg acccgacagg cccgaaggaa tagaagaaga 1740
aggtggagag agagacagag acagatccat tcgattagtg aacggatctc gacggtatcg 1800
gttaactttt aaaagaaaag gggggattgg ggggtacagt gcaggggaaa gaatagtaga 1860
cataatagca acagacatac aaactaaaga attacaaaaa caaattacaa aaattcaaaa 1920
ttttatcgat tacgcgtagg aacagagaaa caggagaata tgggccaaac aggatatctg 1980
tggtaagcag ttcctgcccc ggctcagggc caagaacagt tggaacagca gaatatgggc 2040
caaacaggat atctgtggta agcagttcct gccccggctc agggccaaga acagatggtc 2100
cccagatgcg gtcccgccct cagcagtttc tagagaacca tcagatgttt ccagggtgcc 2160
ccaaggacct gaaatgaccc tgtgccttat ttgaactaac caatcagttc gcttctcgct 2220
tctgttcgcg cgcttctgct ccccgagctc tatataagca gagctcgttt agtgaaccgt 2280
cagatcgcct ggagacgcca tccacgctgt tttgacttcc atagaaggat ctcgaggccg 2340
ccaccatggc tctgcctgtg acagctctgc tgctgcctct ggccctgctg ctccatgccg 2400
ccagacccgg atcccaggta cagctcgttc aatctggggc tgaagtaaaa aagcctggag 2460
cgtctgtaaa ggtatcttgc aaagcgagcg gctacacatt cacaagttat cacatccaat 2520
gggtgagaca ggccccagga caacgcttgg agtggatggg gtggatttac cctggcgacg 2580
gcagcacaca gtacaatgag aaatttaaag gccgggtgac tatcactcgg gacacctccg 2640
ccagcacggc ttatatggag cttagcagtt tgagatccga agatacagcg gtatattact 2700
gcgcgagaga aggaacgtac tacgctatgg actattgggg tcagggcaca accgttacag 2760
tctcctctgt ggacagctcc ggaggtgggg gttcaggagg gggtggaagc ggtggtggtg 2820
gcagtacaag cgatatagta atgacccaaa ccccgctctc tctgagcgtc acgccaggac 2880
aaccagcatc aatctcttgc cgcagtagtc aatccatcgt tcactctaat ggaaacacat 2940
accttgagtg gtatcttcag aaaccaggtc agagccctca gctcctcatc tataaagtct 3000
ctaaccggtt ctcaggtgtt ccggaccggt tcagtggttc cggctcagga acagacttca 3060
ccttgaagat cagtcgagta gaagccgaag acgtgggtgt atattattgc tttcagggtt 3120
cccacgttcc gcgcaccttc ggcggcggga ccaaagttga gatcaaagct agcgccaagc 3180
ctaccaccac ccctgcccct agacctccaa cacccgcccc aacaatcgcc agccagcctc 3240
tgtctctgag gcccgaggct tgtagaccag ctgctggcgg agccgtacac accagaggac 3300
tggatttcgc ctgcgacttt tgggtgctgg tggtggttgg tggagtcctg gcttgctata 3360
gcttgctagt aacagtggcc tttattattt tctgggtgat gcataggagt aagaggagca 3420
ggctcctgca cagtgactac atgaacatga ctccccgccg ccccgggccc acccgcaagc 3480
attaccagcc ctatgcccca ccacgcgact tcgcagccta tcgctcccgg gtgaagttca 3540
gcagaagcgc cgacgcccct gcctaccagc agggccagaa tcagctgtac aacgagctga 3600
acctgggcag aagggaagag tacgacgtcc tggataagcg gagaggccgg gaccctgaga 3660
tgggcggcaa gcctcggcgg aagaaccccc aggaaggcct gtataacgaa ctgcagaaag 3720
acaagatggc cgaggcctac agcgagatcg gcatgaaggg cgagcggagg cggggcaagg 3780
gccacgacgg cctgtatcag ggcctgtcca ccgccaccaa ggatacctac gacgccctgc 3840
acatgcaggc cctgccccca aggactagtg gaagcggagc gactaacttc agcctgctga 3900
agcaggccgg agatgtggag gaaaaccctg gaccgatggg ggcaggtgcc accggacgag 3960
ccatggacgg gccgcgcctg ctgctgttgc tgcttctggg ggtgtccctt ggaggtgcca 4020
aggaggcatg ccccacaggc ctgtacacac acagcggtga gtgctgcaaa gcctgcaacc 4080
tgggcgaggg tgtggcccag ccttgtggag ccaaccagac cgtgtgtgag ccctgcctgg 4140
acagcgtgac gttctccgac gtggtgagcg cgaccgagcc gtgcaagccg tgcaccgagt 4200
gcgtggggct ccagagcatg tcggcgccgt gcgtggaggc cgacgacgcc gtgtgccgct 4260
gcgcctacgg ctactaccag gatgagacga ctgggcgctg cgaggcgtgc cgcgtgtgcg 4320
aggcgggctc gggcctcgtg ttctcctgcc aggacaagca gaacaccgtg tgcgaggagt 4380
gccccgacgg cacgtattcc gacgaggcca accacgtgga cccgtgcctg ccctgcaccg 4440
tgtgcgagga caccgagcgc cagctccgcg agtgcacacg ctgggccgac gccgagtgcg 4500
aggagatccc tggccgttgg attacacggt ccacaccccc agagggctcg gacagcacag 4560
cccccagcac ccaggagcct gaggcacctc cagaacaaga cctcatagcc agcacggtgg 4620
caggtgtggt gaccacagtg atgggcagct cccagcccgt ggtgacccga ggcaccaccg 4680
acaacctcat ccctgtctat tgctccatcc tggctgctgt ggttgtgggt cttgtggcct 4740
acatagcctt caagaggtga tgtcgacaat caacctctgg attacaaaat ttgtgaaaga 4800
ttgactggta ttcttaacta tgttgctcct tttacgctat gtggatacgc tgctttaatg 4860
cctttgtatc atgctattgc ttcccgtatg gctttcattt tctcctcctt gtataaatcc 4920
tggttgctgt ctctttatga ggagttgtgg cccgttgtca ggcaacgtgg cgtggtgtgc 4980
actgtgtttg ctgacgcaac ccccactggt tggggcattg ccaccacctg tcagctcctt 5040
tccgggactt tcgctttccc cctccctatt gccacggcgg aactcatcgc cgcctgcctt 5100
gcccgctgct ggacaggggc tcggctgttg ggcactgaca attccgtggt gttgtcgggg 5160
aagctgacgt cctttccatg gctgctcgcc tgtgttgcca cctggattct gcgcgggacg 5220
tccttctgct acgtcccttc ggccctcaat ccagcggacc ttccttcccg cggcctgctg 5280
ccggctctgc ggcctcttcc gcgtcttcgc cttcgccctc agacgagtcg gatctccctt 5340
tgggccgcct ccccgcctgg aattcgagct cggtaccttt aagaccaatg acttacaagg 5400
cagctgtaga tcttagccac tttttaaaag aaaagggggg actggaaggg ctaattcact 5460
cccaacgaag acaagatctg ctttttgctt gtactgggtc tctctggtta gaccagatct 5520
gagcctggga gctctctggc taactaggga acccactgct taagcctcaa taaagcttgc 5580
cttgagtgct tcaagtagtg tgtgcccgtc tgttgtgtga ctctggtaac tagagatccc 5640
tcagaccctt ttagtcagtg tggaaaatct ctagcagtag tagttcatgt catcttatta 5700
ttcagtattt ataacttgca aagaaatgaa tatcagagag tgagaggaac ttgtttattg 5760
cagcttataa tggttacaaa taaagcaata gcatcacaaa tttcacaaat aaagcatttt 5820
tttcactgca ttctagttgt ggtttgtcca aactcatcaa tgtatcttat catgtctggc 5880
tctagctatc ccgcccctaa ctccgcccag ttccgcccat tctccgcccc atggctgact 5940
aatttttttt atttatgcag aggccgaggc cgcctcggcc tctgagctat tccagaagta 6000
gtgaggaggc ttttttggag gcctaggctt ttgcgtcgag acgtacccaa ttcgccctat 6060
agtgagtcgt attacgcgcg ctcactggcc gtcgttttac aacgtcgtga ctgggaaaac 6120
cctggcgtta cccaacttaa tcgccttgca gcacatcccc ctttcgccag ctggcgtaat 6180
agcgaagagg cccgcaccga tcgcccttcc caacagttgc gcagcctgaa tggcgaatgg 6240
cgcgacgcgc cctgtagcgg cgcattaagc gcggcgggtg tggtggttac gcgcagcgtg 6300
accgctacac ttgccagcgc cctagcgccc gctcctttcg ctttcttccc ttcctttctc 6360
gccacgttcg ccggctttcc ccgtcaagct ctaaatcggg ggctcccttt agggttccga 6420
tttagtgctt tacggcacct cgaccccaaa aaacttgatt agggtgatgg ttcacgtagt 6480
gggccatcgc cctgatagac ggtttttcgc cctttgacgt tggagtccac gttctttaat 6540
agtggactct tgttccaaac tggaacaaca ctcaacccta tctcggtcta ttcttttgat 6600
ttataaggga ttttgccgat ttcggcctat tggttaaaaa atgagctgat ttaacaaaaa 6660
tttaacgcga attttaacaa aatattaacg tttacaattt cccaggtggc acttttcggg 6720
gaaatgtgcg cggaacccct atttgtttat ttttctaaat acattcaaat atgtatccgc 6780
tcatgagaca ataaccctga taaatgcttc aataatattg aaaaaggaag agtatgagta 6840
ttcaacattt ccgtgtcgcc cttattccct tttttgcggc attttgcctt cctgtttttg 6900
ctcacccaga aacgctggtg aaagtaaaag atgctgaaga tcagttgggt gcacgagtgg 6960
gttacatcga actggatctc aacagcggta agatccttga gagttttcgc cccgaagaac 7020
gttttccaat gatgagcact tttaaagttc tgctatgtgg cgcggtatta tcccgtattg 7080
acgccgggca agagcaactc ggtcgccgca tacactattc tcagaatgac ttggttgagt 7140
actcaccagt cacagaaaag catcttacgg atggcatgac agtaagagaa ttatgcagtg 7200
ctgccataac catgagtgat aacactgcgg ccaacttact tctgacaacg atcggaggac 7260
cgaaggagct aaccgctttt ttgcacaaca tgggggatca tgtaactcgc cttgatcgtt 7320
gggaaccgga gctgaatgaa gccataccaa acgacgagcg tgacaccacg atgcctgtag 7380
caatggcaac aacgttgcgc aaactattaa ctggcgaact acttactcta gcttcccggc 7440
aacaattaat agactggatg gaggcggata aagttgcagg accacttctg cgctcggccc 7500
ttccggctgg ctggtttatt gctgataaat ctggagccgg tgagcgtggg tctcgcggta 7560
tcattgcagc actggggcca gatggtaagc cctcccgtat cgtagttatc tacacgacgg 7620
ggagtcaggc aactatggat gaacgaaata gacagatcgc tgagataggt gcctcactga 7680
ttaagcattg gtaactgtca gaccaagttt actcatatat actttagatt gatttaaaac 7740
ttcattttta atttaaaagg atctaggtga agatcctttt tgataatctc atgaccaaaa 7800
tcccttaacg tgagttttcg ttccactgag cgtcagaccc cgtagaaaag atcaaaggat 7860
cttcttgaga tccttttttt ctgcgcgtaa tctgctgctt gcaaacaaaa aaaccaccgc 7920
taccagcggt ggtttgtttg ccggatcaag agctaccaac tctttttccg aaggtaactg 7980
gcttcagcag agcgcagata ccaaatactg tccttctagt gtagccgtag ttaggccacc 8040
acttcaagaa ctctgtagca ccgcctacat acctcgctct gctaatcctg ttaccagtgg 8100
ctgctgccag tggcgataag tcgtgtctta ccgggttgga ctcaagacga tagttaccgg 8160
ataaggcgca gcggtcgggc tgaacggggg gttcgtgcac acagcccagc ttggagcgaa 8220
cgacctacac cgaactgaga tacctacagc gtgagctatg agaaagcgcc acgcttcccg 8280
aagggagaaa ggcggacagg tatccggtaa gcggcagggt cggaacagga gagcgcacga 8340
gggagcttcc agggggaaac gcctggtatc tttatagtcc tgtcgggttt cgccacctct 8400
gacttgagcg tcgatttttg tgatgctcgt caggggggcg gagcctatgg aaaaacgcca 8460
gcaacgcggc ctttttacgg ttcctggcct tttgctggcc ttttgctcac atgttctttc 8520
ctgcgttatc ccctgattct gtggataacc gtattaccgc ctttgagtga gctgataccg 8580
ctcgccgcag ccgaacgacc gagcgcagcg agtcagtgag cgaggaagcg gaagagcgcc 8640
caatacgcaa accgcctctc cccgcgcgtt ggccgattca ttaatgcagc tggcacgaca 8700
ggtttcccga ctggaaagcg ggcagtgagc gcaacgcaat taatgtgagt tagctcactc 8760
attaggcacc ccaggcttta cactttatgc ttccggctcg tatgttgtgt ggaattgtga 8820
gcggataaca atttcacaca ggaaacagct atgaccatga ttacgccaag cgcgcaatta 8880
accctcacta aagggaacaa aagctggagc tgca                             8914

<210> 1417
<211> 2821
<212> DNA
<213> Artificial Sequence

<220> 
<223> extracted sequence from LVA2CAR

<400> 1417
gaacagagaa acaggagaat atgggccaaa caggatatct gtggtaagca gttcctgccc 60
cggctcaggg ccaagaacag ttggaacagc agaatatggg ccaaacagga tatctgtggt 120
aagcagttcc tgccccggct cagggccaag aacagatggt ccccagatgc ggtcccgccc 180
tcagcagttt ctagagaacc atcagatgtt tccagggtgc cccaaggacc tgaaatgacc 240
ctgtgcctta tttgaactaa ccaatcagtt cgcttctcgc ttctgttcgc gcgcttctgc 300
tccccgagct ctatataagc agagctcgtt tagtgaaccg tcagatcgcc tggagacgcc 360
atccacgctg ttttgacttc catagaagga tctcgaggcc gccaccatgg ctctgcctgt 420
gacagctctg ctgctgcctc tggccctgct gctccatgcc gccagacccg gatcccaggt 480
acagctcgtt caatctgggg ctgaagtaaa aaagcctgga gcgtctgtaa aggtatcttg 540
caaagcgagc ggctacacat tcacaagtta tcacatccaa tgggtgagac aggccccagg 600
acaacgcttg gagtggatgg ggtggattta ccctggcgac ggcagcacac agtacaatga 660
gaaatttaaa ggccgggtga ctatcactcg ggacacctcc gccagcacgg cttatatgga 720
gcttagcagt ttgagatccg aagatacagc ggtatattac tgcgcgagag aaggaacgta 780
ctacgctatg gactattggg gtcagggcac aaccgttaca gtctcctctg tggacagctc 840
cggaggtggg ggttcaggag ggggtggaag cggtggtggt ggcagtacaa gcgatatagt 900
aatgacccaa accccgctct ctctgagcgt cacgccagga caaccagcat caatctcttg 960
ccgcagtagt caatccatcg ttcactctaa tggaaacaca taccttgagt ggtatcttca 1020
gaaaccaggt cagagccctc agctcctcat ctataaagtc tctaaccggt tctcaggtgt 1080
tccggaccgg ttcagtggtt ccggctcagg aacagacttc accttgaaga tcagtcgagt 1140
agaagccgaa gacgtgggtg tatattattg ctttcagggt tcccacgttc cgcgcacctt 1200
cggcggcggg accaaagttg agatcaaagc tagcgccaag cctaccacca cccctgcccc 1260
tagacctcca acacccgccc caacaatcgc cagccagcct ctgtctctga ggcccgaggc 1320
ttgtagacca gctgctggcg gagccgtaca caccagagga ctggatttcg cctgcgactt 1380
ttgggtgctg gtggtggttg gtggagtcct ggcttgctat agcttgctag taacagtggc 1440
ctttattatt ttctgggtga tgcataggag taagaggagc aggctcctgc acagtgacta 1500
catgaacatg actccccgcc gccccgggcc cacccgcaag cattaccagc cctatgcccc 1560
accacgcgac ttcgcagcct atcgctcccg ggtgaagttc agcagaagcg ccgacgcccc 1620
tgcctaccag cagggccaga atcagctgta caacgagctg aacctgggca gaagggaaga 1680
gtacgacgtc ctggataagc ggagaggccg ggaccctgag atgggcggca agcctcggcg 1740
gaagaacccc caggaaggcc tgtataacga actgcagaaa gacaagatgg ccgaggccta 1800
cagcgagatc ggcatgaagg gcgagcggag gcggggcaag ggccacgacg gcctgtatca 1860
gggcctgtcc accgccacca aggataccta cgacgccctg cacatgcagg ccctgccccc 1920
aaggactagt ggaagcggag cgactaactt cagcctgctg aagcaggccg gagatgtgga 1980
ggaaaaccct ggaccgatgg gggcaggtgc caccggacga gccatggacg ggccgcgcct 2040
gctgctgttg ctgcttctgg gggtgtccct tggaggtgcc aaggaggcat gccccacagg 2100
cctgtacaca cacagcggtg agtgctgcaa agcctgcaac ctgggcgagg gtgtggccca 2160
gccttgtgga gccaaccaga ccgtgtgtga gccctgcctg gacagcgtga cgttctccga 2220
cgtggtgagc gcgaccgagc cgtgcaagcc gtgcaccgag tgcgtggggc tccagagcat 2280
gtcggcgccg tgcgtggagg ccgacgacgc cgtgtgccgc tgcgcctacg gctactacca 2340
ggatgagacg actgggcgct gcgaggcgtg ccgcgtgtgc gaggcgggct cgggcctcgt 2400
gttctcctgc caggacaagc agaacaccgt gtgcgaggag tgccccgacg gcacgtattc 2460
cgacgaggcc aaccacgtgg acccgtgcct gccctgcacc gtgtgcgagg acaccgagcg 2520
ccagctccgc gagtgcacac gctgggccga cgccgagtgc gaggagatcc ctggccgttg 2580
gattacacgg tccacacccc cagagggctc ggacagcaca gcccccagca cccaggagcc 2640
tgaggcacct ccagaacaag acctcatagc cagcacggtg gcaggtgtgg tgaccacagt 2700
gatgggcagc tcccagcccg tggtgacccg aggcaccacc gacaacctca tccctgtcta 2760
ttgctccatc ctggctgctg tggttgtggg tcttgtggcc tacatagcct tcaagaggtg 2820
a                                                                 2821

<210> 1418
<211> 8455
<212> DNA
<213> Artificial Sequence

<220> 
<223> lentiviral vector expressing a non-signaling A2CAR
      protein

<400> 1418
agcttaatgt agtcttatgc aatactcttg tagtcttgca acatggtaac gatgagttag 60
caacatgcct tacaaggaga gaaaaagcac cgtgcatgcc gattggtgga agtaaggtgg 120
tacgatcgtg ccttattagg aaggcaacag acgggtctga catggattgg acgaaccact 180
gaattgccgc attgcagaga tattgtattt aagtgcctag ctcgatacaa taaacgggtc 240
tctctggtta gaccagatct gagcctggga gctctctggc taactaggga acccactgct 300
taagcctcaa taaagcttgc cttgagtgct tcaagtagtg tgtgcccgtc tgttgtgtga 360
ctctggtaac tagagatccc tcagaccctt ttagtcagtg tggaaaatct ctagcagtgg 420
cgcccgaaca gggacctgaa agcgaaaggg aaaccagagc tctctcgacg caggactcgg 480
cttgctgaag cgcgcacggc aagaggcgag gggcggcgac tggtgagtac gccaaaaatt 540
ttgactagcg gaggctagaa ggagagagat gggtgcgaga gcgtcagtat taagcggggg 600
agaattagat cgcgatggga aaaaattcgg ttaaggccag ggggaaagaa aaaatataaa 660
ttaaaacata tagtatgggc aagcagggag ctagaacgat tcgcagttaa tcctggcctg 720
ttagaaacat cagaaggctg tagacaaata ctgggacagc tacaaccatc ccttcagaca 780
ggatcagaag aacttagatc attatataat acagtagcaa ccctctattg tgtgcatcaa 840
aggatagaga taaaagacac caaggaagct ttagacaaga tagaggaaga gcaaaacaaa 900
agtaagacca ccgcacagca agcggacgct gatcttcaga cctggaggag gagatatgag 960
ggacaattgg agaagtgaat tatataaata taaagtagta aaaattgaac cattaggagt 1020
agcacccacc aaggcaaaga gaagagtggt gcagagagaa aaaagagcag tgggaatagg 1080
agctttgttc cttgggttct tgggagcagc aggaagcact atgggcgcag cctcaatgac 1140
gctgacggta caggccagac aattattgtc tggtatagtg cagcagcaga acaatttgct 1200
gagggctatt gaggcgcaac agcatctgtt gcaactcaca gtctggggca tcaagcagct 1260
ccaggcaaga atcctggctg tggaaagata cctaaaggat caacagctcc tggggatttg 1320
gggttgctct ggaaaactca tttgcaccac tgctgtgcct tggaatgcta gttggagtaa 1380
taaatctctg gaacagattt ggaatcacac gacctggatg gagtgggaca gagaaattaa 1440
caattacaca agcttaatac actccttaat tgaagaatcg caaaaccagc aagaaaagaa 1500
tgaacaagaa ttattggaat tagataaatg ggcaagtttg tggaattggt ttaacataac 1560
aaattggctg tggtatataa aattattcat aatgatagta ggaggcttgg taggtttaag 1620
aatagttttt gctgtacttt ctatagtgaa tagagttagg cagggatatt caccattatc 1680
gtttcagacc cacctcccaa ccccgagggg acccgacagg cccgaaggaa tagaagaaga 1740
aggtggagag agagacagag acagatccat tcgattagtg aacggatctc gacggtatcg 1800
gttaactttt aaaagaaaag gggggattgg ggggtacagt gcaggggaaa gaatagtaga 1860
cataatagca acagacatac aaactaaaga attacaaaaa caaattacaa aaattcaaaa 1920
ttttatcgat tacgcgtagg aacagagaaa caggagaata tgggccaaac aggatatctg 1980
tggtaagcag ttcctgcccc ggctcagggc caagaacagt tggaacagca gaatatgggc 2040
caaacaggat atctgtggta agcagttcct gccccggctc agggccaaga acagatggtc 2100
cccagatgcg gtcccgccct cagcagtttc tagagaacca tcagatgttt ccagggtgcc 2160
ccaaggacct gaaatgaccc tgtgccttat ttgaactaac caatcagttc gcttctcgct 2220
tctgttcgcg cgcttctgct ccccgagctc tatataagca gagctcgttt agtgaaccgt 2280
cagatcgcct ggagacgcca tccacgctgt tttgacttcc atagaaggat ctcgaggccg 2340
ccaccatggc tctgcctgtg acagctctgc tgctgcctct ggccctgctg ctccatgccg 2400
ccagacccgg atcccaggta cagctcgttc aatctggggc tgaagtaaaa aagcctggag 2460
cgtctgtaaa ggtatcttgc aaagcgagcg gctacacatt cacaagttat cacatccaat 2520
gggtgagaca ggccccagga caacgcttgg agtggatggg gtggatttac cctggcgacg 2580
gcagcacaca gtacaatgag aaatttaaag gccgggtgac tatcactcgg gacacctccg 2640
ccagcacggc ttatatggag cttagcagtt tgagatccga agatacagcg gtatattact 2700
gcgcgagaga aggaacgtac tacgctatgg actattgggg tcagggcaca accgttacag 2760
tctcctctgt ggacagctcc ggaggtgggg gttcaggagg gggtggaagc ggtggtggtg 2820
gcagtacaag cgatatagta atgacccaaa ccccgctctc tctgagcgtc acgccaggac 2880
aaccagcatc aatctcttgc cgcagtagtc aatccatcgt tcactctaat ggaaacacat 2940
accttgagtg gtatcttcag aaaccaggtc agagccctca gctcctcatc tataaagtct 3000
ctaaccggtt ctcaggtgtt ccggaccggt tcagtggttc cggctcagga acagacttca 3060
ccttgaagat cagtcgagta gaagccgaag acgtgggtgt atattattgc tttcagggtt 3120
cccacgttcc gcgcaccttc ggcggcggga ccaaagttga gatcaaagct agcgccaagc 3180
ctaccaccac ccctgcccct agacctccaa cacccgcccc aacaatcgcc agccagcctc 3240
tgtctctgag gcccgaggct tgtagaccag ctgctggcgg agccgtacac accagaggac 3300
tggatttcgc ctgcgacttt tgggtgctgg tggtggttgg tggagtcctg gcttgctata 3360
gcttgctagt aacagtggcc tttattattt tctgggtgat gcatactagt ggaagcggag 3420
cgactaactt cagcctgctg aagcaggccg gagatgtgga ggaaaaccct ggaccgatgg 3480
gggcaggtgc caccggacga gccatggacg ggccgcgcct gctgctgttg ctgcttctgg 3540
gggtgtccct tggaggtgcc aaggaggcat gccccacagg cctgtacaca cacagcggtg 3600
agtgctgcaa agcctgcaac ctgggcgagg gtgtggccca gccttgtgga gccaaccaga 3660
ccgtgtgtga gccctgcctg gacagcgtga cgttctccga cgtggtgagc gcgaccgagc 3720
cgtgcaagcc gtgcaccgag tgcgtggggc tccagagcat gtcggcgccg tgcgtggagg 3780
ccgacgacgc cgtgtgccgc tgcgcctacg gctactacca ggatgagacg actgggcgct 3840
gcgaggcgtg ccgcgtgtgc gaggcgggct cgggcctcgt gttctcctgc caggacaagc 3900
agaacaccgt gtgcgaggag tgccccgacg gcacgtattc cgacgaggcc aaccacgtgg 3960
acccgtgcct gccctgcacc gtgtgcgagg acaccgagcg ccagctccgc gagtgcacac 4020
gctgggccga cgccgagtgc gaggagatcc ctggccgttg gattacacgg tccacacccc 4080
cagagggctc ggacagcaca gcccccagca cccaggagcc tgaggcacct ccagaacaag 4140
acctcatagc cagcacggtg gcaggtgtgg tgaccacagt gatgggcagc tcccagcccg 4200
tggtgacccg aggcaccacc gacaacctca tccctgtcta ttgctccatc ctggctgctg 4260
tggttgtggg tcttgtggcc tacatagcct tcaagaggtg atgtcgacaa tcaacctctg 4320
gattacaaaa tttgtgaaag attgactggt attcttaact atgttgctcc ttttacgcta 4380
tgtggatacg ctgctttaat gcctttgtat catgctattg cttcccgtat ggctttcatt 4440
ttctcctcct tgtataaatc ctggttgctg tctctttatg aggagttgtg gcccgttgtc 4500
aggcaacgtg gcgtggtgtg cactgtgttt gctgacgcaa cccccactgg ttggggcatt 4560
gccaccacct gtcagctcct ttccgggact ttcgctttcc ccctccctat tgccacggcg 4620
gaactcatcg ccgcctgcct tgcccgctgc tggacagggg ctcggctgtt gggcactgac 4680
aattccgtgg tgttgtcggg gaagctgacg tcctttccat ggctgctcgc ctgtgttgcc 4740
acctggattc tgcgcgggac gtccttctgc tacgtccctt cggccctcaa tccagcggac 4800
cttccttccc gcggcctgct gccggctctg cggcctcttc cgcgtcttcg ccttcgccct 4860
cagacgagtc ggatctccct ttgggccgcc tccccgcctg gaattcgagc tcggtacctt 4920
taagaccaat gacttacaag gcagctgtag atcttagcca ctttttaaaa gaaaaggggg 4980
gactggaagg gctaattcac tcccaacgaa gacaagatct gctttttgct tgtactgggt 5040
ctctctggtt agaccagatc tgagcctggg agctctctgg ctaactaggg aacccactgc 5100
ttaagcctca ataaagcttg ccttgagtgc ttcaagtagt gtgtgcccgt ctgttgtgtg 5160
actctggtaa ctagagatcc ctcagaccct tttagtcagt gtggaaaatc tctagcagta 5220
gtagttcatg tcatcttatt attcagtatt tataacttgc aaagaaatga atatcagaga 5280
gtgagaggaa cttgtttatt gcagcttata atggttacaa ataaagcaat agcatcacaa 5340
atttcacaaa taaagcattt ttttcactgc attctagttg tggtttgtcc aaactcatca 5400
atgtatctta tcatgtctgg ctctagctat cccgccccta actccgccca gttccgccca 5460
ttctccgccc catggctgac taattttttt tatttatgca gaggccgagg ccgcctcggc 5520
ctctgagcta ttccagaagt agtgaggagg cttttttgga ggcctaggct tttgcgtcga 5580
gacgtaccca attcgcccta tagtgagtcg tattacgcgc gctcactggc cgtcgtttta 5640
caacgtcgtg actgggaaaa ccctggcgtt acccaactta atcgccttgc agcacatccc 5700
cctttcgcca gctggcgtaa tagcgaagag gcccgcaccg atcgcccttc ccaacagttg 5760
cgcagcctga atggcgaatg gcgcgacgcg ccctgtagcg gcgcattaag cgcggcgggt 5820
gtggtggtta cgcgcagcgt gaccgctaca cttgccagcg ccctagcgcc cgctcctttc 5880
gctttcttcc cttcctttct cgccacgttc gccggctttc cccgtcaagc tctaaatcgg 5940
gggctccctt tagggttccg atttagtgct ttacggcacc tcgaccccaa aaaacttgat 6000
tagggtgatg gttcacgtag tgggccatcg ccctgataga cggtttttcg ccctttgacg 6060
ttggagtcca cgttctttaa tagtggactc ttgttccaaa ctggaacaac actcaaccct 6120
atctcggtct attcttttga tttataaggg attttgccga tttcggccta ttggttaaaa 6180
aatgagctga tttaacaaaa atttaacgcg aattttaaca aaatattaac gtttacaatt 6240
tcccaggtgg cacttttcgg ggaaatgtgc gcggaacccc tatttgttta tttttctaaa 6300
tacattcaaa tatgtatccg ctcatgagac aataaccctg ataaatgctt caataatatt 6360
gaaaaaggaa gagtatgagt attcaacatt tccgtgtcgc ccttattccc ttttttgcgg 6420
cattttgcct tcctgttttt gctcacccag aaacgctggt gaaagtaaaa gatgctgaag 6480
atcagttggg tgcacgagtg ggttacatcg aactggatct caacagcggt aagatccttg 6540
agagttttcg ccccgaagaa cgttttccaa tgatgagcac ttttaaagtt ctgctatgtg 6600
gcgcggtatt atcccgtatt gacgccgggc aagagcaact cggtcgccgc atacactatt 6660
ctcagaatga cttggttgag tactcaccag tcacagaaaa gcatcttacg gatggcatga 6720
cagtaagaga attatgcagt gctgccataa ccatgagtga taacactgcg gccaacttac 6780
ttctgacaac gatcggagga ccgaaggagc taaccgcttt tttgcacaac atgggggatc 6840
atgtaactcg ccttgatcgt tgggaaccgg agctgaatga agccatacca aacgacgagc 6900
gtgacaccac gatgcctgta gcaatggcaa caacgttgcg caaactatta actggcgaac 6960
tacttactct agcttcccgg caacaattaa tagactggat ggaggcggat aaagttgcag 7020
gaccacttct gcgctcggcc cttccggctg gctggtttat tgctgataaa tctggagccg 7080
gtgagcgtgg gtctcgcggt atcattgcag cactggggcc agatggtaag ccctcccgta 7140
tcgtagttat ctacacgacg gggagtcagg caactatgga tgaacgaaat agacagatcg 7200
ctgagatagg tgcctcactg attaagcatt ggtaactgtc agaccaagtt tactcatata 7260
tactttagat tgatttaaaa cttcattttt aatttaaaag gatctaggtg aagatccttt 7320
ttgataatct catgaccaaa atcccttaac gtgagttttc gttccactga gcgtcagacc 7380
ccgtagaaaa gatcaaagga tcttcttgag atcctttttt tctgcgcgta atctgctgct 7440
tgcaaacaaa aaaaccaccg ctaccagcgg tggtttgttt gccggatcaa gagctaccaa 7500
ctctttttcc gaaggtaact ggcttcagca gagcgcagat accaaatact gtccttctag 7560
tgtagccgta gttaggccac cacttcaaga actctgtagc accgcctaca tacctcgctc 7620
tgctaatcct gttaccagtg gctgctgcca gtggcgataa gtcgtgtctt accgggttgg 7680
actcaagacg atagttaccg gataaggcgc agcggtcggg ctgaacgggg ggttcgtgca 7740
cacagcccag cttggagcga acgacctaca ccgaactgag atacctacag cgtgagctat 7800
gagaaagcgc cacgcttccc gaagggagaa aggcggacag gtatccggta agcggcaggg 7860
tcggaacagg agagcgcacg agggagcttc cagggggaaa cgcctggtat ctttatagtc 7920
ctgtcgggtt tcgccacctc tgacttgagc gtcgattttt gtgatgctcg tcaggggggc 7980
ggagcctatg gaaaaacgcc agcaacgcgg cctttttacg gttcctggcc ttttgctggc 8040
cttttgctca catgttcttt cctgcgttat cccctgattc tgtggataac cgtattaccg 8100
cctttgagtg agctgatacc gctcgccgca gccgaacgac cgagcgcagc gagtcagtga 8160
gcgaggaagc ggaagagcgc ccaatacgca aaccgcctct ccccgcgcgt tggccgattc 8220
attaatgcag ctggcacgac aggtttcccg actggaaagc gggcagtgag cgcaacgcaa 8280
ttaatgtgag ttagctcact cattaggcac cccaggcttt acactttatg cttccggctc 8340
gtatgttgtg tggaattgtg agcggataac aatttcacac aggaaacagc tatgaccatg 8400
attacgccaa gcgcgcaatt aaccctcact aaagggaaca aaagctggag ctgca      8455

<210> 1419
<211> 2362
<212> DNA
<213> Artificial Sequence

<220> 
<223> extracted sequence from LV. delta A2CAR

<400> 1419
gaacagagaa acaggagaat atgggccaaa caggatatct gtggtaagca gttcctgccc 60
cggctcaggg ccaagaacag ttggaacagc agaatatggg ccaaacagga tatctgtggt 120
aagcagttcc tgccccggct cagggccaag aacagatggt ccccagatgc ggtcccgccc 180
tcagcagttt ctagagaacc atcagatgtt tccagggtgc cccaaggacc tgaaatgacc 240
ctgtgcctta tttgaactaa ccaatcagtt cgcttctcgc ttctgttcgc gcgcttctgc 300
tccccgagct ctatataagc agagctcgtt tagtgaaccg tcagatcgcc tggagacgcc 360
atccacgctg ttttgacttc catagaagga tctcgaggcc gccaccatgg ctctgcctgt 420
gacagctctg ctgctgcctc tggccctgct gctccatgcc gccagacccg gatcccaggt 480
acagctcgtt caatctgggg ctgaagtaaa aaagcctgga gcgtctgtaa aggtatcttg 540
caaagcgagc ggctacacat tcacaagtta tcacatccaa tgggtgagac aggccccagg 600
acaacgcttg gagtggatgg ggtggattta ccctggcgac ggcagcacac agtacaatga 660
gaaatttaaa ggccgggtga ctatcactcg ggacacctcc gccagcacgg cttatatgga 720
gcttagcagt ttgagatccg aagatacagc ggtatattac tgcgcgagag aaggaacgta 780
ctacgctatg gactattggg gtcagggcac aaccgttaca gtctcctctg tggacagctc 840
cggaggtggg ggttcaggag ggggtggaag cggtggtggt ggcagtacaa gcgatatagt 900
aatgacccaa accccgctct ctctgagcgt cacgccagga caaccagcat caatctcttg 960
ccgcagtagt caatccatcg ttcactctaa tggaaacaca taccttgagt ggtatcttca 1020
gaaaccaggt cagagccctc agctcctcat ctataaagtc tctaaccggt tctcaggtgt 1080
tccggaccgg ttcagtggtt ccggctcagg aacagacttc accttgaaga tcagtcgagt 1140
agaagccgaa gacgtgggtg tatattattg ctttcagggt tcccacgttc cgcgcacctt 1200
cggcggcggg accaaagttg agatcaaagc tagcgccaag cctaccacca cccctgcccc 1260
tagacctcca acacccgccc caacaatcgc cagccagcct ctgtctctga ggcccgaggc 1320
ttgtagacca gctgctggcg gagccgtaca caccagagga ctggatttcg cctgcgactt 1380
ttgggtgctg gtggtggttg gtggagtcct ggcttgctat agcttgctag taacagtggc 1440
ctttattatt ttctgggtga tgcatactag tggaagcgga gcgactaact tcagcctgct 1500
gaagcaggcc ggagatgtgg aggaaaaccc tggaccgatg ggggcaggtg ccaccggacg 1560
agccatggac gggccgcgcc tgctgctgtt gctgcttctg ggggtgtccc ttggaggtgc 1620
caaggaggca tgccccacag gcctgtacac acacagcggt gagtgctgca aagcctgcaa 1680
cctgggcgag ggtgtggccc agccttgtgg agccaaccag accgtgtgtg agccctgcct 1740
ggacagcgtg acgttctccg acgtggtgag cgcgaccgag ccgtgcaagc cgtgcaccga 1800
gtgcgtgggg ctccagagca tgtcggcgcc gtgcgtggag gccgacgacg ccgtgtgccg 1860
ctgcgcctac ggctactacc aggatgagac gactgggcgc tgcgaggcgt gccgcgtgtg 1920
cgaggcgggc tcgggcctcg tgttctcctg ccaggacaag cagaacaccg tgtgcgagga 1980
gtgccccgac ggcacgtatt ccgacgaggc caaccacgtg gacccgtgcc tgccctgcac 2040
cgtgtgcgag gacaccgagc gccagctccg cgagtgcaca cgctgggccg acgccgagtg 2100
cgaggagatc cctggccgtt ggattacacg gtccacaccc ccagagggct cggacagcac 2160
agcccccagc acccaggagc ctgaggcacc tccagaacaa gacctcatag ccagcacggt 2220
ggcaggtgtg gtgaccacag tgatgggcag ctcccagccc gtggtgaccc gaggcaccac 2280
cgacaacctc atccctgtct attgctccat cctggctgct gtggttgtgg gtcttgtggc 2340
ctacatagcc ttcaagaggt ga                                          2362

<210> 1420
<211> 7472
<212> DNA
<213> Artificial Sequence

<220> 
<223> TRAC-T4 guide specific AAV

<400> 1420
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtagc 1020
ggccgcactg aaatcatggc ctcttggcca agattgatag cttgtgcctg tccctgagtc 1080
ccagtccatc acgagcagct ggtttctaag atgctatttc ccgtataaag catgagaccg 1140
tgacttgcca gccccacaga gccccgccct tgtccatcac tggcatctgg actccagcct 1200
gggttggggc aaagagggaa atgagatcat gtcctaaccc tgatcctctt gtcccacaga 1260
tatccagaac cctgaccctg ccgtgtacca gctgagagac tctaaatcca gtgacaagtc 1320
tgtctgccta tattaaggaa cagagaaaca ggagaatatg ggccaaacag gatatctgtg 1380
gtaagcagtt cctgccccgg ctcagggcca agaacagttg gaacagcaga atatgggcca 1440
aacaggatat ctgtggtaag cagttcctgc cccggctcag ggccaagaac agatggtccc 1500
cagatgcggt cccgccctca gcagtttcta gagaaccatc agatgtttcc agggtgcccc 1560
aaggacctga aatgaccctg tgccttattt gaactaacca atcagttcgc ttctcgcttc 1620
tgttcgcgcg cttctgctcc ccgagctcta tataagcaga gctcgtttag tgaaccgtca 1680
gatcgcctgg agacgccatc cacgctgttt tgacttccat agaaggatcg actcgagtaa 1740
tgcctctggg cctgctgtgg ctgggcctgg ccctgctggg cgccctgcac gcccaggccg 1800
gcgtgcaggt ggagacaatc tccccaggcg acggacgcac attccctaag cggggccaga 1860
cctgcgtggt gcactataca ggcatgctgg aggatggcaa gaagtttgac agctcccggg 1920
atagaaacaa gccattcaag tttatgctgg gcaagcagga agtgatcaga ggctgggagg 1980
agggcgtggc ccagatgtct gtgggccaga gggccaagct gaccatcagc ccagactacg 2040
cctatggagc aacaggccac ccaggaatca tcccacctca cgccaccctg gtgttcgatg 2100
tggagctgct gaagctgggc gagggatcca acacatcaaa agagaacccc tttctgttcg 2160
cattggaggc cgtagtcata tctgttggat ccatgggact tattatctcc ctgttgtgtg 2220
tgtacttctg gctggaacgg actatgccca ggatccccac gctcaagaat ctggaagatc 2280
tcgtcacaga ataccatggt aatttcagcg cctggagcgg agtctctaag ggtctggccg 2340
aatccctcca acccgattat tctgaacggt tgtgcctcgt atccgaaata ccaccaaaag 2400
gcggggctct gggtgagggc ccaggggcga gtccgtgcaa tcaacacagc ccgtattggg 2460
cccctccttg ttatacgttg aagcccgaaa ctggaagcgg agcgactaac ttttctctgc 2520
ttaaacaggc aggcgatgtc gaggaaaacc ctggaccgac tagtatggct ctgcctgtga 2580
cagctctgct gctgcctctg gccctgctgc tccatgccgc cagacccgga tcccaggtac 2640
agctcgttca atctggggct gaagtaaaaa agcctggagc gtctgtaaag gtatcttgca 2700
aagcgagcgg ctacacattc acaagttatc acatccaatg ggtgagacag gccccaggac 2760
aacgcttgga gtggatgggg tggatttacc ctggcgacgg cagcacacag tacaatgaga 2820
aatttaaagg ccgggtgact atcactcggg acacctccgc cagcacggct tatatggagc 2880
ttagcagttt gagatccgaa gatacagcgg tatattactg cgcgagagaa ggaacgtact 2940
acgctatgga ctattggggt cagggcacaa ccgttacagt ctcctctgtg gacagctccg 3000
gaggtggggg ttcaggaggg ggtggaagcg gtggtggtgg cagtacaagc gatatagtaa 3060
tgacccaaac cccgctctct ctgagcgtca cgccaggaca accagcatca atctcttgcc 3120
gcagtagtca atccatcgtt cactctaatg gaaacacata ccttgagtgg tatcttcaga 3180
aaccaggtca gagccctcag ctcctcatct ataaagtctc taaccggttc tcaggtgttc 3240
cggaccggtt cagtggttcc ggctcaggaa cagacttcac cttgaagatc agtcgagtag 3300
aagccgaaga cgtgggtgta tattattgct ttcagggttc ccacgttccg cgcaccttcg 3360
gcggcgggac caaagttgag atcaaagcta gcgccaagcc taccaccacc cctgccccta 3420
gacctccaac acccgcccca acaatcgcca gccagcctct gtctctgagg cccgaggctt 3480
gtagaccagc tgctggcgga gccgtacaca ccagaggact ggatttcgcc tgcgactttt 3540
gggtgctggt ggtggttggt ggagtcctgg cttgctatag cttgctagta acagtggcct 3600
ttattatttt ctgggtgatg cataggagta agaggagcag gctcctgcac agtgactaca 3660
tgaacatgac tccccgccgc cccgggccca cccgcaagca ttaccagccc tatgccccac 3720
cacgcgactt cgcagcctat cgctcccggg tgaagttcag cagaagcgcc gacgcccctg 3780
cctaccagca gggccagaat cagctgtaca acgagctgaa cctgggcaga agggaagagt 3840
acgacgtcct ggataagcgg agaggccggg accctgagat gggcggcaag cctcggcgga 3900
agaaccccca ggaaggcctg tataacgaac tgcagaaaga caagatggcc gaggcctaca 3960
gcgagatcgg catgaagggc gagcggaggc ggggcaaggg ccacgacggc ctgtatcagg 4020
gcctgtccac cgccaccaag gatacctacg acgccctgca catgcaggcc ctgcccccaa 4080
ggaagcttaa ttgagcggcc gcgctttatt tgtgaaattt gtgatgctat tgctttattt 4140
gtaaccatta taagctgcaa taaacaagtt aacaacaaca attgcattca ttttatgttt 4200
caggttcagg gggagatgtg ggaggttttt taaagctcac cgattttgat tctcaaacaa 4260
atgtgtcaca aagtaaggat tctgatgtgt atatcacaga caaaactgtg ctagacatga 4320
ggtctatgga cttcaagagc aacagtgctg tggcctggag caacaaatct gactttgcat 4380
gtgcaaacgc cttcaacaac agcattattc cagaagacac cttcttcccc agcccaggta 4440
agggcagctt tggtgccttc gcaggctgtt tccttgcttc aggaatggcc aggttctgcc 4500
cagagctctg gtcaatgatg tctaaaactc ctctgattgg tggtctcggc gcggccgcta 4560
cgtagataag tagcatggcg ggttaatcat taactacaag gaacccctag tgatggagtt 4620
ggccactccc tctctgcgcg ctcgctcgct cactgaggcc gggcgaccaa aggtcgcccg 4680
acgcccgggc tttgcccggg cggcctcagt gagcgagcga gcgcgccagc tggcgtaata 4740
gcgaagaggc ccgcaccgat cgcccttccc aacagttgcg cagcctgaat ggcgaatggc 4800
gattccgttg caatggctgg cggtaatatt gttctggata ttaccagcaa ggccgatagt 4860
ttgagttctt ctactcaggc aagtgatgtt attactaatc aaagaagtat tgcgacaacg 4920
gttaatttgc gtgatggaca gactctttta ctcggtggcc tcactgatta taaaaacact 4980
tctcaggatt ctggcgtacc gttcctgtct aaaatccctt taatcggcct cctgtttagc 5040
tcccgctctg attctaacga ggaaagcacg ttatacgtgc tcgtcaaagc aaccatagta 5100
cgcgccctgt agcggcgcat taagcgcggc gggtgtggtg gttacgcgca gcgtgaccgc 5160
tacacttgcc agcgccctag cgcccgctcc tttcgctttc ttcccttcct ttctcgccac 5220
gttcgccggc tttccccgtc aagctctaaa tcgggggctc cctttagggt tccgatttag 5280
tgctttacgg cacctcgacc ccaaaaaact tgattagggt gatggttcac gtagtgggcc 5340
atcgccctga tagacggttt ttcgcccttt gacgttggag tccacgttct ttaatagtgg 5400
actcttgttc caaactggaa caacactcaa ccctatctcg gtctattctt ttgatttata 5460
agggattttg ccgatttcgg cctattggtt aaaaaatgag ctgatttaac aaaaatttaa 5520
cgcgaatttt aacaaaatat taacgtttac aatttaaata tttgcttata caatcttcct 5580
gtttttgggg cttttctgat tatcaaccgg ggtacatatg attgacatgc tagttttacg 5640
attaccgttc atcgattctc ttgtttgctc cagactctca ggcaatgacc tgatagcctt 5700
tgtagagacc tctcaaaaat agctaccctc tccggcatga atttatcagc tagaacggtt 5760
gaatatcata ttgatggtga tttgactgtc tccggccttt ctcacccgtt tgaatcttta 5820
cctacacatt actcaggcat tgcatttaaa atatatgagg gttctaaaaa tttttatcct 5880
tgcgttgaaa taaaggcttc tcccgcaaaa gtattacagg gtcataatgt ttttggtaca 5940
accgatttag ctttatgctc tgaggcttta ttgcttaatt ttgctaattc tttgccttgc 6000
ctgtatgatt tattggatgt tggaatcgcc tgatgcggta ttttctcctt acgcatctgt 6060
gcggtatttc acaccgcata tggtgcactc tcagtacaat ctgctctgat gccgcatagt 6120
taagccagcc ccgacacccg ccaacacccg ctgacgcgcc ctgacgggct tgtctgctcc 6180
cggcatccgc ttacagacaa gctgtgaccg tctccgggag ctgcatgtgt cagaggtttt 6240
caccgtcatc accgaaacgc gcgagacgaa agggcctcgt gatacgccta tttttatagg 6300
ttaatgtcat gataataatg gtttcttaga cgtcaggtgg cacttttcgg ggaaatgtgc 6360
gcggaacccc tatttgttta tttttctaaa tacattcaaa tatgtatccg ctcatgagac 6420
aataaccctg ataaatgctt caataatatt gaaaaaggaa gagtatgagt attcaacatt 6480
tccgtgtcgc ccttattccc ttttttgcgg cattttgcct tcctgttttt gctcacccag 6540
aaacgctggt gaaagtaaaa gatgctgaag atcagttggg tgcacgagtg ggttacatcg 6600
aactggatct caacagcggt aagatccttg agagttttcg ccccgaagaa cgttttccaa 6660
tgatgagcac ttttaaagtt ctgctatgtg gcgcggtatt atcccgtatt gacgccgggc 6720
aagagcaact cggtcgccgc atacactatt ctcagaatga cttggttgag tactcaccag 6780
tcacagaaaa gcatcttacg gatggcatga cagtaagaga attatgcagt gctgccataa 6840
ccatgagtga taacactgcg gccaacttac ttctgacaac gatcggagga ccgaaggagc 6900
taaccgcttt tttgcacaac atgggggatc atgtaactcg ccttgatcgt tgggaaccgg 6960
agctgaatga agccatacca aacgacgagc gtgacaccac gatgcctgta gcaatggcaa 7020
caacgttgcg caaactatta actggcgaac tacttactct agcttcccgg caacaattaa 7080
tagactggat ggaggcggat aaagttgcag gaccacttct gcgctcggcc cttccggctg 7140
gctggtttat tgctgataaa tctggagccg gtgagcgtgg gtctcgcggt atcattgcag 7200
cactggggcc agatggtaag ccctcccgta tcgtagttat ctacacgacg gggagtcagg 7260
caactatgga tgaacgaaat agacagatcg ctgagatagg tgcctcactg attaagcatt 7320
ggtaactgtc agaccaagtt tactcatata tactttagat tgatttaaaa cttcattttt 7380
aatttaaaag gatctaggtg aagatccttt ttgataatct catgaccaaa atcccttaac 7440
gtgagttttc gttccactga gcgtcagacc cc                               7472

<210> 1421
<211> 3525
<212> DNA
<213> Artificial Sequence

<220> 
<223> extracted sequence from 3407

<400> 1421
cactgaaatc atggcctctt ggccaagatt gatagcttgt gcctgtccct gagtcccagt 60
ccatcacgag cagctggttt ctaagatgct atttcccgta taaagcatga gaccgtgact 120
tgccagcccc acagagcccc gcccttgtcc atcactggca tctggactcc agcctgggtt 180
ggggcaaaga gggaaatgag atcatgtcct aaccctgatc ctcttgtccc acagatatcc 240
agaaccctga ccctgccgtg taccagctga gagactctaa atccagtgac aagtctgtct 300
gcctatatta aggaacagag aaacaggaga atatgggcca aacaggatat ctgtggtaag 360
cagttcctgc cccggctcag ggccaagaac agttggaaca gcagaatatg ggccaaacag 420
gatatctgtg gtaagcagtt cctgccccgg ctcagggcca agaacagatg gtccccagat 480
gcggtcccgc cctcagcagt ttctagagaa ccatcagatg tttccagggt gccccaagga 540
cctgaaatga ccctgtgcct tatttgaact aaccaatcag ttcgcttctc gcttctgttc 600
gcgcgcttct gctccccgag ctctatataa gcagagctcg tttagtgaac cgtcagatcg 660
cctggagacg ccatccacgc tgttttgact tccatagaag gatcgactcg agtaatgcct 720
ctgggcctgc tgtggctggg cctggccctg ctgggcgccc tgcacgccca ggccggcgtg 780
caggtggaga caatctcccc aggcgacgga cgcacattcc ctaagcgggg ccagacctgc 840
gtggtgcact atacaggcat gctggaggat ggcaagaagt ttgacagctc ccgggataga 900
aacaagccat tcaagtttat gctgggcaag caggaagtga tcagaggctg ggaggagggc 960
gtggcccaga tgtctgtggg ccagagggcc aagctgacca tcagcccaga ctacgcctat 1020
ggagcaacag gccacccagg aatcatccca cctcacgcca ccctggtgtt cgatgtggag 1080
ctgctgaagc tgggcgaggg atccaacaca tcaaaagaga acccctttct gttcgcattg 1140
gaggccgtag tcatatctgt tggatccatg ggacttatta tctccctgtt gtgtgtgtac 1200
ttctggctgg aacggactat gcccaggatc cccacgctca agaatctgga agatctcgtc 1260
acagaatacc atggtaattt cagcgcctgg agcggagtct ctaagggtct ggccgaatcc 1320
ctccaacccg attattctga acggttgtgc ctcgtatccg aaataccacc aaaaggcggg 1380
gctctgggtg agggcccagg ggcgagtccg tgcaatcaac acagcccgta ttgggcccct 1440
ccttgttata cgttgaagcc cgaaactgga agcggagcga ctaacttttc tctgcttaaa 1500
caggcaggcg atgtcgagga aaaccctgga ccgactagta tggctctgcc tgtgacagct 1560
ctgctgctgc ctctggccct gctgctccat gccgccagac ccggatccca ggtacagctc 1620
gttcaatctg gggctgaagt aaaaaagcct ggagcgtctg taaaggtatc ttgcaaagcg 1680
agcggctaca cattcacaag ttatcacatc caatgggtga gacaggcccc aggacaacgc 1740
ttggagtgga tggggtggat ttaccctggc gacggcagca cacagtacaa tgagaaattt 1800
aaaggccggg tgactatcac tcgggacacc tccgccagca cggcttatat ggagcttagc 1860
agtttgagat ccgaagatac agcggtatat tactgcgcga gagaaggaac gtactacgct 1920
atggactatt ggggtcaggg cacaaccgtt acagtctcct ctgtggacag ctccggaggt 1980
gggggttcag gagggggtgg aagcggtggt ggtggcagta caagcgatat agtaatgacc 2040
caaaccccgc tctctctgag cgtcacgcca ggacaaccag catcaatctc ttgccgcagt 2100
agtcaatcca tcgttcactc taatggaaac acataccttg agtggtatct tcagaaacca 2160
ggtcagagcc ctcagctcct catctataaa gtctctaacc ggttctcagg tgttccggac 2220
cggttcagtg gttccggctc aggaacagac ttcaccttga agatcagtcg agtagaagcc 2280
gaagacgtgg gtgtatatta ttgctttcag ggttcccacg ttccgcgcac cttcggcggc 2340
gggaccaaag ttgagatcaa agctagcgcc aagcctacca ccacccctgc ccctagacct 2400
ccaacacccg ccccaacaat cgccagccag cctctgtctc tgaggcccga ggcttgtaga 2460
ccagctgctg gcggagccgt acacaccaga ggactggatt tcgcctgcga cttttgggtg 2520
ctggtggtgg ttggtggagt cctggcttgc tatagcttgc tagtaacagt ggcctttatt 2580
attttctggg tgatgcatag gagtaagagg agcaggctcc tgcacagtga ctacatgaac 2640
atgactcccc gccgccccgg gcccacccgc aagcattacc agccctatgc cccaccacgc 2700
gacttcgcag cctatcgctc ccgggtgaag ttcagcagaa gcgccgacgc ccctgcctac 2760
cagcagggcc agaatcagct gtacaacgag ctgaacctgg gcagaaggga agagtacgac 2820
gtcctggata agcggagagg ccgggaccct gagatgggcg gcaagcctcg gcggaagaac 2880
ccccaggaag gcctgtataa cgaactgcag aaagacaaga tggccgaggc ctacagcgag 2940
atcggcatga agggcgagcg gaggcggggc aagggccacg acggcctgta tcagggcctg 3000
tccaccgcca ccaaggatac ctacgacgcc ctgcacatgc aggccctgcc cccaaggaag 3060
cttaattgag cggccgcgct ttatttgtga aatttgtgat gctattgctt tatttgtaac 3120
cattataagc tgcaataaac aagttaacaa caacaattgc attcatttta tgtttcaggt 3180
tcagggggag atgtgggagg ttttttaaag ctcaccgatt ttgattctca aacaaatgtg 3240
tcacaaagta aggattctga tgtgtatatc acagacaaaa ctgtgctaga catgaggtct 3300
atggacttca agagcaacag tgctgtggcc tggagcaaca aatctgactt tgcatgtgca 3360
aacgccttca acaacagcat tattccagaa gacaccttct tccccagccc aggtaagggc 3420
agctttggtg ccttcgcagg ctgtttcctt gcttcaggaa tggccaggtt ctgcccagag 3480
ctctggtcaa tgatgtctaa aactcctctg attggtggtc tcggc                 3525

<210> 1422
<211> 7013
<212> DNA
<213> Artificial Sequence

<220> 
<223> TRAC-T4 guide specific AAV

<400> 1422
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtagc 1020
ggccgcactg aaatcatggc ctcttggcca agattgatag cttgtgcctg tccctgagtc 1080
ccagtccatc acgagcagct ggtttctaag atgctatttc ccgtataaag catgagaccg 1140
tgacttgcca gccccacaga gccccgccct tgtccatcac tggcatctgg actccagcct 1200
gggttggggc aaagagggaa atgagatcat gtcctaaccc tgatcctctt gtcccacaga 1260
tatccagaac cctgaccctg ccgtgtacca gctgagagac tctaaatcca gtgacaagtc 1320
tgtctgccta tattaaggaa cagagaaaca ggagaatatg ggccaaacag gatatctgtg 1380
gtaagcagtt cctgccccgg ctcagggcca agaacagttg gaacagcaga atatgggcca 1440
aacaggatat ctgtggtaag cagttcctgc cccggctcag ggccaagaac agatggtccc 1500
cagatgcggt cccgccctca gcagtttcta gagaaccatc agatgtttcc agggtgcccc 1560
aaggacctga aatgaccctg tgccttattt gaactaacca atcagttcgc ttctcgcttc 1620
tgttcgcgcg cttctgctcc ccgagctcta tataagcaga gctcgtttag tgaaccgtca 1680
gatcgcctgg agacgccatc cacgctgttt tgacttccat agaaggatcg actcgagtaa 1740
tgcctctggg cctgctgtgg ctgggcctgg ccctgctggg cgccctgcac gcccaggccg 1800
gcgtgcaggt ggagacaatc tccccaggcg acggacgcac attccctaag cggggccaga 1860
cctgcgtggt gcactataca ggcatgctgg aggatggcaa gaagtttgac agctcccggg 1920
atagaaacaa gccattcaag tttatgctgg gcaagcagga agtgatcaga ggctgggagg 1980
agggcgtggc ccagatgtct gtgggccaga gggccaagct gaccatcagc ccagactacg 2040
cctatggagc aacaggccac ccaggaatca tcccacctca cgccaccctg gtgttcgatg 2100
tggagctgct gaagctgggc gagggatcca acacatcaaa agagaacccc tttctgttcg 2160
cattggaggc cgtagtcata tctgttggat ccatgggact tattatctcc ctgttgtgtg 2220
tgtacttctg gctggaacgg actatgccca ggatccccac gctcaagaat ctggaagatc 2280
tcgtcacaga ataccatggt aatttcagcg cctggagcgg agtctctaag ggtctggccg 2340
aatccctcca acccgattat tctgaacggt tgtgcctcgt atccgaaata ccaccaaaag 2400
gcggggctct gggtgagggc ccaggggcga gtccgtgcaa tcaacacagc ccgtattggg 2460
cccctccttg ttatacgttg aagcccgaaa ctggaagcgg agcgactaac ttttctctgc 2520
ttaaacaggc aggcgatgtc gaggaaaacc ctggaccgac tagtatggct ctgcctgtga 2580
cagctctgct gctgcctctg gccctgctgc tccatgccgc cagacccgga tcccaggtac 2640
agctcgttca atctggggct gaagtaaaaa agcctggagc gtctgtaaag gtatcttgca 2700
aagcgagcgg ctacacattc acaagttatc acatccaatg ggtgagacag gccccaggac 2760
aacgcttgga gtggatgggg tggatttacc ctggcgacgg cagcacacag tacaatgaga 2820
aatttaaagg ccgggtgact atcactcggg acacctccgc cagcacggct tatatggagc 2880
ttagcagttt gagatccgaa gatacagcgg tatattactg cgcgagagaa ggaacgtact 2940
acgctatgga ctattggggt cagggcacaa ccgttacagt ctcctctgtg gacagctccg 3000
gaggtggggg ttcaggaggg ggtggaagcg gtggtggtgg cagtacaagc gatatagtaa 3060
tgacccaaac cccgctctct ctgagcgtca cgccaggaca accagcatca atctcttgcc 3120
gcagtagtca atccatcgtt cactctaatg gaaacacata ccttgagtgg tatcttcaga 3180
aaccaggtca gagccctcag ctcctcatct ataaagtctc taaccggttc tcaggtgttc 3240
cggaccggtt cagtggttcc ggctcaggaa cagacttcac cttgaagatc agtcgagtag 3300
aagccgaaga cgtgggtgta tattattgct ttcagggttc ccacgttccg cgcaccttcg 3360
gcggcgggac caaagttgag atcaaagcta gcgccaagcc taccaccacc cctgccccta 3420
gacctccaac acccgcccca acaatcgcca gccagcctct gtctctgagg cccgaggctt 3480
gtagaccagc tgctggcgga gccgtacaca ccagaggact ggatttcgcc tgcgactttt 3540
gggtgctggt ggtggttggt ggagtcctgg cttgctatag cttgctagta acagtggcct 3600
ttattatttt ctgggtgatg cataagctta attgagcggc cgcgctttat ttgtgaaatt 3660
tgtgatgcta ttgctttatt tgtaaccatt ataagctgca ataaacaagt taacaacaac 3720
aattgcattc attttatgtt tcaggttcag ggggagatgt gggaggtttt ttaaagctca 3780
ccgattttga ttctcaaaca aatgtgtcac aaagtaagga ttctgatgtg tatatcacag 3840
acaaaactgt gctagacatg aggtctatgg acttcaagag caacagtgct gtggcctgga 3900
gcaacaaatc tgactttgca tgtgcaaacg ccttcaacaa cagcattatt ccagaagaca 3960
ccttcttccc cagcccaggt aagggcagct ttggtgcctt cgcaggctgt ttccttgctt 4020
caggaatggc caggttctgc ccagagctct ggtcaatgat gtctaaaact cctctgattg 4080
gtggtctcgg cgcggccgct acgtagataa gtagcatggc gggttaatca ttaactacaa 4140
ggaaccccta gtgatggagt tggccactcc ctctctgcgc gctcgctcgc tcactgaggc 4200
cgggcgacca aaggtcgccc gacgcccggg ctttgcccgg gcggcctcag tgagcgagcg 4260
agcgcgccag ctggcgtaat agcgaagagg cccgcaccga tcgcccttcc caacagttgc 4320
gcagcctgaa tggcgaatgg cgattccgtt gcaatggctg gcggtaatat tgttctggat 4380
attaccagca aggccgatag tttgagttct tctactcagg caagtgatgt tattactaat 4440
caaagaagta ttgcgacaac ggttaatttg cgtgatggac agactctttt actcggtggc 4500
ctcactgatt ataaaaacac ttctcaggat tctggcgtac cgttcctgtc taaaatccct 4560
ttaatcggcc tcctgtttag ctcccgctct gattctaacg aggaaagcac gttatacgtg 4620
ctcgtcaaag caaccatagt acgcgccctg tagcggcgca ttaagcgcgg cgggtgtggt 4680
ggttacgcgc agcgtgaccg ctacacttgc cagcgcccta gcgcccgctc ctttcgcttt 4740
cttcccttcc tttctcgcca cgttcgccgg ctttccccgt caagctctaa atcgggggct 4800
ccctttaggg ttccgattta gtgctttacg gcacctcgac cccaaaaaac ttgattaggg 4860
tgatggttca cgtagtgggc catcgccctg atagacggtt tttcgccctt tgacgttgga 4920
gtccacgttc tttaatagtg gactcttgtt ccaaactgga acaacactca accctatctc 4980
ggtctattct tttgatttat aagggatttt gccgatttcg gcctattggt taaaaaatga 5040
gctgatttaa caaaaattta acgcgaattt taacaaaata ttaacgttta caatttaaat 5100
atttgcttat acaatcttcc tgtttttggg gcttttctga ttatcaaccg gggtacatat 5160
gattgacatg ctagttttac gattaccgtt catcgattct cttgtttgct ccagactctc 5220
aggcaatgac ctgatagcct ttgtagagac ctctcaaaaa tagctaccct ctccggcatg 5280
aatttatcag ctagaacggt tgaatatcat attgatggtg atttgactgt ctccggcctt 5340
tctcacccgt ttgaatcttt acctacacat tactcaggca ttgcatttaa aatatatgag 5400
ggttctaaaa atttttatcc ttgcgttgaa ataaaggctt ctcccgcaaa agtattacag 5460
ggtcataatg tttttggtac aaccgattta gctttatgct ctgaggcttt attgcttaat 5520
tttgctaatt ctttgccttg cctgtatgat ttattggatg ttggaatcgc ctgatgcggt 5580
attttctcct tacgcatctg tgcggtattt cacaccgcat atggtgcact ctcagtacaa 5640
tctgctctga tgccgcatag ttaagccagc cccgacaccc gccaacaccc gctgacgcgc 5700
cctgacgggc ttgtctgctc ccggcatccg cttacagaca agctgtgacc gtctccggga 5760
gctgcatgtg tcagaggttt tcaccgtcat caccgaaacg cgcgagacga aagggcctcg 5820
tgatacgcct atttttatag gttaatgtca tgataataat ggtttcttag acgtcaggtg 5880
gcacttttcg gggaaatgtg cgcggaaccc ctatttgttt atttttctaa atacattcaa 5940
atatgtatcc gctcatgaga caataaccct gataaatgct tcaataatat tgaaaaagga 6000
agagtatgag tattcaacat ttccgtgtcg cccttattcc cttttttgcg gcattttgcc 6060
ttcctgtttt tgctcaccca gaaacgctgg tgaaagtaaa agatgctgaa gatcagttgg 6120
gtgcacgagt gggttacatc gaactggatc tcaacagcgg taagatcctt gagagttttc 6180
gccccgaaga acgttttcca atgatgagca cttttaaagt tctgctatgt ggcgcggtat 6240
tatcccgtat tgacgccggg caagagcaac tcggtcgccg catacactat tctcagaatg 6300
acttggttga gtactcacca gtcacagaaa agcatcttac ggatggcatg acagtaagag 6360
aattatgcag tgctgccata accatgagtg ataacactgc ggccaactta cttctgacaa 6420
cgatcggagg accgaaggag ctaaccgctt ttttgcacaa catgggggat catgtaactc 6480
gccttgatcg ttgggaaccg gagctgaatg aagccatacc aaacgacgag cgtgacacca 6540
cgatgcctgt agcaatggca acaacgttgc gcaaactatt aactggcgaa ctacttactc 6600
tagcttcccg gcaacaatta atagactgga tggaggcgga taaagttgca ggaccacttc 6660
tgcgctcggc ccttccggct ggctggttta ttgctgataa atctggagcc ggtgagcgtg 6720
ggtctcgcgg tatcattgca gcactggggc cagatggtaa gccctcccgt atcgtagtta 6780
tctacacgac ggggagtcag gcaactatgg atgaacgaaa tagacagatc gctgagatag 6840
gtgcctcact gattaagcat tggtaactgt cagaccaagt ttactcatat atactttaga 6900
ttgatttaaa acttcatttt taatttaaaa ggatctaggt gaagatcctt tttgataatc 6960
tcatgaccaa aatcccttaa cgtgagtttt cgttccactg agcgtcagac ccc        7013

<210> 1423
<211> 3066
<212> DNA
<213> Artificial Sequence

<220> 
<223> extracted sequence from 3408

<400> 1423
cactgaaatc atggcctctt ggccaagatt gatagcttgt gcctgtccct gagtcccagt 60
ccatcacgag cagctggttt ctaagatgct atttcccgta taaagcatga gaccgtgact 120
tgccagcccc acagagcccc gcccttgtcc atcactggca tctggactcc agcctgggtt 180
ggggcaaaga gggaaatgag atcatgtcct aaccctgatc ctcttgtccc acagatatcc 240
agaaccctga ccctgccgtg taccagctga gagactctaa atccagtgac aagtctgtct 300
gcctatatta aggaacagag aaacaggaga atatgggcca aacaggatat ctgtggtaag 360
cagttcctgc cccggctcag ggccaagaac agttggaaca gcagaatatg ggccaaacag 420
gatatctgtg gtaagcagtt cctgccccgg ctcagggcca agaacagatg gtccccagat 480
gcggtcccgc cctcagcagt ttctagagaa ccatcagatg tttccagggt gccccaagga 540
cctgaaatga ccctgtgcct tatttgaact aaccaatcag ttcgcttctc gcttctgttc 600
gcgcgcttct gctccccgag ctctatataa gcagagctcg tttagtgaac cgtcagatcg 660
cctggagacg ccatccacgc tgttttgact tccatagaag gatcgactcg agtaatgcct 720
ctgggcctgc tgtggctggg cctggccctg ctgggcgccc tgcacgccca ggccggcgtg 780
caggtggaga caatctcccc aggcgacgga cgcacattcc ctaagcgggg ccagacctgc 840
gtggtgcact atacaggcat gctggaggat ggcaagaagt ttgacagctc ccgggataga 900
aacaagccat tcaagtttat gctgggcaag caggaagtga tcagaggctg ggaggagggc 960
gtggcccaga tgtctgtggg ccagagggcc aagctgacca tcagcccaga ctacgcctat 1020
ggagcaacag gccacccagg aatcatccca cctcacgcca ccctggtgtt cgatgtggag 1080
ctgctgaagc tgggcgaggg atccaacaca tcaaaagaga acccctttct gttcgcattg 1140
gaggccgtag tcatatctgt tggatccatg ggacttatta tctccctgtt gtgtgtgtac 1200
ttctggctgg aacggactat gcccaggatc cccacgctca agaatctgga agatctcgtc 1260
acagaatacc atggtaattt cagcgcctgg agcggagtct ctaagggtct ggccgaatcc 1320
ctccaacccg attattctga acggttgtgc ctcgtatccg aaataccacc aaaaggcggg 1380
gctctgggtg agggcccagg ggcgagtccg tgcaatcaac acagcccgta ttgggcccct 1440
ccttgttata cgttgaagcc cgaaactgga agcggagcga ctaacttttc tctgcttaaa 1500
caggcaggcg atgtcgagga aaaccctgga ccgactagta tggctctgcc tgtgacagct 1560
ctgctgctgc ctctggccct gctgctccat gccgccagac ccggatccca ggtacagctc 1620
gttcaatctg gggctgaagt aaaaaagcct ggagcgtctg taaaggtatc ttgcaaagcg 1680
agcggctaca cattcacaag ttatcacatc caatgggtga gacaggcccc aggacaacgc 1740
ttggagtgga tggggtggat ttaccctggc gacggcagca cacagtacaa tgagaaattt 1800
aaaggccggg tgactatcac tcgggacacc tccgccagca cggcttatat ggagcttagc 1860
agtttgagat ccgaagatac agcggtatat tactgcgcga gagaaggaac gtactacgct 1920
atggactatt ggggtcaggg cacaaccgtt acagtctcct ctgtggacag ctccggaggt 1980
gggggttcag gagggggtgg aagcggtggt ggtggcagta caagcgatat agtaatgacc 2040
caaaccccgc tctctctgag cgtcacgcca ggacaaccag catcaatctc ttgccgcagt 2100
agtcaatcca tcgttcactc taatggaaac acataccttg agtggtatct tcagaaacca 2160
ggtcagagcc ctcagctcct catctataaa gtctctaacc ggttctcagg tgttccggac 2220
cggttcagtg gttccggctc aggaacagac ttcaccttga agatcagtcg agtagaagcc 2280
gaagacgtgg gtgtatatta ttgctttcag ggttcccacg ttccgcgcac cttcggcggc 2340
gggaccaaag ttgagatcaa agctagcgcc aagcctacca ccacccctgc ccctagacct 2400
ccaacacccg ccccaacaat cgccagccag cctctgtctc tgaggcccga ggcttgtaga 2460
ccagctgctg gcggagccgt acacaccaga ggactggatt tcgcctgcga cttttgggtg 2520
ctggtggtgg ttggtggagt cctggcttgc tatagcttgc tagtaacagt ggcctttatt 2580
attttctggg tgatgcataa gcttaattga gcggccgcgc tttatttgtg aaatttgtga 2640
tgctattgct ttatttgtaa ccattataag ctgcaataaa caagttaaca acaacaattg 2700
cattcatttt atgtttcagg ttcaggggga gatgtgggag gttttttaaa gctcaccgat 2760
tttgattctc aaacaaatgt gtcacaaagt aaggattctg atgtgtatat cacagacaaa 2820
actgtgctag acatgaggtc tatggacttc aagagcaaca gtgctgtggc ctggagcaac 2880
aaatctgact ttgcatgtgc aaacgccttc aacaacagca ttattccaga agacaccttc 2940
ttccccagcc caggtaaggg cagctttggt gccttcgcag gctgtttcct tgcttcagga 3000
atggccaggt tctgcccaga gctctggtca atgatgtcta aaactcctct gattggtggt 3060
ctcggc                                                            3066

<210> 1424
<211> 7553
<212> DNA
<213> Artificial Sequence

<220> 
<223> TRAC-T1 guide specific AAV

<400> 1424
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtagc 1020
ggccgcctat taaataaaag aataagcagt attattaagt agccctgcat ttcaggtttc 1080
cttgagtggc aggccaggcc tggccgtgaa cgttcactga aatcatggcc tcttggccaa 1140
gattgatagc ttgtgcctgt ccctgagtcc cagtccatca cgagcagctg gtttctaaga 1200
tgctatttcc cgtataaagc atgagaccgt gacttgccag ccccacagag ccccgccctt 1260
gtccatcact ggcatctgga ctccagcctg ggttggggca aagagggaaa tgagatcatg 1320
tcctaaccct gatcctcttg tcccacagat atccagaacc ctgaccctgc cattaagtag 1380
aacagagaaa caggagaata tgggccaaac aggatatctg tggtaagcag ttcctgcccc 1440
ggctcagggc caagaacagt tggaacagca gaatatgggc caaacaggat atctgtggta 1500
agcagttcct gccccggctc agggccaaga acagatggtc cccagatgcg gtcccgccct 1560
cagcagtttc tagagaacca tcagatgttt ccagggtgcc ccaaggacct gaaatgaccc 1620
tgtgccttat ttgaactaac caatcagttc gcttctcgct tctgttcgcg cgcttctgct 1680
ccccgagctc tatataagca gagctcgttt agtgaaccgt cagatcgcct ggagacgcca 1740
tccacgctgt tttgacttcc atagaaggat cgactcgagt aatgcctctg ggcctgctgt 1800
ggctgggcct ggccctgctg ggcgccctgc acgcccaggc cggcgtgcag gtggagacaa 1860
tctccccagg cgacggacgc acattcccta agcggggcca gacctgcgtg gtgcactata 1920
caggcatgct ggaggatggc aagaagtttg acagctcccg ggatagaaac aagccattca 1980
agtttatgct gggcaagcag gaagtgatca gaggctggga ggagggcgtg gcccagatgt 2040
ctgtgggcca gagggccaag ctgaccatca gcccagacta cgcctatgga gcaacaggcc 2100
acccaggaat catcccacct cacgccaccc tggtgttcga tgtggagctg ctgaagctgg 2160
gcgagggatc caacacatca aaagagaacc cctttctgtt cgcattggag gccgtagtca 2220
tatctgttgg atccatggga cttattatct ccctgttgtg tgtgtacttc tggctggaac 2280
ggactatgcc caggatcccc acgctcaaga atctggaaga tctcgtcaca gaataccatg 2340
gtaatttcag cgcctggagc ggagtctcta agggtctggc cgaatccctc caacccgatt 2400
attctgaacg gttgtgcctc gtatccgaaa taccaccaaa aggcggggct ctgggtgagg 2460
gcccaggggc gagtccgtgc aatcaacaca gcccgtattg ggcccctcct tgttatacgt 2520
tgaagcccga aactggaagc ggagcgacta acttttctct gcttaaacag gcaggcgatg 2580
tcgaggaaaa ccctggaccg actagtatgg ctctgcctgt gacagctctg ctgctgcctc 2640
tggccctgct gctccatgcc gccagacccg gatcccaggt acagctcgtt caatctgggg 2700
ctgaagtaaa aaagcctgga gcgtctgtaa aggtatcttg caaagcgagc ggctacacat 2760
tcacaagtta tcacatccaa tgggtgagac aggccccagg acaacgcttg gagtggatgg 2820
ggtggattta ccctggcgac ggcagcacac agtacaatga gaaatttaaa ggccgggtga 2880
ctatcactcg ggacacctcc gccagcacgg cttatatgga gcttagcagt ttgagatccg 2940
aagatacagc ggtatattac tgcgcgagag aaggaacgta ctacgctatg gactattggg 3000
gtcagggcac aaccgttaca gtctcctctg tggacagctc cggaggtggg ggttcaggag 3060
ggggtggaag cggtggtggt ggcagtacaa gcgatatagt aatgacccaa accccgctct 3120
ctctgagcgt cacgccagga caaccagcat caatctcttg ccgcagtagt caatccatcg 3180
ttcactctaa tggaaacaca taccttgagt ggtatcttca gaaaccaggt cagagccctc 3240
agctcctcat ctataaagtc tctaaccggt tctcaggtgt tccggaccgg ttcagtggtt 3300
ccggctcagg aacagacttc accttgaaga tcagtcgagt agaagccgaa gacgtgggtg 3360
tatattattg ctttcagggt tcccacgttc cgcgcacctt cggcggcggg accaaagttg 3420
agatcaaagc tagcgccaag cctaccacca cccctgcccc tagacctcca acacccgccc 3480
caacaatcgc cagccagcct ctgtctctga ggcccgaggc ttgtagacca gctgctggcg 3540
gagccgtaca caccagagga ctggatttcg cctgcgactt ttgggtgctg gtggtggttg 3600
gtggagtcct ggcttgctat agcttgctag taacagtggc ctttattatt ttctgggtga 3660
tgcataggag taagaggagc aggctcctgc acagtgacta catgaacatg actccccgcc 3720
gccccgggcc cacccgcaag cattaccagc cctatgcccc accacgcgac ttcgcagcct 3780
atcgctcccg ggtgaagttc agcagaagcg ccgacgcccc tgcctaccag cagggccaga 3840
atcagctgta caacgagctg aacctgggca gaagggaaga gtacgacgtc ctggataagc 3900
ggagaggccg ggaccctgag atgggcggca agcctcggcg gaagaacccc caggaaggcc 3960
tgtataacga actgcagaaa gacaagatgg ccgaggccta cagcgagatc ggcatgaagg 4020
gcgagcggag gcggggcaag ggccacgacg gcctgtatca gggcctgtcc accgccacca 4080
aggataccta cgacgccctg cacatgcagg ccctgccccc aaggaagctt tgagctttat 4140
ttgtgaaatt tgtgatgcta ttgctttatt tgtaaccatt ataagctgca ataaacaagt 4200
taacaacaac aattgcattc attttatgtt tcaggttcag ggggagatgt gggaggtttt 4260
ttaaagcagt atatcagctg agagactcta aatccagtga caagtctgtc tgcctattca 4320
ccgattttga ttctcaaaca aatgtgtcac aaagtaagga ttctgatgtg tatatcacag 4380
acaaaactgt gctagacatg aggtctatgg acttcaagag caacagtgct gtggcctgga 4440
gcaacaaatc tgactttgca tgtgcaaacg ccttcaacaa cagcattatt ccagaagaca 4500
ccttcttccc cagcccaggt aagggcagct ttggtgcctt cgcaggctgt ttccttgctt 4560
caggaatggc caggttctgc ccagagctct ggtcaatgat gtctaaaact cctctgattg 4620
gtggtctcgg cgcggccgct acgtagataa gtagcatggc gggttaatca ttaactacaa 4680
ggaaccccta gtgatggagt tggccactcc ctctctgcgc gctcgctcgc tcactgaggc 4740
cgggcgacca aaggtcgccc gacgcccggg ctttgcccgg gcggcctcag tgagcgagcg 4800
agcgcgccag ctggcgtaat agcgaagagg cccgcaccga tcgcccttcc caacagttgc 4860
gcagcctgaa tggcgaatgg cgattccgtt gcaatggctg gcggtaatat tgttctggat 4920
attaccagca aggccgatag tttgagttct tctactcagg caagtgatgt tattactaat 4980
caaagaagta ttgcgacaac ggttaatttg cgtgatggac agactctttt actcggtggc 5040
ctcactgatt ataaaaacac ttctcaggat tctggcgtac cgttcctgtc taaaatccct 5100
ttaatcggcc tcctgtttag ctcccgctct gattctaacg aggaaagcac gttatacgtg 5160
ctcgtcaaag caaccatagt acgcgccctg tagcggcgca ttaagcgcgg cgggtgtggt 5220
ggttacgcgc agcgtgaccg ctacacttgc cagcgcccta gcgcccgctc ctttcgcttt 5280
cttcccttcc tttctcgcca cgttcgccgg ctttccccgt caagctctaa atcgggggct 5340
ccctttaggg ttccgattta gtgctttacg gcacctcgac cccaaaaaac ttgattaggg 5400
tgatggttca cgtagtgggc catcgccctg atagacggtt tttcgccctt tgacgttgga 5460
gtccacgttc tttaatagtg gactcttgtt ccaaactgga acaacactca accctatctc 5520
ggtctattct tttgatttat aagggatttt gccgatttcg gcctattggt taaaaaatga 5580
gctgatttaa caaaaattta acgcgaattt taacaaaata ttaacgttta caatttaaat 5640
atttgcttat acaatcttcc tgtttttggg gcttttctga ttatcaaccg gggtacatat 5700
gattgacatg ctagttttac gattaccgtt catcgattct cttgtttgct ccagactctc 5760
aggcaatgac ctgatagcct ttgtagagac ctctcaaaaa tagctaccct ctccggcatg 5820
aatttatcag ctagaacggt tgaatatcat attgatggtg atttgactgt ctccggcctt 5880
tctcacccgt ttgaatcttt acctacacat tactcaggca ttgcatttaa aatatatgag 5940
ggttctaaaa atttttatcc ttgcgttgaa ataaaggctt ctcccgcaaa agtattacag 6000
ggtcataatg tttttggtac aaccgattta gctttatgct ctgaggcttt attgcttaat 6060
tttgctaatt ctttgccttg cctgtatgat ttattggatg ttggaatcgc ctgatgcggt 6120
attttctcct tacgcatctg tgcggtattt cacaccgcat atggtgcact ctcagtacaa 6180
tctgctctga tgccgcatag ttaagccagc cccgacaccc gccaacaccc gctgacgcgc 6240
cctgacgggc ttgtctgctc ccggcatccg cttacagaca agctgtgacc gtctccggga 6300
gctgcatgtg tcagaggttt tcaccgtcat caccgaaacg cgcgagacga aagggcctcg 6360
tgatacgcct atttttatag gttaatgtca tgataataat ggtttcttag acgtcaggtg 6420
gcacttttcg gggaaatgtg cgcggaaccc ctatttgttt atttttctaa atacattcaa 6480
atatgtatcc gctcatgaga caataaccct gataaatgct tcaataatat tgaaaaagga 6540
agagtatgag tattcaacat ttccgtgtcg cccttattcc cttttttgcg gcattttgcc 6600
ttcctgtttt tgctcaccca gaaacgctgg tgaaagtaaa agatgctgaa gatcagttgg 6660
gtgcacgagt gggttacatc gaactggatc tcaacagcgg taagatcctt gagagttttc 6720
gccccgaaga acgttttcca atgatgagca cttttaaagt tctgctatgt ggcgcggtat 6780
tatcccgtat tgacgccggg caagagcaac tcggtcgccg catacactat tctcagaatg 6840
acttggttga gtactcacca gtcacagaaa agcatcttac ggatggcatg acagtaagag 6900
aattatgcag tgctgccata accatgagtg ataacactgc ggccaactta cttctgacaa 6960
cgatcggagg accgaaggag ctaaccgctt ttttgcacaa catgggggat catgtaactc 7020
gccttgatcg ttgggaaccg gagctgaatg aagccatacc aaacgacgag cgtgacacca 7080
cgatgcctgt agcaatggca acaacgttgc gcaaactatt aactggcgaa ctacttactc 7140
tagcttcccg gcaacaatta atagactgga tggaggcgga taaagttgca ggaccacttc 7200
tgcgctcggc ccttccggct ggctggttta ttgctgataa atctggagcc ggtgagcgtg 7260
ggtctcgcgg tatcattgca gcactggggc cagatggtaa gccctcccgt atcgtagtta 7320
tctacacgac ggggagtcag gcaactatgg atgaacgaaa tagacagatc gctgagatag 7380
gtgcctcact gattaagcat tggtaactgt cagaccaagt ttactcatat atactttaga 7440
ttgatttaaa acttcatttt taatttaaaa ggatctaggt gaagatcctt tttgataatc 7500
tcatgaccaa aatcccttaa cgtgagtttt cgttccactg agcgtcagac ccc        7553

<210> 1425
<211> 3606
<212> DNA
<213> Artificial Sequence

<220> 
<223> extracted sequence from 3409

<400> 1425
cctattaaat aaaagaataa gcagtattat taagtagccc tgcatttcag gtttccttga 60
gtggcaggcc aggcctggcc gtgaacgttc actgaaatca tggcctcttg gccaagattg 120
atagcttgtg cctgtccctg agtcccagtc catcacgagc agctggtttc taagatgcta 180
tttcccgtat aaagcatgag accgtgactt gccagcccca cagagccccg cccttgtcca 240
tcactggcat ctggactcca gcctgggttg gggcaaagag ggaaatgaga tcatgtccta 300
accctgatcc tcttgtccca cagatatcca gaaccctgac cctgccatta agtagaacag 360
agaaacagga gaatatgggc caaacaggat atctgtggta agcagttcct gccccggctc 420
agggccaaga acagttggaa cagcagaata tgggccaaac aggatatctg tggtaagcag 480
ttcctgcccc ggctcagggc caagaacaga tggtccccag atgcggtccc gccctcagca 540
gtttctagag aaccatcaga tgtttccagg gtgccccaag gacctgaaat gaccctgtgc 600
cttatttgaa ctaaccaatc agttcgcttc tcgcttctgt tcgcgcgctt ctgctccccg 660
agctctatat aagcagagct cgtttagtga accgtcagat cgcctggaga cgccatccac 720
gctgttttga cttccataga aggatcgact cgagtaatgc ctctgggcct gctgtggctg 780
ggcctggccc tgctgggcgc cctgcacgcc caggccggcg tgcaggtgga gacaatctcc 840
ccaggcgacg gacgcacatt ccctaagcgg ggccagacct gcgtggtgca ctatacaggc 900
atgctggagg atggcaagaa gtttgacagc tcccgggata gaaacaagcc attcaagttt 960
atgctgggca agcaggaagt gatcagaggc tgggaggagg gcgtggccca gatgtctgtg 1020
ggccagaggg ccaagctgac catcagccca gactacgcct atggagcaac aggccaccca 1080
ggaatcatcc cacctcacgc caccctggtg ttcgatgtgg agctgctgaa gctgggcgag 1140
ggatccaaca catcaaaaga gaaccccttt ctgttcgcat tggaggccgt agtcatatct 1200
gttggatcca tgggacttat tatctccctg ttgtgtgtgt acttctggct ggaacggact 1260
atgcccagga tccccacgct caagaatctg gaagatctcg tcacagaata ccatggtaat 1320
ttcagcgcct ggagcggagt ctctaagggt ctggccgaat ccctccaacc cgattattct 1380
gaacggttgt gcctcgtatc cgaaatacca ccaaaaggcg gggctctggg tgagggccca 1440
ggggcgagtc cgtgcaatca acacagcccg tattgggccc ctccttgtta tacgttgaag 1500
cccgaaactg gaagcggagc gactaacttt tctctgctta aacaggcagg cgatgtcgag 1560
gaaaaccctg gaccgactag tatggctctg cctgtgacag ctctgctgct gcctctggcc 1620
ctgctgctcc atgccgccag acccggatcc caggtacagc tcgttcaatc tggggctgaa 1680
gtaaaaaagc ctggagcgtc tgtaaaggta tcttgcaaag cgagcggcta cacattcaca 1740
agttatcaca tccaatgggt gagacaggcc ccaggacaac gcttggagtg gatggggtgg 1800
atttaccctg gcgacggcag cacacagtac aatgagaaat ttaaaggccg ggtgactatc 1860
actcgggaca cctccgccag cacggcttat atggagctta gcagtttgag atccgaagat 1920
acagcggtat attactgcgc gagagaagga acgtactacg ctatggacta ttggggtcag 1980
ggcacaaccg ttacagtctc ctctgtggac agctccggag gtgggggttc aggagggggt 2040
ggaagcggtg gtggtggcag tacaagcgat atagtaatga cccaaacccc gctctctctg 2100
agcgtcacgc caggacaacc agcatcaatc tcttgccgca gtagtcaatc catcgttcac 2160
tctaatggaa acacatacct tgagtggtat cttcagaaac caggtcagag ccctcagctc 2220
ctcatctata aagtctctaa ccggttctca ggtgttccgg accggttcag tggttccggc 2280
tcaggaacag acttcacctt gaagatcagt cgagtagaag ccgaagacgt gggtgtatat 2340
tattgctttc agggttccca cgttccgcgc accttcggcg gcgggaccaa agttgagatc 2400
aaagctagcg ccaagcctac caccacccct gcccctagac ctccaacacc cgccccaaca 2460
atcgccagcc agcctctgtc tctgaggccc gaggcttgta gaccagctgc tggcggagcc 2520
gtacacacca gaggactgga tttcgcctgc gacttttggg tgctggtggt ggttggtgga 2580
gtcctggctt gctatagctt gctagtaaca gtggccttta ttattttctg ggtgatgcat 2640
aggagtaaga ggagcaggct cctgcacagt gactacatga acatgactcc ccgccgcccc 2700
gggcccaccc gcaagcatta ccagccctat gccccaccac gcgacttcgc agcctatcgc 2760
tcccgggtga agttcagcag aagcgccgac gcccctgcct accagcaggg ccagaatcag 2820
ctgtacaacg agctgaacct gggcagaagg gaagagtacg acgtcctgga taagcggaga 2880
ggccgggacc ctgagatggg cggcaagcct cggcggaaga acccccagga aggcctgtat 2940
aacgaactgc agaaagacaa gatggccgag gcctacagcg agatcggcat gaagggcgag 3000
cggaggcggg gcaagggcca cgacggcctg tatcagggcc tgtccaccgc caccaaggat 3060
acctacgacg ccctgcacat gcaggccctg cccccaagga agctttgagc tttatttgtg 3120
aaatttgtga tgctattgct ttatttgtaa ccattataag ctgcaataaa caagttaaca 3180
acaacaattg cattcatttt atgtttcagg ttcaggggga gatgtgggag gttttttaaa 3240
gcagtatatc agctgagaga ctctaaatcc agtgacaagt ctgtctgcct attcaccgat 3300
tttgattctc aaacaaatgt gtcacaaagt aaggattctg atgtgtatat cacagacaaa 3360
actgtgctag acatgaggtc tatggacttc aagagcaaca gtgctgtggc ctggagcaac 3420
aaatctgact ttgcatgtgc aaacgccttc aacaacagca ttattccaga agacaccttc 3480
ttccccagcc caggtaaggg cagctttggt gccttcgcag gctgtttcct tgcttcagga 3540
atggccaggt tctgcccaga gctctggtca atgatgtcta aaactcctct gattggtggt 3600
ctcggc                                                            3606

<210> 1426
<211> 7094
<212> DNA
<213> Artificial Sequence

<220> 
<223> TRAC-T1 guide specific AAV

<400> 1426
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtagc 1020
ggccgcctat taaataaaag aataagcagt attattaagt agccctgcat ttcaggtttc 1080
cttgagtggc aggccaggcc tggccgtgaa cgttcactga aatcatggcc tcttggccaa 1140
gattgatagc ttgtgcctgt ccctgagtcc cagtccatca cgagcagctg gtttctaaga 1200
tgctatttcc cgtataaagc atgagaccgt gacttgccag ccccacagag ccccgccctt 1260
gtccatcact ggcatctgga ctccagcctg ggttggggca aagagggaaa tgagatcatg 1320
tcctaaccct gatcctcttg tcccacagat atccagaacc ctgaccctgc cattaagtag 1380
aacagagaaa caggagaata tgggccaaac aggatatctg tggtaagcag ttcctgcccc 1440
ggctcagggc caagaacagt tggaacagca gaatatgggc caaacaggat atctgtggta 1500
agcagttcct gccccggctc agggccaaga acagatggtc cccagatgcg gtcccgccct 1560
cagcagtttc tagagaacca tcagatgttt ccagggtgcc ccaaggacct gaaatgaccc 1620
tgtgccttat ttgaactaac caatcagttc gcttctcgct tctgttcgcg cgcttctgct 1680
ccccgagctc tatataagca gagctcgttt agtgaaccgt cagatcgcct ggagacgcca 1740
tccacgctgt tttgacttcc atagaaggat cgactcgagt aatgcctctg ggcctgctgt 1800
ggctgggcct ggccctgctg ggcgccctgc acgcccaggc cggcgtgcag gtggagacaa 1860
tctccccagg cgacggacgc acattcccta agcggggcca gacctgcgtg gtgcactata 1920
caggcatgct ggaggatggc aagaagtttg acagctcccg ggatagaaac aagccattca 1980
agtttatgct gggcaagcag gaagtgatca gaggctggga ggagggcgtg gcccagatgt 2040
ctgtgggcca gagggccaag ctgaccatca gcccagacta cgcctatgga gcaacaggcc 2100
acccaggaat catcccacct cacgccaccc tggtgttcga tgtggagctg ctgaagctgg 2160
gcgagggatc caacacatca aaagagaacc cctttctgtt cgcattggag gccgtagtca 2220
tatctgttgg atccatggga cttattatct ccctgttgtg tgtgtacttc tggctggaac 2280
ggactatgcc caggatcccc acgctcaaga atctggaaga tctcgtcaca gaataccatg 2340
gtaatttcag cgcctggagc ggagtctcta agggtctggc cgaatccctc caacccgatt 2400
attctgaacg gttgtgcctc gtatccgaaa taccaccaaa aggcggggct ctgggtgagg 2460
gcccaggggc gagtccgtgc aatcaacaca gcccgtattg ggcccctcct tgttatacgt 2520
tgaagcccga aactggaagc ggagcgacta acttttctct gcttaaacag gcaggcgatg 2580
tcgaggaaaa ccctggaccg actagtatgg ctctgcctgt gacagctctg ctgctgcctc 2640
tggccctgct gctccatgcc gccagacccg gatcccaggt acagctcgtt caatctgggg 2700
ctgaagtaaa aaagcctgga gcgtctgtaa aggtatcttg caaagcgagc ggctacacat 2760
tcacaagtta tcacatccaa tgggtgagac aggccccagg acaacgcttg gagtggatgg 2820
ggtggattta ccctggcgac ggcagcacac agtacaatga gaaatttaaa ggccgggtga 2880
ctatcactcg ggacacctcc gccagcacgg cttatatgga gcttagcagt ttgagatccg 2940
aagatacagc ggtatattac tgcgcgagag aaggaacgta ctacgctatg gactattggg 3000
gtcagggcac aaccgttaca gtctcctctg tggacagctc cggaggtggg ggttcaggag 3060
ggggtggaag cggtggtggt ggcagtacaa gcgatatagt aatgacccaa accccgctct 3120
ctctgagcgt cacgccagga caaccagcat caatctcttg ccgcagtagt caatccatcg 3180
ttcactctaa tggaaacaca taccttgagt ggtatcttca gaaaccaggt cagagccctc 3240
agctcctcat ctataaagtc tctaaccggt tctcaggtgt tccggaccgg ttcagtggtt 3300
ccggctcagg aacagacttc accttgaaga tcagtcgagt agaagccgaa gacgtgggtg 3360
tatattattg ctttcagggt tcccacgttc cgcgcacctt cggcggcggg accaaagttg 3420
agatcaaagc tagcgccaag cctaccacca cccctgcccc tagacctcca acacccgccc 3480
caacaatcgc cagccagcct ctgtctctga ggcccgaggc ttgtagacca gctgctggcg 3540
gagccgtaca caccagagga ctggatttcg cctgcgactt ttgggtgctg gtggtggttg 3600
gtggagtcct ggcttgctat agcttgctag taacagtggc ctttattatt ttctgggtga 3660
tgcataagct ttgagcttta tttgtgaaat ttgtgatgct attgctttat ttgtaaccat 3720
tataagctgc aataaacaag ttaacaacaa caattgcatt cattttatgt ttcaggttca 3780
gggggagatg tgggaggttt tttaaagcag tatatcagct gagagactct aaatccagtg 3840
acaagtctgt ctgcctattc accgattttg attctcaaac aaatgtgtca caaagtaagg 3900
attctgatgt gtatatcaca gacaaaactg tgctagacat gaggtctatg gacttcaaga 3960
gcaacagtgc tgtggcctgg agcaacaaat ctgactttgc atgtgcaaac gccttcaaca 4020
acagcattat tccagaagac accttcttcc ccagcccagg taagggcagc tttggtgcct 4080
tcgcaggctg tttccttgct tcaggaatgg ccaggttctg cccagagctc tggtcaatga 4140
tgtctaaaac tcctctgatt ggtggtctcg gcgcggccgc tacgtagata agtagcatgg 4200
cgggttaatc attaactaca aggaacccct agtgatggag ttggccactc cctctctgcg 4260
cgctcgctcg ctcactgagg ccgggcgacc aaaggtcgcc cgacgcccgg gctttgcccg 4320
ggcggcctca gtgagcgagc gagcgcgcca gctggcgtaa tagcgaagag gcccgcaccg 4380
atcgcccttc ccaacagttg cgcagcctga atggcgaatg gcgattccgt tgcaatggct 4440
ggcggtaata ttgttctgga tattaccagc aaggccgata gtttgagttc ttctactcag 4500
gcaagtgatg ttattactaa tcaaagaagt attgcgacaa cggttaattt gcgtgatgga 4560
cagactcttt tactcggtgg cctcactgat tataaaaaca cttctcagga ttctggcgta 4620
ccgttcctgt ctaaaatccc tttaatcggc ctcctgttta gctcccgctc tgattctaac 4680
gaggaaagca cgttatacgt gctcgtcaaa gcaaccatag tacgcgccct gtagcggcgc 4740
attaagcgcg gcgggtgtgg tggttacgcg cagcgtgacc gctacacttg ccagcgccct 4800
agcgcccgct cctttcgctt tcttcccttc ctttctcgcc acgttcgccg gctttccccg 4860
tcaagctcta aatcgggggc tccctttagg gttccgattt agtgctttac ggcacctcga 4920
ccccaaaaaa cttgattagg gtgatggttc acgtagtggg ccatcgccct gatagacggt 4980
ttttcgccct ttgacgttgg agtccacgtt ctttaatagt ggactcttgt tccaaactgg 5040
aacaacactc aaccctatct cggtctattc ttttgattta taagggattt tgccgatttc 5100
ggcctattgg ttaaaaaatg agctgattta acaaaaattt aacgcgaatt ttaacaaaat 5160
attaacgttt acaatttaaa tatttgctta tacaatcttc ctgtttttgg ggcttttctg 5220
attatcaacc ggggtacata tgattgacat gctagtttta cgattaccgt tcatcgattc 5280
tcttgtttgc tccagactct caggcaatga cctgatagcc tttgtagaga cctctcaaaa 5340
atagctaccc tctccggcat gaatttatca gctagaacgg ttgaatatca tattgatggt 5400
gatttgactg tctccggcct ttctcacccg tttgaatctt tacctacaca ttactcaggc 5460
attgcattta aaatatatga gggttctaaa aatttttatc cttgcgttga aataaaggct 5520
tctcccgcaa aagtattaca gggtcataat gtttttggta caaccgattt agctttatgc 5580
tctgaggctt tattgcttaa ttttgctaat tctttgcctt gcctgtatga tttattggat 5640
gttggaatcg cctgatgcgg tattttctcc ttacgcatct gtgcggtatt tcacaccgca 5700
tatggtgcac tctcagtaca atctgctctg atgccgcata gttaagccag ccccgacacc 5760
cgccaacacc cgctgacgcg ccctgacggg cttgtctgct cccggcatcc gcttacagac 5820
aagctgtgac cgtctccggg agctgcatgt gtcagaggtt ttcaccgtca tcaccgaaac 5880
gcgcgagacg aaagggcctc gtgatacgcc tatttttata ggttaatgtc atgataataa 5940
tggtttctta gacgtcaggt ggcacttttc ggggaaatgt gcgcggaacc cctatttgtt 6000
tatttttcta aatacattca aatatgtatc cgctcatgag acaataaccc tgataaatgc 6060
ttcaataata ttgaaaaagg aagagtatga gtattcaaca tttccgtgtc gcccttattc 6120
ccttttttgc ggcattttgc cttcctgttt ttgctcaccc agaaacgctg gtgaaagtaa 6180
aagatgctga agatcagttg ggtgcacgag tgggttacat cgaactggat ctcaacagcg 6240
gtaagatcct tgagagtttt cgccccgaag aacgttttcc aatgatgagc acttttaaag 6300
ttctgctatg tggcgcggta ttatcccgta ttgacgccgg gcaagagcaa ctcggtcgcc 6360
gcatacacta ttctcagaat gacttggttg agtactcacc agtcacagaa aagcatctta 6420
cggatggcat gacagtaaga gaattatgca gtgctgccat aaccatgagt gataacactg 6480
cggccaactt acttctgaca acgatcggag gaccgaagga gctaaccgct tttttgcaca 6540
acatggggga tcatgtaact cgccttgatc gttgggaacc ggagctgaat gaagccatac 6600
caaacgacga gcgtgacacc acgatgcctg tagcaatggc aacaacgttg cgcaaactat 6660
taactggcga actacttact ctagcttccc ggcaacaatt aatagactgg atggaggcgg 6720
ataaagttgc aggaccactt ctgcgctcgg cccttccggc tggctggttt attgctgata 6780
aatctggagc cggtgagcgt gggtctcgcg gtatcattgc agcactgggg ccagatggta 6840
agccctcccg tatcgtagtt atctacacga cggggagtca ggcaactatg gatgaacgaa 6900
atagacagat cgctgagata ggtgcctcac tgattaagca ttggtaactg tcagaccaag 6960
tttactcata tatactttag attgatttaa aacttcattt ttaatttaaa aggatctagg 7020
tgaagatcct ttttgataat ctcatgacca aaatccctta acgtgagttt tcgttccact 7080
gagcgtcaga cccc                                                   7094

<210> 1427
<211> 3147
<212> DNA
<213> Artificial Sequence

<220> 
<223> extracted sequence from 3410

<400> 1427
cctattaaat aaaagaataa gcagtattat taagtagccc tgcatttcag gtttccttga 60
gtggcaggcc aggcctggcc gtgaacgttc actgaaatca tggcctcttg gccaagattg 120
atagcttgtg cctgtccctg agtcccagtc catcacgagc agctggtttc taagatgcta 180
tttcccgtat aaagcatgag accgtgactt gccagcccca cagagccccg cccttgtcca 240
tcactggcat ctggactcca gcctgggttg gggcaaagag ggaaatgaga tcatgtccta 300
accctgatcc tcttgtccca cagatatcca gaaccctgac cctgccatta agtagaacag 360
agaaacagga gaatatgggc caaacaggat atctgtggta agcagttcct gccccggctc 420
agggccaaga acagttggaa cagcagaata tgggccaaac aggatatctg tggtaagcag 480
ttcctgcccc ggctcagggc caagaacaga tggtccccag atgcggtccc gccctcagca 540
gtttctagag aaccatcaga tgtttccagg gtgccccaag gacctgaaat gaccctgtgc 600
cttatttgaa ctaaccaatc agttcgcttc tcgcttctgt tcgcgcgctt ctgctccccg 660
agctctatat aagcagagct cgtttagtga accgtcagat cgcctggaga cgccatccac 720
gctgttttga cttccataga aggatcgact cgagtaatgc ctctgggcct gctgtggctg 780
ggcctggccc tgctgggcgc cctgcacgcc caggccggcg tgcaggtgga gacaatctcc 840
ccaggcgacg gacgcacatt ccctaagcgg ggccagacct gcgtggtgca ctatacaggc 900
atgctggagg atggcaagaa gtttgacagc tcccgggata gaaacaagcc attcaagttt 960
atgctgggca agcaggaagt gatcagaggc tgggaggagg gcgtggccca gatgtctgtg 1020
ggccagaggg ccaagctgac catcagccca gactacgcct atggagcaac aggccaccca 1080
ggaatcatcc cacctcacgc caccctggtg ttcgatgtgg agctgctgaa gctgggcgag 1140
ggatccaaca catcaaaaga gaaccccttt ctgttcgcat tggaggccgt agtcatatct 1200
gttggatcca tgggacttat tatctccctg ttgtgtgtgt acttctggct ggaacggact 1260
atgcccagga tccccacgct caagaatctg gaagatctcg tcacagaata ccatggtaat 1320
ttcagcgcct ggagcggagt ctctaagggt ctggccgaat ccctccaacc cgattattct 1380
gaacggttgt gcctcgtatc cgaaatacca ccaaaaggcg gggctctggg tgagggccca 1440
ggggcgagtc cgtgcaatca acacagcccg tattgggccc ctccttgtta tacgttgaag 1500
cccgaaactg gaagcggagc gactaacttt tctctgctta aacaggcagg cgatgtcgag 1560
gaaaaccctg gaccgactag tatggctctg cctgtgacag ctctgctgct gcctctggcc 1620
ctgctgctcc atgccgccag acccggatcc caggtacagc tcgttcaatc tggggctgaa 1680
gtaaaaaagc ctggagcgtc tgtaaaggta tcttgcaaag cgagcggcta cacattcaca 1740
agttatcaca tccaatgggt gagacaggcc ccaggacaac gcttggagtg gatggggtgg 1800
atttaccctg gcgacggcag cacacagtac aatgagaaat ttaaaggccg ggtgactatc 1860
actcgggaca cctccgccag cacggcttat atggagctta gcagtttgag atccgaagat 1920
acagcggtat attactgcgc gagagaagga acgtactacg ctatggacta ttggggtcag 1980
ggcacaaccg ttacagtctc ctctgtggac agctccggag gtgggggttc aggagggggt 2040
ggaagcggtg gtggtggcag tacaagcgat atagtaatga cccaaacccc gctctctctg 2100
agcgtcacgc caggacaacc agcatcaatc tcttgccgca gtagtcaatc catcgttcac 2160
tctaatggaa acacatacct tgagtggtat cttcagaaac caggtcagag ccctcagctc 2220
ctcatctata aagtctctaa ccggttctca ggtgttccgg accggttcag tggttccggc 2280
tcaggaacag acttcacctt gaagatcagt cgagtagaag ccgaagacgt gggtgtatat 2340
tattgctttc agggttccca cgttccgcgc accttcggcg gcgggaccaa agttgagatc 2400
aaagctagcg ccaagcctac caccacccct gcccctagac ctccaacacc cgccccaaca 2460
atcgccagcc agcctctgtc tctgaggccc gaggcttgta gaccagctgc tggcggagcc 2520
gtacacacca gaggactgga tttcgcctgc gacttttggg tgctggtggt ggttggtgga 2580
gtcctggctt gctatagctt gctagtaaca gtggccttta ttattttctg ggtgatgcat 2640
aagctttgag ctttatttgt gaaatttgtg atgctattgc tttatttgta accattataa 2700
gctgcaataa acaagttaac aacaacaatt gcattcattt tatgtttcag gttcaggggg 2760
agatgtggga ggttttttaa agcagtatat cagctgagag actctaaatc cagtgacaag 2820
tctgtctgcc tattcaccga ttttgattct caaacaaatg tgtcacaaag taaggattct 2880
gatgtgtata tcacagacaa aactgtgcta gacatgaggt ctatggactt caagagcaac 2940
agtgctgtgg cctggagcaa caaatctgac tttgcatgtg caaacgcctt caacaacagc 3000
attattccag aagacacctt cttccccagc ccaggtaagg gcagctttgg tgccttcgca 3060
ggctgtttcc ttgcttcagg aatggccagg ttctgcccag agctctggtc aatgatgtct 3120
aaaactcctc tgattggtgg tctcggc                                     3147

<210> 1428
<211> 20
<212> RNA
<213> Artificial Sequence

<220> 
<223> gRNA_2  (human TRAC editing)

<400> 1428
tggatttaga gtctctcagc                                             20

<210> 1429
<211> 20
<212> RNA
<213> Artificial Sequence

<220> 
<223> gRNA_3  (human TRAC editing)

<400> 1429
ctctcagctg gtacacggca                                             20

<210> 1430
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> IGRP epitope

<400> 1430
Gln Leu Tyr His Phe Leu Gln Ile Pro Thr His Glu Glu His Leu Phe
 1               5                  10                  15      
Tyr Val Leu Ser
            20

<210> 1431
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> IGRP epitope

<400> 1431
Lys Trp Cys Ala Asn Pro Asp Trp Ile His Ile Asp Thr Thr Pro Phe
 1               5                  10                  15      
Ala Gly Leu Val
            20

<210> 1432
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> IGRP epitope

<400> 1432
Gln Leu Tyr His Phe Leu Gln Ile Pro Thr His Glu Glu His Leu Phe
 1               5                  10                  15      
Tyr Val Leu Ser
            20

<210> 1433
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> IGRP epitope

<400> 1433
Gln Leu Tyr His Phe Leu Gln Ile Pro Thr His Glu Glu His Leu Phe
 1               5                  10                  15      
Tyr Val Leu Ser
            20

<210> 1434
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> GAD65 epitope

<400> 1434
Lys Val Asn Phe Phe Arg Met Val Ile Ser Asn Pro Ala Ala Thr His
 1               5                  10                  15      
Gln Asp Ile Asp
            20

<210> 1435
<211> 20
<212> PRT
<213> Artificial Sequence

<220> 
<223> GAD65 epitope

<400> 1435
Lys Gly Met Ala Ala Leu Pro Arg Leu Ile Ala Phe Thr Ser Glu His
 1               5                  10                  15      
Ser His Phe Ser
            20

<210> 1436
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> Preproinsulin epitope

<400> 1436
Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly
 1               5                  10                  15

<210> 1437
<211> 251
<212> PRT
<213> Artificial Sequence

<220> 
<223> IL2Rgamma-CISC polypeptide

<400> 1437
Met Pro Leu Gly Leu Leu Trp Leu Gly Leu Ala Leu Leu Gly Ala Leu
 1               5                  10                  15      
His Ala Gln Ala Gly Val Gln Val Glu Thr Ile Ser Pro Gly Asp Gly
            20                  25                  30          
Arg Thr Phe Pro Lys Arg Gly Gln Thr Cys Val Val His Tyr Thr Gly
        35                  40                  45              
Met Leu Glu Asp Gly Lys Lys Phe Asp Ser Ser Arg Asp Arg Asn Lys
    50                  55                  60                  
Pro Phe Lys Phe Met Leu Gly Lys Gln Glu Val Ile Arg Gly Trp Glu
65                  70                  75                  80  
Glu Gly Val Ala Gln Met Ser Val Gly Gln Arg Ala Lys Leu Thr Ile
                85                  90                  95      
Ser Pro Asp Tyr Ala Tyr Gly Ala Thr Gly His Pro Gly Ile Ile Pro
            100                 105                 110         
Pro His Ala Thr Leu Val Phe Asp Val Glu Leu Leu Lys Leu Gly Glu
        115                 120                 125             
Gly Ser Asn Thr Ser Lys Glu Asn Pro Phe Leu Phe Ala Leu Glu Ala
    130                 135                 140                 
Val Val Ile Ser Val Gly Ser Met Gly Leu Ile Ile Ser Leu Leu Cys
145                 150                 155                 160 
Val Tyr Phe Trp Leu Glu Arg Thr Met Pro Arg Ile Pro Thr Leu Lys
                165                 170                 175     
Asn Leu Glu Asp Leu Val Thr Glu Tyr His Gly Asn Phe Ser Ala Trp
            180                 185                 190         
Ser Gly Val Ser Lys Gly Leu Ala Glu Ser Leu Gln Pro Asp Tyr Ser
        195                 200                 205             
Glu Arg Leu Cys Leu Val Ser Glu Ile Pro Pro Lys Gly Gly Ala Leu
    210                 215                 220                 
Gly Glu Gly Pro Gly Ala Ser Pro Cys Asn Gln His Ser Pro Tyr Trp
225                 230                 235                 240 
Ala Pro Pro Cys Tyr Thr Leu Lys Pro Glu Thr
                245                 250

<210> 1438
<211> 90
<212> PRT
<213> Artificial Sequence

<220> 
<223> naked FRB wild-type polypeptide

<400> 1438
Met Glu Met Trp His Glu Gly Leu Glu Glu Ala Ser Arg Leu Tyr Phe
 1               5                  10                  15      
Gly Glu Arg Asn Val Lys Gly Met Phe Glu Val Leu Glu Pro Leu His
            20                  25                  30          
Ala Met Met Glu Arg Gly Pro Gln Thr Leu Lys Glu Thr Ser Phe Asn
        35                  40                  45              
Gln Ala Tyr Gly Arg Asp Leu Met Glu Ala Gln Glu Trp Cys Arg Lys
    50                  55                  60                  
Tyr Met Lys Ser Gly Asn Val Lys Asp Leu Thr Gln Ala Trp Asp Leu
65                  70                  75                  80  
Tyr Tyr His Val Phe Arg Arg Ile Ser Lys
                85                  90

<210> 1439
<211> 90
<212> PRT
<213> Artificial Sequence

<220> 
<223> naked FRB mutant polypeptide

<400> 1439
Met Glu Met Trp His Glu Gly Leu Glu Glu Ala Ser Arg Leu Tyr Phe
 1               5                  10                  15      
Gly Glu Arg Asn Val Lys Gly Met Phe Glu Val Leu Glu Pro Leu His
            20                  25                  30          
Ala Met Met Glu Arg Gly Pro Gln Thr Leu Lys Glu Thr Ser Phe Asn
        35                  40                  45              
Gln Ala Tyr Gly Arg Asp Leu Met Glu Ala Gln Glu Trp Cys Arg Lys
    50                  55                  60                  
Tyr Met Lys Ser Gly Asn Val Lys Asp Leu Leu Gln Ala Trp Asp Leu
65                  70                  75                  80  
Tyr Tyr His Val Phe Arg Arg Ile Ser Lys
                85                  90

<210> 1440
<211> 245
<212> PRT
<213> Artificial Sequence

<220> 
<223> FRB-CISC having a truncated intracellular IL2Rbeta
      domain

<400> 1440
Met Ala Leu Pro Val Thr Ala Leu Leu Leu Pro Leu Ala Leu Leu Leu
 1               5                  10                  15      
His Ala Ala Arg Pro Ile Leu Trp His Glu Met Trp His Glu Gly Leu
            20                  25                  30          
Glu Glu Ala Ser Arg Leu Tyr Phe Gly Glu Arg Asn Val Lys Gly Met
        35                  40                  45              
Phe Glu Val Leu Glu Pro Leu His Ala Met Met Glu Arg Gly Pro Gln
    50                  55                  60                  
Thr Leu Lys Glu Thr Ser Phe Asn Gln Ala Tyr Gly Arg Asp Leu Met
65                  70                  75                  80  
Glu Ala Gln Glu Trp Cys Arg Lys Tyr Met Lys Ser Gly Asn Val Lys
                85                  90                  95      
Asp Leu Leu Gln Ala Trp Asp Leu Tyr Tyr His Val Phe Arg Arg Ile
            100                 105                 110         
Ser Lys Pro Ala Ala Leu Gly Lys Asp Thr Ile Pro Trp Leu Gly His
        115                 120                 125             
Leu Leu Val Gly Leu Ser Gly Ala Phe Gly Phe Ile Ile Leu Val Tyr
    130                 135                 140                 
Leu Leu Ile Asn Cys Arg Asn Thr Gly Pro Trp Leu Lys Lys Val Leu
145                 150                 155                 160 
Lys Cys Asn Thr Pro Asp Pro Ser Lys Phe Phe Ser Gln Leu Ser Ser
                165                 170                 175     
Glu His Gly Gly Asp Val Gln Lys Trp Leu Ser Ser Pro Phe Pro Ser
            180                 185                 190         
Ser Ser Phe Ser Pro Gly Gly Leu Ala Pro Glu Ile Ser Pro Leu Glu
        195                 200                 205             
Val Leu Glu Arg Asp Lys Val Thr Gln Leu Leu Leu Gln Gln Asp Lys
    210                 215                 220                 
Val Pro Glu Pro Ala Ser Leu Ser Leu Asn Thr Asp Ala Tyr Leu Ser
225                 230                 235                 240 
Leu Gln Glu Leu Gln
                245

<210> 1441
<211> 131
<212> PRT
<213> Artificial Sequence

<220> 
<223> truncated IL2Rbeta

<400> 1441
Pro Ala Ala Leu Gly Lys Asp Thr Ile Pro Trp Leu Gly His Leu Leu
 1               5                  10                  15      
Val Gly Leu Ser Gly Ala Phe Gly Phe Ile Ile Leu Val Tyr Leu Leu
            20                  25                  30          
Ile Asn Cys Arg Asn Thr Gly Pro Trp Leu Lys Lys Val Leu Lys Cys
        35                  40                  45              
Asn Thr Pro Asp Pro Ser Lys Phe Phe Ser Gln Leu Ser Ser Glu His
    50                  55                  60                  
Gly Gly Asp Val Gln Lys Trp Leu Ser Ser Pro Phe Pro Ser Ser Ser
65                  70                  75                  80  
Phe Ser Pro Gly Gly Leu Ala Pro Glu Ile Ser Pro Leu Glu Val Leu
                85                  90                  95      
Glu Arg Asp Lys Val Thr Gln Leu Leu Leu Gln Gln Asp Lys Val Pro
            100                 105                 110         
Glu Pro Ala Ser Leu Ser Leu Asn Thr Asp Ala Tyr Leu Ser Leu Gln
        115                 120                 125             
Glu Leu Gln
    130

<210> 1442
<211> 6498
<212> DNA
<213> Artificial Sequence

<220> 
<223> Construct 3324

<400> 1442
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtagc 1020
ggccgcagcc tgtgcagggt gcagggaggg ctagaggcct gaggcttgaa acagctctca 1080
agtggagggg gaaacaacca ttgccctcat agaggacaca tccacaccag ggctgtgcta 1140
gcgtgggcag gcaagccagg tgctggacct ctgcacgtgg ggcatgtgtg ggtatgtaca 1200
tgtacctgtg ttcttggtgt gtgtgtgtgt gtgtgtgtgt gtgtgtgtct agagctgggg 1260
tgcaactatg gggcccctcg ggacatgtcc cagccaatgc ctgctttgac cagaggagtg 1320
tccacgtggc tcaggtggtc gagtatctca taccgcccta gcacacgtgt gactcctttc 1380
ccctattgtc tacgcagcct gcccttggac aaggacccga tgcccaaccc caggcctggc 1440
aagccctcgg ccccttcctt ggcccttggc ccatccccac gcgtaggaac agagaaacag 1500
gagaatatgg gccaaacagg atatctgtgg taagcagttc ctgccccggc tcagggccaa 1560
gaacagttgg aacagcagaa tatgggccaa acaggatatc tgtggtaagc agttcctgcc 1620
ccggctcagg gccaagaaca gatggtcccc agatgcggtc ccgccctcag cagtttctag 1680
agaaccatca gatgtttcca gggtgcccca aggacctgaa atgaccctgt gccttatttg 1740
aactaaccaa tcagttcgct tctcgcttct gttcgcgcgc ttctgctccc cgagctctat 1800
ataagcagag ctcgtttagt gaaccgtcag atcgcctgga gacgccatcc acgctgtttt 1860
gacttccata gaaggatctc gaggccacca tgccactggg actgctgtgg cttggactgg 1920
cccttcttgg agcactgcat gctcaggctg gcgtgcaggt cgagacaatt agtcctggcg 1980
acggccggac ctttcctaag cgaggacaga catgcgtggt gcactacacc ggcatgctgg 2040
aagatggcaa gaagttcgac agcagccggg acagaaacaa gcctttcaag ttcatgctgg 2100
gcaagcaaga agtgatcaga ggctgggaag agggcgtcgc ccagatgtct gttggacaga 2160
gagccaagct gacaatcagc cccgattacg cctatggcgc cacaggacac cctgggatca 2220
ttcctccaca tgccacactg gtgttcgatg tggaactgct gaagctcggc gaaggcagca 2280
ataccagcaa agagaacccc ttcctgttcg ccctggaagc cgtggttatc agcgtgggat 2340
ctatgggcct gatcatctcc ctgctgtgcg tgtacttctg gctggaacgg accatgcctc 2400
ggatccccac actgaagaat ctggaagatc tggtcaccga gtaccacggc aatttcagcg 2460
cttggagtgg cgtgtccaaa ggcctggctg aaagcctgca gcctgactac tctgagagac 2520
tgtgcctggt gtctgagatc cctcctaaag gcggcgctct cggagaagga ccaggcgctt 2580
ctccatgcaa tcagcacagc ccttattggg cccctccttg ctacaccctg aagcctgaaa 2640
ctggatccgg cgccaccaac tttagtctgc tcaagcaagc cggggacgtc gaggaaaatc 2700
ctgggccaga aatgtggcac gaaggactcg aggaagccag tcggctgtat tttggcgagc 2760
ggaatgtgaa agggatgttt gaagtgctcg agcctctcca cgctatgatg gaacggggac 2820
cccagactct caaagaaacc agctttaatc aggcttacgg acgcgacctc atggaagctc 2880
aagaatggtg tagaaagtat atgaagagtg gcaacgtgaa agatctgctg caagcctggg 2940
atctctatta tcacgtgttc agacgcatca gcaaaggcag cggcgccaca aatttctccc 3000
tgctgaaaca ggccggcgac gtggaagaga atcccggacc ttatccatac gatgtcccag 3060
attatgcgcc caatcctaga cctggcaagc ccagcgctcc ttctcttgct cttggacctt 3120
ctcctggtgc ctcgcccagc tggagggctg cacccaaagc ctcagacctg ctgggggccc 3180
ggggcccagg gggaaccttc cagggccgag atcttcgagg cggggcccat gcctcctctt 3240
cttccttgaa ccccatgcca ccatcgcagc tgcaggtgag gccctgggcc caggatgggg 3300
caggcagggt ggggtacctg gacctacagg tgccgacctt tactgtggca ctgggcggga 3360
ggggggctgg ctggggcaca ggaagtggtt tctgggtccc aggcaagtct gtgacttatg 3420
cagatgttgc agggccaaga aaatccccac ctgccaggcc tcagagattg gaggctctcc 3480
ccgacctccc aatccctgtc tcaggagagg aggaggccgt attgtagtcc catgagcata 3540
gctatgtgtc cccatcccca tgtgacaaga gaagaggagg atcctacgta gataagtagc 3600
atggcgggtt aatcattaac tacaaggaac ccctagtgat ggagttggcc actccctctc 3660
tgcgcgctcg ctcgctcact gaggccgggc gaccaaaggt cgcccgacgc ccgggctttg 3720
cccgggcggc ctcagtgagc gagcgagcgc gccagctggc gtaatagcga agaggcccgc 3780
accgatcgcc cttcccaaca gttgcgcagc ctgaatggcg aatggcgatt ccgttgcaat 3840
ggctggcggt aatattgttc tggatattac cagcaaggcc gatagtttga gttcttctac 3900
tcaggcaagt gatgttatta ctaatcaaag aagtattgcg acaacggtta atttgcgtga 3960
tggacagact cttttactcg gtggcctcac tgattataaa aacacttctc aggattctgg 4020
cgtaccgttc ctgtctaaaa tccctttaat cggcctcctg tttagctccc gctctgattc 4080
taacgaggaa agcacgttat acgtgctcgt caaagcaacc atagtacgcg ccctgtagcg 4140
gcgcattaag cgcggcgggt gtggtggtta cgcgcagcgt gaccgctaca cttgccagcg 4200
ccctagcgcc cgctcctttc gctttcttcc cttcctttct cgccacgttc gccggctttc 4260
cccgtcaagc tctaaatcgg gggctccctt tagggttccg atttagtgct ttacggcacc 4320
tcgaccccaa aaaacttgat tagggtgatg gttcacgtag tgggccatcg ccctgataga 4380
cggtttttcg ccctttgacg ttggagtcca cgttctttaa tagtggactc ttgttccaaa 4440
ctggaacaac actcaaccct atctcggtct attcttttga tttataaggg attttgccga 4500
tttcggccta ttggttaaaa aatgagctga tttaacaaaa atttaacgcg aattttaaca 4560
aaatattaac gtttacaatt taaatatttg cttatacaat cttcctgttt ttggggcttt 4620
tctgattatc aaccggggta catatgattg acatgctagt tttacgatta ccgttcatcg 4680
attctcttgt ttgctccaga ctctcaggca atgacctgat agcctttgta gagacctctc 4740
aaaaatagct accctctccg gcatgaattt atcagctaga acggttgaat atcatattga 4800
tggtgatttg actgtctccg gcctttctca cccgtttgaa tctttaccta cacattactc 4860
aggcattgca tttaaaatat atgagggttc taaaaatttt tatccttgcg ttgaaataaa 4920
ggcttctccc gcaaaagtat tacagggtca taatgttttt ggtacaaccg atttagcttt 4980
atgctctgag gctttattgc ttaattttgc taattctttg ccttgcctgt atgatttatt 5040
ggatgttgga atcgcctgat gcggtatttt ctccttacgc atctgtgcgg tatttcacac 5100
cgcatatggt gcactctcag tacaatctgc tctgatgccg catagttaag ccagccccga 5160
cacccgccaa cacccgctga cgcgccctga cgggcttgtc tgctcccggc atccgcttac 5220
agacaagctg tgaccgtctc cgggagctgc atgtgtcaga ggttttcacc gtcatcaccg 5280
aaacgcgcga gacgaaaggg cctcgtgata cgcctatttt tataggttaa tgtcatgata 5340
ataatggttt cttagacgtc aggtggcact tttcggggaa atgtgcgcgg aacccctatt 5400
tgtttatttt tctaaataca ttcaaatatg tatccgctca tgagacaata accctgataa 5460
atgcttcaat aatattgaaa aaggaagagt atgagtattc aacatttccg tgtcgccctt 5520
attccctttt ttgcggcatt ttgccttcct gtttttgctc acccagaaac gctggtgaaa 5580
gtaaaagatg ctgaagatca gttgggtgca cgagtgggtt acatcgaact ggatctcaac 5640
agcggtaaga tccttgagag ttttcgcccc gaagaacgtt ttccaatgat gagcactttt 5700
aaagttctgc tatgtggcgc ggtattatcc cgtattgacg ccgggcaaga gcaactcggt 5760
cgccgcatac actattctca gaatgacttg gttgagtact caccagtcac agaaaagcat 5820
cttacggatg gcatgacagt aagagaatta tgcagtgctg ccataaccat gagtgataac 5880
actgcggcca acttacttct gacaacgatc ggaggaccga aggagctaac cgcttttttg 5940
cacaacatgg gggatcatgt aactcgcctt gatcgttggg aaccggagct gaatgaagcc 6000
ataccaaacg acgagcgtga caccacgatg cctgtagcaa tggcaacaac gttgcgcaaa 6060
ctattaactg gcgaactact tactctagct tcccggcaac aattaataga ctggatggag 6120
gcggataaag ttgcaggacc acttctgcgc tcggcccttc cggctggctg gtttattgct 6180
gataaatctg gagccggtga gcgtgggtct cgcggtatca ttgcagcact ggggccagat 6240
ggtaagccct cccgtatcgt agttatctac acgacgggga gtcaggcaac tatggatgaa 6300
cgaaatagac agatcgctga gataggtgcc tcactgatta agcattggta actgtcagac 6360
caagtttact catatatact ttagattgat ttaaaacttc atttttaatt taaaaggatc 6420
taggtgaaga tcctttttga taatctcatg accaaaatcc cttaacgtga gttttcgttc 6480
cactgagcgt cagacccc                                               6498

<210> 1443
<211> 7663
<212> DNA
<213> Artificial Sequence

<220> 
<223> Construct 3333

<400> 1443
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtagc 1020
ggccgcactg aaatcatggc ctcttggcca agattgatag cttgtgcctg tccctgagtc 1080
ccagtccatc acgagcagct ggtttctaag atgctatttc ccgtataaag catgagaccg 1140
tgacttgcca gccccacaga gccccgccct tgtccatcac tggcatctgg actccagcct 1200
gggttggggc aaagagggaa atgagatcat gtcctaaccc tgatcctctt gtcccacaga 1260
tatccagaac cctgaccctg ccgtgtacca gctgagagac tctaaatcca gtgacaagtc 1320
tgtctgccta tattaaggaa cagagaaaca ggagaatatg ggccaaacag gatatctgtg 1380
gtaagcagtt cctgccccgg ctcagggcca agaacagttg gaacagcaga atatgggcca 1440
aacaggatat ctgtggtaag cagttcctgc cccggctcag ggccaagaac agatggtccc 1500
cagatgcggt cccgccctca gcagtttcta gagaaccatc agatgtttcc agggtgcccc 1560
aaggacctga aatgaccctg tgccttattt gaactaacca atcagttcgc ttctcgcttc 1620
tgttcgcgcg cttctgctcc ccgagctcta tataagcaga gctcgtttag tgaaccgtca 1680
gatcgcctgg agacgccatc cacgctgttt tgacttccat agaaggatct cgagtagcat 1740
gggatcaaga ctgctgtgct gggtgctgct gtgcctgctg ggagccggac ctgtgaaagc 1800
cggggtgact cagactccac gatacctgat caagaccagg ggccagcagg tgacactgtc 1860
ttgcagccca atctccggac accgctccgt gtcttggtac cagcagaccc ctggacaggg 1920
actgcagttc ctgtttgagt atttctctga gacacagcgg aacaagggca atttccccgg 1980
ccggtttagc ggcagacagt ttagcaactc caggtctgag atgaatgtga gcaccctgga 2040
gctgggcgac tccgccctgt acctgtgcgc aagctccctg gccctgggac aggggaatca 2100
gcagtttttc ggacccggaa caaggctgac cgtgctggag gatctacgta acgtgacacc 2160
acccaaagtc tcactgtttg agcctagcaa ggcagaaatt gccaacaagc agaaggccac 2220
cctggtgtgc ctggcaagag ggttctttcc agatcacgtg gagctgtcct ggtgggtcaa 2280
cggcaaagaa gtgcattctg gggtctgcac cgacccccag gcttacaagg agagtaatta 2340
ctcatattgt ctgtcaagcc ggctgagagt gtccgccaca ttctggcaca accctaggaa 2400
tcatttccgc tgccaggtcc agtttcacgg cctgagtgag gaagataaat ggccagaggg 2460
gtcacctaag ccagtgacac agaacatcag cgcagaagcc tggggacgag cagactgtgg 2520
cattactagc gcctcctatc atcagggcgt gctgagcgcc actatcctgt acgagattct 2580
gctgggaaag gccaccctgt atgctgtgct ggtctccggc ctggtgctga tggccatggt 2640
caagaaaaag aactctggga gtggagccac aaatttctct ctgctgaaac aggctggaga 2700
tgtggaggaa aaccccggcc ctatgaagag cctgcgcgtg ctgctggtca tcctgtggct 2760
gcaattgagt tgggtgtgga gccagaagga ccaggtgttt cagcctagca ctgtcgcatc 2820
atcagagggg gccgtcgtgg aaatcttttg taatcacagc gtgtccaacg cctacaattt 2880
cttttggtat ctgcacttcc caggatgcgc acctaggctg ctggtgaagg gctctaagcc 2940
cagccagcag ggccggtaca acatgaccta tgagcggttc agctcctctc tgctgatcct 3000
gcaggtgcgg gaggcagacg cagccgtgta ctattgtgcc gtggaggatc tgaatcaggc 3060
cggcacagcc ctgattttcg gcaaaggaac aaccctgagc gtgagcagcg acatccagaa 3120
ccctgagccc gccgtatacc agctgaagga cccccgatct caggatagta ctctgtgcct 3180
gttcaccgac tttgatagtc agatcaatgt gcctaaaacc atggaatccg gaacttttat 3240
taccgacaag tgcgtgctgg atatgaaagc catggacagt aagtcaaacg gcgccatcgc 3300
ttggagcaat cagacatcct tcacttgcca ggatatcttc aaggagacca acgcaacata 3360
cccatcctct gacgtgccct gtgatgccac cctgacagag aagtctttcg aaacagacat 3420
gaacctgaat tttcagaatc tgagcgtgat gggcctgaga atcctgctgc tgaaggtcgc 3480
tgggtttaat ctgctgatga cactgcggct gtggtcctca ggatctggtg ctactaattt 3540
ttctcttttg aagcaagctg gagatgttga agagaacccc ggtccgatgg ctctgccagt 3600
gacagctctg ctgcttcctc tggctctgtt gctgcatgcc gccagaccta ttctgtggca 3660
cgagatgtgg catgaaggcc tggaagaggc ctccagactg tacttcggcg agagaaacgt 3720
gaagggcatg ttcgaggtgc tggaacccct gcatgccatg atggaaagag gccctcagac 3780
actgaaagag actagcttca accaggccta cggccgggat ctgatggaag cccaagagtg 3840
gtgccggaag tacatgaagt ccggcaatgt gaaggacctc ctgcaggcat gggacctgta 3900
ctaccacgtg ttccggcgga tctctaaggg caaagacaca atcccttggc tgggccatct 3960
gctcgttgga ctgtctggcg ccttcggctt catcatcctg gtgtacctgc tgatcaactg 4020
tcggaacaca ggcccatggc tgaagaaagt gctgaagtgc aacacccctg atccgagcaa 4080
gttctttagc cagctgtcca gcgagcacgg cggagatgtt cagaagtggc tgagcagccc 4140
atttcctagc agcagcttta gccctggcgg actggctcct gagatcagcc cactggaagt 4200
gctggaaagg gacaaagtga cccagctgct cctgcaacag gacaaggtgc cagaacctgc 4260
cagcctgtct taaaagctta attgagcggc cgcgctttat ttgtgaaatt tgtgatgcta 4320
ttgctttatt tgtaaccatt ataagctgca ataaacaagt taacaacaac aattgcattc 4380
attttatgtt tcaggttcag ggggagatgt gggaggtttt ttaaagctca ccgattttga 4440
ttctcaaaca aatgtgtcac aaagtaagga ttctgatgtg tatatcacag acaaaactgt 4500
gctagacatg aggtctatgg acttcaagag caacagtgct gtggcctgga gcaacaaatc 4560
tgactttgca tgtgcaaacg ccttcaacaa cagcattatt ccagaagaca ccttcttccc 4620
cagcccaggt aagggcagct ttggtgcctt cgcaggctgt ttccttgctt caggaatggc 4680
caggttctgc ccagagctct ggtcaatgat gtctaaaact cctctgattg gtggtctcgg 4740
cgcggccgct acgtagataa gtagcatggc gggttaatca ttaactacaa ggaaccccta 4800
gtgatggagt tggccactcc ctctctgcgc gctcgctcgc tcactgaggc cgggcgacca 4860
aaggtcgccc gacgcccggg ctttgcccgg gcggcctcag tgagcgagcg agcgcgccag 4920
ctggcgtaat agcgaagagg cccgcaccga tcgcccttcc caacagttgc gcagcctgaa 4980
tggcgaatgg cgattccgtt gcaatggctg gcggtaatat tgttctggat attaccagca 5040
aggccgatag tttgagttct tctactcagg caagtgatgt tattactaat caaagaagta 5100
ttgcgacaac ggttaatttg cgtgatggac agactctttt actcggtggc ctcactgatt 5160
ataaaaacac ttctcaggat tctggcgtac cgttcctgtc taaaatccct ttaatcggcc 5220
tcctgtttag ctcccgctct gattctaacg aggaaagcac gttatacgtg ctcgtcaaag 5280
caaccatagt acgcgccctg tagcggcgca ttaagcgcgg cgggtgtggt ggttacgcgc 5340
agcgtgaccg ctacacttgc cagcgcccta gcgcccgctc ctttcgcttt cttcccttcc 5400
tttctcgcca cgttcgccgg ctttccccgt caagctctaa atcgggggct ccctttaggg 5460
ttccgattta gtgctttacg gcacctcgac cccaaaaaac ttgattaggg tgatggttca 5520
cgtagtgggc catcgccctg atagacggtt tttcgccctt tgacgttgga gtccacgttc 5580
tttaatagtg gactcttgtt ccaaactgga acaacactca accctatctc ggtctattct 5640
tttgatttat aagggatttt gccgatttcg gcctattggt taaaaaatga gctgatttaa 5700
caaaaattta acgcgaattt taacaaaata ttaacgttta caatttaaat atttgcttat 5760
acaatcttcc tgtttttggg gcttttctga ttatcaaccg gggtacatat gattgacatg 5820
ctagttttac gattaccgtt catcgattct cttgtttgct ccagactctc aggcaatgac 5880
ctgatagcct ttgtagagac ctctcaaaaa tagctaccct ctccggcatg aatttatcag 5940
ctagaacggt tgaatatcat attgatggtg atttgactgt ctccggcctt tctcacccgt 6000
ttgaatcttt acctacacat tactcaggca ttgcatttaa aatatatgag ggttctaaaa 6060
atttttatcc ttgcgttgaa ataaaggctt ctcccgcaaa agtattacag ggtcataatg 6120
tttttggtac aaccgattta gctttatgct ctgaggcttt attgcttaat tttgctaatt 6180
ctttgccttg cctgtatgat ttattggatg ttggaatcgc ctgatgcggt attttctcct 6240
tacgcatctg tgcggtattt cacaccgcat atggtgcact ctcagtacaa tctgctctga 6300
tgccgcatag ttaagccagc cccgacaccc gccaacaccc gctgacgcgc cctgacgggc 6360
ttgtctgctc ccggcatccg cttacagaca agctgtgacc gtctccggga gctgcatgtg 6420
tcagaggttt tcaccgtcat caccgaaacg cgcgagacga aagggcctcg tgatacgcct 6480
atttttatag gttaatgtca tgataataat ggtttcttag acgtcaggtg gcacttttcg 6540
gggaaatgtg cgcggaaccc ctatttgttt atttttctaa atacattcaa atatgtatcc 6600
gctcatgaga caataaccct gataaatgct tcaataatat tgaaaaagga agagtatgag 6660
tattcaacat ttccgtgtcg cccttattcc cttttttgcg gcattttgcc ttcctgtttt 6720
tgctcaccca gaaacgctgg tgaaagtaaa agatgctgaa gatcagttgg gtgcacgagt 6780
gggttacatc gaactggatc tcaacagcgg taagatcctt gagagttttc gccccgaaga 6840
acgttttcca atgatgagca cttttaaagt tctgctatgt ggcgcggtat tatcccgtat 6900
tgacgccggg caagagcaac tcggtcgccg catacactat tctcagaatg acttggttga 6960
gtactcacca gtcacagaaa agcatcttac ggatggcatg acagtaagag aattatgcag 7020
tgctgccata accatgagtg ataacactgc ggccaactta cttctgacaa cgatcggagg 7080
accgaaggag ctaaccgctt ttttgcacaa catgggggat catgtaactc gccttgatcg 7140
ttgggaaccg gagctgaatg aagccatacc aaacgacgag cgtgacacca cgatgcctgt 7200
agcaatggca acaacgttgc gcaaactatt aactggcgaa ctacttactc tagcttcccg 7260
gcaacaatta atagactgga tggaggcgga taaagttgca ggaccacttc tgcgctcggc 7320
ccttccggct ggctggttta ttgctgataa atctggagcc ggtgagcgtg ggtctcgcgg 7380
tatcattgca gcactggggc cagatggtaa gccctcccgt atcgtagtta tctacacgac 7440
ggggagtcag gcaactatgg atgaacgaaa tagacagatc gctgagatag gtgcctcact 7500
gattaagcat tggtaactgt cagaccaagt ttactcatat atactttaga ttgatttaaa 7560
acttcatttt taatttaaaa ggatctaggt gaagatcctt tttgataatc tcatgaccaa 7620
aatcccttaa cgtgagtttt cgttccactg agcgtcagac ccc                   7663

<210> 1444
<211> 7118
<212> DNA
<213> Artificial Sequence

<220> 
<223> Construct 3323

<400> 1444
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtacc 1020
ctattaaata aaagaataag cagtattatt aagtagccct gcatttcagg tttccttgag 1080
tggcaggcca ggcctggccg tgaacgttca ctgaaatcat ggcctcttgg ccaagattga 1140
tagcttgtgc ctgtccctga gtcccagtcc atcacgagca gctggtttct aagatgctat 1200
ttcccgtata aagcatgaga ccgtgacttg ccagccccac agagccccgc ccttgtccat 1260
cactggcatc tggactccag cctgggttgg ggcaaagagg gaaatgagat catgtcctac 1320
gcgtaggaac agagaaacag gagaatatgg gccaaacagg atatctgtgg taagcagttc 1380
ctgccccggc tcagggccaa gaacagttgg aacagcagaa tatgggccaa acaggatatc 1440
tgtggtaagc agttcctgcc ccggctcagg gccaagaaca gatggtcccc agatgcggtc 1500
ccgccctcag cagtttctag agaaccatca gatgtttcca gggtgcccca aggacctgaa 1560
atgaccctgt gccttatttg aactaaccaa tcagttcgct tctcgcttct gttcgcgcgc 1620
ttctgctccc cgagctctat ataagcagag ctcgtttagt gaaccgtcag atcgcctgga 1680
gacgccatcc acgctgtttt gacttccata gaaggatcat ggctctgcca gtgacagctc 1740
tgctgcttcc tctggctctg ttgctgcatg ccgccagacc tattctgtgg cacgagatgt 1800
ggcatgaagg cctggaagag gcctccagac tgtacttcgg cgagagaaac gtgaagggca 1860
tgttcgaggt gctggaaccc ctgcatgcca tgatggaaag aggccctcag acactgaaag 1920
agacaagctt caaccaggcc tacggccggg atctgatgga agcccaagag tggtgccgga 1980
agtacatgaa gtccggcaat gtgaaggacc tcctgcaggc atgggacctg tactaccacg 2040
tgttccggcg gatctctaag ggcaaagaca caatcccttg gctgggccat ctgctcgttg 2100
gactgtctgg cgccttcggc ttcatcatcc tggtgtacct gctgatcaac tgtcggaaca 2160
caggcccatg gctgaagaaa gtgctgaagt gcaacacccc tgatccgagc aagttcttta 2220
gccagctgtc cagcgagcac ggcggagatg ttcagaagtg gctgagcagc ccatttccta 2280
gcagcagctt tagccctggc ggactggctc ctgagatcag cccactggaa gtgctggaaa 2340
gggacaaagt gacccagctg ctcctgcaac aggacaaggt gccagaacct gccagcctgt 2400
ctctgaacac cgatgcctat ctgtccctgc aagagctgca aggatccggc gccaccaact 2460
ttagtctgct caagcaagcc ggggacgtcg aggaaaatcc tgggccaatg ggatcaagac 2520
tgctgtgctg ggtgctgctg tgcctgctgg gagccggacc tgtgaaagcc ggggtgactc 2580
agactccacg atacctgatc aagaccaggg gccagcaggt gacactgtct tgcagcccaa 2640
tctccggaca ccgctccgtg tcttggtacc agcagacccc tggacaggga ctgcagttcc 2700
tgtttgagta tttctctgag acacagcgga acaagggcaa tttccccggc cggtttagcg 2760
gcagacagtt tagcaactcc aggtctgaga tgaatgtgag caccctggag ctgggcgact 2820
ccgccctgta cctgtgcgca agctccctgg ccctgggaca ggggaatcag cagtttttcg 2880
gacccggaac aaggctgacc gtgctggagg atctacgtaa cgtgacacca cccaaagtct 2940
cactgtttga gcctagcaag gcagaaattg ccaacaagca gaaggccacc ctggtgtgcc 3000
tggcaagagg gttctttcca gatcacgtgg agctgtcctg gtgggtcaac ggcaaagaag 3060
tgcattctgg ggtctgcacc gacccccagg cttacaagga gagtaattac tcatattgtc 3120
tgtcaagccg gctgagagtg tccgccacat tctggcacaa ccctaggaat catttccgct 3180
gccaggtcca gtttcacggc ctgagtgagg aagataaatg gccagagggg tcacctaagc 3240
cagtgacaca gaacatcagc gcagaagcct ggggacgagc agactgtggc attactagcg 3300
cctcctatca tcagggcgtg ctgagcgcca ctatcctgta cgagattctg ctgggaaagg 3360
ccaccctgta tgctgtgctg gtctccggcc tggtgctgat ggccatggtc aagaaaaaga 3420
actctgggag tggagccaca aatttctctc tgctgaaaca ggctggagat gtggaggaaa 3480
accccggccc tatgaagagc ctgcgcgtgc tgctggtcat cctgtggctg caattgagtt 3540
gggtgtggag ccagaaggac caggtgtttc agcctagcac tgtcgcatca tcagaggggg 3600
ccgtcgtgga aatcttttgt aatcacagcg tgtccaacgc ctacaatttc ttttggtatc 3660
tgcacttccc aggatgcgca cctaggctgc tggtgaaggg ctctaagccc agccagcagg 3720
gccggtacaa catgacctat gagcggttca gctcctctct gctgatcctg caggtgcggg 3780
aggcagacgc agccgtgtac tattgtgccg tggaggatct gaatcaggcc ggcacagccc 3840
tgattttcgg caaaggaaca accctgagcg tgagcagcat ccagaaccct gacccagccg 3900
tataccagct gagagactct aaatccagtg acaagtctgt ctgcctattc accgattttg 3960
attctcaaac aaatgtgtca caaagtaagg attctgatgt gtatatcaca gacaaaactg 4020
tgctagacat gaggtctatg gacttcaaga gcaacagtgc tgtggcctgg agcaacaaat 4080
ctgactttgc atgtgcaaac gccttcaaca acagcattat tccagaagac accttcttcc 4140
ccagcccagg taagggcagc tttggtgcct tcgcaggctg tttccttgct tcaggaatgg 4200
atcctacgta gataagtagc atggcgggtt aatcattaac tacaaggaac ccctagtgat 4260
ggagttggcc actccctctc tgcgcgctcg ctcgctcact gaggccgggc gaccaaaggt 4320
cgcccgacgc ccgggctttg cccgggcggc ctcagtgagc gagcgagcgc gccagctggc 4380
gtaatagcga agaggcccgc accgatcgcc cttcccaaca gttgcgcagc ctgaatggcg 4440
aatggcgatt ccgttgcaat ggctggcggt aatattgttc tggatattac cagcaaggcc 4500
gatagtttga gttcttctac tcaggcaagt gatgttatta ctaatcaaag aagtattgcg 4560
acaacggtta atttgcgtga tggacagact cttttactcg gtggcctcac tgattataaa 4620
aacacttctc aggattctgg cgtaccgttc ctgtctaaaa tccctttaat cggcctcctg 4680
tttagctccc gctctgattc taacgaggaa agcacgttat acgtgctcgt caaagcaacc 4740
atagtacgcg ccctgtagcg gcgcattaag cgcggcgggt gtggtggtta cgcgcagcgt 4800
gaccgctaca cttgccagcg ccctagcgcc cgctcctttc gctttcttcc cttcctttct 4860
cgccacgttc gccggctttc cccgtcaagc tctaaatcgg gggctccctt tagggttccg 4920
atttagtgct ttacggcacc tcgaccccaa aaaacttgat tagggtgatg gttcacgtag 4980
tgggccatcg ccctgataga cggtttttcg ccctttgacg ttggagtcca cgttctttaa 5040
tagtggactc ttgttccaaa ctggaacaac actcaaccct atctcggtct attcttttga 5100
tttataaggg attttgccga tttcggccta ttggttaaaa aatgagctga tttaacaaaa 5160
atttaacgcg aattttaaca aaatattaac gtttacaatt taaatatttg cttatacaat 5220
cttcctgttt ttggggcttt tctgattatc aaccggggta catatgattg acatgctagt 5280
tttacgatta ccgttcatcg attctcttgt ttgctccaga ctctcaggca atgacctgat 5340
agcctttgta gagacctctc aaaaatagct accctctccg gcatgaattt atcagctaga 5400
acggttgaat atcatattga tggtgatttg actgtctccg gcctttctca cccgtttgaa 5460
tctttaccta cacattactc aggcattgca tttaaaatat atgagggttc taaaaatttt 5520
tatccttgcg ttgaaataaa ggcttctccc gcaaaagtat tacagggtca taatgttttt 5580
ggtacaaccg atttagcttt atgctctgag gctttattgc ttaattttgc taattctttg 5640
ccttgcctgt atgatttatt ggatgttgga atcgcctgat gcggtatttt ctccttacgc 5700
atctgtgcgg tatttcacac cgcatatggt gcactctcag tacaatctgc tctgatgccg 5760
catagttaag ccagccccga cacccgccaa cacccgctga cgcgccctga cgggcttgtc 5820
tgctcccggc atccgcttac agacaagctg tgaccgtctc cgggagctgc atgtgtcaga 5880
ggttttcacc gtcatcaccg aaacgcgcga gacgaaaggg cctcgtgata cgcctatttt 5940
tataggttaa tgtcatgata ataatggttt cttagacgtc aggtggcact tttcggggaa 6000
atgtgcgcgg aacccctatt tgtttatttt tctaaataca ttcaaatatg tatccgctca 6060
tgagacaata accctgataa atgcttcaat aatattgaaa aaggaagagt atgagtattc 6120
aacatttccg tgtcgccctt attccctttt ttgcggcatt ttgccttcct gtttttgctc 6180
acccagaaac gctggtgaaa gtaaaagatg ctgaagatca gttgggtgca cgagtgggtt 6240
acatcgaact ggatctcaac agcggtaaga tccttgagag ttttcgcccc gaagaacgtt 6300
ttccaatgat gagcactttt aaagttctgc tatgtggcgc ggtattatcc cgtattgacg 6360
ccgggcaaga gcaactcggt cgccgcatac actattctca gaatgacttg gttgagtact 6420
caccagtcac agaaaagcat cttacggatg gcatgacagt aagagaatta tgcagtgctg 6480
ccataaccat gagtgataac actgcggcca acttacttct gacaacgatc ggaggaccga 6540
aggagctaac cgcttttttg cacaacatgg gggatcatgt aactcgcctt gatcgttggg 6600
aaccggagct gaatgaagcc ataccaaacg acgagcgtga caccacgatg cctgtagcaa 6660
tggcaacaac gttgcgcaaa ctattaactg gcgaactact tactctagct tcccggcaac 6720
aattaataga ctggatggag gcggataaag ttgcaggacc acttctgcgc tcggcccttc 6780
cggctggctg gtttattgct gataaatctg gagccggtga gcgtgggtct cgcggtatca 6840
ttgcagcact ggggccagat ggtaagccct cccgtatcgt agttatctac acgacgggga 6900
gtcaggcaac tatggatgaa cgaaatagac agatcgctga gataggtgcc tcactgatta 6960
agcattggta actgtcagac caagtttact catatatact ttagattgat ttaaaacttc 7020
atttttaatt taaaaggatc taggtgaaga tcctttttga taatctcatg accaaaatcc 7080
cttaacgtga gttttcgttc cactgagcgt cagacccc                         7118

<210> 1445
<211> 9280
<212> DNA
<213> Artificial Sequence

<220> 
<223> Construct 3312

<400> 1445
agcttaatgt agtcttatgc aatactcttg tagtcttgca acatggtaac gatgagttag 60
caacatgcct tacaaggaga gaaaaagcac cgtgcatgcc gattggtgga agtaaggtgg 120
tacgatcgtg ccttattagg aaggcaacag acgggtctga catggattgg acgaaccact 180
gaattgccgc attgcagaga tattgtattt aagtgcctag ctcgatacaa taaacgggtc 240
tctctggtta gaccagatct gagcctggga gctctctggc taactaggga acccactgct 300
taagcctcaa taaagcttgc cttgagtgct tcaagtagtg tgtgcccgtc tgttgtgtga 360
ctctggtaac tagagatccc tcagaccctt ttagtcagtg tggaaaatct ctagcagtgg 420
cgcccgaaca gggacttgaa agcgaaaggg aaaccagagg agctctctcg acgcaggact 480
cggcttgctg aagcgcgcac ggcaagaggc gaggggcggc gactggtgag tacgccaaaa 540
attttgacta gcggaggcta gaaggagaga gatgggtgcg agagcgtcag tattaagcgg 600
gggagaatta gatcgcgatg ggaaaaaatt cggttaaggc cagggggaaa gaaaaaatat 660
aaattaaaac atatagtatg ggcaagcagg gagctagaac gattcgcagt taatcctggc 720
ctgttagaaa catcagaagg ctgtagacaa atactgggac agctacaacc atcccttcag 780
acaggatcag aagaacttag atcattatat aatacagtag caaccctcta ttgtgtgcat 840
caaaggatag agataaaaga caccaaggaa gctttagaca agatagagga agagcaaaac 900
aaaagtaaga ccaccgcaca gcaagcggcc gctgatcttc agacctggag gaggagatat 960
gagggacaat tggagaagtg aattatataa atataaagta gtaaaaattg aaccattagg 1020
agtagcaccc accaaggcaa agagaagagt ggtgcagaga gaaaaaagag cagtgggaat 1080
aggagctttg ttccttgggt tcttgggagc agcaggaagc actatgggcg cagcctcaat 1140
gacgctgacg gtacaggcca gacaattatt gtctggtata gtgcagcagc agaacaattt 1200
gctgagggct attgaggcgc aacagcatct gttgcaactc acagtctggg gcatcaagca 1260
gctccaggca agaatcctgg ctgtggaaag atacctaaag gatcaacagc tcctggggat 1320
ttggggttgc tctggaaaac tcatttgcac cactgctgtg ccttggaatg ctagttggag 1380
taataaatct ctggaacaga tttggaatca cacgacctgg atggagtggg acagagaaat 1440
taacaattac acaagcttaa tacactcctt aattgaagaa tcgcaaaacc agcaagaaaa 1500
gaatgaacaa gaattattgg aattagataa atgggcaagt ttgtggaatt ggtttaacat 1560
aacaaattgg ctgtggtata taaaattatt cataatgata gtaggaggct tggtaggttt 1620
aagaatagtt tttgctgtac tttctatagt gaatagagtt aggcagggat attcaccatt 1680
atcgtttcag acccacctcc caaccccgag gggacccgac aggcccgaag gaatagaaga 1740
agaaggtgga gagagagaca gagacagatc cattcgatta gtgaacggat ctcgacggta 1800
tcggttaact tttaaaagaa aaggggggat tggggggtac agtgcagggg aaagaatagt 1860
agacataata gcaacagaca tacaaactaa agaattacaa aaacaaatta caaaaattca 1920
aaattttatc gatcacgaga ctagcctcga gaagcttgat atcgaattcc cacggggttg 1980
gacgcgtaga ggctccggtg cccgtcagtg ggcagagcgc acatcgccca cagtccccga 2040
gaagttgggg ggaggggtcg gcaattgaac cggtgcctag agaaggtggc gcggggtaaa 2100
ctgggaaagt gatgtcgtgt actggctccg cctttttccc gagggtgggg gagaaccgta 2160
tataagtgca gtagtcgccg tgaacgttct ttttcgcaac gggtttgccg ccagaacaca 2220
gctagcaccg gtgccgccac catgcctctg ggcctgctgt ggctgggcct ggccctgctg 2280
ggcgccctgc acgcccaggc cggcgtgcag gtggagacaa tctccccagg cgacggacgc 2340
acattcccta agcggggcca gacctgcgtg gtgcactata caggcatgct ggaggatggc 2400
aagaagtttg acagctcccg ggatagaaac aagccattca agtttatgct gggcaagcag 2460
gaagtgatca gaggctggga ggagggcgtg gcccagatgt ctgtgggcca gagggccaag 2520
ctgaccatca gcccagacta cgcctatgga gcaacaggcc acccaggaat catcccacct 2580
cacgccaccc tggtgttcga tgtggagctg ctgaagctgg gcgagggatc caacacatca 2640
aaagagaacc cctttctgtt cgcattggag gccgtagtca tatctgttgg atccatggga 2700
cttattatct ccctgttgtg tgtgtacttc tggctggaac ggactatgcc caggatcccc 2760
acgctcaaga atctggaaga tctcgtcaca gaataccatg gtaatttcag cgcctggagc 2820
ggagtctcta agggtctggc cgaatccctc caacccgatt attctgaacg gttgtgcctc 2880
gtatccgaaa taccaccaaa aggcggggct ctgggtgagg gcccaggggc gagtccgtgc 2940
aatcaacaca gcccgtattg ggcccctcct tgttatacgt tgaagcccga aactggaagc 3000
ggagctacta acttcagcct gctgaagcag gctggagacg tggaggagaa ccctggacct 3060
atggcactgc ccgtgaccgc cctgctgctg cctctggccc tgctgctgca cgcagcccgg 3120
cctatcctgt ggcacgagat gtggcacgag ggcctggagg aggccagcag gctgtatttt 3180
ggcgagcgca acgtgaaggg catgttcgag gtgctggagc ctctgcacgc catgatggag 3240
agaggcccac agaccctgaa ggagacatcc tttaaccagg cctatggacg ggacctgatg 3300
gaggcacagg agtggtgcag aaagtacatg aagtctggca atgtgaagga cctgctgcag 3360
gcctgggatc tgtactatca cgtgtttcgg agaatctcca agggcaaaga cacgattccg 3420
tggcttgggc atctgctcgt tgggctgagt ggtgcgtttg gtttcatcat cttggtctat 3480
ctcttgatca attgcagaaa tacaggccct tggctgaaaa aagtgctcaa gtgtaatacc 3540
cccgacccaa gcaagttctt ctcccagctt tcttcagagc atggaggcga tgtgcagaaa 3600
tggctctctt caccttttcc ctcctcaagc ttctccccgg gagggctggc gcccgagatt 3660
tcacctcttg aggtacttga acgagacaag gttacccaac ttctccttca acaggataag 3720
gtacccgaac ctgcgagcct tagctccaac cactctctta cgagctgctt caccaatcag 3780
ggatacttct ttttccacct tcccgatgcg ctggaaatcg aagcttgtca agtttacttt 3840
acctatgatc catatagcga ggaagatccc gacgaaggag tcgccggtgc gcccacgggt 3900
tcctcacccc aacctctcca gcctctctca ggagaagatg atgcttattg cacttttccc 3960
agtagagacg atctcctcct cttttctcca tctcttttgg ggggaccttc ccccccttct 4020
acggcacctg gcgggtctgg tgctggcgag gagcggatgc cgccgtccct ccaggagcga 4080
gtaccacgag attgggatcc ccagccactt ggacccccca cccccggcgt acctgacctt 4140
gtcgattttc aacctccccc tgaattggtg ctgcgagagg ctggggagga agttccggac 4200
gctgggccga gggagggcgt gtcctttcca tggagtaggc ctccaggtca aggcgagttt 4260
agggctctca acgcgcggct gccgttgaat acagacgctt atctctcact gcaggaactg 4320
caaggtcagg acccaacaca tcttgtagga tctggtgcta ctaatttttc tcttttgaag 4380
caagctggag atgttgaaga gaaccccggt ccggtgagca agggcgagga ggataacatg 4440
gccatcatca aggagttcat gcgcttcaag gtgcacatgg agggctccgt gaacggccac 4500
gagttcgaga tcgagggcga gggcgagggc cgcccctacg agggcaccca gaccgccaag 4560
ctgaaggtga ccaagggtgg ccccctgccc ttcgcctggg acatcctgtc ccctcagttc 4620
atgtacggct ccaaggccta cgtgaagcac cccgccgaca tccccgacta cttgaagctg 4680
tccttccccg agggcttcaa gtgggagcgc gtgatgaact tcgaggacgg cggcgtggtg 4740
accgtgaccc aggactcctc tctgcaggac ggcgagttca tctacaaggt gaagctgcgc 4800
ggcaccaact tcccctccga cggccccgta atgcagaaga agaccatggg ctgggaggcc 4860
tcctccgagc ggatgtaccc cgaggacggc gccctgaagg gcgagatcaa gcagaggctg 4920
aagctgaagg acggcggcca ctacgacgct gaggtcaaga ccacctacaa ggccaagaag 4980
cccgtgcagc tgcccggcgc ctacaacgtc aacatcaagt tggacatcac ctcccacaac 5040
gaggactaca ccatcgtgga acagtacgaa cgcgccgagg gccgccactc caccggcggc 5100
atggacgagc tgtacaagtg aactagtgtc gacaatcaac ctctggatta caaaatttgt 5160
gaaagattga ctggtattct taactatgtt gctcctttta cgctatgtgg atacgctgct 5220
ttaatgcctt tgtatcatgc tattgcttcc cgtatggctt tcattttctc ctccttgtat 5280
aaatcctggt tgctgtctct ttatgaggag ttgtggcccg ttgtcaggca acgtggcgtg 5340
gtgtgcactg tgtttgctga cgcaaccccc actggttggg gcattgccac cacctgtcag 5400
ctcctttccg ggactttcgc tttccccctc cctattgcca cggcggaact catcgccgcc 5460
tgccttgccc gctgctggac aggggctcgg ctgttgggca ctgacaattc cgtggtgttg 5520
tcggggaagc tgacgtcctt tccatggctg ctcgcctgtg ttgccacctg gattctgcgc 5580
gggacgtcct tctgctacgt cccttcggcc ctcaatccag cggaccttcc ttcccgcggc 5640
ctgctgccgg ctctgcggcc tcttccgcgt cttcgccttc gccctcagac gagtcggatc 5700
tccctttggg ccgcctcccc gcctggaatt cgagctcggt acctttaaga ccaatgactt 5760
acaaggcagc tgtagatctt agccactttt taaaagaaaa ggggggactg gaagggctaa 5820
ttcactccca acgaagacaa gatctgcttt ttgcttgtac tgggtctctc tggttagacc 5880
agatctgagc ctgggagctc tctggctaac tagggaaccc actgcttaag cctcaataaa 5940
gcttgccttg agtgcttcaa gtagtgtgtg cccgtctgtt gtgtgactct ggtaactaga 6000
gatccctcag acccttttag tcagtgtgga aaatctctag cagtagtagt tcatgtcatc 6060
ttattattca gtatttataa cttgcaaaga aatgaatatc agagagtgag aggaacttgt 6120
ttattgcagc ttataatggt tacaaataaa gcaatagcat cacaaatttc acaaataaag 6180
catttttttc actgcattct agttgtggtt tgtccaaact catcaatgta tcttatcatg 6240
tctggctcta gctatcccgc ccctaactcc gcccagttcc gcccattctc cgccccatgg 6300
ctgactaatt ttttttattt atgcagaggc cgaggccgcc tcggcctctg agctattcca 6360
gaagtagtga ggaggctttt ttggaggcct aggcttttgc gtcgagacgt acccaattcg 6420
ccctatagtg agtcgtatta cgcgcgctca ctggccgtcg ttttacaacg tcgtgactgg 6480
gaaaaccctg gcgttaccca acttaatcgc cttgcagcac atcccccttt cgccagctgg 6540
cgtaatagcg aagaggcccg caccgatcgc ccttcccaac agttgcgcag cctgaatggc 6600
gaatggcgcg acgcgccctg tagcggcgca ttaagcgcgg cgggtgtggt ggttacgcgc 6660
agcgtgaccg ctacacttgc cagcgcccta gcgcccgctc ctttcgcttt cttcccttcc 6720
tttctcgcca cgttcgccgg ctttccccgt caagctctaa atcgggggct ccctttaggg 6780
ttccgattta gtgctttacg gcacctcgac cccaaaaaac ttgattaggg tgatggttca 6840
cgtagtgggc catcgccctg atagacggtt tttcgccctt tgacgttgga gtccacgttc 6900
tttaatagtg gactcttgtt ccaaactgga acaacactca accctatctc ggtctattct 6960
tttgatttat aagggatttt gccgatttcg gcctattggt taaaaaatga gctgatttaa 7020
caaaaattta acgcgaattt taacaaaata ttaacgttta caatttccca ggtggcactt 7080
ttcggggaaa tgtgcgcgga acccctattt gtttattttt ctaaatacat tcaaatatgt 7140
atccgctcat gagacaataa ccctgataaa tgcttcaata atattgaaaa aggaagagta 7200
tgagtattca acatttccgt gtcgccctta ttcccttttt tgcggcattt tgccttcctg 7260
tttttgctca cccagaaacg ctggtgaaag taaaagatgc tgaagatcag ttgggtgcac 7320
gagtgggtta catcgaactg gatctcaaca gcggtaagat ccttgagagt tttcgccccg 7380
aagaacgttt tccaatgatg agcactttta aagttctgct atgtggcgcg gtattatccc 7440
gtattgacgc cgggcaagag caactcggtc gccgcataca ctattctcag aatgacttgg 7500
ttgagtactc accagtcaca gaaaagcatc ttacggatgg catgacagta agagaattat 7560
gcagtgctgc cataaccatg agtgataaca ctgcggccaa cttacttctg acaacgatcg 7620
gaggaccgaa ggagctaacc gcttttttgc acaacatggg ggatcatgta actcgccttg 7680
atcgttggga accggagctg aatgaagcca taccaaacga cgagcgtgac accacgatgc 7740
ctgtagcaat ggcaacaacg ttgcgcaaac tattaactgg cgaactactt actctagctt 7800
cccggcaaca attaatagac tggatggagg cggataaagt tgcaggacca cttctgcgct 7860
cggcccttcc ggctggctgg tttattgctg ataaatctgg agccggtgag cgtgggtctc 7920
gcggtatcat tgcagcactg gggccagatg gtaagccctc ccgtatcgta gttatctaca 7980
cgacggggag tcaggcaact atggatgaac gaaatagaca gatcgctgag ataggtgcct 8040
cactgattaa gcattggtaa ctgtcagacc aagtttactc atatatactt tagattgatt 8100
taaaacttca tttttaattt aaaaggatct aggtgaagat cctttttgat aatctcatga 8160
ccaaaatccc ttaacgtgag ttttcgttcc actgagcgtc agaccccgta gaaaagatca 8220
aaggatcttc ttgagatcct ttttttctgc gcgtaatctg ctgcttgcaa acaaaaaaac 8280
caccgctacc agcggtggtt tgtttgccgg atcaagagct accaactctt tttccgaagg 8340
taactggctt cagcagagcg cagataccaa atactgtcct tctagtgtag ccgtagttag 8400
gccaccactt caagaactct gtagcaccgc ctacatacct cgctctgcta atcctgttac 8460
cagtggctgc tgccagtggc gataagtcgt gtcttaccgg gttggactca agacgatagt 8520
taccggataa ggcgcagcgg tcgggctgaa cggggggttc gtgcacacag cccagcttgg 8580
agcgaacgac ctacaccgaa ctgagatacc tacagcgtga gctatgagaa agcgccacgc 8640
ttcccgaagg gagaaaggcg gacaggtatc cggtaagcgg cagggtcgga acaggagagc 8700
gcacgaggga gcttccaggg ggaaacgcct ggtatcttta tagtcctgtc gggtttcgcc 8760
acctctgact tgagcgtcga tttttgtgat gctcgtcagg ggggcggagc ctatggaaaa 8820
acgccagcaa cgcggccttt ttacggttcc tggccttttg ctggcctttt gctcacatgt 8880
tctttcctgc gttatcccct gattctgtgg ataaccgtat taccgccttt gagtgagctg 8940
ataccgctcg ccgcagccga acgaccgagc gcagcgagtc agtgagcgag gaagcggaag 9000
agcgcccaat acgcaaaccg cctctccccg cgcgttggcc gattcattaa tgcagctggc 9060
acgacaggtt tcccgactgg aaagcgggca gtgagcgcaa cgcaattaat gtgagttagc 9120
tcactcatta ggcaccccag gctttacact ttatgcttcc ggctcgtatg ttgtgtggaa 9180
ttgtgagcgg ataacaattt cacacaggaa acagctatga ccatgattac gccaagcgcg 9240
caattaaccc tcactaaagg gaacaaaagc tggagctgca                       9280

<210> 1446
<211> 7682
<212> DNA
<213> Artificial Sequence

<220> 
<223> Construct 3354

<400> 1446
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtacc 1020
ctattaaata aaagaataag cagtattatt aagtagccct gcatttcagg tttccttgag 1080
tggcaggcca ggcctggccg tgaacgttca ctgaaatcat ggcctcttgg ccaagattga 1140
tagcttgtgc ctgtccctga gtcccagtcc atcacgagca gctggtttct aagatgctat 1200
ttcccgtata aagcatgaga ccgtgacttg ccagccccac agagccccgc ccttgtccat 1260
cactggcatc tggactccag cctgggttgg ggcaaagagg gaaatgagat catgtcctac 1320
gcgtaggaac agagaaacag gagaatatgg gccaaacagg atatctgtgg taagcagttc 1380
ctgccccggc tcagggccaa gaacagttgg aacagcagaa tatgggccaa acaggatatc 1440
tgtggtaagc agttcctgcc ccggctcagg gccaagaaca gatggtcccc agatgcggtc 1500
ccgccctcag cagtttctag agaaccatca gatgtttcca gggtgcccca aggacctgaa 1560
atgaccctgt gccttatttg aactaaccaa tcagttcgct tctcgcttct gttcgcgcgc 1620
ttctgctccc cgagctctat ataagcagag ctcgtttagt gaaccgtcag atcgcctgga 1680
gacgccatcc acgctgtttt gacttccata gaaggatcat ggctctgcca gtgacagctc 1740
tgctgcttcc tctggctctg ttgctgcatg ccgccagacc tattctgtgg cacgagatgt 1800
ggcatgaagg cctggaagag gcctccagac tgtacttcgg cgagagaaac gtgaagggca 1860
tgttcgaggt gctggaaccc ctgcatgcca tgatggaaag aggccctcag acactgaaag 1920
agacaagctt caaccaggcc tacggccggg atctgatgga agcccaagag tggtgccgga 1980
agtacatgaa gtccggcaat gtgaaggacc tcctgcaggc atgggacctg tactaccacg 2040
tgttccggcg gatctctaag ggcaaagaca cgattccgtg gcttgggcat ctgctcgttg 2100
ggctgagtgg tgcgtttggt ttcatcatct tggtctatct cttgatcaat tgcagaaata 2160
caggcccttg gctgaaaaaa gtgctcaagt gtaatacccc cgacccaagc aagttcttct 2220
cccagctttc ttcagagcat ggaggcgatg tgcagaaatg gctctcttca ccttttccct 2280
cctcaagttt ctccccggga gggctggcgc ccgagatttc acctcttgag gtacttgaac 2340
gagacaaggt tacccaactt ctccttcaac aggataaagt acccgaacct gcgagcctta 2400
gctccaacca ctctcttacg agctgcttca ccaatcaggg atacttcttt ttccaccttc 2460
ccgatgcgct ggaaatcgaa gcatgtcaag tttactttac ctatgatcca tatagcgagg 2520
aagatcccga cgaaggagtc gccggtgcgc ccacgggttc ctcaccccaa cctctccagc 2580
ctctctcagg agaagatgat gcttattgca cttttcccag tagagacgat ctcctcctct 2640
tttctccatc tcttttgggg ggaccttccc ccccttctac ggcacctggc gggtctggtg 2700
ctggcgagga gcggatgccg ccgtccctcc aggagcgagt accacgagat tgggatcccc 2760
agccacttgg accccccacc cccggcgtac ctgaccttgt cgattttcaa cctccccctg 2820
aattggtgct gcgagaggct ggggaggaag ttccggacgc tgggccgagg gagggcgtgt 2880
cctttccatg gagtaggcct ccaggtcaag gcgagtttag ggctctcaac gcgcggctgc 2940
cgttgaatac agacgcttat ctctcactgc aggaactgca aggtcaggac ccaacacatc 3000
ttgtaggatc cggcgccacc aactttagtc tgctcaagca agccggggac gtcgaggaaa 3060
atcctgggcc aatgggatca agactgctgt gctgggtgct gctgtgcctg ctgggagccg 3120
gacctgtgaa agccggggtg actcagactc cacgatacct gatcaagacc aggggccagc 3180
aggtgacact gtcttgcagc ccaatctccg gacaccgctc cgtgtcttgg taccagcaga 3240
cccctggaca gggactgcag ttcctgtttg agtatttctc tgagacacag cggaacaagg 3300
gcaatttccc cggccggttt agcggcagac agtttagcaa ctccaggtct gagatgaatg 3360
tgagcaccct ggagctgggc gactccgccc tgtacctgtg cgcaagctcc ctggccctgg 3420
gacaggggaa tcagcagttt ttcggacccg gaacaaggct gaccgtgctg gaggatctac 3480
gtaacgtgac accacccaaa gtctcactgt ttgagcctag caaggcagaa attgccaaca 3540
agcagaaggc caccctggtg tgcctggcaa gagggttctt tccagatcac gtggagctgt 3600
cctggtgggt caacggcaaa gaagtgcatt ctggggtctg caccgacccc caggcttaca 3660
aggagagtaa ttactcatat tgtctgtcaa gccggctgag agtgtccgcc acattctggc 3720
acaaccctag gaatcatttc cgctgccagg tccagtttca cggcctgagt gaggaagata 3780
aatggccaga ggggtcacct aagccagtga cacagaacat cagcgcagaa gcctggggac 3840
gagcagactg tggcattact agcgcctcct atcatcaggg cgtgctgagc gccactatcc 3900
tgtacgagat tctgctggga aaggccaccc tgtatgctgt gctggtctcc ggcctggtgc 3960
tgatggccat ggtcaagaaa aagaactctg ggagtggagc cacaaatttc tctctgctga 4020
aacaggctgg agatgtggag gaaaaccccg gccctatgaa gagcctgcgc gtgctgctgg 4080
tcatcctgtg gctgcaattg agttgggtgt ggagccagaa ggaccaggtg tttcagccta 4140
gcactgtcgc atcatcagag ggggccgtcg tggaaatctt ttgtaatcac agcgtgtcca 4200
acgcctacaa tttcttttgg tatctgcact tcccaggatg cgcacctagg ctgctggtga 4260
agggctctaa gcccagccag cagggccggt acaacatgac ctatgagcgg ttcagctcct 4320
ctctgctgat cctgcaggtg cgggaggcag acgcagccgt gtactattgt gccgtggagg 4380
atctgaatca ggccggcaca gccctgattt tcggcaaagg aacaaccctg agcgtgagca 4440
gcatccagaa ccctgaccca gccgtatacc agctgagaga ctctaaatcc agtgacaagt 4500
ctgtctgcct attcaccgat tttgattctc aaacaaatgt gtcacaaagt aaggattctg 4560
atgtgtatat cacagacaaa actgtgctag acatgaggtc tatggacttc aagagcaaca 4620
gtgctgtggc ctggagcaac aaatctgact ttgcatgtgc aaacgccttc aacaacagca 4680
ttattccaga agacaccttc ttccccagcc caggtaaggg cagctttggt gccttcgcag 4740
gctgtttcct tgcttcagga atggatccta cgtagataag tagcatggcg ggttaatcat 4800
taactacaag gaacccctag tgatggagtt ggccactccc tctctgcgcg ctcgctcgct 4860
cactgaggcc gggcgaccaa aggtcgcccg acgcccgggc tttgcccggg cggcctcagt 4920
gagcgagcga gcgcgccagc tggcgtaata gcgaagaggc ccgcaccgat cgcccttccc 4980
aacagttgcg cagcctgaat ggcgaatggc gattccgttg caatggctgg cggtaatatt 5040
gttctggata ttaccagcaa ggccgatagt ttgagttctt ctactcaggc aagtgatgtt 5100
attactaatc aaagaagtat tgcgacaacg gttaatttgc gtgatggaca gactctttta 5160
ctcggtggcc tcactgatta taaaaacact tctcaggatt ctggcgtacc gttcctgtct 5220
aaaatccctt taatcggcct cctgtttagc tcccgctctg attctaacga ggaaagcacg 5280
ttatacgtgc tcgtcaaagc aaccatagta cgcgccctgt agcggcgcat taagcgcggc 5340
gggtgtggtg gttacgcgca gcgtgaccgc tacacttgcc agcgccctag cgcccgctcc 5400
tttcgctttc ttcccttcct ttctcgccac gttcgccggc tttccccgtc aagctctaaa 5460
tcgggggctc cctttagggt tccgatttag tgctttacgg cacctcgacc ccaaaaaact 5520
tgattagggt gatggttcac gtagtgggcc atcgccctga tagacggttt ttcgcccttt 5580
gacgttggag tccacgttct ttaatagtgg actcttgttc caaactggaa caacactcaa 5640
ccctatctcg gtctattctt ttgatttata agggattttg ccgatttcgg cctattggtt 5700
aaaaaatgag ctgatttaac aaaaatttaa cgcgaatttt aacaaaatat taacgtttac 5760
aatttaaata tttgcttata caatcttcct gtttttgggg cttttctgat tatcaaccgg 5820
ggtacatatg attgacatgc tagttttacg attaccgttc atcgattctc ttgtttgctc 5880
cagactctca ggcaatgacc tgatagcctt tgtagagacc tctcaaaaat agctaccctc 5940
tccggcatga atttatcagc tagaacggtt gaatatcata ttgatggtga tttgactgtc 6000
tccggccttt ctcacccgtt tgaatcttta cctacacatt actcaggcat tgcatttaaa 6060
atatatgagg gttctaaaaa tttttatcct tgcgttgaaa taaaggcttc tcccgcaaaa 6120
gtattacagg gtcataatgt ttttggtaca accgatttag ctttatgctc tgaggcttta 6180
ttgcttaatt ttgctaattc tttgccttgc ctgtatgatt tattggatgt tggaatcgcc 6240
tgatgcggta ttttctcctt acgcatctgt gcggtatttc acaccgcata tggtgcactc 6300
tcagtacaat ctgctctgat gccgcatagt taagccagcc ccgacacccg ccaacacccg 6360
ctgacgcgcc ctgacgggct tgtctgctcc cggcatccgc ttacagacaa gctgtgaccg 6420
tctccgggag ctgcatgtgt cagaggtttt caccgtcatc accgaaacgc gcgagacgaa 6480
agggcctcgt gatacgccta tttttatagg ttaatgtcat gataataatg gtttcttaga 6540
cgtcaggtgg cacttttcgg ggaaatgtgc gcggaacccc tatttgttta tttttctaaa 6600
tacattcaaa tatgtatccg ctcatgagac aataaccctg ataaatgctt caataatatt 6660
gaaaaaggaa gagtatgagt attcaacatt tccgtgtcgc ccttattccc ttttttgcgg 6720
cattttgcct tcctgttttt gctcacccag aaacgctggt gaaagtaaaa gatgctgaag 6780
atcagttggg tgcacgagtg ggttacatcg aactggatct caacagcggt aagatccttg 6840
agagttttcg ccccgaagaa cgttttccaa tgatgagcac ttttaaagtt ctgctatgtg 6900
gcgcggtatt atcccgtatt gacgccgggc aagagcaact cggtcgccgc atacactatt 6960
ctcagaatga cttggttgag tactcaccag tcacagaaaa gcatcttacg gatggcatga 7020
cagtaagaga attatgcagt gctgccataa ccatgagtga taacactgcg gccaacttac 7080
ttctgacaac gatcggagga ccgaaggagc taaccgcttt tttgcacaac atgggggatc 7140
atgtaactcg ccttgatcgt tgggaaccgg agctgaatga agccatacca aacgacgagc 7200
gtgacaccac gatgcctgta gcaatggcaa caacgttgcg caaactatta actggcgaac 7260
tacttactct agcttcccgg caacaattaa tagactggat ggaggcggat aaagttgcag 7320
gaccacttct gcgctcggcc cttccggctg gctggtttat tgctgataaa tctggagccg 7380
gtgagcgtgg gtctcgcggt atcattgcag cactggggcc agatggtaag ccctcccgta 7440
tcgtagttat ctacacgacg gggagtcagg caactatgga tgaacgaaat agacagatcg 7500
ctgagatagg tgcctcactg attaagcatt ggtaactgtc agaccaagtt tactcatata 7560
tactttagat tgatttaaaa cttcattttt aatttaaaag gatctaggtg aagatccttt 7620
ttgataatct catgaccaaa atcccttaac gtgagttttc gttccactga gcgtcagacc 7680
cc                                                                7682

<210> 1447
<211> 7017
<212> DNA
<213> Artificial Sequence

<220> 
<223> Construct 3362

<400> 1447
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtagc 1020
ggccgcagcc tgtgcagggt gcagggaggg ctagaggcct gaggcttgaa acagctctca 1080
agtggagggg gaaacaacca ttgccctcat agaggacaca tccacaccag ggctgtgcta 1140
gcgtgggcag gcaagccagg tgctggacct ctgcacgtgg ggcatgtgtg ggtatgtaca 1200
tgtacctgtg ttcttggtgt gtgtgtgtgt gtgtgtgtgt gtgtgtgtct agagctgggg 1260
tgcaactatg gggcccctcg ggacatgtcc cagccaatgc ctgctttgac cagaggagtg 1320
tccacgtggc tcaggtggtc gagtatctca taccgcccta gcacacgtgt gactcctttc 1380
ccctattgtc tacgcagcct gcccttggac aaggacccga tgcccaaccc caggcctggc 1440
aagccctcgg ccccttcctt ggcccttggc ccatccccac gcgtaggaac agagaaacag 1500
gagaatatgg gccaaacagg atatctgtgg taagcagttc ctgccccggc tcagggccaa 1560
gaacagttgg aacagcagaa tatgggccaa acaggatatc tgtggtaagc agttcctgcc 1620
ccggctcagg gccaagaaca gatggtcccc agatgcggtc ccgccctcag cagtttctag 1680
agaaccatca gatgtttcca gggtgcccca aggacctgaa atgaccctgt gccttatttg 1740
aactaaccaa tcagttcgct tctcgcttct gttcgcgcgc ttctgctccc cgagctctat 1800
ataagcagag ctcgtttagt gaaccgtcag atcgcctgga gacgccatcc acgctgtttt 1860
gacttccata gaaggatctc gaggccacca tgcctctggg cctgctgtgg ctgggcctgg 1920
ccctgctggg cgccctgcac gcccaggccg agatgtggca cgagggcctg gaggaggcca 1980
gcaggctgta ttttggcgag cgcaacgtga agggcatgtt cgaggtgctg gagcctctgc 2040
acgccatgat ggagagaggc ccacagaccc tgaaggagac atcctttaac caggcctatg 2100
gacgggacct gatggaggca caggagtggt gcagaaagta catgaagtct ggcaatgtga 2160
aggacctgct gcaggcctgg gatctgtact atcacgtgtt tcggagaatc tccaagggca 2220
aagacacgat tccgtggctt gggcatctgc tcgttgggct gagtggtgcg tttggtttca 2280
tcatcttggt ctatctcttg atcaattgca gaaatacagg cccttggctg aaaaaagtgc 2340
tcaagtgtaa tacccccgac ccaagcaagt tcttctccca gctttcttca gagcatggag 2400
gcgatgtgca gaaatggctc tcttcacctt ttccctcctc aagtttctcc ccgggagggc 2460
tggcgcccga gatttcacct cttgaggtac ttgaacgaga caaggttacc caacttctcc 2520
ttcaacagga taaggtaccc gaacctgcga gccttagctc caaccactct cttacgagct 2580
gcttcaccaa tcagggatac ttctttttcc accttcccga tgcgctggaa atcgaagcat 2640
gtcaagttta ctttacctat gatccatata gcgaggaaga tcccgacgaa ggagtcgccg 2700
gtgcgcccac gggttcctca ccccaacctc tccagcctct ctcaggagaa gatgatgctt 2760
attgcacttt tcccagtaga gacgatctcc tcctcttttc tccatctctt ttggggggac 2820
cttccccccc ttctacggca cctggcgggt ctggtgctgg cgaggagcgg atgccgccgt 2880
ccctccagga gcgagtacca cgagattggg atccccagcc acttggacca ccaactccag 2940
gcgtacctga ccttgtcgat tttcaacctc cccctgaatt ggtgctgcga gaggctgggg 3000
aggaagttcc ggacgctggg ccgagggagg gcgtgtcctt tccatggagt aggcctccag 3060
gtcaaggcga gtttagggct ctcaacgcgc ggctgccgtt gaatacagac gcttatctct 3120
cactgcagga actgcaaggt caggacccaa cacatcttgt aggatccggc gccaccaact 3180
ttagtctgct caagcaagcc ggggacgtcg aggaaaatcc tgggccagaa atgtggcacg 3240
aaggactcga ggaagccagt cggctgtatt ttggcgagcg gaatgtgaaa gggatgtttg 3300
aagtgctcga gcctctccac gctatgatgg aacggggacc ccagactctc aaagaaacca 3360
gctttaatca ggcttacgga cgcgacctca tggaagctca agaatggtgt agaaagtata 3420
tgaagagtgg caacgtgaaa gatctgctgc aagcctggga tctctattat cacgtgttca 3480
gacgcatcag caaaggcagc ggcgccacaa atttctccct gctgaaacag gccggcgacg 3540
tggaagagaa tcccggacct tatccatacg atgtcccaga ttatgcgccc aatcctagac 3600
ctggcaagcc cagcgctcct tctcttgctc ttggaccttc tcctggtgcc tcgcccagct 3660
ggagggctgc acccaaagcc tcagacctgc tgggggcccg gggcccaggg ggaaccttcc 3720
agggccgaga tcttcgaggc ggggcccatg cctcctcttc ttccttgaac cccatgccac 3780
catcgcagct gcaggtgagg ccctgggccc aggatggggc aggcagggtg gggtacctgg 3840
acctacaggt gccgaccttt actgtggcac tgggcgggag gggggctggc tggggcacag 3900
gaagtggttt ctgggtccca ggcaagtctg tgacttatgc agatgttgca gggccaagaa 3960
aatccccacc tgccaggcct cagagattgg aggctctccc cgacctccca atccctgtct 4020
caggagagga ggaggccgta ttgtagtccc atgagcatag ctatgtgtcc ccatccccat 4080
gtgacaagag aagaggagga tcctacgtag ataagtagca tggcgggtta atcattaact 4140
acaaggaacc cctagtgatg gagttggcca ctccctctct gcgcgctcgc tcgctcactg 4200
aggccgggcg accaaaggtc gcccgacgcc cgggctttgc ccgggcggcc tcagtgagcg 4260
agcgagcgcg ccagctggcg taatagcgaa gaggcccgca ccgatcgccc ttcccaacag 4320
ttgcgcagcc tgaatggcga atggcgattc cgttgcaatg gctggcggta atattgttct 4380
ggatattacc agcaaggccg atagtttgag ttcttctact caggcaagtg atgttattac 4440
taatcaaaga agtattgcga caacggttaa tttgcgtgat ggacagactc ttttactcgg 4500
tggcctcact gattataaaa acacttctca ggattctggc gtaccgttcc tgtctaaaat 4560
ccctttaatc ggcctcctgt ttagctcccg ctctgattct aacgaggaaa gcacgttata 4620
cgtgctcgtc aaagcaacca tagtacgcgc cctgtagcgg cgcattaagc gcggcgggtg 4680
tggtggttac gcgcagcgtg accgctacac ttgccagcgc cctagcgccc gctcctttcg 4740
ctttcttccc ttcctttctc gccacgttcg ccggctttcc ccgtcaagct ctaaatcggg 4800
ggctcccttt agggttccga tttagtgctt tacggcacct cgaccccaaa aaacttgatt 4860
agggtgatgg ttcacgtagt gggccatcgc cctgatagac ggtttttcgc cctttgacgt 4920
tggagtccac gttctttaat agtggactct tgttccaaac tggaacaaca ctcaacccta 4980
tctcggtcta ttcttttgat ttataaggga ttttgccgat ttcggcctat tggttaaaaa 5040
atgagctgat ttaacaaaaa tttaacgcga attttaacaa aatattaacg tttacaattt 5100
aaatatttgc ttatacaatc ttcctgtttt tggggctttt ctgattatca accggggtac 5160
atatgattga catgctagtt ttacgattac cgttcatcga ttctcttgtt tgctccagac 5220
tctcaggcaa tgacctgata gcctttgtag agacctctca aaaatagcta ccctctccgg 5280
catgaattta tcagctagaa cggttgaata tcatattgat ggtgatttga ctgtctccgg 5340
cctttctcac ccgtttgaat ctttacctac acattactca ggcattgcat ttaaaatata 5400
tgagggttct aaaaattttt atccttgcgt tgaaataaag gcttctcccg caaaagtatt 5460
acagggtcat aatgtttttg gtacaaccga tttagcttta tgctctgagg ctttattgct 5520
taattttgct aattctttgc cttgcctgta tgatttattg gatgttggaa tcgcctgatg 5580
cggtattttc tccttacgca tctgtgcggt atttcacacc gcatatggtg cactctcagt 5640
acaatctgct ctgatgccgc atagttaagc cagccccgac acccgccaac acccgctgac 5700
gcgccctgac gggcttgtct gctcccggca tccgcttaca gacaagctgt gaccgtctcc 5760
gggagctgca tgtgtcagag gttttcaccg tcatcaccga aacgcgcgag acgaaagggc 5820
ctcgtgatac gcctattttt ataggttaat gtcatgataa taatggtttc ttagacgtca 5880
ggtggcactt ttcggggaaa tgtgcgcgga acccctattt gtttattttt ctaaatacat 5940
tcaaatatgt atccgctcat gagacaataa ccctgataaa tgcttcaata atattgaaaa 6000
aggaagagta tgagtattca acatttccgt gtcgccctta ttcccttttt tgcggcattt 6060
tgccttcctg tttttgctca cccagaaacg ctggtgaaag taaaagatgc tgaagatcag 6120
ttgggtgcac gagtgggtta catcgaactg gatctcaaca gcggtaagat ccttgagagt 6180
tttcgccccg aagaacgttt tccaatgatg agcactttta aagttctgct atgtggcgcg 6240
gtattatccc gtattgacgc cgggcaagag caactcggtc gccgcataca ctattctcag 6300
aatgacttgg ttgagtactc accagtcaca gaaaagcatc ttacggatgg catgacagta 6360
agagaattat gcagtgctgc cataaccatg agtgataaca ctgcggccaa cttacttctg 6420
acaacgatcg gaggaccgaa ggagctaacc gcttttttgc acaacatggg ggatcatgta 6480
actcgccttg atcgttggga accggagctg aatgaagcca taccaaacga cgagcgtgac 6540
accacgatgc ctgtagcaat ggcaacaacg ttgcgcaaac tattaactgg cgaactactt 6600
actctagctt cccggcaaca attaatagac tggatggagg cggataaagt tgcaggacca 6660
cttctgcgct cggcccttcc ggctggctgg tttattgctg ataaatctgg agccggtgag 6720
cgtgggtctc gcggtatcat tgcagcactg gggccagatg gtaagccctc ccgtatcgta 6780
gttatctaca cgacggggag tcaggcaact atggatgaac gaaatagaca gatcgctgag 6840
ataggtgcct cactgattaa gcattggtaa ctgtcagacc aagtttactc atatatactt 6900
tagattgatt taaaacttca tttttaattt aaaaggatct aggtgaagat cctttttgat 6960
aatctcatga ccaaaatccc ttaacgtgag ttttcgttcc actgagcgtc agacccc    7017

<210> 1448
<211> 7148
<212> DNA
<213> Artificial Sequence

<220> 
<223> Construct 3363

<400> 1448
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtacc 1020
ctattaaata aaagaataag cagtattatt aagtagccct gcatttcagg tttccttgag 1080
tggcaggcca ggcctggccg tgaacgttca ctgaaatcat ggcctcttgg ccaagattga 1140
tagcttgtgc ctgtccctga gtcccagtcc atcacgagca gctggtttct aagatgctat 1200
ttcccgtata aagcatgaga ccgtgacttg ccagccccac agagccccgc ccttgtccat 1260
cactggcatc tggactccag cctgggttgg ggcaaagagg gaaatgagat catgtcctac 1320
gcgtaggaac agagaaacag gagaatatgg gccaaacagg atatctgtgg taagcagttc 1380
ctgccccggc tcagggccaa gaacagttgg aacagcagaa tatgggccaa acaggatatc 1440
tgtggtaagc agttcctgcc ccggctcagg gccaagaaca gatggtcccc agatgcggtc 1500
ccgccctcag cagtttctag agaaccatca gatgtttcca gggtgcccca aggacctgaa 1560
atgaccctgt gccttatttg aactaaccaa tcagttcgct tctcgcttct gttcgcgcgc 1620
ttctgctccc cgagctctat ataagcagag ctcgtttagt gaaccgtcag atcgcctgga 1680
gacgccatcc acgctgtttt gacttccata gaaggatcat gcctctgggc ctgctgtggc 1740
tgggcctggc cctgctgggc gccctgcacg cccaggccgg cgtgcaggtg gagacaatct 1800
ccccaggcga cggacgcaca ttccctaagc ggggccagac ctgcgtggtg cactatacag 1860
gcatgctgga ggatggcaag aagtttgaca gctcccggga tagaaacaag ccattcaagt 1920
ttatgctggg caagcaggaa gtgatcagag gctgggagga gggcgtggcc cagatgtctg 1980
tgggccagag ggccaagctg accatcagcc cagactacgc ctatggagca acaggccacc 2040
caggaatcat cccacctcac gccaccctgg tgttcgatgt ggagctgctg aagctgggcg 2100
agggatccaa cacatcaaaa gagaacccct ttctgttcgc attggaggcc gtagtcatat 2160
ctgttggatc catgggactt attatctccc tgttgtgtgt gtacttctgg ctggaacgga 2220
ctatgcccag gatccccacg ctcaagaatc tggaagatct cgtcacagaa taccatggta 2280
atttcagcgc ctggagcgga gtctctaagg gtctggccga atccctccaa cccgattatt 2340
ctgaacggtt gtgcctcgta tccgaaatac caccaaaagg cggggctctg ggtgagggcc 2400
caggggcgag tccgtgcaat caacacagcc cgtattgggc ccctccttgt tatacgttga 2460
agcccgaaac tggatccggc gccaccaact ttagtctgct caagcaagcc ggggacgtcg 2520
aggaaaatcc tgggccaatg ggatcaagac tgctgtgctg ggtgctgctg tgcctgctgg 2580
gagccggacc tgtgaaagcc ggggtgactc agactccacg atacctgatc aagaccaggg 2640
gccagcaggt gacactgtct tgcagcccaa tctccggaca ccgctccgtg tcttggtacc 2700
agcagacccc tggacaggga ctgcagttcc tgtttgagta tttctctgag acacagcgga 2760
acaagggcaa tttccccggc cggtttagcg gcagacagtt tagcaactcc aggtctgaga 2820
tgaatgtgag caccctggag ctgggcgact ccgccctgta cctgtgcgca agctccctgg 2880
ccctgggaca ggggaatcag cagtttttcg gacccggaac aaggctgacc gtgctggagg 2940
atctacgtaa cgtgacacca cccaaagtct cactgtttga gcctagcaag gcagaaattg 3000
ccaacaagca gaaggccacc ctggtgtgcc tggcaagagg gttctttcca gatcacgtgg 3060
agctgtcctg gtgggtcaac ggcaaagaag tgcattctgg ggtctgcacc gacccccagg 3120
cttacaagga gagtaattac tcatattgtc tgtcaagccg gctgagagtg tccgccacat 3180
tctggcacaa ccctaggaat catttccgct gccaggtcca gtttcacggc ctgagtgagg 3240
aagataaatg gccagagggg tcacctaagc cagtgacaca gaacatcagc gcagaagcct 3300
ggggacgagc agactgtggc attactagcg cctcctatca tcagggcgtg ctgagcgcca 3360
ctatcctgta cgagattctg ctgggaaagg ccaccctgta tgctgtgctg gtctccggcc 3420
tggtgctgat ggccatggtc aagaaaaaga actctgggag tggagccaca aatttctctc 3480
tgctgaaaca ggctggagat gtggaggaaa accccggccc tatgaagagc ctgcgcgtgc 3540
tgctggtcat cctgtggctg caattgagtt gggtgtggag ccagaaggac caggtgtttc 3600
agcctagcac tgtcgcatca tcagaggggg ccgtcgtgga aatcttttgt aatcacagcg 3660
tgtccaacgc ctacaatttc ttttggtatc tgcacttccc aggatgcgca cctaggctgc 3720
tggtgaaggg ctctaagccc agccagcagg gccggtacaa catgacctat gagcggttca 3780
gctcctctct gctgatcctg caggtgcggg aggcagacgc agccgtgtac tattgtgccg 3840
tggaggatct gaatcaggcc ggcacagccc tgattttcgg caaaggaaca accctgagcg 3900
tgagcagcat ccagaaccct gacccagccg tataccagct gagagactct aaatccagtg 3960
acaagtctgt ctgcctattc accgattttg attctcaaac aaatgtgtca caaagtaagg 4020
attctgatgt gtatatcaca gacaaaactg tgctagacat gaggtctatg gacttcaaga 4080
gcaacagtgc tgtggcctgg agcaacaaat ctgactttgc atgtgcaaac gccttcaaca 4140
acagcattat tccagaagac accttcttcc ccagcccagg taagggcagc tttggtgcct 4200
tcgcaggctg tttccttgct tcaggaatgg atcctacgta gataagtagc atggcgggtt 4260
aatcattaac tacaaggaac ccctagtgat ggagttggcc actccctctc tgcgcgctcg 4320
ctcgctcact gaggccgggc gaccaaaggt cgcccgacgc ccgggctttg cccgggcggc 4380
ctcagtgagc gagcgagcgc gccagctggc gtaatagcga agaggcccgc accgatcgcc 4440
cttcccaaca gttgcgcagc ctgaatggcg aatggcgatt ccgttgcaat ggctggcggt 4500
aatattgttc tggatattac cagcaaggcc gatagtttga gttcttctac tcaggcaagt 4560
gatgttatta ctaatcaaag aagtattgcg acaacggtta atttgcgtga tggacagact 4620
cttttactcg gtggcctcac tgattataaa aacacttctc aggattctgg cgtaccgttc 4680
ctgtctaaaa tccctttaat cggcctcctg tttagctccc gctctgattc taacgaggaa 4740
agcacgttat acgtgctcgt caaagcaacc atagtacgcg ccctgtagcg gcgcattaag 4800
cgcggcgggt gtggtggtta cgcgcagcgt gaccgctaca cttgccagcg ccctagcgcc 4860
cgctcctttc gctttcttcc cttcctttct cgccacgttc gccggctttc cccgtcaagc 4920
tctaaatcgg gggctccctt tagggttccg atttagtgct ttacggcacc tcgaccccaa 4980
aaaacttgat tagggtgatg gttcacgtag tgggccatcg ccctgataga cggtttttcg 5040
ccctttgacg ttggagtcca cgttctttaa tagtggactc ttgttccaaa ctggaacaac 5100
actcaaccct atctcggtct attcttttga tttataaggg attttgccga tttcggccta 5160
ttggttaaaa aatgagctga tttaacaaaa atttaacgcg aattttaaca aaatattaac 5220
gtttacaatt taaatatttg cttatacaat cttcctgttt ttggggcttt tctgattatc 5280
aaccggggta catatgattg acatgctagt tttacgatta ccgttcatcg attctcttgt 5340
ttgctccaga ctctcaggca atgacctgat agcctttgta gagacctctc aaaaatagct 5400
accctctccg gcatgaattt atcagctaga acggttgaat atcatattga tggtgatttg 5460
actgtctccg gcctttctca cccgtttgaa tctttaccta cacattactc aggcattgca 5520
tttaaaatat atgagggttc taaaaatttt tatccttgcg ttgaaataaa ggcttctccc 5580
gcaaaagtat tacagggtca taatgttttt ggtacaaccg atttagcttt atgctctgag 5640
gctttattgc ttaattttgc taattctttg ccttgcctgt atgatttatt ggatgttgga 5700
atcgcctgat gcggtatttt ctccttacgc atctgtgcgg tatttcacac cgcatatggt 5760
gcactctcag tacaatctgc tctgatgccg catagttaag ccagccccga cacccgccaa 5820
cacccgctga cgcgccctga cgggcttgtc tgctcccggc atccgcttac agacaagctg 5880
tgaccgtctc cgggagctgc atgtgtcaga ggttttcacc gtcatcaccg aaacgcgcga 5940
gacgaaaggg cctcgtgata cgcctatttt tataggttaa tgtcatgata ataatggttt 6000
cttagacgtc aggtggcact tttcggggaa atgtgcgcgg aacccctatt tgtttatttt 6060
tctaaataca ttcaaatatg tatccgctca tgagacaata accctgataa atgcttcaat 6120
aatattgaaa aaggaagagt atgagtattc aacatttccg tgtcgccctt attccctttt 6180
ttgcggcatt ttgccttcct gtttttgctc acccagaaac gctggtgaaa gtaaaagatg 6240
ctgaagatca gttgggtgca cgagtgggtt acatcgaact ggatctcaac agcggtaaga 6300
tccttgagag ttttcgcccc gaagaacgtt ttccaatgat gagcactttt aaagttctgc 6360
tatgtggcgc ggtattatcc cgtattgacg ccgggcaaga gcaactcggt cgccgcatac 6420
actattctca gaatgacttg gttgagtact caccagtcac agaaaagcat cttacggatg 6480
gcatgacagt aagagaatta tgcagtgctg ccataaccat gagtgataac actgcggcca 6540
acttacttct gacaacgatc ggaggaccga aggagctaac cgcttttttg cacaacatgg 6600
gggatcatgt aactcgcctt gatcgttggg aaccggagct gaatgaagcc ataccaaacg 6660
acgagcgtga caccacgatg cctgtagcaa tggcaacaac gttgcgcaaa ctattaactg 6720
gcgaactact tactctagct tcccggcaac aattaataga ctggatggag gcggataaag 6780
ttgcaggacc acttctgcgc tcggcccttc cggctggctg gtttattgct gataaatctg 6840
gagccggtga gcgtgggtct cgcggtatca ttgcagcact ggggccagat ggtaagccct 6900
cccgtatcgt agttatctac acgacgggga gtcaggcaac tatggatgaa cgaaatagac 6960
agatcgctga gataggtgcc tcactgatta agcattggta actgtcagac caagtttact 7020
catatatact ttagattgat ttaaaacttc atttttaatt taaaaggatc taggtgaaga 7080
tcctttttga taatctcatg accaaaatcc cttaacgtga gttttcgttc cactgagcgt 7140
cagacccc                                                          7148

<210> 1449
<211> 7732
<212> DNA
<213> Artificial Sequence

<220> 
<223> Construct 3364

<400> 1449
gtagaaaaga tcaaaggatc ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg 60
caaacaaaaa aaccaccgct accagcggtg gtttgtttgc cggatcaaga gctaccaact 120
ctttttccga aggtaactgg cttcagcaga gcgcagatac caaatactgt ccttctagtg 180
tagccgtagt taggccacca cttcaagaac tctgtagcac cgcctacata cctcgctctg 240
ctaatcctgt taccagtggc tgctgccagt ggcgataagt cgtgtcttac cgggttggac 300
tcaagacgat agttaccgga taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca 360
cagcccagct tggagcgaac gacctacacc gaactgagat acctacagcg tgagctatga 420
gaaagcgcca cgcttcccga agggagaaag gcggacaggt atccggtaag cggcagggtc 480
ggaacaggag agcgcacgag ggagcttcca gggggaaacg cctggtatct ttatagtcct 540
gtcgggtttc gccacctctg acttgagcgt cgatttttgt gatgctcgtc aggggggcgg 600
agcctatgga aaaacgccag caacgcggcc tttttacggt tcctggcctt ttgctggcct 660
tttgctcaca tgttctttcc tgcgttatcc cctgattctg tggataaccg tattaccgcc 720
tttgagtgag ctgataccgc tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc 780
gaggaagcgg aagagcgccc aatacgcaaa ccgcctctcc ccgcgcgttg gccgattcat 840
taatgcagct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 900
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaact 960
ccatcactag gggttccttg tagttaatga ttaacccgcc atgctactta tctacgtagc 1020
ggccgcactg aaatcatggc ctcttggcca agattgatag cttgtgcctg tccctgagtc 1080
ccagtccatc acgagcagct ggtttctaag atgctatttc ccgtataaag catgagaccg 1140
tgacttgcca gccccacaga gccccgccct tgtccatcac tggcatctgg actccagcct 1200
gggttggggc aaagagggaa atgagatcat gtcctaaccc tgatcctctt gtcccacaga 1260
tatccagaac cctgaccctg ccgtgtacca gctgagagac tctaaatcca gtgacaagtc 1320
tgtctgccta tattaaggaa cagagaaaca ggagaatatg ggccaaacag gatatctgtg 1380
gtaagcagtt cctgccccgg ctcagggcca agaacagttg gaacagcaga atatgggcca 1440
aacaggatat ctgtggtaag cagttcctgc cccggctcag ggccaagaac agatggtccc 1500
cagatgcggt cccgccctca gcagtttcta gagaaccatc agatgtttcc agggtgcccc 1560
aaggacctga aatgaccctg tgccttattt gaactaacca atcagttcgc ttctcgcttc 1620
tgttcgcgcg cttctgctcc ccgagctcta tataagcaga gctcgtttag tgaaccgtca 1680
gatcgcctgg agacgccatc cacgctgttt tgacttccat agaaggatcg actcgagtaa 1740
tgcctctggg cctgctgtgg ctgggcctgg ccctgctggg cgccctgcac gcccaggccg 1800
gcgtgcaggt ggagacaatc tccccaggcg acggacgcac attccctaag cggggccaga 1860
cctgcgtggt gcactataca ggcatgctgg aggatggcaa gaagtttgac agctcccggg 1920
atagaaacaa gccattcaag tttatgctgg gcaagcagga agtgatcaga ggctgggagg 1980
agggcgtggc ccagatgtct gtgggccaga gggccaagct gaccatcagc ccagactacg 2040
cctatggagc aacaggccac ccaggaatca tcccacctca cgccaccctg gtgttcgatg 2100
tggagctgct gaagctgggc gagggatcca acacatcaaa agagaacccc tttctgttcg 2160
cattggaggc cgtagtcata tctgttggat ccatgggact tattatctcc ctgttgtgtg 2220
tgtacttctg gctggaacgg actatgccca ggatccccac gctcaagaat ctggaagatc 2280
tcgtcacaga ataccatggt aatttcagcg cctggagcgg agtctctaag ggtctggccg 2340
aatccctcca acccgattat tctgaacggt tgtgcctcgt atccgaaata ccaccaaaag 2400
gcggggctct gggtgagggc ccaggggcga gtccgtgcaa tcaacacagc ccgtattggg 2460
cccctccttg ttatacgttg aagcccgaaa ctggctccgg cgccaccaac tttagtctgc 2520
tcaagcaagc cggggacgtc gaggaaaatc ctgggccaat gggatcaaga ctgctgtgct 2580
gggtgctgct gtgcctgctg ggagccggac ctgtgaaagc cggggtgact cagactccac 2640
gatacctgat caagaccagg ggccagcagg tgacactgtc ttgcagccca atctccggac 2700
accgctccgt gtcttggtac cagcagaccc ctggacaggg actgcagttc ctgtttgagt 2760
atttctctga gacacagcgg aacaagggca atttccccgg ccggtttagc ggcagacagt 2820
ttagcaactc caggtctgag atgaatgtga gcaccctgga gctgggcgac tccgccctgt 2880
acctgtgcgc aagctccctg gccctgggac aggggaatca gcagtttttc ggacccggaa 2940
caaggctgac cgtgctggag gatctacgta acgtgacacc acccaaagtc tcactgtttg 3000
agcctagcaa ggcagaaatt gccaacaagc agaaggccac cctggtgtgc ctggcaagag 3060
ggttctttcc agatcacgtg gagctgtcct ggtgggtcaa cggcaaagaa gtgcattctg 3120
gggtctgcac cgacccccag gcttacaagg agagtaatta ctcatattgt ctgtcaagcc 3180
ggctgagagt gtccgccaca ttctggcaca accctaggaa tcatttccgc tgccaggtcc 3240
agtttcacgg cctgagtgag gaagataaat ggccagaggg gtcacctaag ccagtgacac 3300
agaacatcag cgcagaagcc tggggacgag cagactgtgg cattactagc gcctcctatc 3360
atcagggcgt gctgagcgcc actatcctgt acgagattct gctgggaaag gccaccctgt 3420
atgctgtgct ggtctccggc ctggtgctga tggccatggt caagaaaaag aactctggga 3480
gtggagccac aaatttctct ctgctgaaac aggctggaga tgtggaggaa aaccccggcc 3540
ctatgaagag cctgcgcgtg ctgctggtca tcctgtggct gcaattgagt tgggtgtgga 3600
gccagaagga ccaggtgttt cagcctagca ctgtcgcatc atcagagggg gccgtcgtgg 3660
aaatcttttg taatcacagc gtgtccaacg cctacaattt cttttggtat ctgcacttcc 3720
caggatgcgc acctaggctg ctggtgaagg gctctaagcc cagccagcag ggccggtaca 3780
acatgaccta tgagcggttc agctcctctc tgctgatcct gcaggtgcgg gaggcagacg 3840
cagccgtgta ctattgtgcc gtggaggatc tgaatcaggc cggcacagcc ctgattttcg 3900
gcaaaggaac aaccctgagc gtgagcagcg acatccagaa ccctgagccc gccgtatacc 3960
agctgaagga cccccgatct caggatagta ctctgtgcct gttcaccgac tttgatagtc 4020
agatcaatgt gcctaaaacc atggaatccg gaacttttat taccgacaag tgcgtgctgg 4080
atatgaaagc catggacagt aagtcaaacg gcgccatcgc ttggagcaat cagacatcct 4140
tcacttgcca ggatatcttc aaggagacca acgcaacata cccatcctct gacgtgccct 4200
gtgatgccac cctgacagag aagtctttcg aaacagacat gaacctgaat tttcagaatc 4260
tgagcgtgat gggcctgaga atcctgctgc tgaaggtcgc tgggtttaat ctgctgatga 4320
cactgcggct gtggtcctca taaagcttaa ttgagcggcc gcgctttatt tgtgaaattt 4380
gtgatgctat tgctttattt gtaaccatta taagctgcaa taaacaagtt aacaacaaca 4440
attgcattca ttttatgttt caggttcagg gggagatgtg ggaggttttt taaagctcac 4500
cgattttgat tctcaaacaa atgtgtcaca aagtaaggat tctgatgtgt atatcacaga 4560
caaaactgtg ctagacatga ggtctatgga cttcaagagc aacagtgctg tggcctggag 4620
caacaaatct gactttgcat gtgcaaacgc cttcaacaac agcattattc cagaagacac 4680
cttcttcccc agcccaggta agggcagctt tggtgccttc gcaggctgtt tccttgcttc 4740
aggaatggcc aggttctgcc cagagctctg gtcaatgatg tctaaaactc ctctgattgg 4800
tggtctcggc gcggccgcta cgtagataag tagcatggcg ggttaatcat taactacaag 4860
gaacccctag tgatggagtt ggccactccc tctctgcgcg ctcgctcgct cactgaggcc 4920
gggcgaccaa aggtcgcccg acgcccgggc tttgcccggg cggcctcagt gagcgagcga 4980
gcgcgccagc tggcgtaata gcgaagaggc ccgcaccgat cgcccttccc aacagttgcg 5040
cagcctgaat ggcgaatggc gattccgttg caatggctgg cggtaatatt gttctggata 5100
ttaccagcaa ggccgatagt ttgagttctt ctactcaggc aagtgatgtt attactaatc 5160
aaagaagtat tgcgacaacg gttaatttgc gtgatggaca gactctttta ctcggtggcc 5220
tcactgatta taaaaacact tctcaggatt ctggcgtacc gttcctgtct aaaatccctt 5280
taatcggcct cctgtttagc tcccgctctg attctaacga ggaaagcacg ttatacgtgc 5340
tcgtcaaagc aaccatagta cgcgccctgt agcggcgcat taagcgcggc gggtgtggtg 5400
gttacgcgca gcgtgaccgc tacacttgcc agcgccctag cgcccgctcc tttcgctttc 5460
ttcccttcct ttctcgccac gttcgccggc tttccccgtc aagctctaaa tcgggggctc 5520
cctttagggt tccgatttag tgctttacgg cacctcgacc ccaaaaaact tgattagggt 5580
gatggttcac gtagtgggcc atcgccctga tagacggttt ttcgcccttt gacgttggag 5640
tccacgttct ttaatagtgg actcttgttc caaactggaa caacactcaa ccctatctcg 5700
gtctattctt ttgatttata agggattttg ccgatttcgg cctattggtt aaaaaatgag 5760
ctgatttaac aaaaatttaa cgcgaatttt aacaaaatat taacgtttac aatttaaata 5820
tttgcttata caatcttcct gtttttgggg cttttctgat tatcaaccgg ggtacatatg 5880
attgacatgc tagttttacg attaccgttc atcgattctc ttgtttgctc cagactctca 5940
ggcaatgacc tgatagcctt tgtagagacc tctcaaaaat agctaccctc tccggcatga 6000
atttatcagc tagaacggtt gaatatcata ttgatggtga tttgactgtc tccggccttt 6060
ctcacccgtt tgaatcttta cctacacatt actcaggcat tgcatttaaa atatatgagg 6120
gttctaaaaa tttttatcct tgcgttgaaa taaaggcttc tcccgcaaaa gtattacagg 6180
gtcataatgt ttttggtaca accgatttag ctttatgctc tgaggcttta ttgcttaatt 6240
ttgctaattc tttgccttgc ctgtatgatt tattggatgt tggaatcgcc tgatgcggta 6300
ttttctcctt acgcatctgt gcggtatttc acaccgcata tggtgcactc tcagtacaat 6360
ctgctctgat gccgcatagt taagccagcc ccgacacccg ccaacacccg ctgacgcgcc 6420
ctgacgggct tgtctgctcc cggcatccgc ttacagacaa gctgtgaccg tctccgggag 6480
ctgcatgtgt cagaggtttt caccgtcatc accgaaacgc gcgagacgaa agggcctcgt 6540
gatacgccta tttttatagg ttaatgtcat gataataatg gtttcttaga cgtcaggtgg 6600
cacttttcgg ggaaatgtgc gcggaacccc tatttgttta tttttctaaa tacattcaaa 6660
tatgtatccg ctcatgagac aataaccctg ataaatgctt caataatatt gaaaaaggaa 6720
gagtatgagt attcaacatt tccgtgtcgc ccttattccc ttttttgcgg cattttgcct 6780
tcctgttttt gctcacccag aaacgctggt gaaagtaaaa gatgctgaag atcagttggg 6840
tgcacgagtg ggttacatcg aactggatct caacagcggt aagatccttg agagttttcg 6900
ccccgaagaa cgttttccaa tgatgagcac ttttaaagtt ctgctatgtg gcgcggtatt 6960
atcccgtatt gacgccgggc aagagcaact cggtcgccgc atacactatt ctcagaatga 7020
cttggttgag tactcaccag tcacagaaaa gcatcttacg gatggcatga cagtaagaga 7080
attatgcagt gctgccataa ccatgagtga taacactgcg gccaacttac ttctgacaac 7140
gatcggagga ccgaaggagc taaccgcttt tttgcacaac atgggggatc atgtaactcg 7200
ccttgatcgt tgggaaccgg agctgaatga agccatacca aacgacgagc gtgacaccac 7260
gatgcctgta gcaatggcaa caacgttgcg caaactatta actggcgaac tacttactct 7320
agcttcccgg caacaattaa tagactggat ggaggcggat aaagttgcag gaccacttct 7380
gcgctcggcc cttccggctg gctggtttat tgctgataaa tctggagccg gtgagcgtgg 7440
gtctcgcggt atcattgcag cactggggcc agatggtaag ccctcccgta tcgtagttat 7500
ctacacgacg gggagtcagg caactatgga tgaacgaaat agacagatcg ctgagatagg 7560
tgcctcactg attaagcatt ggtaactgtc agaccaagtt tactcatata tactttagat 7620
tgatttaaaa cttcattttt aatttaaaag gatctaggtg aagatccttt ttgataatct 7680
catgaccaaa atcccttaac gtgagttttc gttccactga gcgtcagacc cc         7732

<210> 1450
<211> 89
<212> PRT
<213> Artificial Sequence

<220> 
<223> naked FRB wild-type polypeptide

<400> 1450
Glu Met Trp His Glu Gly Leu Glu Glu Ala Ser Arg Leu Tyr Phe Gly
 1               5                  10                  15      
Glu Arg Asn Val Lys Gly Met Phe Glu Val Leu Glu Pro Leu His Ala
            20                  25                  30          
Met Met Glu Arg Gly Pro Gln Thr Leu Lys Glu Thr Ser Phe Asn Gln
        35                  40                  45              
Ala Tyr Gly Arg Asp Leu Met Glu Ala Gln Glu Trp Cys Arg Lys Tyr
    50                  55                  60                  
Met Lys Ser Gly Asn Val Lys Asp Leu Thr Gln Ala Trp Asp Leu Tyr
65                  70                  75                  80  
Tyr His Val Phe Arg Arg Ile Ser Lys
                85

<210> 1451
<211> 1212
<212> DNA
<213> Artificial Sequence

<220> 
<223> FRB-CISC having a truncated intracellular IL2Rbeta
      domain

<400> 1451
gagatgtggc acgagggcct ggaggaggcc agcaggctgt attttggcga gcgcaacgtg 60
aagggcatgt tcgaggtgct ggagcctctg cacgccatga tggagagagg cccacagacc 120
ctgaaggaga catcctttaa ccaggcctat ggacgggacc tgatggaggc acaggagtgg 180
tgcagaaagt acatgaagtc tggcaatgtg aaggacctga cgcaggcctg ggatctgtac 240
tatcacgtgt ttcggagaat ctccaagggc aaagacacga ttccgtggct tgggcatctg 300
ctcgttgggc tgagtggtgc gtttggtttc atcatcttgg tctatctctt gatcaattgc 360
agaaatacag gcccttggct gaaaaaagtg ctcaagtgta atacccccga cccaagcaag 420
ttcttctccc agctttcttc agagcatgga ggcgatgtgc agaaatggct ctcttcacct 480
tttccctcct caagtttctc cccgggaggg ctggcgcccg agatttcacc tcttgaggta 540
cttgaacgag acaaggttac ccaacttctc cttcaacagg ataaggtacc cgaacctgcg 600
agccttagct ccaaccactc tcttacgagc tgcttcacca atcagggata cttctttttc 660
caccttcccg atgcgctgga aatcgaagca tgtcaagttt actttaccta tgatccatat 720
agcgaggaag atcccgacga aggagtcgcc ggtgcgccca cgggttcctc accccaacct 780
ctccagcctc tctcaggaga agatgatgct tattgcactt ttcccagtag agacgatctc 840
ctcctctttt ctccatctct tttgggggga ccttcccccc cttctacggc acctggcggg 900
tctggtgctg gcgaggagcg gatgccgccg tccctccagg agcgagtacc acgagattgg 960
gatccccagc cacttggacc accaactcca ggcgtacctg accttgtcga ttttcaacct 1020
ccccctgaat tggtgctgcg agaggctggg gaggaagttc cggacgctgg gccgagggag 1080
ggcgtgtcct ttccatggag taggcctcca ggtcaaggcg agtttagggc tctcaacgcg 1140
cggctgccgt tgaatacaga cgcttatctc tcactgcagg aactgcaagg tcaggaccca 1200
acacatcttg ta                                                     1212

<210> 1452
<211> 267
<212> DNA
<213> Artificial Sequence

<220> 
<223> FRB domain of polypeptide encoded by SEQ ID:1451

<400> 1452
gagatgtggc acgagggcct ggaggaggcc agcaggctgt attttggcga gcgcaacgtg 60
aagggcatgt tcgaggtgct ggagcctctg cacgccatga tggagagagg cccacagacc 120
ctgaaggaga catcctttaa ccaggcctat ggacgggacc tgatggaggc acaggagtgg 180
tgcagaaagt acatgaagtc tggcaatgtg aaggacctga cgcaggcctg ggatctgtac 240
tatcacgtgt ttcggagaat ctccaag                                     267

<210> 1453
<211> 12
<212> DNA
<213> Artificial Sequence

<220> 
<223> IL2Rbeta domain of polypeptide encoded by SEQ
      ID:1451

<400> 1453
ggcaaagaca cg                                                     12

<210> 1454
<211> 75
<212> DNA
<213> Artificial Sequence

<220> 
<223> Transmembrane domain of polypeptide encoded by SEQ
      ID:1451

<400> 1454
attccgtggc ttgggcatct gctcgttggg ctgagtggtg cgtttggttt catcatcttg 60
gtctatctct tgatc                                                  75

<210> 1455
<211> 858
<212> DNA
<213> Artificial Sequence

<220> 
<223> Intracellular domain of polypeptide encoded by SEQ
      ID:1451

<400> 1455
aattgcagaa atacaggccc ttggctgaaa aaagtgctca agtgtaatac ccccgaccca 60
agcaagttct tctcccagct ttcttcagag catggaggcg atgtgcagaa atggctctct 120
tcaccttttc cctcctcaag tttctccccg ggagggctgg cgcccgagat ttcacctctt 180
gaggtacttg aacgagacaa ggttacccaa cttctccttc aacaggataa ggtacccgaa 240
cctgcgagcc ttagctccaa ccactctctt acgagctgct tcaccaatca gggatacttc 300
tttttccacc ttcccgatgc gctggaaatc gaagcatgtc aagtttactt tacctatgat 360
ccatatagcg aggaagatcc cgacgaagga gtcgccggtg cgcccacggg ttcctcaccc 420
caacctctcc agcctctctc aggagaagat gatgcttatt gcacttttcc cagtagagac 480
gatctcctcc tcttttctcc atctcttttg gggggacctt cccccccttc tacggcacct 540
ggcgggtctg gtgctggcga ggagcggatg ccgccgtccc tccaggagcg agtaccacga 600
gattgggatc cccagccact tggaccacca actccaggcg tacctgacct tgtcgatttt 660
caacctcccc ctgaattggt gctgcgagag gctggggagg aagttccgga cgctgggccg 720
agggagggcg tgtcctttcc atggagtagg cctccaggtc aaggcgagtt tagggctctc 780
aacgcgcggc tgccgttgaa tacagacgct tatctctcac tgcaggaact gcaaggtcag 840
gacccaacac atcttgta                                               858
